data_2hh3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hh3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 60' ' ' ILE . 25.4 pt . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.151 0.501 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HB3' HG21 ' A' ' 57' ' ' ILE . 5.1 m-20 -97.59 114.05 25.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -119.06 132.55 23.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -170.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.86 124.36 12.18 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.685 2.257 . . . . 0.0 112.119 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 78' ' ' LEU . 11.3 p -131.99 111.56 14.5 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.965 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.671 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 50.7 Cg_exo -52.83 133.61 51.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.849 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 16.2 mtp180 -66.9 -15.76 63.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.326 0.584 . . . . 0.0 110.468 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -88.49 -13.29 40.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.216 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -107.71 -20.65 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.92 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 m -58.5 -24.7 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.656 0.265 . . . . 0.0 111.535 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.88 91.27 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.98 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.19 -38.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.293 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.34 -37.91 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.81 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.583 HG23 ' HA2' ' A' ' 30' ' ' GLY . 27.0 mm -79.73 -38.14 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.12 -119.84 9.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -120.87 131.7 54.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 70.26 -5.37 1.35 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.464 0.478 . . . . 0.0 111.84 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.583 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 85.94 12.69 70.86 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -170.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.5 -39.6 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.758 0.423 . . . . 0.0 110.716 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.6 tpt -65.89 -46.17 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 30' ' ' GLY . 10.0 tt -70.39 -26.41 28.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.418 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 51.7 mttp -68.61 -37.11 79.52 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.117 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.544 HG22 HG22 ' A' ' 73' ' ' ILE . 85.9 mt -65.23 -53.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -57.53 -31.74 66.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.329 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.95 -55.33 13.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.279 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -29.52 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.413 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.749 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -83.19 -29.02 28.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.908 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.17 42.2 24.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 70' ' ' ALA . 31.2 m -130.37 178.67 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 tpp180 -120.65 128.35 52.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.212 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.469 HD13 HD11 ' A' ' 74' ' ' ILE . 59.5 mt -119.5 109.21 25.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -111.7 119.2 37.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.466 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -76.01 114.92 15.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.024 0.44 . . . . 0.0 110.127 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 54.4 mtpt . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.374 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 32.5 mt-10 . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.222 0.534 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.849 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.0 mtpp -97.53 173.17 7.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.438 173.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.569 ' HB ' ' HD3' ' A' ' 47' ' ' LYS . 46.6 mm -109.22 114.58 47.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.552 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -80.06 118.57 21.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -97.09 102.06 13.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.585 HD12 HD13 ' A' ' 13' ' ' ILE . 17.5 mt -88.57 137.01 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.8 mtm -147.82 160.44 42.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 0.0 111.531 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 127.53 -122.34 4.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.43 145.63 18.85 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.917 2.411 . . . . 0.0 110.89 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 -41.92 18.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.021 2.481 . . . . 0.0 113.023 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.03 -37.37 61.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.474 0.654 . . . . 0.0 109.339 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.3 tpp180 -61.78 -32.99 73.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.053 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 99.7 m -56.51 -41.95 77.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.465 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.45 -34.39 65.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -60.7 -49.67 76.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB3' HG13 ' A' ' 42' ' ' VAL . . . -69.75 -30.37 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB3' HD13 ' A' ' 13' ' ' ILE . . . -60.03 -41.64 92.68 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.792 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 12.4 tpt180 -69.31 -38.25 78.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.544 HG22 HG22 ' A' ' 36' ' ' ILE . 65.1 mt -54.92 -52.1 46.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.136 0.493 . . . . 0.0 110.149 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.505 HD12 HD11 ' A' ' 60' ' ' ILE . 53.2 mt -68.75 -45.94 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.949 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -60.38 -46.09 91.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.342 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.34 -39.76 84.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.74 -37.55 84.87 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.595 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.459 HD12 HG21 ' A' ' 17' ' ' VAL . 88.2 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.647 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.775 HD13 HD11 ' A' ' 60' ' ' ILE . 41.8 pt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 121.064 0.459 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.31 105.46 12.89 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.064 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -106.83 127.49 27.96 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 112.171 -173.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.3 Cg_exo -69.96 116.32 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.992 2.462 . . . . 0.0 111.981 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 111.24 32.82 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 110.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD2' HD13 ' A' ' 78' ' ' LEU . 79.5 Cg_exo -49.26 128.35 19.83 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.501 2.801 . . . . 0.0 112.522 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -60.47 -31.69 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -77.81 -18.82 55.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 m -91.84 -18.3 24.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.074 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.07 -31.85 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.569 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.88 -30.84 70.49 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.84 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.26 -35.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.556 -0.379 . . . . 0.0 110.242 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HD21 ' A' ' 77' ' ' LEU . 48.7 t -65.85 -38.65 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.894 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.588 HD11 ' CE1' ' A' ' 46' ' ' PHE . 28.8 mm -79.77 -51.56 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.358 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 28' ' ' ARG . . . 98.83 -96.11 1.67 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.317 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 27' ' ' GLY . 23.8 mmt180 -132.81 -56.65 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -98.89 -17.06 18.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.005 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 110.34 15.34 11.56 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -173.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -73.77 -23.25 59.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.959 -175.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.485 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.9 tpt -73.6 -38.89 64.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.032 0.444 . . . . 0.0 109.972 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 44' ' ' ILE . 10.5 tt -77.44 -22.57 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 29.3 mmtp -64.49 -38.45 91.08 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 32' ' ' MET . 1.2 tmtp? -57.45 -47.37 82.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.787 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.417 HD13 HG13 ' A' ' 33' ' ' ILE . 38.8 mt -61.51 -48.8 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.661 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -63.35 -30.12 71.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.085 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -82.65 -46.16 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.583 0.23 . . . . 0.0 111.323 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -46.8 88.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.32 -22.98 26.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.458 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.93 33.7 45.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.655 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.9 m -113.64 -177.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 111.639 -174.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 40.3 ttt180 -126.22 133.57 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.064 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.663 HD11 HD13 ' A' ' 74' ' ' ILE . 37.3 mt -132.57 109.95 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.345 0.403 . . . . 0.0 110.311 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -114.6 139.36 49.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.945 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' HD11 ' A' ' 26' ' ' ILE . 82.1 m-85 -84.17 112.78 20.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.136 0.493 . . . . 0.0 110.332 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.297 -179.155 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.078 0.466 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HD3' ' HD2' ' A' ' 46' ' ' PHE . 27.0 mttm -89.77 171.3 9.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.469 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.61 111.59 36.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.993 0.425 . . . . 0.0 109.944 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB3' HG22 ' A' ' 15' ' ' VAL . . . -80.54 133.58 35.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -105.87 101.34 10.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.29 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.775 HD11 HD13 ' A' ' 13' ' ' ILE . 33.5 mt -91.0 137.03 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.983 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.8 mtm -146.11 162.11 38.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.964 0.411 . . . . 0.0 111.407 -169.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 124.98 -119.32 3.58 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 6.3 Cg_exo -83.0 129.64 5.42 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.13 2.553 . . . . 0.0 110.965 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 54.0 Cg_exo -54.41 -34.73 82.34 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.631 2.888 . . . . 0.0 113.813 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -81.24 -40.05 24.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.1 tpp180 -64.0 -26.8 68.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.951 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.84 -43.69 86.02 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.82 -37.36 84.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.751 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.47 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -61.7 -44.81 96.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB3' HG23 ' A' ' 60' ' ' ILE . . . -67.07 -37.76 84.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.26 -38.04 85.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.89 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -68.85 -38.58 79.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.551 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 69' ' ' HIS . 77.0 mt -62.85 -48.81 86.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.598 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.663 HD13 HD11 ' A' ' 44' ' ' ILE . 91.2 mt -64.71 -39.89 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.474 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -62.3 -45.93 91.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.747 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.54 -39.62 84.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.951 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 25' ' ' VAL . 6.6 tt -63.81 -48.08 78.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.643 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.342 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 26.4 pt . . . . . 0 C--O 1.237 0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -109.66 117.55 34.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.327 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.46 124.99 30.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.073 -173.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HA ' HD13 ' A' ' 57' ' ' ILE . 19.1 Cg_endo -77.01 111.5 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.106 1.87 . . . . 0.0 111.323 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 46' ' ' PHE . 6.3 p -114.96 114.62 43.76 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.518 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.613 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.1 Cg_exo -48.64 126.98 15.4 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.176 2.584 . . . . 0.0 111.766 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.787 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 83.9 mtp180 -59.97 -33.6 72.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.102 -172.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -82.72 -13.83 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.575 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -94.91 -13.37 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.98 0.419 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.577 HG21 ' HD3' ' A' ' 56' ' ' LYS . 25.3 t -57.41 -33.48 44.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.773 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.9 61.07 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.002 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 t -88.75 -35.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 32' ' ' MET . 45.0 t -66.07 -36.28 77.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.426 0.632 . . . . 0.0 110.162 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.522 HD12 ' CE1' ' A' ' 46' ' ' PHE . 44.9 mm -81.59 -60.18 2.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.271 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.84 -116.73 4.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.656 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.56 -49.15 2.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 109.954 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -119.59 -0.64 10.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 112.0 22.04 6.09 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.567 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -51.05 -50.91 57.7 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.876 0.47 . . . . 0.0 111.68 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.1 tpt -68.3 -47.31 67.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.166 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 44' ' ' ILE . 11.4 tt -69.23 -29.75 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.76 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 59.0 mttm -63.09 -42.44 99.62 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 7.2 tmtm? -65.73 -44.79 84.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.988 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 32' ' ' MET . 77.7 mt -60.29 -50.48 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.032 0.444 . . . . 0.0 110.761 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 42' ' ' VAL . 11.4 mt-30 -62.31 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.031 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.38 -46.07 18.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.522 0.201 . . . . 0.0 110.971 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.69 -46.27 87.63 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.272 0.558 . . . . 0.0 111.146 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.53 -21.05 23.1 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.682 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.26 37.92 63.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.852 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 70' ' ' ALA . 25.7 m -113.17 -179.48 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 0.0 111.003 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -126.82 133.36 50.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 166.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 74' ' ' ILE . 72.1 mt -123.96 109.07 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.189 0.931 . . . . 0.0 109.301 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.661 HE21 ' HE3' ' A' ' 61' ' ' MET . 26.7 pt20 -126.89 136.89 52.94 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CE1' HD12 ' A' ' 26' ' ' ILE . 75.4 m-85 -85.32 118.39 24.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.036 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.161 -175.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.457 0.646 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.787 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 27.9 mtpp -86.41 175.86 8.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 16' ' ' PRO . 46.0 mm -119.86 108.69 24.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.643 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.555 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -73.78 130.02 39.11 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -104.47 102.85 12.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.726 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.71 HD11 HD12 ' A' ' 74' ' ' ILE . 40.6 mt -89.61 136.21 24.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.661 ' HE3' HE21 ' A' ' 45' ' ' GLN . 40.0 mtm -145.1 144.23 30.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.63 -169.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 139.18 -124.51 2.81 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.147 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.34 138.3 12.37 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 123.438 2.759 . . . . 0.0 112.099 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.05 -49.28 16.62 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 113.399 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.07 -41.63 70.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.219 0.533 . . . . 0.0 110.625 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.59 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.0 tpp180 -65.49 -31.22 72.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.438 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 94.0 m -58.34 -44.7 88.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -70.46 -32.9 70.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.673 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 4.3 t60 -56.71 -50.05 73.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' HG23 ' A' ' 60' ' ' ILE . . . -70.03 -34.66 73.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.861 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . . . -62.28 -41.39 98.44 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.012 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -66.78 -37.56 84.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.121 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 73.4 mt -57.13 -50.62 75.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.529 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 60' ' ' ILE . 68.5 mt -68.67 -44.81 82.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.039 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -61.06 -49.95 75.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.798 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.18 -39.57 75.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.97 -50.11 63.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.526 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.613 HD13 ' HD2' ' A' ' 18' ' ' PRO . 94.0 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.302 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 60' ' ' ILE . 29.3 pt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.582 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 14.7 p-10 -111.03 120.11 41.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.821 0.819 . . . . 0.0 109.544 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.638 HG23 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -116.65 133.77 22.99 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.985 -167.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 57' ' ' ILE . 11.1 Cg_exo -69.24 117.48 5.08 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 123.109 2.539 . . . . 0.0 112.13 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -132.25 108.63 13.67 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.368 0.604 . . . . 0.0 110.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 83.7 Cg_exo -48.81 141.44 21.19 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.543 2.828 . . . . 0.0 113.487 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -54.82 -53.7 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.725 0.298 . . . . 0.0 111.545 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.72 -26.87 67.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.113 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.9 m -79.16 -25.13 42.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.378 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.7 t -60.12 -32.69 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.01 -29.82 68.84 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.13 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -89.5 -35.33 7.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 21' ' ' SER . 61.1 t -68.19 -38.31 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.525 HD13 ' CE1' ' A' ' 46' ' ' PHE . 34.7 mm -79.37 -55.99 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.464 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.2 -134.3 12.07 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 2.5 mmp_? -105.39 -59.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -93.21 -18.19 22.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.859 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 123.2 13.92 4.24 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.238 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -57.21 -39.05 74.65 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.19 0.596 . . . . 0.0 111.352 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.497 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -68.82 -49.32 59.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.675 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.576 HD13 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -68.7 -30.02 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 110.402 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 32.3 mmtp -72.94 -29.72 63.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.91 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.92 -42.28 77.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 32' ' ' MET . 74.8 mt -60.65 -49.38 84.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.352 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.66 -27.34 68.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.294 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.34 -50.04 15.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.79 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.68 -53.22 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 111.173 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.47 -11.34 52.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.934 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.34 37.94 95.63 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.371 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.0 m -113.34 177.11 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.322 0.582 . . . . 0.0 110.827 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -122.36 123.44 41.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.681 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 33' ' ' ILE . 86.6 mt -105.68 108.43 25.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -115.47 114.99 25.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.148 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE1' HD13 ' A' ' 26' ' ' ILE . 58.6 m-85 -70.93 114.23 8.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.525 0.678 . . . . 0.0 110.804 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.933 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.6 mt-10 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -96.21 175.69 6.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.757 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 43.4 mm -122.7 114.58 42.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.638 ' HB2' HG23 ' A' ' 15' ' ' VAL . . . -81.55 140.45 34.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.611 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -114.11 103.64 11.33 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 70' ' ' ALA . 45.1 mt -88.64 137.62 20.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.4 mtm -143.48 171.51 14.05 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.599 -173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.02 -128.74 8.14 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_exo -75.98 141.48 23.95 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.788 2.325 . . . . 0.0 111.204 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 27.9 Cg_exo -62.7 -35.69 67.69 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.563 2.842 . . . . 0.0 113.266 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.43 -31.04 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.548 0.69 . . . . 0.0 109.717 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.596 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.5 tpp180 -66.09 -27.09 67.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.676 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.1 m -55.77 -37.77 68.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.402 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 mt-10 -79.31 -30.89 43.07 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.453 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 73' ' ' ILE . 2.3 t-160 -57.56 -50.62 72.49 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB3' HG23 ' A' ' 60' ' ' ILE . . . -73.11 -32.82 65.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.208 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . . . -61.74 -41.07 97.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.955 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 18.4 tpt180 -63.5 -43.91 95.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.44 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 69' ' ' HIS . 70.3 mt -54.33 -50.51 56.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.804 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.553 HD11 HD13 ' A' ' 60' ' ' ILE . 70.3 mt -71.36 -42.57 73.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.148 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -61.77 -50.27 73.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.93 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.036 0.446 . . . . 0.0 110.395 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.37 -48.18 80.9 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.5 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.67 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 60' ' ' ILE . 22.1 pt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.538 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 8.3 p-10 -117.24 128.64 55.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.08 122.8 23.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.996 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -65.42 103.53 0.55 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.082 2.522 . . . . 0.0 111.898 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 46' ' ' PHE . 7.4 p -102.34 118.13 59.58 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 52.5 Cg_exo -56.01 122.41 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.59 2.194 . . . . 0.0 111.438 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.729 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 53.5 mtp180 -62.76 -28.16 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -73.53 -18.37 61.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 m -102.75 -11.37 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.94 -35.29 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.33 63.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.928 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.0 t -89.21 -34.17 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.138 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.88 -39.39 67.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.412 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.488 HD12 ' CE1' ' A' ' 46' ' ' PHE . 38.8 mm -86.42 -56.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.973 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.27 -127.45 8.66 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -113.35 -45.99 3.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.049 0.424 . . . . 0.0 110.342 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.2 m -95.6 -36.13 11.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.439 0.638 . . . . 0.0 109.843 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 128.38 12.63 2.77 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.596 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.64 -28.16 69.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 110.997 -174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 17.6 tpt -67.72 -43.82 79.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.371 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HG23 ' A' ' 44' ' ' ILE . 10.9 tt -79.93 -24.73 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 74.4 mmtt -62.77 -40.43 97.27 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 32' ' ' MET . 53.2 tttm -59.85 -45.92 90.9 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.55 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -60.75 -49.24 85.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.56 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -59.69 -39.64 85.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.388 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.97 -49.35 38.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.252 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.0 -46.72 86.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.437 -173.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.572 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.41 44.1 7.6 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 34.4 m -129.31 172.98 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.277 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -117.69 137.35 52.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.695 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.556 HG23 HD12 ' A' ' 33' ' ' ILE . 29.2 mt -123.44 106.06 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -105.75 119.05 38.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.066 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.488 ' CE1' HD12 ' A' ' 26' ' ' ILE . 55.8 m-85 -73.13 126.06 29.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 21.6 mtpp . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.167 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.724 ' CD ' ' HA ' ' A' ' 18' ' ' PRO . 4.0 mm-40 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.729 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.6 mtpp -92.47 160.69 14.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.677 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.9 mm -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.895 174.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -75.12 140.07 43.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.5 t60 -118.06 108.43 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.592 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 13' ' ' ILE . 45.7 mt -88.68 131.49 35.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.7 mtp -131.03 128.24 39.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.88 0.371 . . . . 0.0 111.691 -162.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.05 -135.35 6.64 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.851 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 11.3 Cg_exo -69.17 150.08 71.39 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.403 2.735 . . . . 0.0 112.227 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.04 -50.0 8.44 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -71.87 -30.51 65.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 109.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.732 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.35 -42.79 87.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.595 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.7 -40.35 87.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.824 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -74.19 -35.24 63.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.406 ' O ' HG13 ' A' ' 73' ' ' ILE . 17.9 t-160 -68.69 -41.5 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 60' ' ' ILE . . . -67.93 -34.41 76.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.332 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.645 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -61.23 -37.77 84.27 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.734 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -74.59 -31.88 62.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.487 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.485 HD13 ' HB1' ' A' ' 40' ' ' ALA . 74.6 mt -60.37 -50.48 80.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 109.933 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 76.7 mt -67.29 -39.5 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.714 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -64.55 -45.96 84.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.165 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -57.85 -40.1 79.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.819 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.29 -41.89 90.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.59 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 67.4 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.696 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 67' ' ' CYS . 16.7 pt . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.147 0.498 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.447 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 5.2 p-10 -97.71 122.04 40.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.951 175.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -119.31 125.67 27.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.044 -175.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.29 104.58 1.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.187 2.592 . . . . 0.0 111.999 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.594 HG21 HD23 ' A' ' 78' ' ' LEU . 11.2 p -106.75 113.65 62.6 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.282 0.563 . . . . 0.0 109.686 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.0 Cg_exo -60.4 129.76 31.06 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.098 2.532 . . . . 0.0 112.978 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.703 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 98.6 mtt180 -55.67 -29.94 60.2 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.996 0.81 . . . . 0.0 112.587 -172.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -71.96 -34.48 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.478 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -90.32 -19.72 23.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.447 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -60.35 -33.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.56 87.71 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.125 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.31 -36.1 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.391 . . . . 0.0 110.391 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.0 -36.7 78.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.253 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.56 HD13 ' CE2' ' A' ' 46' ' ' PHE . 36.8 mm -81.41 -58.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.59 -113.01 4.12 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -118.44 -61.02 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -93.51 -28.96 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.739 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 133.75 19.98 0.89 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.104 -175.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.22 -37.78 81.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.5 -40.82 69.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.551 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -75.02 -27.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 49.4 mtpt -63.72 -36.82 85.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.26 -43.92 96.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.15 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.5 mt -63.47 -46.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.171 0.51 . . . . 0.0 110.468 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.73 -30.83 71.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.317 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -74.97 -48.07 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.56 -42.94 86.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -90.78 -16.41 28.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.851 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 31.96 65.64 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.983 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.4 m -113.58 176.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.413 0.625 . . . . 0.0 111.205 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -117.87 131.19 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.891 167.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.551 ' CG2' HD11 ' A' ' 33' ' ' ILE . 81.7 mt -115.34 108.54 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.485 ' HA ' ' OE1' ' A' ' 45' ' ' GLN . 4.3 tp60 -123.73 131.67 53.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 26' ' ' ILE . 78.7 m-85 -84.07 131.17 34.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.447 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 24.8 mtpp . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.183 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.621 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 1.6 mp0 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.356 0.598 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.703 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 30.3 mtpp -109.67 165.95 11.28 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.447 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.6 mm -114.78 110.12 30.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.022 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.75 140.15 38.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -114.49 108.25 16.6 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.517 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 70' ' ' ALA . 38.8 mt -88.46 127.94 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.5 mtm -141.54 167.01 23.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 111.357 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.13 -118.65 3.86 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.4 135.92 10.9 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.999 2.466 . . . . 0.0 111.449 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.23 -36.05 98.98 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.478 2.785 . . . . 0.0 112.915 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.87 -36.62 70.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.078 0.942 . . . . 0.0 109.799 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.668 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 18.7 tpp85 -71.6 -31.91 67.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.897 -171.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 13' ' ' ILE . 21.2 p -58.85 -41.85 87.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.46 -37.03 79.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.059 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -61.56 -46.12 91.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.103 0.477 . . . . 0.0 109.901 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.653 ' HB3' HG22 ' A' ' 60' ' ' ILE . . . -72.54 -28.13 62.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.879 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -58.25 -42.11 85.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.0 tmm_? -65.62 -45.41 83.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.976 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.06 -52.43 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 65.0 mt -67.88 -43.33 86.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -61.28 -48.84 79.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.1 -32.43 74.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.96 -49.78 68.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 17' ' ' VAL . 88.7 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.897 HD12 HD11 ' A' ' 60' ' ' ILE . 30.9 pt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.464 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 36.6 m-20 -116.86 110.17 18.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.128 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.489 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -110.82 128.81 24.72 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.004 -171.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.6 Cg_exo -71.44 99.06 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.419 2.746 . . . . 0.0 111.933 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 17' ' ' VAL . 14.3 p -110.15 109.82 58.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.451 0.643 . . . . 0.0 110.677 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 50.0 Cg_exo -55.91 149.64 50.55 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.217 2.611 . . . . 0.0 113.425 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -68.18 -26.14 65.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.759 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -79.34 -22.88 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.328 0.585 . . . . 0.0 109.526 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.8 m -86.44 -37.69 18.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.534 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 16.4 m -57.69 -27.17 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.22 92.27 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.423 ' HB ' HD23 ' A' ' 77' ' ' LEU . 40.6 t -89.6 -31.61 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.812 0.339 . . . . 0.0 110.365 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 21' ' ' SER . 93.7 t -61.79 -38.63 80.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.168 0.509 . . . . 0.0 109.851 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.08 -58.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.115 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.6 -138.1 13.65 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.686 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -69.24 -77.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.379 . . . . 0.0 110.586 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.467 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 66.1 m -93.79 -53.5 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.642 0.734 . . . . 0.0 109.567 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -174.29 20.54 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.362 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 1.6 mm-40 -47.05 -53.03 13.53 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.398 0.679 . . . . 0.0 111.827 -169.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.575 ' HE3' HD11 ' A' ' 77' ' ' LEU . 15.9 tpt -68.45 -45.16 73.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.116 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 44' ' ' ILE . 8.3 tt -72.47 -29.77 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.812 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 28.2 mmmt -69.47 -40.67 76.95 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.58 -46.15 91.1 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.678 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 32' ' ' MET . 84.0 mt -60.71 -49.37 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.659 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.02 -29.9 67.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.814 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -87.43 -35.69 18.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.653 0.264 . . . . 0.0 111.671 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.04 -40.98 78.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 0.0 110.018 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.506 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -93.03 -23.91 18.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.226 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.94 47.55 9.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.227 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 70' ' ' ALA . 33.5 m -127.4 177.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.5 tpt180 -120.04 128.35 53.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.842 168.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 33' ' ' ILE . 72.3 mt -125.92 112.59 30.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.964 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.92 138.78 39.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.125 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 58' ' ' ALA . 12.5 m-85 -85.5 121.0 27.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.574 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HZ2' ' HB3' ' A' ' 47' ' ' LYS . 8.0 mtpm? . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.183 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.9 mt-10 . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.335 0.588 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -107.41 155.63 19.81 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.836 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 38.1 mm -98.51 104.69 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.682 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -76.54 140.38 41.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.979 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -115.58 109.95 18.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.897 HD11 HD12 ' A' ' 13' ' ' ILE . 40.0 mt -93.49 146.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.713 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -145.33 166.87 24.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.945 0.402 . . . . 0.0 111.989 -172.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.91 -124.92 5.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -81.03 134.89 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.994 2.463 . . . . 0.0 110.75 174.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.82 -42.92 54.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.617 2.878 . . . . 0.0 113.293 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.26 -39.94 65.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.7 tpp180 -61.7 -34.64 76.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.979 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 85.2 m -57.94 -42.9 85.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.458 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.84 -41.58 91.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -66.65 -38.75 87.53 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -66.95 -35.51 80.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.27 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -62.5 -36.86 83.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.441 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -67.79 -39.28 84.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.472 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.6 mt -59.93 -49.56 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.438 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.61 HD12 HD13 ' A' ' 44' ' ' ILE . 84.5 mt -65.28 -45.27 94.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.781 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.73 -37.08 86.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.88 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.75 -43.42 80.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.404 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.575 HD11 ' HE3' ' A' ' 32' ' ' MET . 9.8 tt -63.54 -43.2 97.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.932 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 21.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.113 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 60' ' ' ILE . 38.6 pt . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -114.34 126.88 55.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.308 173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -131.04 117.05 16.97 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.43 . . . . 0.0 111.603 -176.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.52 102.24 0.59 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.219 2.612 . . . . 0.0 112.298 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.65 117.91 58.75 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.3 Cg_exo -57.17 131.15 43.42 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.241 2.628 . . . . 0.0 112.371 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.764 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 76.6 mtt180 -66.29 -26.44 67.33 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.815 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -80.51 -15.15 57.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.0 110.242 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 25' ' ' VAL . 30.1 m -101.41 -14.82 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.435 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 18' ' ' PRO . 24.1 t -56.49 -38.57 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.451 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.93 -35.47 53.63 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.751 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.34 -36.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.662 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 21' ' ' SER . 60.0 t -62.32 -36.97 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.417 0.627 . . . . 0.0 109.904 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.468 HD12 ' CE1' ' A' ' 46' ' ' PHE . 35.9 mm -78.46 -58.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.614 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.87 63.5 1.67 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.889 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 63.97 -87.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.492 0.717 . . . . 0.0 112.162 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.524 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 75.4 m -84.03 -20.37 32.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.128 0.49 . . . . 0.0 110.339 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 119.9 4.59 11.4 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.524 ' OE1' ' HB2' ' A' ' 29' ' ' SER . 0.8 OUTLIER -63.03 -15.07 55.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 tpt -80.08 -45.36 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.595 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.703 HG13 HD12 ' A' ' 36' ' ' ILE . 8.0 tt -74.78 -21.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 31.7 mmtp -57.4 -49.65 75.53 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.153 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.703 HD12 HG13 ' A' ' 33' ' ' ILE . 35.6 mt -61.36 -58.29 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 0.0 110.148 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -65.3 -23.78 67.12 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.133 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.55 -45.11 19.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.072 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.18 -53.46 24.8 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 110.441 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -77.41 -14.43 59.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.565 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.78 34.33 88.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.254 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.11 171.22 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.22 0.533 . . . . 0.0 110.725 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.4 tpp180 -116.75 125.56 51.82 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.333 170.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 33' ' ' ILE . 84.7 mt -110.83 114.0 45.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.34 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -113.26 155.76 24.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.647 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 82.0 m-85 -111.21 112.65 24.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.932 0.396 . . . . 0.0 110.97 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 47' ' ' LYS . 9.1 mtpm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.366 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.184 0.516 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.764 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 57.3 mtpt -123.26 146.19 48.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.64 107.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.33 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -77.38 140.62 39.96 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 22.2 t60 -118.16 109.68 16.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 13' ' ' ILE . 46.8 mt -89.23 147.64 5.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.453 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 49.5 mtt -130.62 137.22 49.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.492 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 135.85 -134.95 7.51 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.264 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -81.29 139.92 11.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.554 2.836 . . . . 0.0 112.382 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 76.7 Cg_exo -50.43 -50.09 14.59 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.242 1.961 . . . . 0.0 112.931 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.67 -40.1 80.3 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 0.0 110.725 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.628 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 12.8 tpp180 -64.82 -40.36 95.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.329 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 84.2 m -59.58 -45.33 92.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.364 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 45.0 mt-10 -63.0 -36.65 84.26 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 111.204 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.94 -46.87 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.041 0.448 . . . . 0.0 109.812 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.71 70.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.284 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.81 98.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.674 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.463 ' HA ' ' HB3' ' A' ' 75' ' ' ASN . 58.9 ttt180 -76.53 -24.57 53.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.721 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.649 HG21 HG23 ' A' ' 36' ' ' ILE . 58.0 mt -57.47 -50.54 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.652 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 56.8 mt -68.93 -45.9 79.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.761 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 72' ' ' ARG . 62.0 t30 -60.73 -48.32 82.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.743 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.29 -35.31 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.745 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.53 -44.43 94.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.732 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 60' ' ' ILE . 38.4 pt . . . . . 0 C--O 1.238 0.453 0 CA-C-O 121.126 0.488 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.571 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 6.3 p-10 -117.65 129.42 55.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.827 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.742 HG21 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.04 127.79 24.28 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.085 0.469 . . . . 0.0 111.973 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.1 Cg_exo -70.72 112.78 3.33 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.226 2.617 . . . . 0.0 111.897 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.1 113.53 26.37 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.559 0.695 . . . . 0.0 110.47 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' VAL . 46.9 Cg_exo -57.95 138.78 87.74 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.126 2.551 . . . . 0.0 112.013 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 71.3 mtp180 -62.9 -34.52 77.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.722 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -69.08 -26.28 64.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB3' HD23 ' A' ' 78' ' ' LEU . 18.9 m -86.86 -28.83 22.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.267 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 18' ' ' PRO . 45.7 t -55.28 -35.41 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.882 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.7 61.82 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.799 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.7 t -82.53 -38.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 21' ' ' SER . 33.5 t -62.49 -37.8 79.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.398 0.618 . . . . 0.0 109.938 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.512 HD11 ' CE2' ' A' ' 46' ' ' PHE . 34.9 mm -79.49 -51.84 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.599 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.06 30.9 49.77 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.365 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 72.04 -56.43 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.612 0.765 . . . . 0.0 112.393 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 m -78.03 -25.26 47.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 111.002 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.67 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 100.13 -0.2 56.06 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -169.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -47.81 -49.59 28.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.691 0.796 . . . . 0.0 111.947 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.57 -41.45 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.73 0.3 . . . . 0.0 111.594 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 44' ' ' ILE . 9.4 tt -73.03 -27.43 24.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.487 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 30.0 mmmt -68.96 -35.31 76.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -60.93 -43.51 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.484 HG22 HG23 ' A' ' 73' ' ' ILE . 70.6 mt -62.34 -50.54 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.544 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -58.27 -34.49 70.57 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.593 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -78.21 -40.17 38.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.8 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.56 -47.25 64.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.069 0.461 . . . . 0.0 110.786 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.72 -16.11 40.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 44.67 54.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.519 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.432 HG11 ' HB1' ' A' ' 70' ' ' ALA . 32.4 m -125.14 176.96 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.402 0.62 . . . . 0.0 111.178 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -120.78 129.99 53.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.46 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 74' ' ' ILE . 45.7 mt -123.79 107.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.8 139.45 53.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 62.4 m-85 -84.1 133.2 34.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.416 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.061 176.368 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' A' ' 46' ' ' PHE . 16.5 mtpp -90.09 161.96 15.55 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 110.646 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 34.8 mm -107.92 105.61 19.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.103 0.478 . . . . 0.0 110.133 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.742 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -73.23 127.75 33.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -103.79 101.92 11.74 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.394 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.806 HD12 HD13 ' A' ' 13' ' ' ILE . 41.2 mt -91.83 131.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.053 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.8 mtm -143.12 166.66 24.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.16 -122.09 4.95 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.6 Cg_exo -78.89 131.18 9.94 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.039 2.492 . . . . 0.0 110.896 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.07 -36.97 99.43 Favored 'Trans proline' 0 N--CA 1.475 0.384 0 C-N-CA 123.344 2.696 . . . . 0.0 113.122 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.39 -32.59 60.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 11.4 tpp180 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.391 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.485 ' HB3' HG12 ' A' ' 13' ' ' ILE . 84.4 m -54.14 -40.1 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.276 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -66.11 -40.33 90.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.903 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' HG13 ' A' ' 73' ' ' ILE . 11.9 t-80 -66.73 -43.1 85.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.189 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' ' 60' ' ' ILE . . . -64.68 -34.34 78.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -61.23 -43.79 98.31 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.535 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -64.78 -35.26 80.52 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.244 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.484 HG23 HG22 ' A' ' 36' ' ' ILE . 64.6 mt -62.25 -50.24 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.0 110.208 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 44' ' ' ILE . 68.6 mt -66.49 -46.62 86.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.962 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -70.19 -32.42 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -33.83 76.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.9 -44.62 92.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 65.8 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.515 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.744 HD11 HD13 ' A' ' 60' ' ' ILE . 39.8 pt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -106.29 105.28 15.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.233 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.697 HG21 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -105.45 132.04 21.23 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 5.5 Cg_exo -72.78 112.92 3.61 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.289 2.659 . . . . 0.0 112.191 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG22 HD23 ' A' ' 78' ' ' LEU . 7.4 p -121.02 107.3 37.87 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 22' ' ' VAL . 72.4 Cg_exo -48.53 133.45 26.06 Favored 'Trans proline' 0 N--CA 1.47 0.118 0 C-N-CA 123.505 2.803 . . . . 0.0 112.39 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.64 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 22.8 mtm180 -62.84 -28.32 69.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.693 -176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.7 -32.14 63.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.249 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.6 m -79.99 -24.22 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 18' ' ' PRO . 62.3 t -54.97 -35.06 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.173 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.07 65.49 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.418 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.61 -36.89 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 0.0 110.556 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 21' ' ' SER . 38.3 t -67.91 -40.39 83.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.596 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -82.32 -46.65 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.38 -118.74 4.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.041 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -97.96 -77.74 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.481 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 21.0 m -82.56 -55.63 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.74 0.781 . . . . 0.0 109.443 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 175.18 32.21 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 4.2 mm-40 -57.49 -47.49 81.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.261 -0.47 . . . . 0.0 111.724 -167.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.6 tpt -66.55 -45.88 77.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 44' ' ' ILE . 6.1 tt -69.0 -31.15 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.912 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 92.9 mttt -62.97 -42.35 99.8 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -66.6 -37.95 85.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 32' ' ' MET . 75.6 mt -63.16 -51.13 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.0 -35.71 73.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.581 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -77.98 -32.98 51.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.94 -46.52 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.619 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -81.69 -28.43 33.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.465 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.31 39.03 8.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' A' ' 70' ' ' ALA . 33.4 m -122.47 175.72 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.381 0.61 . . . . 0.0 111.517 -174.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -116.43 127.0 54.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.863 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD12 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -125.54 108.61 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.43 154.18 27.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -100.78 120.68 40.46 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.213 0.53 . . . . 0.0 112.055 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.831 172.159 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.9 mt-10 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.64 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 44.8 mtpt -78.24 177.78 8.14 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.665 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.1 mm -115.24 113.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.426 0.631 . . . . 0.0 111.174 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.697 ' HB1' HG21 ' A' ' 15' ' ' VAL . . . -84.79 140.6 31.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -110.83 101.51 10.11 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.744 HD13 HD11 ' A' ' 13' ' ' ILE . 21.5 mt -91.24 137.37 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.1 mtm -142.82 163.33 33.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 111.823 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.04 -135.53 9.75 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.61 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 7.7 Cg_exo -69.27 150.86 71.67 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.675 2.25 . . . . 0.0 111.692 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.08 -48.85 5.69 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.538 2.159 . . . . 0.0 112.742 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.57 -34.79 77.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.429 0.633 . . . . 0.0 109.431 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.8 tpp180 -61.82 -38.95 90.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.587 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 76.9 m -58.95 -47.99 83.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.228 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -69.53 -34.99 75.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.678 0.275 . . . . 0.0 110.823 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -62.68 -46.35 88.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.469 . . . . 0.0 110.169 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' HG22 ' A' ' 60' ' ' ILE . . . -71.06 -35.72 72.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.519 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.42 -36.9 79.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.824 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 72' ' ' ARG . 11.5 ttm180 -66.08 -43.04 88.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.187 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.68 -49.49 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.613 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.735 HD11 HD12 ' A' ' 44' ' ' ILE . 77.0 mt -68.93 -46.24 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.28 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.01 -43.67 98.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.25 -34.0 77.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.275 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.88 -45.64 85.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.032 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.4 mt . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.769 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.812 HD13 HD13 ' A' ' 60' ' ' ILE . 38.1 pt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.51 105.34 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.128 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.734 HG21 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.81 130.29 23.0 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.8 Cg_exo -75.06 104.15 1.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.372 2.715 . . . . 0.0 112.259 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.5 HG22 HD23 ' A' ' 78' ' ' LEU . 7.7 p -112.83 113.02 50.21 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.367 0.603 . . . . 0.0 110.214 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.36 134.57 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 123.096 2.531 . . . . 0.0 112.042 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -61.04 -33.14 72.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.035 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.35 -22.87 60.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 109.798 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 m -87.03 -25.74 24.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.037 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.3 -32.28 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.616 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.44 -33.73 62.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.213 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.71 -34.36 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.644 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.52 -38.55 82.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 46' ' ' PHE . 42.8 mm -79.83 -54.76 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.205 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.572 ' O ' ' HD2' ' A' ' 28' ' ' ARG . . . 105.04 -128.52 9.47 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 15.0 mmm180 -125.76 -29.7 3.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.064 0.459 . . . . 0.0 110.186 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -114.32 3.72 15.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.853 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 10.44 84.04 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -63.89 -32.53 74.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.841 0.456 . . . . 0.0 111.4 -172.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -70.81 -45.35 64.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.537 HD11 ' CG2' ' A' ' 44' ' ' ILE . 7.9 tt -72.2 -28.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.188 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -67.22 -36.53 81.87 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.01 -44.21 89.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.239 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 73' ' ' ILE . 78.9 mt -58.11 -52.09 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.231 0.539 . . . . 0.0 110.523 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.84 -33.68 75.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.411 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.29 -44.1 65.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.32 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.85 -53.15 29.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.364 . . . . 0.0 111.409 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.589 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -77.53 -27.08 51.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.89 42.22 9.91 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 70' ' ' ALA . 20.4 m -125.79 174.34 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.074 -174.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.6 tpp180 -116.91 131.86 56.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.169 167.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.537 ' CG2' HD11 ' A' ' 33' ' ' ILE . 80.4 mt -111.35 108.64 26.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -118.23 117.1 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.694 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' A' ' 26' ' ' ILE . 96.9 m-85 -72.66 126.04 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -175.429 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 121.115 0.483 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -86.87 149.37 24.87 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mm -95.96 108.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.418 0.627 . . . . 0.0 110.115 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 15' ' ' VAL . . . -76.58 123.61 26.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.597 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.428 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 7.7 t-160 -98.52 101.29 12.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.812 HD13 HD13 ' A' ' 13' ' ' ILE . 47.0 mt -89.07 136.09 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -143.52 164.37 30.55 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.058 -168.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.11 -115.81 2.98 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -85.53 126.69 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.263 2.642 . . . . 0.0 110.212 172.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.02 -35.44 94.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.474 2.783 . . . . 0.0 113.408 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.38 -33.06 32.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.001 0.429 . . . . 0.0 110.175 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.589 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.4 tpp180 -65.78 -28.73 69.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.381 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.47 ' HB3' HG12 ' A' ' 13' ' ' ILE . 82.9 m -59.63 -30.09 68.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.48 -32.21 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.019 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.481 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -64.27 -42.8 96.29 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' HG21 ' A' ' 60' ' ' ILE . . . -69.21 -33.77 73.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.215 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.22 98.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.5 -46.25 90.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.543 HG22 HG21 ' A' ' 36' ' ' ILE . 67.1 mt -55.0 -51.42 53.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.732 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.637 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 75.6 mt -66.76 -48.21 80.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.791 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -59.84 -46.57 88.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.192 0.52 . . . . 0.0 111.611 -176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.72 -36.1 79.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.544 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.76 -40.73 79.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 77.3 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.596 HD13 HD12 ' A' ' 60' ' ' ILE . 45.8 pt . . . . . 0 C--O 1.236 0.35 0 CA-C-O 121.69 0.757 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 7.1 m-20 -123.44 112.46 17.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.334 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.03 129.0 24.98 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.383 -171.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 18.4 Cg_endo -79.52 106.89 2.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.42 2.08 . . . . 0.0 111.52 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.81 113.23 47.42 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.419 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.14 134.11 49.08 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.335 2.69 . . . . 0.0 112.522 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -58.73 -35.09 72.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.447 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -80.71 -6.08 57.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.698 0.285 . . . . 0.0 111.207 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -107.11 -16.9 14.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.0 -38.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.194 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.25 57.0 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.006 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.6 t -85.08 -39.15 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.368 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.517 HG23 HD22 ' A' ' 77' ' ' LEU . 42.5 t -63.68 -37.19 79.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.35 0.595 . . . . 0.0 110.108 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 46' ' ' PHE . 40.4 mm -79.61 -50.95 17.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.853 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.79 -147.87 19.18 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -83.09 -70.77 0.53 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.418 0.609 . . . . 0.0 110.471 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -96.76 26.22 4.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.53 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 26' ' ' ILE . . . 78.81 7.81 88.09 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.476 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -54.54 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.603 0.761 . . . . 0.0 112.538 -173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.414 ' HE2' HD12 ' A' ' 77' ' ' LEU . 15.2 tpt -74.47 -50.63 17.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.72 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.535 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 tt -69.09 -27.41 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.412 . . . . 0.0 110.363 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -68.25 -40.14 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.045 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -59.6 -42.51 92.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 HG21 HG21 ' A' ' 73' ' ' ILE . 67.6 mt -63.87 -54.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.819 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.26 -39.02 81.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.036 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -81.87 -26.21 34.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.439 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.5 -49.77 24.93 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.345 0.593 . . . . 0.0 109.78 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . -84.16 -9.86 58.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.748 -175.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.66 31.98 80.08 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.255 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 70' ' ' ALA . 27.7 m -112.77 172.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.719 -174.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.9 ttm180 -117.75 129.18 55.54 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 60' ' ' ILE . 68.7 mt -119.53 108.93 24.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.875 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -119.16 131.85 55.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 110.552 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 26' ' ' ILE . 85.8 m-85 -81.17 115.06 20.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.948 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HB3' ' HZ3' ' A' ' 47' ' ' LYS . 8.6 mtpm? . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.212 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.964 0.412 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 22.3 mtpp -81.99 174.75 10.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.562 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 48.4 mm -120.96 111.11 30.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.117 0.485 . . . . 0.0 110.227 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -82.2 125.18 30.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 171.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -102.56 102.96 13.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.375 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 44' ' ' ILE . 47.0 mt -92.86 144.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.603 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 50.2 mtm -145.16 174.93 10.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.888 0.375 . . . . 0.0 111.935 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 112.7 -125.54 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.097 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.48 ' CG ' ' HB3' ' A' ' 66' ' ' ARG . 5.8 Cg_exo -82.89 134.12 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.232 2.621 . . . . 0.0 111.689 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.56 -34.61 73.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.818 3.012 . . . . 0.0 113.586 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.59 -42.58 24.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.659 0.743 . . . . 0.0 109.759 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 18.5 tpp85 -67.57 -34.29 76.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.814 -176.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.5 p -61.86 -40.48 95.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.026 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -68.26 -34.25 75.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.375 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.3 t60 -63.7 -44.78 92.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.01 -36.3 83.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.444 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.03 87.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -69.69 -35.82 75.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.524 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.2 mt -60.52 -49.01 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.79 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.611 HD13 HD11 ' A' ' 44' ' ' ILE . 87.4 mt -64.28 -40.94 90.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.793 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.65 -37.77 82.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.944 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.87 -36.27 78.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.428 0.633 . . . . 0.0 110.012 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.517 HD22 HG23 ' A' ' 25' ' ' VAL . 9.7 tt -66.83 -44.15 81.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.685 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 81.0 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.669 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.67 HD12 HD13 ' A' ' 60' ' ' ILE . 42.0 pt . . . . . 0 C--O 1.233 0.196 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 22.2 m-20 -122.57 114.18 20.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.099 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.757 HG23 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -113.04 126.23 28.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.177 -175.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 15.0 Cg_exo -67.15 116.45 4.18 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.908 2.405 . . . . 0.0 111.965 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.654 HG21 HD21 ' A' ' 78' ' ' LEU . 7.6 p -123.64 108.98 30.73 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 121.506 0.669 . . . . 0.0 110.807 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 75.9 Cg_exo -50.96 131.86 35.97 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.192 2.595 . . . . 0.0 112.054 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 48.2 mtp85 -58.22 -32.5 68.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.716 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.43 . . . . 0.0 110.535 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' HG21 ' A' ' 25' ' ' VAL . 17.9 m -88.42 -23.28 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.9 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.51 -32.7 65.04 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.604 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.39 -36.93 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.69 0.281 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 HG23 HD22 ' A' ' 77' ' ' LEU . 48.2 t -65.34 -37.02 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 110.444 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.498 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.8 mm -81.51 -61.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.174 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.12 -152.1 18.46 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.641 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -37.49 9.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.246 0.546 . . . . 0.0 109.957 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 m -106.23 3.06 27.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.024 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 74.59 24.59 72.24 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -168.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.16 90.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.488 -0.856 . . . . 0.0 111.909 -174.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -72.77 -42.25 64.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.03 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 30' ' ' GLY . 5.7 tt -66.27 -30.83 51.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 48.7 mttp -69.61 -45.99 67.3 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -54.16 -45.55 72.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 32' ' ' MET . 62.2 mt -65.39 -48.97 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.737 0.304 . . . . 0.0 110.921 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.48 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 46.1 mt-30 -59.77 -33.69 72.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.55 -42.96 23.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.251 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.18 -37.1 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.46 -14.91 19.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.532 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.32 47.16 53.49 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.499 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 37' ' ' GLN . 31.5 m -124.77 176.23 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.283 -174.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 19.0 tpt180 -116.57 128.91 55.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.247 168.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 33' ' ' ILE . 88.8 mt -113.28 108.79 26.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -122.78 129.87 52.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CE1' HD11 ' A' ' 26' ' ' ILE . 38.0 m-85 -85.11 123.7 30.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 111.456 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 mttp . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.592 177.502 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 13.9 mp0 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 23.6 mtpp -83.49 178.66 7.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.09 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 50.2 mm -117.45 114.04 44.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.342 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.757 ' HB2' HG23 ' A' ' 15' ' ' VAL . . . -82.45 130.37 35.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 13.2 t-160 -104.42 101.46 11.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 13' ' ' ILE . 48.9 mt -88.71 132.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.9 mtm -143.21 160.07 41.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.297 0.57 . . . . 0.0 111.754 -170.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.23 -119.48 2.65 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -175.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -82.04 131.0 6.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.675 2.25 . . . . 0.0 110.499 172.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 40.8 Cg_exo -57.23 -28.93 81.8 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.254 2.636 . . . . 0.0 112.863 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.04 -40.05 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 110.075 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.614 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.4 tpp180 -60.59 -35.49 76.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.82 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.489 ' HB3' HG12 ' A' ' 13' ' ' ILE . 85.7 m -56.6 -33.91 66.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.8 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.69 -43.48 72.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -69.19 -39.83 78.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.0 0.429 . . . . 0.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HB3' HG22 ' A' ' 60' ' ' ILE . . . -67.7 -30.94 70.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.424 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -58.95 -41.3 87.09 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.337 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -65.47 -42.47 92.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.916 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.89 -50.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.395 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.661 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.0 mt -69.73 -51.01 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.148 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -62.54 -41.48 98.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.866 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.44 -35.79 82.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.423 . . . . 0.0 110.22 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD22 HG23 ' A' ' 25' ' ' VAL . 59.0 tp -63.84 -47.61 80.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 79.3 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.646 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.785 HD13 HD11 ' A' ' 60' ' ' ILE . 41.6 pt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.055 0.455 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.57 124.71 43.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.457 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 t -123.15 121.76 27.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.61 0.243 . . . . 0.0 111.336 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.74 104.37 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.906 2.404 . . . . 0.0 111.928 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 p -118.09 105.88 46.25 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.644 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 85.3 Cg_exo -46.82 133.53 17.49 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.447 2.765 . . . . 0.0 112.604 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.646 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 38.4 mtt180 -60.4 -29.48 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -83.18 -13.13 56.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.9 m -99.61 -14.52 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.785 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.544 HG21 ' HD3' ' A' ' 56' ' ' LYS . 28.0 t -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.133 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.04 -24.57 60.87 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.9 -42.04 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.89 -37.24 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.877 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' A' ' 46' ' ' PHE . 47.0 mm -79.66 -51.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.616 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.4 44.24 11.44 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.876 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 65.6 -73.14 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.457 0.703 . . . . 0.0 111.828 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 m -75.98 -16.55 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.701 0.286 . . . . 0.0 111.73 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 97.15 2.02 59.34 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -173.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.53 -32.88 69.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.094 -0.553 . . . . 0.0 111.751 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.1 tpt -74.48 -43.0 58.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.949 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.545 HD12 ' HB ' ' A' ' 44' ' ' ILE . 13.0 tt -69.32 -31.34 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 7.2 mmpt? -65.26 -36.11 83.11 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.69 174.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 32' ' ' MET . 28.1 tptp -62.59 -51.02 68.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.259 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.448 HG21 HG23 ' A' ' 73' ' ' ILE . 73.4 mt -60.69 -50.26 81.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.5 -33.08 74.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.064 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.41 -32.24 60.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.989 0.423 . . . . 0.0 110.456 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.28 -46.84 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.053 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.12 -28.44 20.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.844 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.58 40.17 7.9 Favored Glycine 0 CA--C 1.517 0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.773 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 28.8 m -121.93 176.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 0.0 111.194 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -118.58 131.98 56.2 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.545 ' HB ' HD12 ' A' ' 33' ' ' ILE . 85.0 mt -111.92 109.01 26.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.463 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 15.7 tm0? -121.71 120.85 35.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CE1' HD12 ' A' ' 26' ' ' ILE . 80.4 m-85 -74.02 116.4 14.6 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.145 0.498 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.646 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 26.9 mtpp -88.18 177.34 6.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 50.1 mm -120.91 107.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.618 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -79.55 140.08 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 45' ' ' GLN . 3.2 p-80 -118.91 112.46 19.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.121 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 13' ' ' ILE . 22.2 mt -92.17 148.77 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.623 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 mtm -142.92 175.23 9.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 111.86 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.66 -137.37 14.19 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.032 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 11.2 Cg_exo -67.13 148.31 80.79 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.72 2.28 . . . . 0.0 111.472 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 37.0 Cg_exo -60.11 -48.3 12.52 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.502 2.135 . . . . 0.0 112.484 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.75 -32.69 74.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.462 0.649 . . . . 0.0 109.739 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 5.7 tpp85 -64.96 -37.21 86.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.715 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.87 -48.53 81.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.11 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.67 -33.43 68.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 0.0 111.27 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 73' ' ' ILE . 3.5 t-160 -61.1 -49.75 76.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 60' ' ' ILE . . . -68.6 -31.92 71.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.43 92.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.633 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -64.85 -34.78 79.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 36' ' ' ILE . 69.6 mt -62.76 -51.27 74.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.024 0.44 . . . . 0.0 110.698 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.643 HD12 HD13 ' A' ' 60' ' ' ILE . 53.7 mt -66.06 -43.88 92.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.641 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.92 -36.42 83.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.615 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.45 -38.21 80.15 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.5 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.231 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.725 -173.765 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 60' ' ' ILE . 32.7 pt . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.813 0.339 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -121.6 105.92 10.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.526 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -104.25 131.76 21.62 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.2 108.28 2.13 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.546 2.831 . . . . 0.0 111.968 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.464 HG13 ' HE1' ' A' ' 46' ' ' PHE . 7.8 p -113.97 113.38 46.91 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.984 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.67 128.34 25.89 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.417 2.078 . . . . 0.0 111.253 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -62.5 -22.55 66.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.834 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.18 -27.76 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 25' ' ' VAL . 16.5 m -83.33 -23.41 32.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.471 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.51 -35.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.36 -29.98 64.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.469 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -88.93 -35.25 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 110.442 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 21' ' ' SER . 47.8 t -66.84 -39.13 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.317 0.58 . . . . 0.0 109.923 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.558 HD12 ' CE2' ' A' ' 46' ' ' PHE . 37.2 mm -79.52 -45.18 23.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.965 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.08 -86.02 1.29 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.138 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -133.94 -72.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.304 0.242 . . . . 0.0 110.368 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -109.38 44.52 1.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.012 0.434 . . . . 0.0 110.262 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 64.11 23.69 68.11 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -60.65 -43.85 97.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.389 -0.906 . . . . 0.0 111.364 -168.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.412 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.3 tpt -77.42 -34.14 54.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 44' ' ' ILE . 9.0 tt -78.1 -23.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.843 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 73.3 mmtt -63.25 -36.52 83.94 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 32' ' ' MET . 17.8 tppt? -63.24 -44.29 95.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.486 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.97 -52.14 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.466 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.558 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 44.6 mt-30 -61.86 -27.6 68.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.352 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -75.34 -49.37 19.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.921 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -68.96 -43.45 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 111.35 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -85.83 -17.72 34.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.555 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.95 32.75 66.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.763 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -113.75 -179.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.443 0.639 . . . . 0.0 111.533 -173.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 31.4 tpt180 -123.05 135.25 54.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.951 169.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 33' ' ' ILE . 89.7 mt -116.54 109.09 26.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.016 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.788 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 12.8 mm100 -97.05 107.74 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.752 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 26' ' ' ILE . 27.2 m-85 -73.43 111.28 8.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.103 0.478 . . . . 0.0 109.765 174.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt . . . . . 0 N--CA 1.44 -0.953 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.326 -176.636 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.489 0.661 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -100.07 170.65 8.34 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.312 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.98 117.97 57.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.307 0.575 . . . . 0.0 111.218 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.723 ' HB3' HG22 ' A' ' 15' ' ' VAL . . . -87.53 133.53 33.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 27.6 t60 -111.69 101.98 10.31 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.332 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 13' ' ' ILE . 31.6 mt -89.23 139.97 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.049 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.8 mtm -139.82 156.42 46.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 111.796 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.61 -126.05 4.57 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.255 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.0 Cg_exo -78.57 137.59 14.69 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.245 2.63 . . . . 0.0 111.604 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.84 -49.28 17.78 Favored 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 122.717 2.278 . . . . 0.0 113.083 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.52 -38.79 84.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.175 0.512 . . . . 0.0 110.533 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 23.9 tpp180 -63.95 -29.22 70.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.733 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.0 m -62.57 -46.47 88.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.69 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.0 110.274 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.49 -43.68 96.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.251 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.535 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.85 -32.68 65.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.583 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -59.32 -42.48 91.53 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.58 0.705 . . . . 0.0 109.361 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -62.83 -42.28 99.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.73 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -57.69 -52.11 61.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 110.529 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.63 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.7 mt -64.73 -50.64 74.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.093 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -67.1 -32.42 73.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.458 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.23 -31.67 72.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.261 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.85 -42.22 61.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.563 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 83.8 mt . . . . . 0 C--O 1.224 -0.265 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.241 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.873 HD13 HD12 ' A' ' 60' ' ' ILE . 39.6 pt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -111.54 123.44 50.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -122.52 123.86 26.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.33 -173.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.47 105.37 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.734 2.289 . . . . 0.0 111.801 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG22 HD22 ' A' ' 78' ' ' LEU . 7.7 p -117.17 110.02 41.83 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.363 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 77.0 Cg_exo -47.46 129.99 17.21 Favored 'Trans proline' 0 CA--C 1.522 -0.11 0 C-N-CA 123.232 2.621 . . . . 0.0 112.129 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -62.96 -28.17 69.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.845 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -75.92 -24.8 55.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.467 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -92.16 -14.78 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.996 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -33.86 46.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.41 68.23 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.618 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -83.82 -43.8 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 109.977 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.78 -41.35 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.633 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.7 mm -79.96 -67.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.708 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.76 -169.9 54.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.077 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.84 117.34 7.4 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.711 -0.288 . . . . 0.0 110.557 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m 62.53 16.36 8.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 71.84 26.5 72.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.166 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.26 -39.48 75.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 111.654 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.2 tpt -70.76 -39.3 73.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.981 0.419 . . . . 0.0 110.555 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 44' ' ' ILE . 7.3 tt -76.3 -26.54 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.081 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 45.1 mmtm -61.72 -43.1 99.51 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -58.87 -41.71 87.74 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.708 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG21 HG22 ' A' ' 73' ' ' ILE . 70.2 mt -66.81 -49.96 69.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 110.852 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -61.89 -28.16 69.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.559 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -80.91 -51.26 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.54 -53.16 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.088 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.604 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -79.3 -18.51 52.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.403 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.43 40.44 60.06 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 70' ' ' ALA . 35.5 m -126.81 165.66 24.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.975 0.417 . . . . 0.0 111.159 -174.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -104.87 135.27 46.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.512 167.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.612 HG21 HD11 ' A' ' 33' ' ' ILE . 88.9 mt -116.06 108.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.53 106.67 12.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.016 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 26' ' ' ILE . 87.1 m-85 -65.15 136.4 56.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 mttt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.931 177.325 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 42.2 mt-10 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.387 0.613 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -92.17 172.61 8.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.76 114.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.434 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -85.9 140.48 30.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 24.2 t60 -116.24 108.88 16.67 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.48 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.873 HD12 HD13 ' A' ' 13' ' ' ILE . 55.0 mt -88.3 148.8 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.886 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.1 mmt -122.27 147.38 46.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.61 -137.88 11.17 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.515 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.69 ' HG2' ' CB ' ' A' ' 66' ' ' ARG . 56.6 Cg_endo -91.09 147.59 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.436 2.757 . . . . 0.0 112.56 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.11 -48.88 19.41 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 113.318 -172.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.91 -43.3 96.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.69 ' CB ' ' HG2' ' A' ' 63' ' ' PRO . 2.8 tpp180 -68.37 -37.23 80.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.149 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 96.4 m -59.06 -42.42 90.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.165 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.54 -31.7 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.294 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.433 0.635 . . . . 0.0 109.304 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 42' ' ' VAL . . . -72.84 -34.78 67.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.603 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.04 90.44 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.677 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -60.57 -47.6 85.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.434 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 40' ' ' ALA . 70.4 mt -56.7 -49.01 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.156 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.69 HD13 HD11 ' A' ' 60' ' ' ILE . 78.8 mt -67.81 -46.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.987 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.68 -44.18 96.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.094 -177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.84 -40.89 94.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.818 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.96 -46.48 90.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.945 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 58.1 mt . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.054 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.08 0.467 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -110.22 114.8 28.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -118.42 126.15 27.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.4 Cg_exo -69.45 113.69 3.41 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 123.15 2.567 . . . . 0.0 112.237 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.1 p -119.14 114.41 35.03 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.25 133.42 58.01 Favored 'Trans proline' 0 N--CA 1.469 0.044 0 C-N-CA 122.773 2.315 . . . . 0.0 112.236 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -62.71 -13.3 30.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -85.59 -45.04 12.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.101 0.477 . . . . 0.0 109.877 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -79.1 -22.43 45.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.671 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.71 -24.49 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.648 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.07 -35.27 88.78 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.688 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -75.96 -31.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 110.127 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.38 -38.02 81.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.938 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.08 -51.24 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.348 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.05 -133.57 14.43 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.651 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -108.17 127.14 53.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m 62.37 6.45 1.92 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.882 0.473 . . . . 0.0 111.781 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 80.93 8.04 87.91 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.231 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -54.03 -32.54 54.72 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.477 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.5 tpt -70.13 -46.39 64.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.525 HD13 ' CG2' ' A' ' 44' ' ' ILE . 6.3 tt -73.76 -23.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.139 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 96.1 mttt -65.11 -38.24 90.03 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -64.17 -44.22 92.72 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 33' ' ' ILE . 12.5 mt -58.09 -56.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.484 0.659 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.43 -23.65 66.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.703 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.39 -45.41 11.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.14 -32.69 69.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.36 -10.92 23.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.65 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.54 34.06 88.91 Favored Glycine 0 C--N 1.328 0.112 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.982 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.53 178.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.352 0.596 . . . . 0.0 111.248 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.5 tpp180 -119.06 131.49 55.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.077 170.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.525 ' CG2' HD13 ' A' ' 33' ' ' ILE . 89.7 mt -119.46 108.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 123.682 0.614 . . . . 0.0 109.761 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -124.11 118.38 26.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.802 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.502 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 22.1 m-85 -76.99 109.67 11.0 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.64 -178.746 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 53.8 mtpt -83.96 163.95 19.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.97 112.25 39.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.617 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.683 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -78.39 135.6 37.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 11.7 t-160 -107.47 101.48 10.82 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.811 HD11 HD12 ' A' ' 13' ' ' ILE . 34.9 mt -89.76 135.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.8 mtm -141.6 169.69 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.816 -171.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 120.08 -124.34 5.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -174.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.3 Cg_exo -80.9 133.07 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.066 2.511 . . . . 0.0 110.74 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 76.2 Cg_exo -51.64 -40.92 63.63 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.889 3.059 . . . . 0.0 114.077 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.28 -38.18 43.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.37 0.605 . . . . 0.0 109.946 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 12.2 tpp85 -62.57 -32.85 73.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.797 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.0 m -58.83 -44.24 90.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.491 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.27 -25.75 51.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.221 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -73.07 -40.2 65.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.02 68.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.858 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.31 77.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.494 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -68.64 -40.28 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.331 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.486 HG23 HG22 ' A' ' 36' ' ' ILE . 65.3 mt -56.73 -46.26 83.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.418 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 60' ' ' ILE . 73.6 mt -72.03 -45.06 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -59.83 -44.82 93.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' ' HE ' ' A' ' 72' ' ' ARG . 15.5 t70 -58.75 -40.76 84.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.462 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.98 -48.85 77.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.756 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 75.8 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 110.536 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 60' ' ' ILE . 37.6 pt . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.924 0.392 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -110.19 105.48 14.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.785 HG22 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -103.41 120.27 52.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 112.163 -176.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.6 103.66 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.221 2.614 . . . . 0.0 111.497 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.29 110.03 53.69 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.39 129.0 15.64 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.316 2.677 . . . . 0.0 112.103 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.51 -25.56 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.483 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.48 -33.43 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 110.288 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 25' ' ' VAL . 39.9 m -79.23 -22.08 45.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.386 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.511 HG21 ' HD3' ' A' ' 56' ' ' LYS . 37.8 t -54.95 -34.83 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -31.38 68.83 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.724 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 t -89.38 -36.37 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.763 0.316 . . . . 0.0 110.417 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 21' ' ' SER . 57.8 t -64.51 -37.52 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.115 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.493 HD12 ' CE1' ' A' ' 46' ' ' PHE . 44.2 mm -79.09 -40.49 22.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.657 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.3 -115.11 4.99 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.365 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 29.0 ttp85 -133.08 121.32 22.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.2 m 67.8 22.12 8.92 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.505 0.503 . . . . 0.0 110.637 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 71.37 13.13 73.63 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.499 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -52.57 -40.99 63.17 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.768 0.427 . . . . 0.0 111.32 -175.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.76 -35.96 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.494 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 36' ' ' ILE . 8.2 tt -75.94 -28.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.34 0.59 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -66.85 -34.7 78.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.661 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 35' ' ' LYS . 5.0 tppt? -59.62 -44.37 93.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.944 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD13 HG12 ' A' ' 74' ' ' ILE . 8.8 mt -62.88 -62.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.432 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -52.98 -40.12 63.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.738 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.24 -49.77 58.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.603 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -83.75 -26.58 29.56 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -84.36 -25.59 29.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.899 0.38 . . . . 0.0 110.893 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.48 26.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.774 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 70' ' ' ALA . 32.8 m -126.35 173.06 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.307 0.575 . . . . 0.0 111.148 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 17.4 tpt180 -116.63 122.46 44.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.167 170.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.501 ' CG2' HD11 ' A' ' 33' ' ' ILE . 67.6 mt -109.6 108.32 25.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.36 115.57 19.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.736 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.493 ' CE1' HD12 ' A' ' 26' ' ' ILE . 90.8 m-85 -63.4 128.34 35.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.734 -177.252 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.241 0.543 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' HD3' HG21 ' A' ' 22' ' ' VAL . 63.5 mtpt -84.59 166.08 17.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.0 mm -113.26 108.94 26.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.609 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -80.98 139.41 35.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.868 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -109.83 101.95 10.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 13' ' ' ILE . 36.0 mt -89.8 137.65 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -138.2 161.97 35.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.463 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.43 -127.81 6.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.082 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.0 Cg_exo -81.01 134.21 9.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.145 2.563 . . . . 0.0 110.965 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.2 -39.6 80.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.638 2.892 . . . . 0.0 113.359 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.54 -37.1 68.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.171 0.51 . . . . 0.0 110.011 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 5.5 tpp180 -70.56 -28.86 65.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.664 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.2 m -62.17 -41.48 98.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.04 -36.86 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.957 0.408 . . . . 0.0 110.597 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.89 -38.5 88.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 42' ' ' VAL . . . -72.5 -36.67 68.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.254 177.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.72 79.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.185 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -63.51 -44.08 95.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.886 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.602 HD13 ' HB1' ' A' ' 40' ' ' ALA . 54.6 mt -61.06 -50.24 81.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.603 HD13 HD13 ' A' ' 60' ' ' ILE . 83.8 mt -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -68.73 -33.91 74.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.244 0.545 . . . . 0.0 110.778 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.75 -29.22 70.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.493 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.74 -46.26 38.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 90.4 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.231 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.885 HD13 HD11 ' A' ' 60' ' ' ILE . 39.9 pt . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.986 0.422 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -119.8 112.9 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.57 HG21 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -113.72 127.15 27.14 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.714 -170.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.8 Cg_exo -71.0 104.91 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.994 2.462 . . . . 0.0 111.88 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.46 116.87 41.22 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.16 135.09 68.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.808 2.339 . . . . 0.0 111.674 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.767 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 80.9 mtm180 -62.31 -38.38 89.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.33 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -68.25 -30.57 69.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.046 0.45 . . . . 0.0 110.172 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -80.0 -26.49 39.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.722 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.85 -37.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.93 -28.91 61.33 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.534 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.3 -37.09 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.728 0.299 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.92 -37.83 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.496 0.665 . . . . 0.0 110.233 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.485 HD13 ' CE2' ' A' ' 46' ' ' PHE . 41.2 mm -82.58 -41.19 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.579 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.54 -65.3 3.07 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -173.28 -68.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -72.79 -35.5 67.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.304 0.574 . . . . 0.0 110.061 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 119.49 12.21 6.87 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.057 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -59.44 -35.2 73.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.962 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -67.12 -47.63 70.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.705 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.615 HD13 ' CG2' ' A' ' 44' ' ' ILE . 18.0 tt -71.45 -30.41 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.603 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mtmt -65.97 -30.05 70.54 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -77.93 -38.83 44.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 32' ' ' MET . 80.2 mt -59.1 -47.2 90.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.44 0.638 . . . . 0.0 109.746 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -63.1 -31.92 73.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.021 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -70.97 -48.45 53.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.03 -36.33 77.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.594 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -92.53 -22.91 19.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.43 37.12 42.17 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 70' ' ' ALA . 27.9 m -119.25 -177.3 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 111.485 -174.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.4 ttt85 -127.8 125.21 39.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.198 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.615 ' CG2' HD13 ' A' ' 33' ' ' ILE . 61.6 mt -111.14 108.99 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.603 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -102.72 163.65 12.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.919 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' A' ' 26' ' ' ILE . 84.7 m-85 -105.63 113.32 26.82 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.7 tttm . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.347 -177.716 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.767 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.7 mtpp -98.95 174.46 6.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.622 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 48.6 mm -120.82 110.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -77.49 135.55 38.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -115.99 100.95 8.33 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.885 HD11 HD13 ' A' ' 13' ' ' ILE . 37.1 mt -89.85 146.73 5.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.529 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.3 mtm -142.98 160.78 39.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -172.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.74 -125.39 5.54 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.396 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -81.13 136.22 10.12 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.161 2.574 . . . . 0.0 111.187 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.46 -49.56 17.02 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.574 2.183 . . . . 0.0 112.778 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -41.28 97.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.339 0.59 . . . . 0.0 110.424 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.626 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 4.7 tpp180 -66.46 -31.96 73.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.142 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 75.3 m -60.96 -44.31 97.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.27 -28.5 57.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.78 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.501 ' O ' HG13 ' A' ' 73' ' ' ILE . 5.6 t60 -59.34 -46.97 87.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -69.92 -34.22 73.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.696 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.71 -42.5 99.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.452 0.644 . . . . 0.0 109.663 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttm105 -67.17 -34.14 76.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.572 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' HIS . 74.8 mt -62.26 -48.6 87.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 110.261 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 78.9 mt -64.89 -45.49 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.626 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -63.16 -36.9 85.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.546 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.54 -39.7 88.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.703 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.8 tp -66.66 -30.41 70.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 110.458 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 78.5 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.778 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.568 HD11 HD11 ' A' ' 60' ' ' ILE . 28.3 pt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.414 ' HB3' HG23 ' A' ' 57' ' ' ILE . 17.1 m-20 -122.28 108.31 13.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.908 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.52 127.11 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.478 -170.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.8 Cg_exo -71.07 106.47 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.908 2.406 . . . . 0.0 111.922 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.48 HG21 HD22 ' A' ' 78' ' ' LEU . 6.4 p -116.02 109.68 44.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.787 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 80.6 Cg_exo -46.09 129.14 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.5 2.8 . . . . 0.0 112.853 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.626 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 37.2 mtt180 -59.71 -27.97 66.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.936 -175.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -79.57 -27.8 41.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.928 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -88.43 -18.35 28.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 18' ' ' PRO . 37.9 t -52.72 -34.72 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.77 68.25 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 t -80.96 -38.39 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.912 0.387 . . . . 0.0 110.456 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 24.7 t -64.36 -35.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.221 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 46' ' ' PHE . 30.0 mm -78.44 -65.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.24 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.16 86.58 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.421 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 30' ' ' GLY . 37.8 ttm180 60.1 82.99 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.864 0.465 . . . . 0.0 111.808 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m 70.59 -25.33 0.16 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.454 0.702 . . . . 0.0 111.491 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 28' ' ' ARG . . . 113.1 74.27 0.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.25 -25.77 11.34 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.8 tpt -77.06 -51.88 10.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.305 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 44' ' ' ILE . 11.5 tt -70.23 -27.28 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.934 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -76.14 -32.47 59.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -62.96 -41.8 99.63 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.32 170.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 33' ' ' ILE . 94.0 mt -59.78 -52.37 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.911 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.4 -40.03 73.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.562 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -81.03 -17.79 49.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.966 0.412 . . . . 0.0 111.534 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.81 -40.17 17.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -96.24 -13.18 23.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.28 46.44 49.69 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG12 ' HB1' ' A' ' 70' ' ' ALA . 34.9 m -128.19 177.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.705 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.7 ttt180 -126.34 135.37 51.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.357 171.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.626 HG21 HD12 ' A' ' 33' ' ' ILE . 65.4 mt -119.94 108.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.87 119.14 38.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 26' ' ' ILE . 74.0 m-85 -75.47 110.73 10.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.366 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 22.8 mtpp . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.245 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 43.1 mt-10 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.626 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 41.3 mttp -79.65 165.65 22.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 HG23 ' HB3' ' A' ' 14' ' ' ASP . 50.4 mm -111.62 108.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.501 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.631 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -77.61 127.13 31.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -105.92 101.9 11.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 74' ' ' ILE . 47.8 mt -89.58 143.12 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.508 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.7 mtm -144.36 178.49 7.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.838 0.352 . . . . 0.0 110.966 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 107.96 -125.15 7.8 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.83 133.58 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.903 2.402 . . . . 0.0 111.1 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.1 Cg_exo -56.75 -35.94 98.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.463 2.775 . . . . 0.0 113.315 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.52 -36.68 28.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.637 0.732 . . . . 0.0 109.816 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 7.8 tpp85 -67.91 -39.32 83.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.66 -176.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -58.46 -38.65 77.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.88 -36.07 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -72.6 -36.46 68.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.077 0.465 . . . . 0.0 110.288 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -69.32 -31.55 70.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.995 175.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.45 -37.6 81.49 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.49 175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -72.6 -31.76 65.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.528 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.435 HG21 HG21 ' A' ' 36' ' ' ILE . 57.6 mt -57.57 -52.39 57.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 109.785 174.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 60' ' ' ILE . 64.5 mt -67.35 -46.73 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.778 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -61.72 -39.38 91.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.158 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.51 -44.46 93.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.79 -44.04 94.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.426 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 17' ' ' VAL . 80.0 mt . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.111 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.444 -0.826 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.585 HD13 HD12 ' A' ' 60' ' ' ILE . 25.4 pt -128.06 142.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.151 0.501 . . . . 0.0 111.336 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.519 ' HB3' HG21 ' A' ' 57' ' ' ILE . 5.1 m-20 -97.59 114.05 25.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -119.06 132.55 23.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -170.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.86 124.36 12.18 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.685 2.257 . . . . 0.0 112.119 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 78' ' ' LEU . 11.3 p -131.99 111.56 14.5 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.965 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.671 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 50.7 Cg_exo -52.83 133.61 51.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.849 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 16.2 mtp180 -66.9 -15.76 63.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.326 0.584 . . . . 0.0 110.468 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -88.49 -13.29 40.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.216 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.572 ' HB3' HD12 ' A' ' 81' ' ' LEU . 20.0 m -107.71 -20.65 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.92 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 m -58.5 -24.7 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.656 0.265 . . . . 0.0 111.535 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.88 91.27 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.98 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.19 -38.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.293 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.34 -37.91 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.81 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.583 HG23 ' HA2' ' A' ' 30' ' ' GLY . 27.0 mm -79.73 -38.14 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.12 -119.84 9.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -120.87 131.7 54.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 70.26 -5.37 1.35 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.464 0.478 . . . . 0.0 111.84 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.583 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 85.94 12.69 70.86 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -170.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.5 -39.6 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.758 0.423 . . . . 0.0 110.716 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.6 tpt -65.89 -46.17 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG21 ' O ' ' A' ' 30' ' ' GLY . 10.0 tt -70.39 -26.41 28.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.418 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 51.7 mttp -68.61 -37.11 79.52 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.117 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.544 HG22 HG22 ' A' ' 73' ' ' ILE . 85.9 mt -65.23 -53.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -57.53 -31.74 66.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.329 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.95 -55.33 13.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.279 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -29.52 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.413 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.749 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -83.19 -29.02 28.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.908 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.17 42.2 24.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.565 HG13 ' HB3' ' A' ' 70' ' ' ALA . 31.2 m -130.37 178.67 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 tpp180 -120.65 128.35 52.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.212 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.469 HD13 HD11 ' A' ' 74' ' ' ILE . 59.5 mt -119.5 109.21 25.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -111.7 119.2 37.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.466 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -76.01 114.92 15.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.024 0.44 . . . . 0.0 110.127 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 54.4 mtpt -75.9 171.99 13.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.374 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -49.64 -61.49 2.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.393 0.616 . . . . 0.0 110.094 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -155.77 -75.8 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.783 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.03 144.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.013 0.82 . . . . 0.0 112.752 169.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.58 -51.33 3.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.262 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 55' ' ' GLU . 6.6 t -140.72 -167.6 2.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' H ' ' HD2' ' A' ' 54' ' ' PRO . . . -108.71 -64.56 0.56 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.926 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.419 ' HD2' ' H ' ' A' ' 53' ' ' GLY . 56.9 Cg_endo -73.07 -2.02 11.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.851 2.367 . . . . 0.0 113.054 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.671 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 32.5 mt-10 -125.58 150.01 47.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.222 0.534 . . . . 0.0 110.662 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.849 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.0 mtpp -97.53 173.17 7.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.438 173.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.569 ' HB ' ' HD3' ' A' ' 47' ' ' LYS . 46.6 mm -109.22 114.58 47.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.552 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -80.06 118.57 21.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -97.09 102.06 13.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.585 HD12 HD13 ' A' ' 13' ' ' ILE . 17.5 mt -88.57 137.01 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.8 mtm -147.82 160.44 42.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 0.0 111.531 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 127.53 -122.34 4.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.43 145.63 18.85 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.917 2.411 . . . . 0.0 110.89 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 -41.92 18.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.021 2.481 . . . . 0.0 113.023 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.03 -37.37 61.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.474 0.654 . . . . 0.0 109.339 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.749 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.3 tpp180 -61.78 -32.99 73.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.053 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.432 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 99.7 m -56.51 -41.95 77.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.465 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.45 -34.39 65.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -60.7 -49.67 76.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.565 ' HB3' HG13 ' A' ' 42' ' ' VAL . . . -69.75 -30.37 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.477 ' HB3' HD13 ' A' ' 13' ' ' ILE . . . -60.03 -41.64 92.68 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.792 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 12.4 tpt180 -69.31 -38.25 78.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.544 HG22 HG22 ' A' ' 36' ' ' ILE . 65.1 mt -54.92 -52.1 46.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.136 0.493 . . . . 0.0 110.149 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.505 HD12 HD11 ' A' ' 60' ' ' ILE . 53.2 mt -68.75 -45.94 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.949 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -60.38 -46.09 91.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.342 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.34 -39.76 84.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.74 -37.55 84.87 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.595 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.459 HD12 HG21 ' A' ' 17' ' ' VAL . 88.2 mt -80.65 -9.91 59.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.647 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -58.17 -50.36 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.736 0.303 . . . . 0.0 110.627 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -71.03 -31.34 67.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 21' ' ' SER . 97.2 mt -76.47 -33.47 58.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 7.8 ptp180 . . . . . 0 C--N 1.33 -0.274 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.253 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.775 HD13 HD11 ' A' ' 60' ' ' ILE . 41.8 pt -116.31 149.68 18.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 0.0 110.653 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.31 105.46 12.89 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.064 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -106.83 127.49 27.96 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 112.171 -173.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.3 Cg_exo -69.96 116.32 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.992 2.462 . . . . 0.0 111.981 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 111.24 32.82 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 110.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HD2' HD13 ' A' ' 78' ' ' LEU . 79.5 Cg_exo -49.26 128.35 19.83 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.501 2.801 . . . . 0.0 112.522 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -60.47 -31.69 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -77.81 -18.82 55.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 m -91.84 -18.3 24.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.074 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.07 -31.85 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.569 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.88 -30.84 70.49 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.84 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.26 -35.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.556 -0.379 . . . . 0.0 110.242 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 HD21 ' A' ' 77' ' ' LEU . 48.7 t -65.85 -38.65 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.894 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.588 HD11 ' CE1' ' A' ' 46' ' ' PHE . 28.8 mm -79.77 -51.56 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.358 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 28' ' ' ARG . . . 98.83 -96.11 1.67 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.317 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 27' ' ' GLY . 23.8 mmt180 -132.81 -56.65 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -98.89 -17.06 18.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.005 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.584 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 110.34 15.34 11.56 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -173.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -73.77 -23.25 59.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.959 -175.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.485 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.9 tpt -73.6 -38.89 64.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.032 0.444 . . . . 0.0 109.972 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 44' ' ' ILE . 10.5 tt -77.44 -22.57 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 29.3 mmtp -64.49 -38.45 91.08 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 32' ' ' MET . 1.2 tmtp? -57.45 -47.37 82.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.787 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 HD13 HG13 ' A' ' 33' ' ' ILE . 38.8 mt -61.51 -48.8 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.661 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -63.35 -30.12 71.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.085 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -82.65 -46.16 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.583 0.23 . . . . 0.0 111.323 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -46.8 88.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.32 -22.98 26.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.458 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.93 33.7 45.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.655 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.9 m -113.64 -177.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 111.639 -174.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 40.3 ttt180 -126.22 133.57 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.064 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.663 HD11 HD13 ' A' ' 74' ' ' ILE . 37.3 mt -132.57 109.95 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.345 0.403 . . . . 0.0 110.311 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -114.6 139.36 49.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.945 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.588 ' CE1' HD11 ' A' ' 26' ' ' ILE . 82.1 m-85 -84.17 112.78 20.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.136 0.493 . . . . 0.0 110.332 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -75.46 146.19 40.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.297 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -93.17 -15.34 26.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -76.63 159.94 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.896 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.26 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.702 0.626 . . . . 0.0 110.294 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.77 94.04 0.01 OUTLIER Glycine 0 C--N 1.33 0.232 0 O-C-N 123.305 0.378 . . . . 0.0 112.995 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 p -90.6 30.88 1.09 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.303 -0.527 . . . . 0.0 112.325 -175.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.82 -111.37 4.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.765 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.86 0.65 9.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.887 2.391 . . . . 0.0 112.344 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -122.25 135.09 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.359 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HD3' ' HD2' ' A' ' 46' ' ' PHE . 27.0 mttm -89.77 171.3 9.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.469 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.61 111.59 36.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.993 0.425 . . . . 0.0 109.944 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' HB3' HG22 ' A' ' 15' ' ' VAL . . . -80.54 133.58 35.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -105.87 101.34 10.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.29 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.775 HD11 HD13 ' A' ' 13' ' ' ILE . 33.5 mt -91.0 137.03 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.983 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.8 mtm -146.11 162.11 38.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.964 0.411 . . . . 0.0 111.407 -169.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 124.98 -119.32 3.58 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 6.3 Cg_exo -83.0 129.64 5.42 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.13 2.553 . . . . 0.0 110.965 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 54.0 Cg_exo -54.41 -34.73 82.34 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.631 2.888 . . . . 0.0 113.813 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -81.24 -40.05 24.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.1 tpp180 -64.0 -26.8 68.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.951 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.84 -43.69 86.02 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.82 -37.36 84.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.751 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.47 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -61.7 -44.81 96.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HB3' HG23 ' A' ' 60' ' ' ILE . . . -67.07 -37.76 84.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.26 -38.04 85.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.89 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -68.85 -38.58 79.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.551 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 69' ' ' HIS . 77.0 mt -62.85 -48.81 86.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.598 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.663 HD13 HD11 ' A' ' 44' ' ' ILE . 91.2 mt -64.71 -39.89 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.474 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -62.3 -45.93 91.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.747 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.54 -39.62 84.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.951 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.426 HD21 HG22 ' A' ' 25' ' ' VAL . 6.6 tt -63.81 -48.08 78.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.643 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt -67.13 -23.33 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.342 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -63.85 -36.91 85.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 t -69.65 -23.24 63.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.442 0.639 . . . . 0.0 109.797 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -98.1 12.21 35.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.256 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 . . . . . 0 C--O 1.233 0.225 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.493 177.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.496 ' CD1' ' HB3' ' A' ' 71' ' ' ALA . 26.4 pt -127.28 149.17 32.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.028 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -109.66 117.55 34.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.327 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.46 124.99 30.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.073 -173.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HA ' HD13 ' A' ' 57' ' ' ILE . 19.1 Cg_endo -77.01 111.5 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.106 1.87 . . . . 0.0 111.323 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 46' ' ' PHE . 6.3 p -114.96 114.62 43.76 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.518 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.613 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.1 Cg_exo -48.64 126.98 15.4 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.176 2.584 . . . . 0.0 111.766 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.787 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 83.9 mtp180 -59.97 -33.6 72.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.102 -172.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -82.72 -13.83 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.575 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -94.91 -13.37 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.98 0.419 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.577 HG21 ' HD3' ' A' ' 56' ' ' LYS . 25.3 t -57.41 -33.48 44.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.773 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.9 61.07 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.002 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.4 ' HB ' HD11 ' A' ' 81' ' ' LEU . 31.1 t -88.75 -35.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 32' ' ' MET . 45.0 t -66.07 -36.28 77.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.426 0.632 . . . . 0.0 110.162 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.522 HD12 ' CE1' ' A' ' 46' ' ' PHE . 44.9 mm -81.59 -60.18 2.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.271 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.84 -116.73 4.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.656 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.56 -49.15 2.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 109.954 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -119.59 -0.64 10.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 112.0 22.04 6.09 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.567 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -51.05 -50.91 57.7 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.876 0.47 . . . . 0.0 111.68 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.1 tpt -68.3 -47.31 67.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.166 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.402 HD13 ' HB ' ' A' ' 44' ' ' ILE . 11.4 tt -69.23 -29.75 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.76 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 59.0 mttm -63.09 -42.44 99.62 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 7.2 tmtm? -65.73 -44.79 84.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.988 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 32' ' ' MET . 77.7 mt -60.29 -50.48 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.032 0.444 . . . . 0.0 110.761 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.403 ' HA ' HG23 ' A' ' 42' ' ' VAL . 11.4 mt-30 -62.31 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.031 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.38 -46.07 18.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.522 0.201 . . . . 0.0 110.971 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.69 -46.27 87.63 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.272 0.558 . . . . 0.0 111.146 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.53 -21.05 23.1 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.682 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.26 37.92 63.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.852 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 70' ' ' ALA . 25.7 m -113.17 -179.48 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 0.0 111.003 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -126.82 133.36 50.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 166.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 74' ' ' ILE . 72.1 mt -123.96 109.07 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.189 0.931 . . . . 0.0 109.301 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.661 HE21 ' HE3' ' A' ' 61' ' ' MET . 26.7 pt20 -126.89 136.89 52.94 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.522 ' CE1' HD12 ' A' ' 26' ' ' ILE . 75.4 m-85 -85.32 118.39 24.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.036 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -91.22 144.12 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.161 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -93.5 -2.56 54.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.804 0.812 . . . . 0.0 108.911 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.71 -76.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.597 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.651 ' HB2' HG13 ' A' ' 57' ' ' ILE . 1.9 m-20 -77.25 -16.08 59.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.944 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.5 122.89 27.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.727 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -158.89 151.39 21.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.846 0.355 . . . . 0.0 110.344 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.19 -136.12 26.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.129 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.41 6.4 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.088 2.526 . . . . 0.0 112.886 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.08 131.36 44.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.457 0.646 . . . . 0.0 111.618 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.787 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 27.9 mtpp -86.41 175.86 8.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.651 HG13 ' HB2' ' A' ' 50' ' ' ASP . 46.0 mm -119.86 108.69 24.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.643 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -73.78 130.02 39.11 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -104.47 102.85 12.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.726 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.71 HD11 HD12 ' A' ' 74' ' ' ILE . 40.6 mt -89.61 136.21 24.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.661 ' HE3' HE21 ' A' ' 45' ' ' GLN . 40.0 mtm -145.1 144.23 30.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.63 -169.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 139.18 -124.51 2.81 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.147 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.59 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.34 138.3 12.37 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 123.438 2.759 . . . . 0.0 112.099 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.05 -49.28 16.62 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 113.399 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.07 -41.63 70.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.219 0.533 . . . . 0.0 110.625 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.59 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.0 tpp180 -65.49 -31.22 72.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.438 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 94.0 m -58.34 -44.7 88.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -70.46 -32.9 70.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.673 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 4.3 t60 -56.71 -50.05 73.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.512 ' HB1' HG23 ' A' ' 60' ' ' ILE . . . -70.03 -34.66 73.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.861 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB3' ' CD1' ' A' ' 13' ' ' ILE . . . -62.28 -41.39 98.44 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.012 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -66.78 -37.56 84.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.121 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 73.4 mt -57.13 -50.62 75.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.529 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 60' ' ' ILE . 68.5 mt -68.67 -44.81 82.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.039 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -61.06 -49.95 75.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.798 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.18 -39.57 75.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.1 tp -66.97 -50.11 63.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.526 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.613 HD13 ' HD2' ' A' ' 18' ' ' PRO . 94.0 mt -64.44 -28.42 69.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.302 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -53.69 -42.66 68.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.48 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -88.45 -18.03 29.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.029 0.442 . . . . 0.0 110.76 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 90.3 mt -86.48 -13.65 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.056 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 82' ' ' ARG . 63.5 mtt180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 0.0 111.34 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.843 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 60' ' ' ILE . 29.3 pt -97.35 145.51 9.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.873 0.368 . . . . 0.0 110.635 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.582 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 14.7 p-10 -111.03 120.11 41.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.821 0.819 . . . . 0.0 109.544 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.638 HG23 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -116.65 133.77 22.99 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.985 -167.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.449 ' HA ' HD12 ' A' ' 57' ' ' ILE . 11.1 Cg_exo -69.24 117.48 5.08 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 123.109 2.539 . . . . 0.0 112.13 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -132.25 108.63 13.67 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.368 0.604 . . . . 0.0 110.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 83.7 Cg_exo -48.81 141.44 21.19 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.543 2.828 . . . . 0.0 113.487 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -54.82 -53.7 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.725 0.298 . . . . 0.0 111.545 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.72 -26.87 67.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.113 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.441 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.9 m -79.16 -25.13 42.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.378 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.7 t -60.12 -32.69 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.01 -29.82 68.84 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.13 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.418 HG12 HD22 ' A' ' 81' ' ' LEU . 40.3 t -89.5 -35.33 7.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 21' ' ' SER . 61.1 t -68.19 -38.31 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.525 HD13 ' CE1' ' A' ' 46' ' ' PHE . 34.7 mm -79.37 -55.99 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.464 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.2 -134.3 12.07 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.421 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 2.5 mmp_? -105.39 -59.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.0 m -93.21 -18.19 22.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.859 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 123.2 13.92 4.24 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.238 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.4 mp0 -57.21 -39.05 74.65 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.19 0.596 . . . . 0.0 111.352 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.497 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -68.82 -49.32 59.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.675 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.576 HD13 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -68.7 -30.02 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 110.402 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 32.3 mmtp -72.94 -29.72 63.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.91 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.92 -42.28 77.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 32' ' ' MET . 74.8 mt -60.65 -49.38 84.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.352 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.66 -27.34 68.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.294 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.34 -50.04 15.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.79 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.68 -53.22 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 111.173 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.546 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.47 -11.34 52.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.934 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.34 37.94 95.63 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.371 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.0 m -113.34 177.11 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.322 0.582 . . . . 0.0 110.827 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -122.36 123.44 41.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.681 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.576 ' CG2' HD13 ' A' ' 33' ' ' ILE . 86.6 mt -105.68 108.43 25.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -115.47 114.99 25.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.148 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE1' HD13 ' A' ' 26' ' ' ILE . 58.6 m-85 -70.93 114.23 8.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.525 0.678 . . . . 0.0 110.804 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' A' ' 49' ' ' ASP . 47.9 mtpt -68.46 -39.27 81.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.933 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? 72.06 -34.19 0.29 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.223 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 47' ' ' LYS . 6.7 t70 -68.66 -177.38 0.95 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 2.8 m-20 65.05 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -168.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.75 97.14 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.33 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 55' ' ' GLU . 3.2 p -84.16 21.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.356 -0.497 . . . . 0.0 111.262 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.93 -104.77 1.7 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.857 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.66 13.0 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.966 2.444 . . . . 0.0 112.11 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.6 mt-10 -121.95 143.4 49.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.09 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -96.21 175.69 6.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.757 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 43.4 mm -122.7 114.58 42.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.638 ' HB2' HG23 ' A' ' 15' ' ' VAL . . . -81.55 140.45 34.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.611 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -114.11 103.64 11.33 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.575 HG23 ' HB3' ' A' ' 70' ' ' ALA . 45.1 mt -88.64 137.62 20.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.4 mtm -143.48 171.51 14.05 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.599 -173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.02 -128.74 8.14 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.596 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_exo -75.98 141.48 23.95 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.788 2.325 . . . . 0.0 111.204 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 27.9 Cg_exo -62.7 -35.69 67.69 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.563 2.842 . . . . 0.0 113.266 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.43 -31.04 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.548 0.69 . . . . 0.0 109.717 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.596 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.5 tpp180 -66.09 -27.09 67.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.676 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.1 m -55.77 -37.77 68.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.402 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 mt-10 -79.31 -30.89 43.07 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.453 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.522 ' O ' HG13 ' A' ' 73' ' ' ILE . 2.3 t-160 -57.56 -50.62 72.49 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' HB3' HG23 ' A' ' 60' ' ' ILE . . . -73.11 -32.82 65.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.208 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . . . -61.74 -41.07 97.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.955 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 18.4 tpt180 -63.5 -43.91 95.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.44 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 69' ' ' HIS . 70.3 mt -54.33 -50.51 56.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.804 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.553 HD11 HD13 ' A' ' 60' ' ' ILE . 70.3 mt -71.36 -42.57 73.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.148 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -61.77 -50.27 73.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.93 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.036 0.446 . . . . 0.0 110.395 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.37 -48.18 80.9 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.5 mt -66.05 -27.45 68.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.67 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -66.38 -37.81 86.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.901 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 m -72.15 -26.81 62.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 HD22 HG12 ' A' ' 24' ' ' VAL . 90.7 mt -78.84 -12.05 60.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.665 176.766 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 CA-C-O 120.734 0.074 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 60' ' ' ILE . 22.1 pt -107.07 165.35 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.596 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.538 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 8.3 p-10 -117.24 128.64 55.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.08 122.8 23.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.996 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HB3' HG23 ' A' ' 52' ' ' THR . 26.0 Cg_exo -65.42 103.53 0.55 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.082 2.522 . . . . 0.0 111.898 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.453 HG11 ' HE2' ' A' ' 46' ' ' PHE . 7.4 p -102.34 118.13 59.58 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 52.5 Cg_exo -56.01 122.41 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.59 2.194 . . . . 0.0 111.438 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.729 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 53.5 mtp180 -62.76 -28.16 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -73.53 -18.37 61.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 m -102.75 -11.37 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.94 -35.29 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.33 63.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.928 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 81' ' ' LEU . 36.0 t -89.21 -34.17 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.138 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.88 -39.39 67.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.412 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.488 HD12 ' CE1' ' A' ' 46' ' ' PHE . 38.8 mm -86.42 -56.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.973 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.27 -127.45 8.66 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -113.35 -45.99 3.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.049 0.424 . . . . 0.0 110.342 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.2 m -95.6 -36.13 11.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.439 0.638 . . . . 0.0 109.843 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 128.38 12.63 2.77 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.596 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.64 -28.16 69.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 110.997 -174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 17.6 tpt -67.72 -43.82 79.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.371 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HG23 ' A' ' 44' ' ' ILE . 10.9 tt -79.93 -24.73 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 74.4 mmtt -62.77 -40.43 97.27 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 32' ' ' MET . 53.2 tttm -59.85 -45.92 90.9 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.55 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -60.75 -49.24 85.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.56 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -59.69 -39.64 85.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.388 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.97 -49.35 38.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.252 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.0 -46.72 86.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.437 -173.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.572 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.41 44.1 7.6 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 34.4 m -129.31 172.98 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.277 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -117.69 137.35 52.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.695 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.556 HG23 HD12 ' A' ' 33' ' ' ILE . 29.2 mt -123.44 106.06 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -105.75 119.05 38.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.066 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.488 ' CE1' HD12 ' A' ' 26' ' ' ILE . 55.8 m-85 -73.13 126.06 29.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.448 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 21.6 mtpp -58.55 144.59 42.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.167 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -80.55 6.0 13.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.229 0.538 . . . . 0.0 110.093 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.35 140.37 49.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.497 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.97 85.51 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.67 -30.0 68.13 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.756 -170.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.77 HG21 ' HB2' ' A' ' 55' ' ' GLU . 5.3 t -132.23 90.75 2.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.596 0.712 . . . . 0.0 110.989 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.65 -116.79 9.85 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' O ' ' HD3' ' A' ' 19' ' ' ARG . 75.5 Cg_endo -96.69 13.15 1.02 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.062 2.508 . . . . 0.0 113.249 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.77 ' HB2' HG21 ' A' ' 52' ' ' THR . 4.0 mm-40 -108.43 153.3 23.5 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 111.217 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.729 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.6 mtpp -92.47 160.69 14.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.677 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.538 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.9 mm -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.895 174.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -75.12 140.07 43.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.5 t60 -118.06 108.43 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.592 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 13' ' ' ILE . 45.7 mt -88.68 131.49 35.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.7 mtp -131.03 128.24 39.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.88 0.371 . . . . 0.0 111.691 -162.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.05 -135.35 6.64 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.851 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 11.3 Cg_exo -69.17 150.08 71.39 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.403 2.735 . . . . 0.0 112.227 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.04 -50.0 8.44 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 -176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -71.87 -30.51 65.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 109.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.732 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.35 -42.79 87.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.595 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.7 -40.35 87.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.824 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -74.19 -35.24 63.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.406 ' O ' HG13 ' A' ' 73' ' ' ILE . 17.9 t-160 -68.69 -41.5 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 60' ' ' ILE . . . -67.93 -34.41 76.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.332 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.645 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -61.23 -37.77 84.27 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.734 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -74.59 -31.88 62.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.487 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.485 HD13 ' HB1' ' A' ' 40' ' ' ALA . 74.6 mt -60.37 -50.48 80.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 109.933 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.432 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 76.7 mt -67.29 -39.5 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.714 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -64.55 -45.96 84.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.165 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -57.85 -40.1 79.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.819 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.8 tp -59.29 -41.89 90.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.59 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 67.4 mt -69.94 -33.28 71.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.696 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.75 -32.59 74.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -76.61 -21.99 54.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 24' ' ' VAL . 90.6 mt -79.57 -29.94 41.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.535 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.511 0.672 . . . . 0.0 111.819 -175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.524 HG12 ' HB2' ' A' ' 67' ' ' CYS . 16.7 pt -96.43 145.8 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.147 0.498 . . . . 0.0 111.786 -174.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.447 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 5.2 p-10 -97.71 122.04 40.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.951 175.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.689 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -119.31 125.67 27.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.044 -175.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.29 104.58 1.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.187 2.592 . . . . 0.0 111.999 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.594 HG21 HD23 ' A' ' 78' ' ' LEU . 11.2 p -106.75 113.65 62.6 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.282 0.563 . . . . 0.0 109.686 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.703 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.0 Cg_exo -60.4 129.76 31.06 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.098 2.532 . . . . 0.0 112.978 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.703 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 98.6 mtt180 -55.67 -29.94 60.2 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.996 0.81 . . . . 0.0 112.587 -172.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -71.96 -34.48 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.478 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -90.32 -19.72 23.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.447 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -60.35 -33.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.56 87.71 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.125 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.693 HG23 HD11 ' A' ' 81' ' ' LEU . 42.9 t -75.31 -36.1 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.391 . . . . 0.0 110.391 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.0 -36.7 78.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.253 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.56 HD13 ' CE2' ' A' ' 46' ' ' PHE . 36.8 mm -81.41 -58.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.59 -113.01 4.12 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -118.44 -61.02 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -93.51 -28.96 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.739 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 133.75 19.98 0.89 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.104 -175.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.22 -37.78 81.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.5 -40.82 69.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.551 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -75.02 -27.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 49.4 mtpt -63.72 -36.82 85.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.26 -43.92 96.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.15 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.5 mt -63.47 -46.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.171 0.51 . . . . 0.0 110.468 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.73 -30.83 71.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.317 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -74.97 -48.07 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.56 -42.94 86.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -90.78 -16.41 28.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.851 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 31.96 65.64 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.983 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.4 m -113.58 176.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.413 0.625 . . . . 0.0 111.205 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -117.87 131.19 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.891 167.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.551 ' CG2' HD11 ' A' ' 33' ' ' ILE . 81.7 mt -115.34 108.54 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.485 ' HA ' ' OE1' ' A' ' 45' ' ' GLN . 4.3 tp60 -123.73 131.67 53.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.56 ' CE2' HD13 ' A' ' 26' ' ' ILE . 78.7 m-85 -84.07 131.17 34.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.447 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 50' ' ' ASP . 24.8 mtpp -70.46 109.81 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.183 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -89.63 22.45 3.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.489 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -120.55 -68.73 0.89 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.158 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 14.8 m-20 -84.88 107.4 17.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -103.52 126.4 8.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.602 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 p -92.8 52.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 111.444 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.81 -125.36 8.3 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.078 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.77 9.49 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.954 2.436 . . . . 0.0 112.49 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.621 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 1.6 mp0 -108.3 166.42 10.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.356 0.598 . . . . 0.0 110.873 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.703 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 30.3 mtpp -109.67 165.95 11.28 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.447 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.6 mm -114.78 110.12 30.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.022 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.75 140.15 38.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -114.49 108.25 16.6 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.517 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.653 HG22 ' HB3' ' A' ' 70' ' ' ALA . 38.8 mt -88.46 127.94 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.5 mtm -141.54 167.01 23.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 111.357 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.13 -118.65 3.86 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.4 135.92 10.9 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.999 2.466 . . . . 0.0 111.449 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.23 -36.05 98.98 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.478 2.785 . . . . 0.0 112.915 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.87 -36.62 70.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.078 0.942 . . . . 0.0 109.799 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.668 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 18.7 tpp85 -71.6 -31.91 67.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.897 -171.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 13' ' ' ILE . 21.2 p -58.85 -41.85 87.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.46 -37.03 79.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.059 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -61.56 -46.12 91.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.103 0.477 . . . . 0.0 109.901 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.653 ' HB3' HG22 ' A' ' 60' ' ' ILE . . . -72.54 -28.13 62.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.879 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -58.25 -42.11 85.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.0 tmm_? -65.62 -45.41 83.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.976 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.6 mt -55.06 -52.43 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.573 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 65.0 mt -67.88 -43.33 86.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -61.28 -48.84 79.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.1 -32.43 74.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.96 -49.78 68.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD23 HG21 ' A' ' 17' ' ' VAL . 88.7 mt -61.26 -35.07 76.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.609 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 62.9 tp60 -63.15 -23.02 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.328 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.4 t -67.72 -28.6 67.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.041 0.448 . . . . 0.0 110.078 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.693 HD11 HG23 ' A' ' 24' ' ' VAL . 85.8 mt -103.09 -5.7 23.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.306 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.609 ' HB3' ' HA ' ' A' ' 79' ' ' GLN . 41.5 ttm180 . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.783 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.794 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.897 HD12 HD11 ' A' ' 60' ' ' ILE . 30.9 pt -128.31 160.38 38.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.813 0.34 . . . . 0.0 111.109 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.464 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 36.6 m-20 -116.86 110.17 18.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.128 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.489 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 0.1 OUTLIER -110.82 128.81 24.72 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.004 -171.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.6 Cg_exo -71.44 99.06 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.419 2.746 . . . . 0.0 111.933 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 17' ' ' VAL . 14.3 p -110.15 109.82 58.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.451 0.643 . . . . 0.0 110.677 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 50.0 Cg_exo -55.91 149.64 50.55 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.217 2.611 . . . . 0.0 113.425 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -68.18 -26.14 65.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.759 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -79.34 -22.88 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.328 0.585 . . . . 0.0 109.526 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 25' ' ' VAL . 14.8 m -86.44 -37.69 18.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.534 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 16.4 m -57.69 -27.17 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.22 92.27 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.423 ' HB ' HD23 ' A' ' 77' ' ' LEU . 40.6 t -89.6 -31.61 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.812 0.339 . . . . 0.0 110.365 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 21' ' ' SER . 93.7 t -61.79 -38.63 80.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.168 0.509 . . . . 0.0 109.851 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.08 -58.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.115 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.6 -138.1 13.65 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.686 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -69.24 -77.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.379 . . . . 0.0 110.586 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.467 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 66.1 m -93.79 -53.5 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.642 0.734 . . . . 0.0 109.567 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -174.29 20.54 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.362 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 1.6 mm-40 -47.05 -53.03 13.53 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.398 0.679 . . . . 0.0 111.827 -169.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.575 ' HE3' HD11 ' A' ' 77' ' ' LEU . 15.9 tpt -68.45 -45.16 73.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.116 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.648 HD13 HG23 ' A' ' 44' ' ' ILE . 8.3 tt -72.47 -29.77 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.812 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 28.2 mmmt -69.47 -40.67 76.95 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.58 -46.15 91.1 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.678 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 32' ' ' MET . 84.0 mt -60.71 -49.37 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.659 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.02 -29.9 67.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.814 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -87.43 -35.69 18.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.653 0.264 . . . . 0.0 111.671 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.04 -40.98 78.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 0.0 110.018 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.506 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -93.03 -23.91 18.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.226 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.94 47.55 9.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.227 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 70' ' ' ALA . 33.5 m -127.4 177.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.5 tpt180 -120.04 128.35 53.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.842 168.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.648 HG23 HD13 ' A' ' 33' ' ' ILE . 72.3 mt -125.92 112.59 30.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.964 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.92 138.78 39.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.125 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 58' ' ' ALA . 12.5 m-85 -85.5 121.0 27.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.574 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.599 ' HZ2' ' HB3' ' A' ' 47' ' ' LYS . 8.0 mtpm? -66.71 108.16 2.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.183 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -71.81 -12.53 61.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.677 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -96.33 -6.04 38.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.622 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.65 81.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.58 117.04 3.56 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -84.73 -11.52 55.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.511 . . . . 0.0 110.989 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.11 -100.79 0.29 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.42 -5.12 15.84 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.477 2.118 . . . . 0.0 111.352 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.9 mt-10 -128.75 145.81 51.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.631 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -107.41 155.63 19.81 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.836 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 38.1 mm -98.51 104.69 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.682 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -76.54 140.38 41.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.979 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -115.58 109.95 18.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.897 HD11 HD12 ' A' ' 13' ' ' ILE . 40.0 mt -93.49 146.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.713 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -145.33 166.87 24.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.945 0.402 . . . . 0.0 111.989 -172.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.91 -124.92 5.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -81.03 134.89 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.994 2.463 . . . . 0.0 110.75 174.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.82 -42.92 54.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.617 2.878 . . . . 0.0 113.293 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.26 -39.94 65.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.7 tpp180 -61.7 -34.64 76.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.979 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 85.2 m -57.94 -42.9 85.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.458 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.84 -41.58 91.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.1 t60 -66.65 -38.75 87.53 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.542 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -66.95 -35.51 80.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.27 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -62.5 -36.86 83.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.441 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -67.79 -39.28 84.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.472 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.6 mt -59.93 -49.56 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.438 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.61 HD12 HD13 ' A' ' 44' ' ' ILE . 84.5 mt -65.28 -45.27 94.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.781 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.73 -37.08 86.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.88 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.75 -43.42 80.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.404 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.575 HD11 ' HE3' ' A' ' 32' ' ' MET . 9.8 tt -63.54 -43.2 97.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.932 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 21.2 mt -61.09 -44.13 97.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.113 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.606 ' OE1' ' HD2' ' A' ' 82' ' ' ARG . 7.1 tp60 -59.83 -40.96 90.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.569 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.5 m -64.3 -39.15 93.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' A' ' 21' ' ' SER . 74.0 mt -68.55 -48.6 63.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.626 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.606 ' HD2' ' OE1' ' A' ' 79' ' ' GLN . 6.4 ptp180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 60' ' ' ILE . 38.6 pt -138.65 163.45 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.062 0.458 . . . . 0.0 111.613 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -114.34 126.88 55.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.308 173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.665 HG22 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -131.04 117.05 16.97 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.43 . . . . 0.0 111.603 -176.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.52 102.24 0.59 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.219 2.612 . . . . 0.0 112.298 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.65 117.91 58.75 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.3 Cg_exo -57.17 131.15 43.42 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.241 2.628 . . . . 0.0 112.371 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.764 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 76.6 mtt180 -66.29 -26.44 67.33 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.815 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -80.51 -15.15 57.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.0 110.242 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.441 ' HB3' HD12 ' A' ' 81' ' ' LEU . 30.1 m -101.41 -14.82 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.435 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 18' ' ' PRO . 24.1 t -56.49 -38.57 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.451 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.93 -35.47 53.63 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.751 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 ' HB ' HD11 ' A' ' 81' ' ' LEU . 44.6 t -86.34 -36.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.662 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 21' ' ' SER . 60.0 t -62.32 -36.97 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.417 0.627 . . . . 0.0 109.904 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.468 HD12 ' CE1' ' A' ' 46' ' ' PHE . 35.9 mm -78.46 -58.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.614 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.87 63.5 1.67 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.889 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 63.97 -87.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.492 0.717 . . . . 0.0 112.162 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.524 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 75.4 m -84.03 -20.37 32.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.128 0.49 . . . . 0.0 110.339 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.666 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 119.9 4.59 11.4 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.524 ' OE1' ' HB2' ' A' ' 29' ' ' SER . 0.8 OUTLIER -63.03 -15.07 55.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.385 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 tpt -80.08 -45.36 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.595 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.703 HG13 HD12 ' A' ' 36' ' ' ILE . 8.0 tt -74.78 -21.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.666 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 31.7 mmtp -57.4 -49.65 75.53 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.153 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.703 HD12 HG13 ' A' ' 33' ' ' ILE . 35.6 mt -61.36 -58.29 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 0.0 110.148 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -65.3 -23.78 67.12 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.133 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.55 -45.11 19.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.072 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.18 -53.46 24.8 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 110.441 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -77.41 -14.43 59.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.565 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.78 34.33 88.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.254 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.11 171.22 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.22 0.533 . . . . 0.0 110.725 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.4 tpp180 -116.75 125.56 51.82 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.333 170.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 33' ' ' ILE . 84.7 mt -110.83 114.0 45.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.34 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -113.26 155.76 24.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.647 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 82.0 m-85 -111.21 112.65 24.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.932 0.396 . . . . 0.0 110.97 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 47' ' ' LYS . 9.1 mtpm? -77.7 87.01 3.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.366 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -74.68 -13.47 60.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.677 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 15.8 p-10 -71.16 -34.81 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.359 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.46 98.25 4.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.299 0.571 . . . . 0.0 110.73 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.36 130.06 9.96 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.503 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.447 ' OG1' ' HB2' ' A' ' 55' ' ' GLU . 20.3 p -83.74 63.0 7.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.291 0.567 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.9 -115.63 4.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.668 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -85.79 14.78 2.37 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.088 2.526 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 45.4 mt-10 -119.68 163.4 17.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.074 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.764 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 57.3 mtpt -123.26 146.19 48.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.64 107.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.33 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.665 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -77.38 140.62 39.96 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 22.2 t60 -118.16 109.68 16.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.972 HD11 HD11 ' A' ' 13' ' ' ILE . 46.8 mt -89.23 147.64 5.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.453 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 49.5 mtt -130.62 137.22 49.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.492 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 135.85 -134.95 7.51 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.264 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -81.29 139.92 11.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.554 2.836 . . . . 0.0 112.382 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 76.7 Cg_exo -50.43 -50.09 14.59 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.242 1.961 . . . . 0.0 112.931 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.67 -40.1 80.3 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 0.0 110.725 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.628 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 12.8 tpp180 -64.82 -40.36 95.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.329 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 84.2 m -59.58 -45.33 92.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.364 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 45.0 mt-10 -63.0 -36.65 84.26 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 111.204 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.94 -46.87 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.041 0.448 . . . . 0.0 109.812 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.71 70.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.284 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.81 98.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.674 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.463 ' HA ' ' HB3' ' A' ' 75' ' ' ASN . 58.9 ttt180 -76.53 -24.57 53.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.721 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.649 HG21 HG23 ' A' ' 36' ' ' ILE . 58.0 mt -57.47 -50.54 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.652 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 56.8 mt -68.93 -45.9 79.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.761 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 72' ' ' ARG . 62.0 t30 -60.73 -48.32 82.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.743 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 7.6 t70 -63.29 -35.31 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.53 -44.43 94.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt -63.71 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.732 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 18.8 pt20 -71.56 -25.21 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.542 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -68.26 -29.92 68.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 110.088 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' A' ' 21' ' ' SER . 66.9 mt -87.48 -27.52 22.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.521 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.854 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 60' ' ' ILE . 38.4 pt -115.96 165.64 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.126 0.488 . . . . 0.0 111.065 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.571 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 6.3 p-10 -117.65 129.42 55.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.827 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.742 HG21 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.04 127.79 24.28 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.085 0.469 . . . . 0.0 111.973 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.588 ' HB3' HG22 ' A' ' 52' ' ' THR . 7.1 Cg_exo -70.72 112.78 3.33 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.226 2.617 . . . . 0.0 111.897 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.1 113.53 26.37 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.559 0.695 . . . . 0.0 110.47 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 22' ' ' VAL . 46.9 Cg_exo -57.95 138.78 87.74 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.126 2.551 . . . . 0.0 112.013 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 71.3 mtp180 -62.9 -34.52 77.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.722 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -69.08 -26.28 64.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB3' HD23 ' A' ' 78' ' ' LEU . 18.9 m -86.86 -28.83 22.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.267 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 18' ' ' PRO . 45.7 t -55.28 -35.41 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.882 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.7 61.82 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.799 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG13 HD22 ' A' ' 81' ' ' LEU . 33.7 t -82.53 -38.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 21' ' ' SER . 33.5 t -62.49 -37.8 79.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.398 0.618 . . . . 0.0 109.938 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.512 HD11 ' CE2' ' A' ' 46' ' ' PHE . 34.9 mm -79.49 -51.84 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.599 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.06 30.9 49.77 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.365 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 72.04 -56.43 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.612 0.765 . . . . 0.0 112.393 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 m -78.03 -25.26 47.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 111.002 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.67 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 100.13 -0.2 56.06 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -169.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -47.81 -49.59 28.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.691 0.796 . . . . 0.0 111.947 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.57 -41.45 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.73 0.3 . . . . 0.0 111.594 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 44' ' ' ILE . 9.4 tt -73.03 -27.43 24.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.487 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 30.0 mmmt -68.96 -35.31 76.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -60.93 -43.51 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.484 HG22 HG23 ' A' ' 73' ' ' ILE . 70.6 mt -62.34 -50.54 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.544 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -58.27 -34.49 70.57 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.593 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -78.21 -40.17 38.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.8 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.56 -47.25 64.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.069 0.461 . . . . 0.0 110.786 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.72 -16.11 40.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 44.67 54.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.519 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.432 HG11 ' HB1' ' A' ' 70' ' ' ALA . 32.4 m -125.14 176.96 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.402 0.62 . . . . 0.0 111.178 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -120.78 129.99 53.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.46 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 74' ' ' ILE . 45.7 mt -123.79 107.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.8 139.45 53.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 62.4 m-85 -84.1 133.2 34.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.416 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -71.96 142.06 49.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.66 -16.63 41.22 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -106.99 89.3 2.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.865 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.467 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 21.2 m-20 -79.04 143.64 35.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.735 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.533 ' H ' ' CG1' ' A' ' 57' ' ' ILE . . . -84.85 -19.77 59.02 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.222 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -97.78 -25.46 15.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 108.13 -105.31 2.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.903 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 24.0 Cg_exo -64.45 -43.12 14.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.72 2.28 . . . . 0.0 111.171 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -69.84 143.75 52.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' A' ' 46' ' ' PHE . 16.5 mtpp -90.09 161.96 15.55 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 110.646 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 34.8 mm -107.92 105.61 19.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.103 0.478 . . . . 0.0 110.133 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.742 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -73.23 127.75 33.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -103.79 101.92 11.74 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.394 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.806 HD12 HD13 ' A' ' 13' ' ' ILE . 41.2 mt -91.83 131.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.053 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.8 mtm -143.12 166.66 24.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.16 -122.09 4.95 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.6 Cg_exo -78.89 131.18 9.94 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.039 2.492 . . . . 0.0 110.896 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.07 -36.97 99.43 Favored 'Trans proline' 0 N--CA 1.475 0.384 0 C-N-CA 123.344 2.696 . . . . 0.0 113.122 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.39 -32.59 60.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 11.4 tpp180 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.391 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.485 ' HB3' HG12 ' A' ' 13' ' ' ILE . 84.4 m -54.14 -40.1 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.276 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -66.11 -40.33 90.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.903 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.451 ' O ' HG13 ' A' ' 73' ' ' ILE . 11.9 t-80 -66.73 -43.1 85.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.189 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.643 ' HB2' HG22 ' A' ' 60' ' ' ILE . . . -64.68 -34.34 78.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -61.23 -43.79 98.31 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.535 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -64.78 -35.26 80.52 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.244 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.484 HG23 HG22 ' A' ' 36' ' ' ILE . 64.6 mt -62.25 -50.24 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.0 110.208 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 44' ' ' ILE . 68.6 mt -66.49 -46.62 86.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.962 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -70.19 -32.42 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -33.83 76.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 8.4 tt -63.9 -44.62 92.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 65.8 mt -61.8 -40.88 96.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.515 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -61.14 -38.57 86.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.675 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 m -65.03 -29.78 70.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.694 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD22 HG13 ' A' ' 24' ' ' VAL . 85.8 mt -76.93 -54.01 7.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.415 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.215 -172.702 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.002 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.744 HD11 HD13 ' A' ' 60' ' ' ILE . 39.8 pt -109.46 150.16 12.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.111 0.481 . . . . 0.0 111.265 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -106.29 105.28 15.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.233 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.697 HG21 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -105.45 132.04 21.23 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 5.5 Cg_exo -72.78 112.92 3.61 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.289 2.659 . . . . 0.0 112.191 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG22 HD23 ' A' ' 78' ' ' LEU . 7.4 p -121.02 107.3 37.87 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 22' ' ' VAL . 72.4 Cg_exo -48.53 133.45 26.06 Favored 'Trans proline' 0 N--CA 1.47 0.118 0 C-N-CA 123.505 2.803 . . . . 0.0 112.39 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.64 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 22.8 mtm180 -62.84 -28.32 69.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.693 -176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.7 -32.14 63.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.249 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.6 m -79.99 -24.22 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 18' ' ' PRO . 62.3 t -54.97 -35.06 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.173 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.07 65.49 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.418 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.61 -36.89 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 0.0 110.556 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 21' ' ' SER . 38.3 t -67.91 -40.39 83.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.596 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -82.32 -46.65 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.38 -118.74 4.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.041 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -97.96 -77.74 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.481 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 21.0 m -82.56 -55.63 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.74 0.781 . . . . 0.0 109.443 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 175.18 32.21 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 4.2 mm-40 -57.49 -47.49 81.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.261 -0.47 . . . . 0.0 111.724 -167.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.6 tpt -66.55 -45.88 77.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 44' ' ' ILE . 6.1 tt -69.0 -31.15 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.912 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 92.9 mttt -62.97 -42.35 99.8 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -66.6 -37.95 85.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 32' ' ' MET . 75.6 mt -63.16 -51.13 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.0 -35.71 73.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.581 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -77.98 -32.98 51.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.94 -46.52 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.619 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -81.69 -28.43 33.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.465 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.31 39.03 8.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG12 ' HB3' ' A' ' 70' ' ' ALA . 33.4 m -122.47 175.72 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.381 0.61 . . . . 0.0 111.517 -174.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -116.43 127.0 54.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.863 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD12 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -125.54 108.61 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.43 154.18 27.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -100.78 120.68 40.46 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.213 0.53 . . . . 0.0 112.055 -174.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -87.46 130.12 34.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.831 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.37 -21.28 66.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.59 109.93 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 4.3 p30 -81.69 140.81 34.12 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.93 -3.44 54.84 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.618 -170.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -160.64 12.67 0.11 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.913 0.356 . . . . 0.0 111.387 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -93.36 0.68 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.768 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.68 -11.03 14.24 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.576 2.184 . . . . 0.0 112.753 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.9 mt-10 -107.27 124.71 50.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.71 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.64 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 44.8 mtpt -78.24 177.78 8.14 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.665 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.1 mm -115.24 113.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.426 0.631 . . . . 0.0 111.174 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.697 ' HB1' HG21 ' A' ' 15' ' ' VAL . . . -84.79 140.6 31.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -110.83 101.51 10.11 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.744 HD13 HD11 ' A' ' 13' ' ' ILE . 21.5 mt -91.24 137.37 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.1 mtm -142.82 163.33 33.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 111.823 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.04 -135.53 9.75 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.61 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 7.7 Cg_exo -69.27 150.86 71.67 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.675 2.25 . . . . 0.0 111.692 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.08 -48.85 5.69 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.538 2.159 . . . . 0.0 112.742 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.57 -34.79 77.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.429 0.633 . . . . 0.0 109.431 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.619 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.8 tpp180 -61.82 -38.95 90.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.587 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 76.9 m -58.95 -47.99 83.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.228 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -69.53 -34.99 75.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.678 0.275 . . . . 0.0 110.823 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -62.68 -46.35 88.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.469 . . . . 0.0 110.169 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' HG22 ' A' ' 60' ' ' ILE . . . -71.06 -35.72 72.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.519 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.42 -36.9 79.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.824 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 72' ' ' ARG . 11.5 ttm180 -66.08 -43.04 88.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.187 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.68 -49.49 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.613 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.735 HD11 HD12 ' A' ' 44' ' ' ILE . 77.0 mt -68.93 -46.24 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.28 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.01 -43.67 98.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.25 -34.0 77.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.275 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.88 -45.64 85.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.032 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.4 mt -61.02 -34.72 75.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.25 -35.2 79.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 m -71.8 -14.96 62.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.039 0.447 . . . . 0.0 110.798 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.4 mt -96.59 -34.96 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.329 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 27.5 ptt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.005 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.812 HD13 HD13 ' A' ' 60' ' ' ILE . 38.1 pt -124.35 160.23 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.905 0.383 . . . . 0.0 111.293 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.51 105.34 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.128 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.734 HG21 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.81 130.29 23.0 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.8 Cg_exo -75.06 104.15 1.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.372 2.715 . . . . 0.0 112.259 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.5 HG22 HD23 ' A' ' 78' ' ' LEU . 7.7 p -112.83 113.02 50.21 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.367 0.603 . . . . 0.0 110.214 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.36 134.57 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 123.096 2.531 . . . . 0.0 112.042 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -61.04 -33.14 72.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.035 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.35 -22.87 60.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 109.798 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 m -87.03 -25.74 24.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.037 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.3 -32.28 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.616 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.44 -33.73 62.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.213 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.71 -34.36 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.644 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.52 -38.55 82.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.425 HD13 ' CE1' ' A' ' 46' ' ' PHE . 42.8 mm -79.83 -54.76 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.205 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' O ' ' HD2' ' A' ' 28' ' ' ARG . . . 105.04 -128.52 9.47 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.572 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 15.0 mmm180 -125.76 -29.7 3.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.064 0.459 . . . . 0.0 110.186 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -114.32 3.72 15.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.853 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 10.44 84.04 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -63.89 -32.53 74.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.841 0.456 . . . . 0.0 111.4 -172.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -70.81 -45.35 64.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.537 HD11 ' CG2' ' A' ' 44' ' ' ILE . 7.9 tt -72.2 -28.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.188 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -67.22 -36.53 81.87 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.01 -44.21 89.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.239 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 73' ' ' ILE . 78.9 mt -58.11 -52.09 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.231 0.539 . . . . 0.0 110.523 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.84 -33.68 75.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.411 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.29 -44.1 65.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.32 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.85 -53.15 29.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.364 . . . . 0.0 111.409 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.589 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -77.53 -27.08 51.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.89 42.22 9.91 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 70' ' ' ALA . 20.4 m -125.79 174.34 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.074 -174.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.6 tpp180 -116.91 131.86 56.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.169 167.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.537 ' CG2' HD11 ' A' ' 33' ' ' ILE . 80.4 mt -111.35 108.64 26.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -118.23 117.1 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.694 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' A' ' 26' ' ' ILE . 96.9 m-85 -72.66 126.04 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -75.94 -175.27 2.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -81.06 166.27 20.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 -176.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.7 38.39 1.97 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.233 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 69.69 -70.32 0.15 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.778 ' HA3' HG12 ' A' ' 57' ' ' ILE . . . 152.49 -65.29 0.35 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.046 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.805 HG21 ' HB2' ' A' ' 55' ' ' GLU . 3.0 t -150.78 72.19 1.07 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.85 . . . . 0.0 111.097 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 -116.77 4.77 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.354 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.86 -4.11 12.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.894 2.396 . . . . 0.0 111.879 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.805 ' HB2' HG21 ' A' ' 52' ' ' THR . 44.2 mt-10 -108.48 129.37 55.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -86.87 149.37 24.87 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.778 HG12 ' HA3' ' A' ' 51' ' ' GLY . 40.9 mm -95.96 108.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.418 0.627 . . . . 0.0 110.115 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 15' ' ' VAL . . . -76.58 123.61 26.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.597 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.428 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 7.7 t-160 -98.52 101.29 12.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.812 HD13 HD13 ' A' ' 13' ' ' ILE . 47.0 mt -89.07 136.09 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -143.52 164.37 30.55 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.058 -168.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.11 -115.81 2.98 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -85.53 126.69 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.263 2.642 . . . . 0.0 110.212 172.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.02 -35.44 94.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.474 2.783 . . . . 0.0 113.408 -174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.38 -33.06 32.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.001 0.429 . . . . 0.0 110.175 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.589 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.4 tpp180 -65.78 -28.73 69.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.381 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.47 ' HB3' HG12 ' A' ' 13' ' ' ILE . 82.9 m -59.63 -30.09 68.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.48 -32.21 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.019 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.481 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -64.27 -42.8 96.29 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.583 ' HB1' HG21 ' A' ' 60' ' ' ILE . . . -69.21 -33.77 73.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.215 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.22 98.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.5 -46.25 90.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.543 HG22 HG21 ' A' ' 36' ' ' ILE . 67.1 mt -55.0 -51.42 53.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.732 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.637 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 75.6 mt -66.76 -48.21 80.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.791 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -59.84 -46.57 88.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.192 0.52 . . . . 0.0 111.611 -176.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.72 -36.1 79.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.544 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.76 -40.73 79.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 77.3 mt -64.05 -32.54 74.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.338 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -58.17 -38.92 77.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.365 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 -30.09 70.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.184 0.516 . . . . 0.0 110.758 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.01 -29.45 17.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.02 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.917 -178.268 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.596 HD13 HD12 ' A' ' 60' ' ' ILE . 45.8 pt -119.43 155.39 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.69 0.757 . . . . 0.0 112.419 -174.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.446 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 7.1 m-20 -123.44 112.46 17.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.334 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.03 129.0 24.98 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.383 -171.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 18.4 Cg_endo -79.52 106.89 2.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.42 2.08 . . . . 0.0 111.52 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.81 113.23 47.42 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.419 -176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.14 134.11 49.08 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.335 2.69 . . . . 0.0 112.522 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 97.7 mtt180 -58.73 -35.09 72.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.447 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -80.71 -6.08 57.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.698 0.285 . . . . 0.0 111.207 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -107.11 -16.9 14.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.4 t -57.0 -38.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.194 178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.25 57.0 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.006 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.6 t -85.08 -39.15 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.368 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.517 HG23 HD22 ' A' ' 77' ' ' LEU . 42.5 t -63.68 -37.19 79.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.35 0.595 . . . . 0.0 110.108 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 46' ' ' PHE . 40.4 mm -79.61 -50.95 17.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.853 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.79 -147.87 19.18 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -83.09 -70.77 0.53 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.418 0.609 . . . . 0.0 110.471 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -96.76 26.22 4.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.53 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 26' ' ' ILE . . . 78.81 7.81 88.09 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.476 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -54.54 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.603 0.761 . . . . 0.0 112.538 -173.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.414 ' HE2' HD12 ' A' ' 77' ' ' LEU . 15.2 tpt -74.47 -50.63 17.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.72 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.535 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 tt -69.09 -27.41 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.412 . . . . 0.0 110.363 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -68.25 -40.14 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.045 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -59.6 -42.51 92.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 HG21 HG21 ' A' ' 73' ' ' ILE . 67.6 mt -63.87 -54.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.819 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.26 -39.02 81.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.036 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -81.87 -26.21 34.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.439 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.5 -49.77 24.93 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.345 0.593 . . . . 0.0 109.78 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . -84.16 -9.86 58.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.748 -175.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.66 31.98 80.08 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.255 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 70' ' ' ALA . 27.7 m -112.77 172.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.719 -174.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.9 ttm180 -117.75 129.18 55.54 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 60' ' ' ILE . 68.7 mt -119.53 108.93 24.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.875 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -119.16 131.85 55.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 110.552 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 26' ' ' ILE . 85.8 m-85 -81.17 115.06 20.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.948 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.71 ' HB3' ' HZ3' ' A' ' 47' ' ' LYS . 8.6 mtpm? -62.98 131.21 47.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.212 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 46.58 0.45 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.638 0.733 . . . . 0.0 109.176 173.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 47' ' ' LYS . 12.2 t70 -171.98 97.3 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.316 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 17.4 m-20 -77.68 128.15 33.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.297 -176.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.484 ' H ' HG12 ' A' ' 57' ' ' ILE . . . -83.99 -13.64 74.18 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.3 m -107.89 -52.81 2.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.429 . . . . 0.0 110.633 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.24 -82.63 0.29 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 15.0 Cg_exo -69.95 -26.92 26.18 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.873 2.382 . . . . 0.0 110.731 171.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.02 132.82 45.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.091 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 22.3 mtpp -81.99 174.75 10.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.562 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.484 HG12 ' H ' ' A' ' 51' ' ' GLY . 48.4 mm -120.96 111.11 30.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.117 0.485 . . . . 0.0 110.227 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -82.2 125.18 30.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 171.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -102.56 102.96 13.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.375 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG12 HG12 ' A' ' 44' ' ' ILE . 47.0 mt -92.86 144.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.603 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 50.2 mtm -145.16 174.93 10.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.888 0.375 . . . . 0.0 111.935 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 112.7 -125.54 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.097 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.48 ' CG ' ' HB3' ' A' ' 66' ' ' ARG . 5.8 Cg_exo -82.89 134.12 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.232 2.621 . . . . 0.0 111.689 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.56 -34.61 73.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.818 3.012 . . . . 0.0 113.586 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.59 -42.58 24.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.659 0.743 . . . . 0.0 109.759 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 18.5 tpp85 -67.57 -34.29 76.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.814 -176.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.5 p -61.86 -40.48 95.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.026 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -68.26 -34.25 75.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.375 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.503 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.3 t60 -63.7 -44.78 92.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.475 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.01 -36.3 83.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.444 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.03 87.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -69.69 -35.82 75.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.524 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.2 mt -60.52 -49.01 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.79 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.611 HD13 HD11 ' A' ' 44' ' ' ILE . 87.4 mt -64.28 -40.94 90.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.793 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.65 -37.77 82.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.944 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 15.7 t70 -60.87 -36.27 78.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.428 0.633 . . . . 0.0 110.012 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.517 HD22 HG23 ' A' ' 25' ' ' VAL . 9.7 tt -66.83 -44.15 81.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.685 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 81.0 mt -67.57 -39.72 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.669 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.5 pt20 -65.78 -20.13 66.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.734 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.5 m -80.06 -23.95 41.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.143 0.496 . . . . 0.0 110.394 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.4 mt -93.25 -49.74 5.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.193 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.467 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 11.4 ptm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.266 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 113.517 0.167 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.67 HD12 HD13 ' A' ' 60' ' ' ILE . 42.0 pt -118.81 166.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 22.2 m-20 -122.57 114.18 20.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.099 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.757 HG23 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -113.04 126.23 28.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.177 -175.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 15.0 Cg_exo -67.15 116.45 4.18 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.908 2.405 . . . . 0.0 111.965 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.654 HG21 HD21 ' A' ' 78' ' ' LEU . 7.6 p -123.64 108.98 30.73 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 121.506 0.669 . . . . 0.0 110.807 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 75.9 Cg_exo -50.96 131.86 35.97 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.192 2.595 . . . . 0.0 112.054 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 48.2 mtp85 -58.22 -32.5 68.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.716 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.43 . . . . 0.0 110.535 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.457 ' HB3' HD11 ' A' ' 81' ' ' LEU . 17.9 m -88.42 -23.28 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.9 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.51 -32.7 65.04 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.604 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.39 -36.93 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.69 0.281 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 HG23 HD22 ' A' ' 77' ' ' LEU . 48.2 t -65.34 -37.02 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 110.444 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.498 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.8 mm -81.51 -61.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.174 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.12 -152.1 18.46 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.641 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -37.49 9.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.246 0.546 . . . . 0.0 109.957 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 m -106.23 3.06 27.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.024 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.542 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 74.59 24.59 72.24 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -168.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.16 90.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.488 -0.856 . . . . 0.0 111.909 -174.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -72.77 -42.25 64.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.03 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.457 HG21 ' O ' ' A' ' 30' ' ' GLY . 5.7 tt -66.27 -30.83 51.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 48.7 mttp -69.61 -45.99 67.3 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -54.16 -45.55 72.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 32' ' ' MET . 62.2 mt -65.39 -48.97 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.737 0.304 . . . . 0.0 110.921 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.48 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 46.1 mt-30 -59.77 -33.69 72.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.55 -42.96 23.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.251 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.18 -37.1 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.46 -14.91 19.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.532 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.32 47.16 53.49 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.499 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 37' ' ' GLN . 31.5 m -124.77 176.23 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.283 -174.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 19.0 tpt180 -116.57 128.91 55.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.247 168.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 33' ' ' ILE . 88.8 mt -113.28 108.79 26.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -122.78 129.87 52.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CE1' HD11 ' A' ' 26' ' ' ILE . 38.0 m-85 -85.11 123.7 30.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 111.456 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.1 mttp -66.99 144.87 55.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.592 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -95.99 5.42 51.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -107.58 75.04 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.985 175.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -68.07 121.41 16.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 0.0 110.415 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -31.43 80.23 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.028 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -119.21 -42.39 2.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.913 0.357 . . . . 0.0 111.434 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.25 -78.81 0.38 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.312 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 11.3 Cg_endo -58.84 -27.77 85.14 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.747 2.298 . . . . 0.0 111.211 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.547 ' HB2' ' CG2' ' A' ' 52' ' ' THR . 13.9 mp0 -106.38 130.04 54.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.483 171.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 23.6 mtpp -83.49 178.66 7.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.09 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 50.2 mm -117.45 114.04 44.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.342 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.757 ' HB2' HG23 ' A' ' 15' ' ' VAL . . . -82.45 130.37 35.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.443 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 13.2 t-160 -104.42 101.46 11.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 13' ' ' ILE . 48.9 mt -88.71 132.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.9 mtm -143.21 160.07 41.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.297 0.57 . . . . 0.0 111.754 -170.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.23 -119.48 2.65 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -175.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.614 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -82.04 131.0 6.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.675 2.25 . . . . 0.0 110.499 172.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 40.8 Cg_exo -57.23 -28.93 81.8 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.254 2.636 . . . . 0.0 112.863 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.04 -40.05 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 110.075 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.614 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.4 tpp180 -60.59 -35.49 76.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.82 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.489 ' HB3' HG12 ' A' ' 13' ' ' ILE . 85.7 m -56.6 -33.91 66.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.8 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.69 -43.48 72.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -69.19 -39.83 78.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.0 0.429 . . . . 0.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HB3' HG22 ' A' ' 60' ' ' ILE . . . -67.7 -30.94 70.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.424 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -58.95 -41.3 87.09 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.337 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -65.47 -42.47 92.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.916 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.89 -50.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.395 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.661 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.0 mt -69.73 -51.01 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.148 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -62.54 -41.48 98.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.866 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.44 -35.79 82.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.423 . . . . 0.0 110.22 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 59.0 tp -63.84 -47.61 80.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 79.3 mt -57.82 -46.84 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.646 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -27.7 69.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.795 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 t -80.25 -15.63 56.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.466 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 67.2 mt -95.27 -21.11 18.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.489 . . . . 0.0 110.42 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.525 179.504 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.785 HD13 HD11 ' A' ' 60' ' ' ILE . 41.6 pt -124.99 155.98 33.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.055 0.455 . . . . 0.0 111.409 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.57 124.71 43.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.457 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 t -123.15 121.76 27.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.61 0.243 . . . . 0.0 111.336 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -70.74 104.37 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.906 2.404 . . . . 0.0 111.928 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 p -118.09 105.88 46.25 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.644 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 85.3 Cg_exo -46.82 133.53 17.49 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.447 2.765 . . . . 0.0 112.604 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.646 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 38.4 mtt180 -60.4 -29.48 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -83.18 -13.13 56.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.475 ' HG ' ' HB3' ' A' ' 81' ' ' LEU . 18.9 m -99.61 -14.52 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.785 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.544 HG21 ' HD3' ' A' ' 56' ' ' LYS . 28.0 t -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.133 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.04 -24.57 60.87 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.9 -42.04 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.89 -37.24 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.877 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' A' ' 46' ' ' PHE . 47.0 mm -79.66 -51.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.616 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.4 44.24 11.44 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.876 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 65.6 -73.14 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.457 0.703 . . . . 0.0 111.828 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 m -75.98 -16.55 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.701 0.286 . . . . 0.0 111.73 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 97.15 2.02 59.34 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -173.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.53 -32.88 69.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.094 -0.553 . . . . 0.0 111.751 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.1 tpt -74.48 -43.0 58.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.949 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.545 HD12 ' HB ' ' A' ' 44' ' ' ILE . 13.0 tt -69.32 -31.34 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 7.2 mmpt? -65.26 -36.11 83.11 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.69 174.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 32' ' ' MET . 28.1 tptp -62.59 -51.02 68.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.259 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 HG21 HG23 ' A' ' 73' ' ' ILE . 73.4 mt -60.69 -50.26 81.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.5 -33.08 74.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.064 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.41 -32.24 60.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.989 0.423 . . . . 0.0 110.456 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.28 -46.84 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.053 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.12 -28.44 20.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.844 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.58 40.17 7.9 Favored Glycine 0 CA--C 1.517 0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.773 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 28.8 m -121.93 176.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 0.0 111.194 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -118.58 131.98 56.2 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.545 ' HB ' HD12 ' A' ' 33' ' ' ILE . 85.0 mt -111.92 109.01 26.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.463 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 15.7 tm0? -121.71 120.85 35.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CE1' HD12 ' A' ' 26' ' ' ILE . 80.4 m-85 -74.02 116.4 14.6 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -60.32 127.56 32.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -70.67 -13.82 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.041 0.448 . . . . 0.0 110.788 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -117.55 -158.12 0.69 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.406 ' O ' HG12 ' A' ' 57' ' ' ILE . 1.4 m-20 59.43 47.82 10.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.251 0.548 . . . . 0.0 111.309 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.08 84.75 1.59 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.456 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.5 p -74.33 91.74 2.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 111.522 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.6 -132.34 47.2 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.266 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.63 8.11 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.628 2.218 . . . . 0.0 112.284 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -121.27 138.98 53.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.145 0.498 . . . . 0.0 111.035 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.646 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 26.9 mtpp -88.18 177.34 6.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 50.1 mm -120.91 107.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.618 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -79.55 140.08 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 45' ' ' GLN . 3.2 p-80 -118.91 112.46 19.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.121 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.785 HD11 HD13 ' A' ' 13' ' ' ILE . 22.2 mt -92.17 148.77 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.623 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 mtm -142.92 175.23 9.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 111.86 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.66 -137.37 14.19 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.032 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 11.2 Cg_exo -67.13 148.31 80.79 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.72 2.28 . . . . 0.0 111.472 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 37.0 Cg_exo -60.11 -48.3 12.52 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.502 2.135 . . . . 0.0 112.484 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.75 -32.69 74.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.462 0.649 . . . . 0.0 109.739 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 5.7 tpp85 -64.96 -37.21 86.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.715 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.87 -48.53 81.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.11 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.67 -33.43 68.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 0.0 111.27 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 73' ' ' ILE . 3.5 t-160 -61.1 -49.75 76.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB2' HG23 ' A' ' 60' ' ' ILE . . . -68.6 -31.92 71.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.43 92.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.633 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -64.85 -34.78 79.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 36' ' ' ILE . 69.6 mt -62.76 -51.27 74.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.024 0.44 . . . . 0.0 110.698 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.643 HD12 HD13 ' A' ' 60' ' ' ILE . 53.7 mt -66.06 -43.88 92.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.641 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.92 -36.42 83.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.615 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.548 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 16.5 t70 -59.45 -38.21 80.15 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.5 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.231 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.589 HD22 HD13 ' A' ' 81' ' ' LEU . 82.9 mt -70.13 -26.14 63.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.725 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.0 pt20 -64.04 -25.86 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.858 0.361 . . . . 0.0 111.089 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.2 t -87.56 -35.66 18.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.039 0.447 . . . . 0.0 110.171 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.589 HD13 HD22 ' A' ' 78' ' ' LEU . 79.4 mt -73.23 -6.57 46.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.81 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.256 175.623 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 60' ' ' ILE . 32.7 pt -129.22 166.55 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.813 0.339 . . . . 0.0 111.261 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -121.6 105.92 10.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.526 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.723 HG22 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -104.25 131.76 21.62 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.2 108.28 2.13 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.546 2.831 . . . . 0.0 111.968 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.464 HG13 ' HE1' ' A' ' 46' ' ' PHE . 7.8 p -113.97 113.38 46.91 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.984 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.67 128.34 25.89 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.417 2.078 . . . . 0.0 111.253 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -62.5 -22.55 66.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.834 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.18 -27.76 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.401 ' O ' HG22 ' A' ' 25' ' ' VAL . 16.5 m -83.33 -23.41 32.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.471 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.51 -35.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.36 -29.98 64.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.469 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -88.93 -35.25 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 110.442 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 21' ' ' SER . 47.8 t -66.84 -39.13 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.317 0.58 . . . . 0.0 109.923 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.558 HD12 ' CE2' ' A' ' 46' ' ' PHE . 37.2 mm -79.52 -45.18 23.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.965 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.08 -86.02 1.29 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.138 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -133.94 -72.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.304 0.242 . . . . 0.0 110.368 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -109.38 44.52 1.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.012 0.434 . . . . 0.0 110.262 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.625 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 64.11 23.69 68.11 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -60.65 -43.85 97.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.389 -0.906 . . . . 0.0 111.364 -168.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.412 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.3 tpt -77.42 -34.14 54.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 44' ' ' ILE . 9.0 tt -78.1 -23.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.843 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 73.3 mmtt -63.25 -36.52 83.94 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 32' ' ' MET . 17.8 tppt? -63.24 -44.29 95.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.486 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.97 -52.14 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.466 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.558 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 44.6 mt-30 -61.86 -27.6 68.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.352 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -75.34 -49.37 19.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.921 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -68.96 -43.45 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 111.35 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -85.83 -17.72 34.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.555 -177.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.95 32.75 66.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.763 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -113.75 -179.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.443 0.639 . . . . 0.0 111.533 -173.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 31.4 tpt180 -123.05 135.25 54.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.951 169.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.574 HG22 HD12 ' A' ' 33' ' ' ILE . 89.7 mt -116.54 109.09 26.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.016 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.788 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 12.8 mm100 -97.05 107.74 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.752 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CE2' HD12 ' A' ' 26' ' ' ILE . 27.2 m-85 -73.43 111.28 8.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.103 0.478 . . . . 0.0 109.765 174.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 29.2 mtmt -96.03 138.61 33.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.326 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -98.38 -7.11 29.37 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 161.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.587 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 33.4 t70 -51.63 -45.44 63.28 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.526 174.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.37 127.27 48.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.819 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.27 115.54 0.71 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 p -85.91 3.2 42.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.532 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 117.73 -88.61 0.46 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.825 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 6.7 Cg_exo -75.35 -20.91 15.74 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.006 2.471 . . . . 0.0 112.027 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.91 139.27 50.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.489 0.661 . . . . 0.0 111.288 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -100.07 170.65 8.34 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.312 178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.98 117.97 57.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.307 0.575 . . . . 0.0 111.218 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.723 ' HB3' HG22 ' A' ' 15' ' ' VAL . . . -87.53 133.53 33.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 27.6 t60 -111.69 101.98 10.31 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.332 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.76 HD11 HD11 ' A' ' 13' ' ' ILE . 31.6 mt -89.23 139.97 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.049 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.8 mtm -139.82 156.42 46.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 111.796 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.61 -126.05 4.57 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.255 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.643 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.0 Cg_exo -78.57 137.59 14.69 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.245 2.63 . . . . 0.0 111.604 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.84 -49.28 17.78 Favored 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 122.717 2.278 . . . . 0.0 113.083 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.52 -38.79 84.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.175 0.512 . . . . 0.0 110.533 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.643 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 23.9 tpp180 -63.95 -29.22 70.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.733 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.0 m -62.57 -46.47 88.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.69 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.0 110.274 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.49 -43.68 96.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.251 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.535 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.85 -32.68 65.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.583 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 13' ' ' ILE . . . -59.32 -42.48 91.53 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.58 0.705 . . . . 0.0 109.361 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -62.83 -42.28 99.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.73 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -57.69 -52.11 61.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 110.529 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.63 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.7 mt -64.73 -50.64 74.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.093 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -67.1 -32.42 73.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.458 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.514 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 t70 -65.23 -31.67 72.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.261 176.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.85 -42.22 61.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.563 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 83.8 mt -62.6 -34.59 77.33 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.241 -175.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 29.7 pt20 -61.38 -19.92 62.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 t -87.24 -19.86 27.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.571 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.6 mt -104.41 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -177.569 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.873 HD13 HD12 ' A' ' 60' ' ' ILE . 39.6 pt -120.75 162.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.761 0.315 . . . . 0.0 111.134 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -111.54 123.44 50.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -122.52 123.86 26.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.33 -173.516 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -68.47 105.37 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.734 2.289 . . . . 0.0 111.801 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG22 HD22 ' A' ' 78' ' ' LEU . 7.7 p -117.17 110.02 41.83 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.363 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 77.0 Cg_exo -47.46 129.99 17.21 Favored 'Trans proline' 0 CA--C 1.522 -0.11 0 C-N-CA 123.232 2.621 . . . . 0.0 112.129 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -62.96 -28.17 69.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.845 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -75.92 -24.8 55.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.467 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -92.16 -14.78 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.996 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -33.86 46.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.41 68.23 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.618 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG23 HD13 ' A' ' 81' ' ' LEU . 38.4 t -83.82 -43.8 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 109.977 177.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.78 -41.35 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.633 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.7 mm -79.96 -67.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.708 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 75.76 -169.9 54.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.077 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.84 117.34 7.4 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.711 -0.288 . . . . 0.0 110.557 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m 62.53 16.36 8.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 71.84 26.5 72.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.166 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.26 -39.48 75.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 111.654 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.2 tpt -70.76 -39.3 73.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.981 0.419 . . . . 0.0 110.555 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.612 HD11 HG21 ' A' ' 44' ' ' ILE . 7.3 tt -76.3 -26.54 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.081 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 45.1 mmtm -61.72 -43.1 99.51 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -58.87 -41.71 87.74 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.708 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG21 HG22 ' A' ' 73' ' ' ILE . 70.2 mt -66.81 -49.96 69.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 110.852 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -61.89 -28.16 69.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.559 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -80.91 -51.26 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.54 -53.16 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.088 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.604 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -79.3 -18.51 52.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.403 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.43 40.44 60.06 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 70' ' ' ALA . 35.5 m -126.81 165.66 24.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.975 0.417 . . . . 0.0 111.159 -174.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -104.87 135.27 46.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.512 167.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.612 HG21 HD11 ' A' ' 33' ' ' ILE . 88.9 mt -116.06 108.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.53 106.67 12.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.016 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 26' ' ' ILE . 87.1 m-85 -65.15 136.4 56.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -82.51 150.97 26.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.931 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 13.1 mm100 -107.59 168.19 9.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER 71.55 -72.72 0.11 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.858 0.724 . . . . 0.0 111.681 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.11 119.54 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.904 0.859 . . . . 0.0 111.577 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.1 113.58 0.59 Allowed Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -67.3 95.37 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -170.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.67 -132.05 31.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.2 3.18 7.87 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.955 2.437 . . . . 0.0 111.928 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.527 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 42.2 mt-10 -115.73 139.06 50.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.471 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -92.17 172.61 8.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.76 114.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.434 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -85.9 140.48 30.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 24.2 t60 -116.24 108.88 16.67 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.48 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.873 HD12 HD13 ' A' ' 13' ' ' ILE . 55.0 mt -88.3 148.8 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.886 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.1 mmt -122.27 147.38 46.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.61 -137.88 11.17 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.515 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.69 ' HG2' ' CB ' ' A' ' 66' ' ' ARG . 56.6 Cg_endo -91.09 147.59 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.436 2.757 . . . . 0.0 112.56 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.11 -48.88 19.41 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 113.318 -172.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.91 -43.3 96.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.69 ' CB ' ' HG2' ' A' ' 63' ' ' PRO . 2.8 tpp180 -68.37 -37.23 80.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.149 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 96.4 m -59.06 -42.42 90.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.165 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.54 -31.7 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.294 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.433 0.635 . . . . 0.0 109.304 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HB3' HG12 ' A' ' 42' ' ' VAL . . . -72.84 -34.78 67.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.603 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.04 90.44 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.677 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -60.57 -47.6 85.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.434 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' A' ' 40' ' ' ALA . 70.4 mt -56.7 -49.01 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.156 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.69 HD13 HD11 ' A' ' 60' ' ' ILE . 78.8 mt -67.81 -46.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.987 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.68 -44.18 96.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.094 -177.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.84 -40.89 94.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.818 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.96 -46.48 90.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.945 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 58.1 mt -68.17 -27.74 66.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.054 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -58.19 -39.51 79.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.638 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 t -72.09 -19.76 61.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD13 HG23 ' A' ' 24' ' ' VAL . 70.2 mt -97.47 19.08 13.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.371 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 1.2 ptp180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.507 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.811 HD12 HD11 ' A' ' 60' ' ' ILE . 39.1 pt -120.69 157.02 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.08 0.467 . . . . 0.0 111.088 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -110.22 114.8 28.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -118.42 126.15 27.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.4 Cg_exo -69.45 113.69 3.41 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 123.15 2.567 . . . . 0.0 112.237 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.1 p -119.14 114.41 35.03 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.25 133.42 58.01 Favored 'Trans proline' 0 N--CA 1.469 0.044 0 C-N-CA 122.773 2.315 . . . . 0.0 112.236 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -62.71 -13.3 30.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -85.59 -45.04 12.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.101 0.477 . . . . 0.0 109.877 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.478 ' HB3' HD13 ' A' ' 81' ' ' LEU . 14.4 m -79.1 -22.43 45.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.671 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.71 -24.49 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.648 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.07 -35.27 88.78 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.688 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -75.96 -31.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 110.127 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.38 -38.02 81.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.938 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.08 -51.24 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.348 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.05 -133.57 14.43 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.651 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -108.17 127.14 53.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m 62.37 6.45 1.92 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.882 0.473 . . . . 0.0 111.781 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 80.93 8.04 87.91 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.231 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -54.03 -32.54 54.72 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.477 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.5 tpt -70.13 -46.39 64.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.525 HD13 ' CG2' ' A' ' 44' ' ' ILE . 6.3 tt -73.76 -23.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.139 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.652 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 96.1 mttt -65.11 -38.24 90.03 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -64.17 -44.22 92.72 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 33' ' ' ILE . 12.5 mt -58.09 -56.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.484 0.659 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.43 -23.65 66.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.703 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.39 -45.41 11.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.14 -32.69 69.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.36 -10.92 23.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.65 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.54 34.06 88.91 Favored Glycine 0 C--N 1.328 0.112 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.982 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.53 178.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.352 0.596 . . . . 0.0 111.248 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.5 tpp180 -119.06 131.49 55.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.077 170.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.525 ' CG2' HD13 ' A' ' 33' ' ' ILE . 89.7 mt -119.46 108.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 123.682 0.614 . . . . 0.0 109.761 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -124.11 118.38 26.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.802 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.502 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 22.1 m-85 -76.99 109.67 11.0 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 41.6 mtpt -61.43 112.72 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.64 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -76.34 -6.93 53.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.659 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.59 -42.43 6.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.881 0.372 . . . . 0.0 110.062 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 1.4 m-20 -72.26 86.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.86 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.68 87.74 0.42 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.977 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 p -75.93 85.62 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 110.798 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.26 -126.28 35.7 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.873 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -84.42 8.91 4.36 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.777 2.318 . . . . 0.0 112.419 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -117.15 123.11 45.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 0.0 110.896 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 53.8 mtpt -83.96 163.95 19.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.97 112.25 39.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.617 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.683 ' HB2' HG21 ' A' ' 15' ' ' VAL . . . -78.39 135.6 37.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 11.7 t-160 -107.47 101.48 10.82 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.811 HD11 HD12 ' A' ' 13' ' ' ILE . 34.9 mt -89.76 135.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.8 mtm -141.6 169.69 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.816 -171.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 120.08 -124.34 5.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -174.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.3 Cg_exo -80.9 133.07 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.066 2.511 . . . . 0.0 110.74 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 76.2 Cg_exo -51.64 -40.92 63.63 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.889 3.059 . . . . 0.0 114.077 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.28 -38.18 43.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.37 0.605 . . . . 0.0 109.946 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 12.2 tpp85 -62.57 -32.85 73.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.797 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.0 m -58.83 -44.24 90.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.491 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.27 -25.75 51.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.221 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -73.07 -40.2 65.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.02 68.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.858 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.31 77.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.494 174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -68.64 -40.28 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.331 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.486 HG23 HG22 ' A' ' 36' ' ' ILE . 65.3 mt -56.73 -46.26 83.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.418 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.59 HD11 HD13 ' A' ' 60' ' ' ILE . 73.6 mt -72.03 -45.06 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -59.83 -44.82 93.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' ' HE ' ' A' ' 72' ' ' ARG . 15.5 t70 -58.75 -40.76 84.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.462 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.98 -48.85 77.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.756 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 75.8 mt -60.88 -38.58 86.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 82' ' ' ARG . 30.7 tt0 -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -69.62 -14.87 63.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.727 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 ' HB3' ' A' ' 21' ' ' SER . 70.9 mt -101.39 4.41 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.511 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 15.4 ptp180 . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.162 0.506 . . . . 0.0 110.986 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 60' ' ' ILE . 37.6 pt -106.97 160.43 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.924 0.392 . . . . 0.0 111.447 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -110.19 105.48 14.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.785 HG22 ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -103.41 120.27 52.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 112.163 -176.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.6 103.66 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.221 2.614 . . . . 0.0 111.497 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.29 110.03 53.69 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -47.39 129.0 15.64 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.316 2.677 . . . . 0.0 112.103 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.51 -25.56 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.483 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.48 -33.43 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 110.288 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 25' ' ' VAL . 39.9 m -79.23 -22.08 45.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.386 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.511 HG21 ' HD3' ' A' ' 56' ' ' LYS . 37.8 t -54.95 -34.83 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -31.38 68.83 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.724 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 t -89.38 -36.37 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.763 0.316 . . . . 0.0 110.417 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 21' ' ' SER . 57.8 t -64.51 -37.52 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.115 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.493 HD12 ' CE1' ' A' ' 46' ' ' PHE . 44.2 mm -79.09 -40.49 22.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.657 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.3 -115.11 4.99 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.365 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 29.0 ttp85 -133.08 121.32 22.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.2 m 67.8 22.12 8.92 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.505 0.503 . . . . 0.0 110.637 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 33' ' ' ILE . . . 71.37 13.13 73.63 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.499 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -52.57 -40.99 63.17 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.768 0.427 . . . . 0.0 111.32 -175.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.76 -35.96 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.494 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 36' ' ' ILE . 8.2 tt -75.94 -28.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.34 0.59 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -66.85 -34.7 78.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.661 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HB2' ' HE2' ' A' ' 35' ' ' LYS . 5.0 tppt? -59.62 -44.37 93.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.944 176.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD13 HG12 ' A' ' 74' ' ' ILE . 8.8 mt -62.88 -62.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.432 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -52.98 -40.12 63.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.738 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.24 -49.77 58.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.603 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -83.75 -26.58 29.56 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -84.36 -25.59 29.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.899 0.38 . . . . 0.0 110.893 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.48 26.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.774 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 70' ' ' ALA . 32.8 m -126.35 173.06 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.307 0.575 . . . . 0.0 111.148 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 17.4 tpt180 -116.63 122.46 44.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.167 170.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.501 ' CG2' HD11 ' A' ' 33' ' ' ILE . 67.6 mt -109.6 108.32 25.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.36 115.57 19.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.736 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.496 ' CB ' ' HA ' ' A' ' 49' ' ' ASP . 90.8 m-85 -63.4 128.34 35.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.61 98.55 0.18 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.734 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 62.85 13.05 6.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.435 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 46' ' ' PHE . 31.9 t70 54.76 31.75 16.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.739 0.78 . . . . 0.0 110.428 -171.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -110.16 -179.09 3.69 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.048 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.722 ' HA3' ' HA ' ' A' ' 56' ' ' LYS . . . -157.86 158.69 29.31 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.82 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -86.68 52.01 2.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.52 0.676 . . . . 0.0 111.051 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.47 -119.41 4.5 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.961 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.19 -25.04 10.46 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.125 2.55 . . . . 0.0 112.289 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -114.56 128.8 56.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.241 0.543 . . . . 0.0 110.925 -178.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.722 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 63.5 mtpt -84.59 166.08 17.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.0 mm -113.26 108.94 26.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.609 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HB1' HG22 ' A' ' 15' ' ' VAL . . . -80.98 139.41 35.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.868 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -109.83 101.95 10.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 13' ' ' ILE . 36.0 mt -89.8 137.65 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -138.2 161.97 35.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.463 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.43 -127.81 6.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.082 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.63 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.0 Cg_exo -81.01 134.21 9.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.145 2.563 . . . . 0.0 110.965 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.2 -39.6 80.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.638 2.892 . . . . 0.0 113.359 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.54 -37.1 68.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.171 0.51 . . . . 0.0 110.011 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 5.5 tpp180 -70.56 -28.86 65.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.664 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.2 m -62.17 -41.48 98.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.04 -36.86 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.957 0.408 . . . . 0.0 110.597 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.89 -38.5 88.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.611 ' HB2' HG12 ' A' ' 42' ' ' VAL . . . -72.5 -36.67 68.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.254 177.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.72 79.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.185 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -63.51 -44.08 95.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.886 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.602 HD13 ' HB1' ' A' ' 40' ' ' ALA . 54.6 mt -61.06 -50.24 81.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.603 HD13 HD13 ' A' ' 60' ' ' ILE . 83.8 mt -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -68.73 -33.91 74.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.244 0.545 . . . . 0.0 110.778 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 36.1 t70 -64.75 -29.22 70.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.493 177.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.74 -46.26 38.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 90.4 mt -62.98 -37.7 88.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.231 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.5 pt20 -61.65 -27.97 69.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.8 m -75.57 -30.72 59.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -87.04 -25.92 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.211 0.529 . . . . 0.0 110.378 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.146 -175.426 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.885 HD13 HD11 ' A' ' 60' ' ' ILE . 39.9 pt -134.81 164.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -119.8 112.9 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.57 HG21 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -113.72 127.15 27.14 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.714 -170.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.8 Cg_exo -71.0 104.91 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.994 2.462 . . . . 0.0 111.88 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.46 116.87 41.22 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.16 135.09 68.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.808 2.339 . . . . 0.0 111.674 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.767 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 80.9 mtm180 -62.31 -38.38 89.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.33 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -68.25 -30.57 69.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.046 0.45 . . . . 0.0 110.172 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.1 m -80.0 -26.49 39.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.722 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.85 -37.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.93 -28.91 61.33 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.534 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.3 -37.09 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.728 0.299 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -63.92 -37.83 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.496 0.665 . . . . 0.0 110.233 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.485 HD13 ' CE2' ' A' ' 46' ' ' PHE . 41.2 mm -82.58 -41.19 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.579 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.54 -65.3 3.07 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -173.28 -68.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -72.79 -35.5 67.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.304 0.574 . . . . 0.0 110.061 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 119.49 12.21 6.87 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.057 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -59.44 -35.2 73.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.962 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -67.12 -47.63 70.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.705 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.615 HD13 ' CG2' ' A' ' 44' ' ' ILE . 18.0 tt -71.45 -30.41 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.603 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mtmt -65.97 -30.05 70.54 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -77.93 -38.83 44.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 32' ' ' MET . 80.2 mt -59.1 -47.2 90.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.44 0.638 . . . . 0.0 109.746 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -63.1 -31.92 73.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.021 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -70.97 -48.45 53.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.03 -36.33 77.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.594 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -92.53 -22.91 19.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.43 37.12 42.17 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG13 ' HB2' ' A' ' 70' ' ' ALA . 27.9 m -119.25 -177.3 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 111.485 -174.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.4 ttt85 -127.8 125.21 39.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.198 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.615 ' CG2' HD13 ' A' ' 33' ' ' ILE . 61.6 mt -111.14 108.99 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.603 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -102.72 163.65 12.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.919 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.485 ' CE2' HD13 ' A' ' 26' ' ' ILE . 84.7 m-85 -105.63 113.32 26.82 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.477 ' HG2' ' OD1' ' A' ' 49' ' ' ASP . 31.7 tttm -61.43 121.03 11.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.347 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -80.03 31.6 0.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.198 0.523 . . . . 0.0 111.614 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 5.5 m-20 -110.34 32.07 5.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 69.45 -56.91 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.94 0.896 . . . . 0.0 110.484 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.712 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 129.46 -86.95 0.31 Allowed Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 55' ' ' GLU . 13.1 t -145.88 3.27 0.94 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.455 0.645 . . . . 0.0 109.436 172.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.29 -94.3 0.64 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.92 -16.74 41.38 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.637 2.225 . . . . 0.0 112.033 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 52' ' ' THR . 56.5 mt-10 -125.42 151.74 45.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.169 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.767 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.7 mtpp -98.95 174.46 6.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.622 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.712 HG12 ' HA2' ' A' ' 51' ' ' GLY . 48.6 mm -120.82 110.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' O ' HG21 ' A' ' 15' ' ' VAL . . . -77.49 135.55 38.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -115.99 100.95 8.33 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.885 HD11 HD13 ' A' ' 13' ' ' ILE . 37.1 mt -89.85 146.73 5.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.529 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.3 mtm -142.98 160.78 39.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -172.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.74 -125.39 5.54 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.396 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.626 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -81.13 136.22 10.12 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.161 2.574 . . . . 0.0 111.187 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.46 -49.56 17.02 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.574 2.183 . . . . 0.0 112.778 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -41.28 97.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.339 0.59 . . . . 0.0 110.424 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.626 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 4.7 tpp180 -66.46 -31.96 73.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.142 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.445 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 75.3 m -60.96 -44.31 97.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.27 -28.5 57.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.78 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.501 ' O ' HG13 ' A' ' 73' ' ' ILE . 5.6 t60 -59.34 -46.97 87.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB2' HG13 ' A' ' 42' ' ' VAL . . . -69.92 -34.22 73.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.696 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.71 -42.5 99.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.452 0.644 . . . . 0.0 109.663 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttm105 -67.17 -34.14 76.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.572 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' HIS . 74.8 mt -62.26 -48.6 87.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 110.261 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 78.9 mt -64.89 -45.49 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.626 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -63.16 -36.9 85.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.546 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.54 -39.7 88.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.703 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.8 tp -66.66 -30.41 70.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 110.458 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.591 HD23 HD12 ' A' ' 81' ' ' LEU . 78.5 mt -75.54 -7.17 53.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.778 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -63.48 -34.14 77.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.9 t -86.7 -14.65 41.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.034 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.591 HD12 HD23 ' A' ' 78' ' ' LEU . 76.3 mt -96.84 -4.05 41.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.141 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.384 176.813 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.568 HD11 HD11 ' A' ' 60' ' ' ILE . 28.3 pt -110.89 161.51 9.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.17 0.51 . . . . 0.0 111.603 -177.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.414 ' HB3' HG23 ' A' ' 57' ' ' ILE . 17.1 m-20 -122.28 108.31 13.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.908 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.52 127.11 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.478 -170.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.8 Cg_exo -71.07 106.47 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.908 2.406 . . . . 0.0 111.922 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.48 HG21 HD22 ' A' ' 78' ' ' LEU . 6.4 p -116.02 109.68 44.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.787 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 80.6 Cg_exo -46.09 129.14 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.5 2.8 . . . . 0.0 112.853 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.626 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 37.2 mtt180 -59.71 -27.97 66.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.936 -175.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -79.57 -27.8 41.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.928 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -88.43 -18.35 28.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG21 ' O ' ' A' ' 18' ' ' PRO . 37.9 t -52.72 -34.72 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.77 68.25 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 t -80.96 -38.39 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.912 0.387 . . . . 0.0 110.456 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 24.7 t -64.36 -35.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.221 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.528 HD13 ' CE2' ' A' ' 46' ' ' PHE . 30.0 mm -78.44 -65.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.24 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.16 86.58 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.421 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 30' ' ' GLY . 37.8 ttm180 60.1 82.99 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.864 0.465 . . . . 0.0 111.808 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m 70.59 -25.33 0.16 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.454 0.702 . . . . 0.0 111.491 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 28' ' ' ARG . . . 113.1 74.27 0.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.25 -25.77 11.34 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.8 tpt -77.06 -51.88 10.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.305 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.626 HD12 HG21 ' A' ' 44' ' ' ILE . 11.5 tt -70.23 -27.28 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.934 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -76.14 -32.47 59.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -62.96 -41.8 99.63 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.32 170.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.618 HD11 ' HA ' ' A' ' 33' ' ' ILE . 94.0 mt -59.78 -52.37 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.911 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.4 -40.03 73.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.562 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -81.03 -17.79 49.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.966 0.412 . . . . 0.0 111.534 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.81 -40.17 17.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.492 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -96.24 -13.18 23.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.28 46.44 49.69 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG12 ' HB1' ' A' ' 70' ' ' ALA . 34.9 m -128.19 177.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.705 -174.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.623 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.7 ttt180 -126.34 135.37 51.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.357 171.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.626 HG21 HD12 ' A' ' 33' ' ' ILE . 65.4 mt -119.94 108.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.87 119.14 38.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 26' ' ' ILE . 74.0 m-85 -75.47 110.73 10.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.366 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 22.8 mtpp -76.14 105.0 6.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.245 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -80.61 -18.02 49.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.859 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -78.24 137.53 38.16 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.734 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.92 -75.56 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.425 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.47 103.17 0.03 OUTLIER Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.634 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.3 p -69.74 85.96 0.48 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.046 0.45 . . . . 0.0 112.022 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.76 -132.33 40.62 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.817 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.56 10.99 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.113 2.542 . . . . 0.0 112.529 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 43.1 mt-10 -124.6 132.45 53.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.973 0.416 . . . . 0.0 110.777 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.626 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 41.3 mttp -79.65 165.65 22.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 HG23 ' HB3' ' A' ' 14' ' ' ASP . 50.4 mm -111.62 108.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.501 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.631 ' O ' HG22 ' A' ' 15' ' ' VAL . . . -77.61 127.13 31.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -105.92 101.9 11.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 74' ' ' ILE . 47.8 mt -89.58 143.12 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.508 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.7 mtm -144.36 178.49 7.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.838 0.352 . . . . 0.0 110.966 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 107.96 -125.15 7.8 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.83 133.58 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.903 2.402 . . . . 0.0 111.1 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.1 Cg_exo -56.75 -35.94 98.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.463 2.775 . . . . 0.0 113.315 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.52 -36.68 28.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.637 0.732 . . . . 0.0 109.816 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 7.8 tpp85 -67.91 -39.32 83.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.66 -176.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -58.46 -38.65 77.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.88 -36.07 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -72.6 -36.46 68.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.077 0.465 . . . . 0.0 110.288 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.408 ' HB1' HG12 ' A' ' 42' ' ' VAL . . . -69.32 -31.55 70.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.995 175.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.475 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.45 -37.6 81.49 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.49 175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -72.6 -31.76 65.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.528 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.435 HG21 HG21 ' A' ' 36' ' ' ILE . 57.6 mt -57.57 -52.39 57.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 109.785 174.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 60' ' ' ILE . 64.5 mt -67.35 -46.73 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.778 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -61.72 -39.38 91.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.158 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.51 -44.46 93.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.79 -44.04 94.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.426 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 17' ' ' VAL . 80.0 mt -62.82 -37.57 87.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.111 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.31 -42.08 81.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.342 . . . . 0.0 111.006 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.4 t -63.48 -34.81 78.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.469 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.9 mt -88.75 -19.89 25.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.435 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 -174.857 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 60' ' ' ILE . 25.4 pt . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.151 0.501 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 57' ' ' ILE . 5.1 m-20 -97.59 114.05 25.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -119.06 132.55 23.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -170.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.86 124.36 12.18 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.685 2.257 . . . . 0.0 112.119 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.51 HG23 HD11 ' A' ' 78' ' ' LEU . 11.3 p -131.99 111.56 14.5 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.965 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 50.7 Cg_exo -52.83 133.61 51.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.874 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 16.2 mtp180 -66.9 -15.76 63.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.326 0.584 . . . . 0.0 110.468 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -88.49 -13.29 40.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.216 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -107.71 -20.65 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.92 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 m -58.5 -24.7 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.656 0.265 . . . . 0.0 111.535 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.88 91.27 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.98 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.19 -38.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.293 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.34 -37.91 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.81 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.586 HG23 ' HA2' ' A' ' 30' ' ' GLY . 27.0 mm -79.73 -38.14 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.12 -119.84 9.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -120.87 131.7 54.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 70.26 -5.37 1.35 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.464 0.478 . . . . 0.0 111.84 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 85.94 12.69 70.86 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -170.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.5 -39.6 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.758 0.423 . . . . 0.0 110.716 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.6 tpt -65.89 -46.17 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.0 tt -70.39 -26.41 28.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.418 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 51.7 mttp -68.61 -37.11 79.52 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.117 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 73' ' ' ILE . 85.9 mt -65.23 -53.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.53 -31.74 66.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.329 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.95 -55.33 13.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.279 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -29.52 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.413 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.758 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -83.19 -29.02 28.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.908 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.17 42.2 24.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.493 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 31.2 m -130.37 178.67 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 tpp180 -120.65 128.35 52.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.212 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 74' ' ' ILE . 59.5 mt -119.5 109.21 25.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -111.7 119.2 37.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.466 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -76.01 114.92 15.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.024 0.44 . . . . 0.0 110.127 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 54.4 mtpt . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.374 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 32.5 mt-10 . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.222 0.534 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.0 mtpp -97.53 173.17 7.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.438 173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.571 ' HB ' ' HD3' ' A' ' 47' ' ' LYS . 46.6 mm -109.22 114.58 47.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.552 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -80.06 118.57 21.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.09 102.06 13.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 13' ' ' ILE . 17.5 mt -88.57 137.01 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.8 mtm -147.82 160.44 42.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 0.0 111.531 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 127.53 -122.34 4.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.43 145.63 18.85 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.917 2.411 . . . . 0.0 110.89 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 -41.92 18.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.021 2.481 . . . . 0.0 113.023 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.03 -37.37 61.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.474 0.654 . . . . 0.0 109.339 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.3 tpp180 -61.78 -32.99 73.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.053 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 99.7 m -56.51 -41.95 77.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.465 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.45 -34.39 65.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -60.7 -49.67 76.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -69.75 -30.37 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.03 -41.64 92.68 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.792 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 12.4 tpt180 -69.31 -38.25 78.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.532 HG21 HG23 ' A' ' 36' ' ' ILE . 65.1 mt -54.92 -52.1 46.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.136 0.493 . . . . 0.0 110.149 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 60' ' ' ILE . 53.2 mt -68.75 -45.94 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.949 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -60.38 -46.09 91.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.342 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.34 -39.76 84.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.74 -37.55 84.87 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.595 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HG23 ' A' ' 17' ' ' VAL . 88.2 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.647 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 60' ' ' ILE . 41.8 pt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 121.064 0.459 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.31 105.46 12.89 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.064 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -106.83 127.49 27.96 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 112.171 -173.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.3 Cg_exo -69.96 116.32 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.992 2.462 . . . . 0.0 111.981 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 111.24 32.82 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 110.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 78' ' ' LEU . 79.5 Cg_exo -49.26 128.35 19.83 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.501 2.801 . . . . 0.0 112.522 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -60.47 -31.69 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -77.81 -18.82 55.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 m -91.84 -18.3 24.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.074 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.07 -31.85 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.569 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.88 -30.84 70.49 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.84 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.26 -35.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.556 -0.379 . . . . 0.0 110.242 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 77' ' ' LEU . 48.7 t -65.85 -38.65 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.894 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.607 HD11 ' CE1' ' A' ' 46' ' ' PHE . 28.8 mm -79.77 -51.56 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.358 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 28' ' ' ARG . . . 98.83 -96.11 1.67 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.317 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 27' ' ' GLY . 23.8 mmt180 -132.81 -56.65 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -98.89 -17.06 18.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.005 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 110.34 15.34 11.56 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -173.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -73.77 -23.25 59.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.959 -175.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.9 tpt -73.6 -38.89 64.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.032 0.444 . . . . 0.0 109.972 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.5 tt -77.44 -22.57 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 29.3 mmtp -64.49 -38.45 91.08 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 32' ' ' MET . 1.2 tmtp? -57.45 -47.37 82.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.787 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 33' ' ' ILE . 38.8 mt -61.51 -48.8 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.661 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -63.35 -30.12 71.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.085 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -82.65 -46.16 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.583 0.23 . . . . 0.0 111.323 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -46.8 88.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.32 -22.98 26.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.458 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.93 33.7 45.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.655 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.9 m -113.64 -177.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 111.639 -174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 40.3 ttt180 -126.22 133.57 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.064 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.651 HD13 HD11 ' A' ' 74' ' ' ILE . 37.3 mt -132.57 109.95 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.345 0.403 . . . . 0.0 110.311 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -114.6 139.36 49.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.945 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CE1' HD11 ' A' ' 26' ' ' ILE . 82.1 m-85 -84.17 112.78 20.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.136 0.493 . . . . 0.0 110.332 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 52.6 mtpt . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.297 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.078 0.466 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 46' ' ' PHE . 27.0 mttm -89.77 171.3 9.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.469 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.61 111.59 36.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.993 0.425 . . . . 0.0 109.944 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.54 133.58 35.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.524 ' CD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -105.87 101.34 10.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.29 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 13' ' ' ILE . 33.5 mt -91.0 137.03 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.983 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.8 mtm -146.11 162.11 38.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.964 0.411 . . . . 0.0 111.407 -169.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 124.98 -119.32 3.58 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 6.3 Cg_exo -83.0 129.64 5.42 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.13 2.553 . . . . 0.0 110.965 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 54.0 Cg_exo -54.41 -34.73 82.34 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.631 2.888 . . . . 0.0 113.813 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -81.24 -40.05 24.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.1 tpp180 -64.0 -26.8 68.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.951 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.84 -43.69 86.02 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.82 -37.36 84.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.751 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 43.9 t-80 -61.7 -44.81 96.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.07 -37.76 84.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.26 -38.04 85.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.89 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -68.85 -38.58 79.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.551 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 77.0 mt -62.85 -48.81 86.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.598 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 60' ' ' ILE . 91.2 mt -64.71 -39.89 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.474 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -62.3 -45.93 91.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.747 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.54 -39.62 84.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.951 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 25' ' ' VAL . 6.6 tt -63.81 -48.08 78.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.643 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.342 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 26.4 pt . . . . . 0 C--O 1.237 0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -109.66 117.55 34.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.327 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.46 124.99 30.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.073 -173.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 57' ' ' ILE . 19.1 Cg_endo -77.01 111.5 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.106 1.87 . . . . 0.0 111.323 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG11 ' HE2' ' A' ' 46' ' ' PHE . 6.3 p -114.96 114.62 43.76 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.518 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.623 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.1 Cg_exo -48.64 126.98 15.4 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.176 2.584 . . . . 0.0 111.766 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.814 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 83.9 mtp180 -59.97 -33.6 72.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.102 -172.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -82.72 -13.83 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.575 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -94.91 -13.37 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.98 0.419 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.611 HG21 ' HD3' ' A' ' 56' ' ' LYS . 25.3 t -57.41 -33.48 44.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.773 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.9 61.07 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.002 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 t -88.75 -35.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 32' ' ' MET . 45.0 t -66.07 -36.28 77.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.426 0.632 . . . . 0.0 110.162 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.9 mm -81.59 -60.18 2.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.271 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.84 -116.73 4.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.656 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.56 -49.15 2.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 109.954 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -119.59 -0.64 10.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 112.0 22.04 6.09 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.567 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -51.05 -50.91 57.7 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.876 0.47 . . . . 0.0 111.68 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.507 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.1 tpt -68.3 -47.31 67.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.166 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.41 HD11 ' HB ' ' A' ' 44' ' ' ILE . 11.4 tt -69.23 -29.75 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.76 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 59.0 mttm -63.09 -42.44 99.62 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 7.2 tmtm? -65.73 -44.79 84.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.988 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 32' ' ' MET . 77.7 mt -60.29 -50.48 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.032 0.444 . . . . 0.0 110.761 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 mt-30 -62.31 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.031 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.38 -46.07 18.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.522 0.201 . . . . 0.0 110.971 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.69 -46.27 87.63 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.272 0.558 . . . . 0.0 111.146 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.53 -21.05 23.1 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.682 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.26 37.92 63.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.852 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 37' ' ' GLN . 25.7 m -113.17 -179.48 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 0.0 111.003 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -126.82 133.36 50.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 166.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 60' ' ' ILE . 72.1 mt -123.96 109.07 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.189 0.931 . . . . 0.0 109.301 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.89 136.89 52.94 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 75.4 m-85 -85.32 118.39 24.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.036 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.161 -175.987 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.457 0.646 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.814 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 27.9 mtpp -86.41 175.86 8.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 16' ' ' PRO . 46.0 mm -119.86 108.69 24.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.643 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -73.78 130.02 39.11 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -104.47 102.85 12.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.726 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.683 HD11 HD12 ' A' ' 74' ' ' ILE . 40.6 mt -89.61 136.21 24.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.403 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 40.0 mtm -145.1 144.23 30.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.63 -169.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 139.18 -124.51 2.81 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.147 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.34 138.3 12.37 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 123.438 2.759 . . . . 0.0 112.099 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.05 -49.28 16.62 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 113.399 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.07 -41.63 70.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.219 0.533 . . . . 0.0 110.625 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.0 tpp180 -65.49 -31.22 72.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.438 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 94.0 m -58.34 -44.7 88.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -70.46 -32.9 70.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.673 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 4.3 t60 -56.71 -50.05 73.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -70.03 -34.66 73.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.861 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.28 -41.39 98.44 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.012 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -66.78 -37.56 84.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.121 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 73.4 mt -57.13 -50.62 75.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.529 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 60' ' ' ILE . 68.5 mt -68.67 -44.81 82.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.039 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -61.06 -49.95 75.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.798 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.18 -39.57 75.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.97 -50.11 63.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.526 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' HD2' ' A' ' 18' ' ' PRO . 94.0 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.302 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 60' ' ' ILE . 29.3 pt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 14.7 p-10 -111.03 120.11 41.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.821 0.819 . . . . 0.0 109.544 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -116.65 133.77 22.99 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.985 -167.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HA ' HD13 ' A' ' 57' ' ' ILE . 11.1 Cg_exo -69.24 117.48 5.08 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 123.109 2.539 . . . . 0.0 112.13 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -132.25 108.63 13.67 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.368 0.604 . . . . 0.0 110.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.721 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 83.7 Cg_exo -48.81 141.44 21.19 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.543 2.828 . . . . 0.0 113.487 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -54.82 -53.7 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.725 0.298 . . . . 0.0 111.545 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.72 -26.87 67.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.113 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.9 m -79.16 -25.13 42.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.378 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.7 t -60.12 -32.69 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.01 -29.82 68.84 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.13 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -89.5 -35.33 7.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 21' ' ' SER . 61.1 t -68.19 -38.31 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.543 HD11 ' CE1' ' A' ' 46' ' ' PHE . 34.7 mm -79.37 -55.99 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.464 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.2 -134.3 12.07 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 2.5 mmp_? -105.39 -59.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 50.0 m -93.21 -18.19 22.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.859 174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 123.2 13.92 4.24 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.238 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 29' ' ' SER . 18.4 mp0 -57.21 -39.05 74.65 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.19 0.596 . . . . 0.0 111.352 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.5 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -68.82 -49.32 59.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.675 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.577 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -68.7 -30.02 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 110.402 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 32.3 mmtp -72.94 -29.72 63.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.91 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.92 -42.28 77.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 32' ' ' MET . 74.8 mt -60.65 -49.38 84.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.352 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.66 -27.34 68.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.294 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.34 -50.04 15.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.79 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.68 -53.22 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 111.173 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.47 -11.34 52.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.934 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.34 37.94 95.63 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.371 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.0 m -113.34 177.11 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.322 0.582 . . . . 0.0 110.827 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -122.36 123.44 41.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.681 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HD11 ' A' ' 33' ' ' ILE . 86.6 mt -105.68 108.43 25.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -115.47 114.99 25.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.148 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CE1' HD11 ' A' ' 26' ' ' ILE . 58.6 m-85 -70.93 114.23 8.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.525 0.678 . . . . 0.0 110.804 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.933 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.6 mt-10 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -96.21 175.69 6.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.757 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 43.4 mm -122.7 114.58 42.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.699 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -81.55 140.45 34.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.611 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -114.11 103.64 11.33 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 70' ' ' ALA . 45.1 mt -88.64 137.62 20.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.4 mtm -143.48 171.51 14.05 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.599 -173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 116.02 -128.74 8.14 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_exo -75.98 141.48 23.95 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.788 2.325 . . . . 0.0 111.204 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 27.9 Cg_exo -62.7 -35.69 67.69 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.563 2.842 . . . . 0.0 113.266 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.43 -31.04 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.548 0.69 . . . . 0.0 109.717 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.5 tpp180 -66.09 -27.09 67.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.676 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.1 m -55.77 -37.77 68.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.402 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 mt-10 -79.31 -30.89 43.07 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.453 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 73' ' ' ILE . 2.3 t-160 -57.56 -50.62 72.49 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -73.11 -32.82 65.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.208 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . . . -61.74 -41.07 97.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.955 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 18.4 tpt180 -63.5 -43.91 95.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.44 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 69' ' ' HIS . 70.3 mt -54.33 -50.51 56.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.804 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 60' ' ' ILE . 70.3 mt -71.36 -42.57 73.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.148 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -61.77 -50.27 73.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.93 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.036 0.446 . . . . 0.0 110.395 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.37 -48.18 80.9 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.5 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.67 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 60' ' ' ILE . 22.1 pt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 8.3 p-10 -117.24 128.64 55.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.08 122.8 23.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.996 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -65.42 103.53 0.55 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.082 2.522 . . . . 0.0 111.898 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.4 p -102.34 118.13 59.58 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.715 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 52.5 Cg_exo -56.01 122.41 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.59 2.194 . . . . 0.0 111.438 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.749 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 53.5 mtp180 -62.76 -28.16 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -73.53 -18.37 61.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 m -102.75 -11.37 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.94 -35.29 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.33 63.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.928 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.0 t -89.21 -34.17 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.138 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.88 -39.39 67.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.412 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 ' CE1' ' A' ' 46' ' ' PHE . 38.8 mm -86.42 -56.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.973 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.27 -127.45 8.66 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -113.35 -45.99 3.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.049 0.424 . . . . 0.0 110.342 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.2 m -95.6 -36.13 11.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.439 0.638 . . . . 0.0 109.843 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.632 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 128.38 12.63 2.77 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.596 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.64 -28.16 69.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 110.997 -174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 17.6 tpt -67.72 -43.82 79.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.371 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG21 ' A' ' 44' ' ' ILE . 10.9 tt -79.93 -24.73 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 74.4 mmtt -62.77 -40.43 97.27 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 32' ' ' MET . 53.2 tttm -59.85 -45.92 90.9 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.55 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -60.75 -49.24 85.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.56 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -59.69 -39.64 85.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.388 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.97 -49.35 38.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.252 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.0 -46.72 86.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.437 -173.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.747 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.572 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.41 44.1 7.6 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 34.4 m -129.31 172.98 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.277 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -117.69 137.35 52.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.695 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 33' ' ' ILE . 29.2 mt -123.44 106.06 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -105.75 119.05 38.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.066 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE1' HD11 ' A' ' 26' ' ' ILE . 55.8 m-85 -73.13 126.06 29.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 21.6 mtpp . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.167 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.715 ' CD ' ' HA ' ' A' ' 18' ' ' PRO . 4.0 mm-40 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.749 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.6 mtpp -92.47 160.69 14.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.677 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.9 mm -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.895 174.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -75.12 140.07 43.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 35.1 t-80 -118.06 108.43 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.592 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -88.68 131.49 35.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.7 mtp -131.03 128.24 39.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.88 0.371 . . . . 0.0 111.691 -162.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.05 -135.35 6.64 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.851 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 11.3 Cg_exo -69.17 150.08 71.39 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.403 2.735 . . . . 0.0 112.227 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 32.3 Cg_exo -60.04 -50.0 8.44 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -71.87 -30.51 65.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 109.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.747 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.35 -42.79 87.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.595 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.7 -40.35 87.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.824 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -74.19 -35.24 63.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 73' ' ' ILE . 17.9 t-160 -68.69 -41.5 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.93 -34.41 76.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.332 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -37.77 84.27 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.734 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -74.59 -31.88 62.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.487 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.515 HD12 ' HB2' ' A' ' 40' ' ' ALA . 74.6 mt -60.37 -50.48 80.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 109.933 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 76.7 mt -67.29 -39.5 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.714 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -64.55 -45.96 84.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.165 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -57.85 -40.1 79.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.819 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.29 -41.89 90.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.59 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 67.4 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.696 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 67' ' ' CYS . 16.7 pt . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.147 0.498 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.466 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 5.2 p-10 -97.71 122.04 40.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.951 175.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -119.31 125.67 27.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.044 -175.063 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 12.1 Cg_exo -69.29 104.58 1.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.187 2.592 . . . . 0.0 111.999 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 22' ' ' VAL . 11.2 p -106.75 113.65 62.6 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.282 0.563 . . . . 0.0 109.686 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.0 Cg_exo -60.4 129.76 31.06 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.098 2.532 . . . . 0.0 112.978 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.731 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 98.6 mtt180 -55.67 -29.94 60.2 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.996 0.81 . . . . 0.0 112.587 -172.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -71.96 -34.48 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.478 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -90.32 -19.72 23.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.447 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 17' ' ' VAL . 6.0 t -60.35 -33.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.56 87.71 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.125 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.31 -36.1 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.391 . . . . 0.0 110.391 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.0 -36.7 78.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.253 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 46' ' ' PHE . 36.8 mm -81.41 -58.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.59 -113.01 4.12 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -118.44 -61.02 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -93.51 -28.96 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.739 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 133.75 19.98 0.89 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.104 -175.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.22 -37.78 81.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.5 -40.82 69.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.562 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -75.02 -27.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 49.4 mtpt -63.72 -36.82 85.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.26 -43.92 96.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.15 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 73' ' ' ILE . 60.5 mt -63.47 -46.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.171 0.51 . . . . 0.0 110.468 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.73 -30.83 71.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.317 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -74.97 -48.07 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.56 -42.94 86.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -90.78 -16.41 28.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.851 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 31.96 65.64 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.983 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.4 m -113.58 176.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.413 0.625 . . . . 0.0 111.205 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -117.87 131.19 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.891 167.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.562 ' CG2' HD11 ' A' ' 33' ' ' ILE . 81.7 mt -115.34 108.54 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 45' ' ' GLN . 4.3 tp60 -123.73 131.67 53.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 26' ' ' ILE . 78.7 m-85 -84.07 131.17 34.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.447 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 24.8 mtpp . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.183 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 1.6 mp0 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.356 0.598 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.731 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 30.3 mtpp -109.67 165.95 11.28 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.6 mm -114.78 110.12 30.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.022 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.75 140.15 38.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -114.49 108.25 16.6 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.517 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.634 HG21 ' HB3' ' A' ' 70' ' ' ALA . 38.8 mt -88.46 127.94 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.5 mtm -141.54 167.01 23.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 111.357 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.13 -118.65 3.86 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.4 135.92 10.9 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.999 2.466 . . . . 0.0 111.449 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 50.5 Cg_exo -57.23 -36.05 98.98 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.478 2.785 . . . . 0.0 112.915 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.87 -36.62 70.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.078 0.942 . . . . 0.0 109.799 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.657 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 18.7 tpp85 -71.6 -31.91 67.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.897 -171.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.522 ' HB2' HG12 ' A' ' 13' ' ' ILE . 21.2 p -58.85 -41.85 87.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.46 -37.03 79.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.059 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -61.56 -46.12 91.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.103 0.477 . . . . 0.0 109.901 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.634 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.54 -28.13 62.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.879 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.25 -42.11 85.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.0 tmm_? -65.62 -45.41 83.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.976 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 36' ' ' ILE . 66.6 mt -55.06 -52.43 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 65.0 mt -67.88 -43.33 86.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -61.28 -48.84 79.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.1 -32.43 74.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.96 -49.78 68.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 17' ' ' VAL . 88.7 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.907 HD11 HD12 ' A' ' 60' ' ' ILE . 30.9 pt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 36.6 m-20 -116.86 110.17 18.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.128 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -110.82 128.81 24.72 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.004 -171.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.6 Cg_exo -71.44 99.06 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.419 2.746 . . . . 0.0 111.933 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 17' ' ' VAL . 14.3 p -110.15 109.82 58.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.451 0.643 . . . . 0.0 110.677 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 50.0 Cg_exo -55.91 149.64 50.55 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.217 2.611 . . . . 0.0 113.425 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -68.18 -26.14 65.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.759 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -79.34 -22.88 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.328 0.585 . . . . 0.0 109.526 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.8 m -86.44 -37.69 18.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.534 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 16.4 m -57.69 -27.17 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.22 92.27 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HB ' HD21 ' A' ' 77' ' ' LEU . 40.6 t -89.6 -31.61 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.812 0.339 . . . . 0.0 110.365 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 21' ' ' SER . 93.7 t -61.79 -38.63 80.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.168 0.509 . . . . 0.0 109.851 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.08 -58.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.115 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.6 -138.1 13.65 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.686 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -69.24 -77.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.379 . . . . 0.0 110.586 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.459 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 66.1 m -93.79 -53.5 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.642 0.734 . . . . 0.0 109.567 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -174.29 20.54 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.362 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 1.6 mm-40 -47.05 -53.03 13.53 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.398 0.679 . . . . 0.0 111.827 -169.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.548 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.9 tpt -68.45 -45.16 73.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.116 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 HG22 ' A' ' 44' ' ' ILE . 8.3 tt -72.47 -29.77 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.812 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 28.2 mmmt -69.47 -40.67 76.95 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.58 -46.15 91.1 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.678 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 32' ' ' MET . 84.0 mt -60.71 -49.37 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.659 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.02 -29.9 67.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.814 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -87.43 -35.69 18.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.653 0.264 . . . . 0.0 111.671 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.04 -40.98 78.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 0.0 110.018 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -93.03 -23.91 18.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.226 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.94 47.55 9.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.227 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.5 m -127.4 177.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.5 tpt180 -120.04 128.35 53.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.842 168.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.633 HD13 HD11 ' A' ' 74' ' ' ILE . 72.3 mt -125.92 112.59 30.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.964 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.92 138.78 39.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.125 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' ALA . 12.5 m-85 -85.5 121.0 27.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.574 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.183 178.815 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.9 mt-10 . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.335 0.588 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 56.0 mtpt -107.41 155.63 19.81 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.836 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 38.1 mm -98.51 104.69 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.682 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.54 140.38 41.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.979 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -115.58 109.95 18.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 13' ' ' ILE . 40.0 mt -93.49 146.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.713 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -145.33 166.87 24.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.945 0.402 . . . . 0.0 111.989 -172.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 122.91 -124.92 5.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -81.03 134.89 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.994 2.463 . . . . 0.0 110.75 174.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 74.6 Cg_exo -51.82 -42.92 54.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.617 2.878 . . . . 0.0 113.293 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.26 -39.94 65.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.7 tpp180 -61.7 -34.64 76.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.979 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 85.2 m -57.94 -42.9 85.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.458 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.84 -41.58 91.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 73' ' ' ILE . 24.1 t60 -66.65 -38.75 87.53 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -66.95 -35.51 80.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.27 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.5 -36.86 83.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.441 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -67.79 -39.28 84.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.472 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.6 mt -59.93 -49.56 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.438 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.633 HD11 HD13 ' A' ' 44' ' ' ILE . 84.5 mt -65.28 -45.27 94.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.781 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.73 -37.08 86.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.88 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.75 -43.42 80.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.404 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD21 ' HB ' ' A' ' 24' ' ' VAL . 9.8 tt -63.54 -43.2 97.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.932 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 21.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.113 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 60' ' ' ILE . 38.6 pt . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -114.34 126.88 55.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.308 173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -131.04 117.05 16.97 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.43 . . . . 0.0 111.603 -176.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 17.2 Cg_exo -66.52 102.24 0.59 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.219 2.612 . . . . 0.0 112.298 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.65 117.91 58.75 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.3 Cg_exo -57.17 131.15 43.42 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.241 2.628 . . . . 0.0 112.371 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.8 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 76.6 mtt180 -66.29 -26.44 67.33 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.815 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -80.51 -15.15 57.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.0 110.242 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.1 m -101.41 -14.82 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.435 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 18' ' ' PRO . 24.1 t -56.49 -38.57 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.451 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.93 -35.47 53.63 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.751 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.34 -36.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.662 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 21' ' ' SER . 60.0 t -62.32 -36.97 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.417 0.627 . . . . 0.0 109.904 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.476 HD11 ' CE1' ' A' ' 46' ' ' PHE . 35.9 mm -78.46 -58.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.614 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.87 63.5 1.67 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.889 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 63.97 -87.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.492 0.717 . . . . 0.0 112.162 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.55 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 75.4 m -84.03 -20.37 32.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.128 0.49 . . . . 0.0 110.339 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 119.9 4.59 11.4 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 29' ' ' SER . 0.8 OUTLIER -63.03 -15.07 55.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.385 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 tpt -80.08 -45.36 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.595 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.717 HG13 HD12 ' A' ' 36' ' ' ILE . 8.0 tt -74.78 -21.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 31.7 mmtp -57.4 -49.65 75.53 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.153 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 33' ' ' ILE . 35.6 mt -61.36 -58.29 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 0.0 110.148 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -65.3 -23.78 67.12 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.133 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.55 -45.11 19.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.072 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.18 -53.46 24.8 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 110.441 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -77.41 -14.43 59.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.565 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.78 34.33 88.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.254 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.11 171.22 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.22 0.533 . . . . 0.0 110.725 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.4 tpp180 -116.75 125.56 51.82 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.333 170.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 33' ' ' ILE . 84.7 mt -110.83 114.0 45.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.34 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -113.26 155.76 24.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.647 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 82.0 m-85 -111.21 112.65 24.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.932 0.396 . . . . 0.0 110.97 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 9.1 mtpm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.366 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.184 0.516 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.8 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 57.3 mtpt -123.26 146.19 48.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.64 107.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.33 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -77.38 140.62 39.96 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 65.4 t-80 -118.16 109.68 16.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.971 HD12 HD11 ' A' ' 13' ' ' ILE . 46.8 mt -89.23 147.64 5.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 49.5 mtt -130.62 137.22 49.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.492 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 135.85 -134.95 7.51 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.264 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -81.29 139.92 11.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.554 2.836 . . . . 0.0 112.382 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 76.7 Cg_exo -50.43 -50.09 14.59 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.242 1.961 . . . . 0.0 112.931 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.67 -40.1 80.3 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 0.0 110.725 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.601 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 12.8 tpp180 -64.82 -40.36 95.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.329 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 84.2 m -59.58 -45.33 92.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.364 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 45.0 mt-10 -63.0 -36.65 84.26 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 111.204 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.94 -46.87 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.041 0.448 . . . . 0.0 109.812 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.71 70.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.284 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.81 98.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.674 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' A' ' 75' ' ' ASN . 58.9 ttt180 -76.53 -24.57 53.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.721 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 36' ' ' ILE . 58.0 mt -57.47 -50.54 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.663 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 56.8 mt -68.93 -45.9 79.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.761 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 72' ' ' ARG . 62.0 t30 -60.73 -48.32 82.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.743 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.29 -35.31 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.745 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.53 -44.43 94.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.732 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.823 HD11 HD12 ' A' ' 60' ' ' ILE . 38.4 pt . . . . . 0 C--O 1.238 0.453 0 CA-C-O 121.126 0.488 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 6.3 p-10 -117.65 129.42 55.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.827 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.04 127.79 24.28 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.085 0.469 . . . . 0.0 111.973 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.1 Cg_exo -70.72 112.78 3.33 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.226 2.617 . . . . 0.0 111.897 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.1 113.53 26.37 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.559 0.695 . . . . 0.0 110.47 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 22' ' ' VAL . 46.9 Cg_exo -57.95 138.78 87.74 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.126 2.551 . . . . 0.0 112.013 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 71.3 mtp180 -62.9 -34.52 77.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.722 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -69.08 -26.28 64.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB3' HD22 ' A' ' 78' ' ' LEU . 18.9 m -86.86 -28.83 22.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.267 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 18' ' ' PRO . 45.7 t -55.28 -35.41 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.882 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.7 61.82 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.799 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.7 t -82.53 -38.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 21' ' ' SER . 33.5 t -62.49 -37.8 79.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.398 0.618 . . . . 0.0 109.938 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE2' ' A' ' 46' ' ' PHE . 34.9 mm -79.49 -51.84 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.599 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.06 30.9 49.77 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.365 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 72.04 -56.43 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.612 0.765 . . . . 0.0 112.393 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 m -78.03 -25.26 47.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 111.002 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 100.13 -0.2 56.06 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -169.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -47.81 -49.59 28.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.691 0.796 . . . . 0.0 111.947 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.57 -41.45 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.73 0.3 . . . . 0.0 111.594 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.4 tt -73.03 -27.43 24.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.487 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 30.0 mmmt -68.96 -35.31 76.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -60.93 -43.51 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.496 HG23 HG21 ' A' ' 73' ' ' ILE . 70.6 mt -62.34 -50.54 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.544 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -58.27 -34.49 70.57 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.593 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -78.21 -40.17 38.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.8 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.56 -47.25 64.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.069 0.461 . . . . 0.0 110.786 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.72 -16.11 40.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 44.67 54.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.519 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.4 m -125.14 176.96 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.402 0.62 . . . . 0.0 111.178 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -120.78 129.99 53.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.46 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -123.79 107.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.8 139.45 53.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.61 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 62.4 m-85 -84.1 133.2 34.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.416 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.061 176.368 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' PHE . 16.5 mtpp -90.09 161.96 15.55 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 110.646 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 34.8 mm -107.92 105.61 19.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.103 0.478 . . . . 0.0 110.133 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -73.23 127.75 33.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -103.79 101.92 11.74 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.394 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 13' ' ' ILE . 41.2 mt -91.83 131.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.053 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.8 mtm -143.12 166.66 24.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.16 -122.09 4.95 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.6 Cg_exo -78.89 131.18 9.94 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.039 2.492 . . . . 0.0 110.896 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.4 Cg_exo -57.07 -36.97 99.43 Favored 'Trans proline' 0 N--CA 1.475 0.384 0 C-N-CA 123.344 2.696 . . . . 0.0 113.122 -176.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.39 -32.59 60.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 11.4 tpp180 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.391 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 13' ' ' ILE . 84.4 m -54.14 -40.1 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.276 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -66.11 -40.33 90.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.903 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 73' ' ' ILE . 11.9 t-80 -66.73 -43.1 85.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.189 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.68 -34.34 78.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -43.79 98.31 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.535 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -64.78 -35.26 80.52 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.244 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.496 HG21 HG23 ' A' ' 36' ' ' ILE . 64.6 mt -62.25 -50.24 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.0 110.208 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 44' ' ' ILE . 68.6 mt -66.49 -46.62 86.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.962 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -70.19 -32.42 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -33.83 76.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD22 HG22 ' A' ' 25' ' ' VAL . 8.4 tt -63.9 -44.62 92.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 21' ' ' SER . 65.8 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.515 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.753 HD11 HD12 ' A' ' 60' ' ' ILE . 39.8 pt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -106.29 105.28 15.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.233 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -105.45 132.04 21.23 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.2 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 5.5 Cg_exo -72.78 112.92 3.61 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.289 2.659 . . . . 0.0 112.191 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 HD21 ' A' ' 78' ' ' LEU . 7.4 p -121.02 107.3 37.87 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 72.4 Cg_exo -48.53 133.45 26.06 Favored 'Trans proline' 0 N--CA 1.47 0.118 0 C-N-CA 123.505 2.803 . . . . 0.0 112.39 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 22.8 mtm180 -62.84 -28.32 69.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.693 -176.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.7 -32.14 63.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.249 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.6 m -79.99 -24.22 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' PRO . 62.3 t -54.97 -35.06 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.173 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.07 65.49 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.418 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.61 -36.89 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 0.0 110.556 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 21' ' ' SER . 38.3 t -67.91 -40.39 83.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.596 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -82.32 -46.65 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.38 -118.74 4.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.041 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -97.96 -77.74 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.484 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 21.0 m -82.56 -55.63 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.74 0.781 . . . . 0.0 109.443 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 175.18 32.21 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 4.2 mm-40 -57.49 -47.49 81.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.261 -0.47 . . . . 0.0 111.724 -167.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.6 tpt -66.55 -45.88 77.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 44' ' ' ILE . 6.1 tt -69.0 -31.15 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.912 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 92.9 mttt -62.97 -42.35 99.8 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -66.6 -37.95 85.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 32' ' ' MET . 75.6 mt -63.16 -51.13 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.0 -35.71 73.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.581 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -77.98 -32.98 51.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.94 -46.52 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -81.69 -28.43 33.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.465 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.31 39.03 8.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.4 m -122.47 175.72 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.381 0.61 . . . . 0.0 111.517 -174.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -116.43 127.0 54.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.863 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -125.54 108.61 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.43 154.18 27.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.482 ' HE2' HG22 ' A' ' 22' ' ' VAL . 4.4 m-85 -100.78 120.68 40.46 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.213 0.53 . . . . 0.0 112.055 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.831 172.159 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.9 mt-10 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 44.8 mtpt -78.24 177.78 8.14 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.665 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.1 mm -115.24 113.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.426 0.631 . . . . 0.0 111.174 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.745 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -84.79 140.6 31.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -110.83 101.51 10.11 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.753 HD12 HD11 ' A' ' 13' ' ' ILE . 21.5 mt -91.24 137.37 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.1 mtm -142.82 163.33 33.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 111.823 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.04 -135.53 9.75 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.61 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 7.7 Cg_exo -69.27 150.86 71.67 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.675 2.25 . . . . 0.0 111.692 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.08 -48.85 5.69 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.538 2.159 . . . . 0.0 112.742 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.57 -34.79 77.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.429 0.633 . . . . 0.0 109.431 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.635 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.8 tpp180 -61.82 -38.95 90.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.587 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 76.9 m -58.95 -47.99 83.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.228 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -69.53 -34.99 75.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.678 0.275 . . . . 0.0 110.823 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -62.68 -46.35 88.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.469 . . . . 0.0 110.169 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -71.06 -35.72 72.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.42 -36.9 79.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.824 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 72' ' ' ARG . 11.5 ttm180 -66.08 -43.04 88.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.187 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.68 -49.49 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.613 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 44' ' ' ILE . 77.0 mt -68.93 -46.24 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.28 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.01 -43.67 98.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.25 -34.0 77.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.275 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.88 -45.64 85.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.032 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.4 mt . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.769 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 60' ' ' ILE . 38.1 pt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.51 105.34 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.128 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.81 130.29 23.0 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.8 Cg_exo -75.06 104.15 1.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.372 2.715 . . . . 0.0 112.259 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -112.83 113.02 50.21 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.367 0.603 . . . . 0.0 110.214 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.36 134.57 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 123.096 2.531 . . . . 0.0 112.042 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -61.04 -33.14 72.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.035 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.35 -22.87 60.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 109.798 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 25' ' ' VAL . 17.9 m -87.03 -25.74 24.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.037 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.3 -32.28 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.616 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.44 -33.73 62.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.213 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.71 -34.36 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.644 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 21' ' ' SER . 95.6 t -64.52 -38.55 82.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 46' ' ' PHE . 42.8 mm -79.83 -54.76 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.205 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.579 ' O ' ' HD2' ' A' ' 28' ' ' ARG . . . 105.04 -128.52 9.47 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 15.0 mmm180 -125.76 -29.7 3.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.064 0.459 . . . . 0.0 110.186 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -114.32 3.72 15.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.853 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 10.44 84.04 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -63.89 -32.53 74.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.841 0.456 . . . . 0.0 111.4 -172.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -70.81 -45.35 64.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 44' ' ' ILE . 7.9 tt -72.2 -28.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.188 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -67.22 -36.53 81.87 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.01 -44.21 89.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.239 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 HG21 ' A' ' 73' ' ' ILE . 78.9 mt -58.11 -52.09 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.231 0.539 . . . . 0.0 110.523 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.84 -33.68 75.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.411 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.29 -44.1 65.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.32 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.85 -53.15 29.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.364 . . . . 0.0 111.409 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -77.53 -27.08 51.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.89 42.22 9.91 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 70' ' ' ALA . 20.4 m -125.79 174.34 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.074 -174.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.6 tpp180 -116.91 131.86 56.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.169 167.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 33' ' ' ILE . 80.4 mt -111.35 108.64 26.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -118.23 117.1 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.694 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 26' ' ' ILE . 96.9 m-85 -72.66 126.04 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -175.429 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 121.115 0.483 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -86.87 149.37 24.87 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mm -95.96 108.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.418 0.627 . . . . 0.0 110.115 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.767 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.58 123.61 26.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.597 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.52 101.29 12.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 13' ' ' ILE . 47.0 mt -89.07 136.09 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -143.52 164.37 30.55 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.058 -168.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.11 -115.81 2.98 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.7 Cg_endo -85.53 126.69 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.263 2.642 . . . . 0.0 110.212 172.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 52.8 Cg_exo -56.02 -35.44 94.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.474 2.783 . . . . 0.0 113.408 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.38 -33.06 32.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.001 0.429 . . . . 0.0 110.175 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.4 tpp180 -65.78 -28.73 69.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.381 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 13' ' ' ILE . 82.9 m -59.63 -30.09 68.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.48 -32.21 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.019 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.486 ' O ' HG13 ' A' ' 73' ' ' ILE . 27.3 t-80 -64.27 -42.8 96.29 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.21 -33.77 73.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.215 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.22 98.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.5 -46.25 90.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 36' ' ' ILE . 67.1 mt -55.0 -51.42 53.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.732 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.648 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 75.6 mt -66.76 -48.21 80.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.791 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -59.84 -46.57 88.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.192 0.52 . . . . 0.0 111.611 -176.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.72 -36.1 79.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.544 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.76 -40.73 79.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 77.3 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 60' ' ' ILE . 45.8 pt . . . . . 0 C--O 1.236 0.35 0 CA-C-O 121.69 0.757 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 7.1 m-20 -123.44 112.46 17.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.334 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.03 129.0 24.98 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.383 -171.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 18.4 Cg_endo -79.52 106.89 2.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.42 2.08 . . . . 0.0 111.52 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 56' ' ' LYS . 7.6 p -113.81 113.23 47.42 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.419 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.2 Cg_exo -52.14 134.11 49.08 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.335 2.69 . . . . 0.0 112.522 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -58.73 -35.09 72.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.447 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -80.71 -6.08 57.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.698 0.285 . . . . 0.0 111.207 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -107.11 -16.9 14.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.4 t -57.0 -38.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.194 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.25 57.0 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.006 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.6 t -85.08 -39.15 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.368 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 77' ' ' LEU . 42.5 t -63.68 -37.19 79.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.35 0.595 . . . . 0.0 110.108 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 46' ' ' PHE . 40.4 mm -79.61 -50.95 17.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.853 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.79 -147.87 19.18 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -83.09 -70.77 0.53 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.418 0.609 . . . . 0.0 110.471 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -96.76 26.22 4.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.53 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 78.81 7.81 88.09 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.476 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 18.4 mt-10 -54.54 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.603 0.761 . . . . 0.0 112.538 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.2 tpt -74.47 -50.63 17.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.72 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 tt -69.09 -27.41 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.412 . . . . 0.0 110.363 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -68.25 -40.14 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.045 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -59.6 -42.51 92.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG23 HG21 ' A' ' 73' ' ' ILE . 67.6 mt -63.87 -54.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.819 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.26 -39.02 81.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.036 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -81.87 -26.21 34.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.439 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.5 -49.77 24.93 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.345 0.593 . . . . 0.0 109.78 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . -84.16 -9.86 58.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.748 -175.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.66 31.98 80.08 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.255 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 172.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.719 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.9 ttm180 -117.75 129.18 55.54 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 60' ' ' ILE . 68.7 mt -119.53 108.93 24.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.875 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -119.16 131.85 55.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 110.552 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.599 ' CE1' HD11 ' A' ' 26' ' ' ILE . 85.8 m-85 -81.17 115.06 20.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.948 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 8.6 mtpm? . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.212 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.964 0.412 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 22.3 mtpp -81.99 174.75 10.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.562 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 48.4 mm -120.96 111.11 30.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.117 0.485 . . . . 0.0 110.227 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -82.2 125.18 30.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 171.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -102.56 102.96 13.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.375 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 44' ' ' ILE . 47.0 mt -92.86 144.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.603 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 50.2 mtm -145.16 174.93 10.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.888 0.375 . . . . 0.0 111.935 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 112.7 -125.54 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.097 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.493 ' CG ' ' HB3' ' A' ' 66' ' ' ARG . 5.8 Cg_exo -82.89 134.12 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.232 2.621 . . . . 0.0 111.689 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 56.4 Cg_exo -53.56 -34.61 73.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.818 3.012 . . . . 0.0 113.586 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.59 -42.58 24.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.659 0.743 . . . . 0.0 109.759 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.547 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 18.5 tpp85 -67.57 -34.29 76.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.814 -176.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.5 p -61.86 -40.48 95.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.026 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -68.26 -34.25 75.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.375 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 51.9 t-80 -63.7 -44.78 92.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.01 -36.3 83.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.444 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.03 87.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -69.69 -35.82 75.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.524 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.2 mt -60.52 -49.01 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.79 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 44' ' ' ILE . 87.4 mt -64.28 -40.94 90.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.793 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.65 -37.77 82.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.944 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.87 -36.27 78.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.428 0.633 . . . . 0.0 110.012 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 25' ' ' VAL . 9.7 tt -66.83 -44.15 81.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.685 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 81.0 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.669 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 60' ' ' ILE . 42.0 pt . . . . . 0 C--O 1.233 0.196 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 22.2 m-20 -122.57 114.18 20.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.099 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -113.04 126.23 28.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.177 -175.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 15.0 Cg_exo -67.15 116.45 4.18 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.908 2.405 . . . . 0.0 111.965 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.627 HG23 HD21 ' A' ' 78' ' ' LEU . 7.6 p -123.64 108.98 30.73 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 121.506 0.669 . . . . 0.0 110.807 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 75.9 Cg_exo -50.96 131.86 35.97 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.192 2.595 . . . . 0.0 112.054 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 48.2 mtp85 -58.22 -32.5 68.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.716 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.43 . . . . 0.0 110.535 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 25' ' ' VAL . 17.9 m -88.42 -23.28 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.9 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.51 -32.7 65.04 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.604 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.39 -36.93 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.69 0.281 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 77' ' ' LEU . 48.2 t -65.34 -37.02 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 110.444 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.8 mm -81.51 -61.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.174 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.12 -152.1 18.46 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.641 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -37.49 9.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.246 0.546 . . . . 0.0 109.957 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 m -106.23 3.06 27.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.024 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 74.59 24.59 72.24 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -168.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.16 90.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.488 -0.856 . . . . 0.0 111.909 -174.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -72.77 -42.25 64.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.03 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 30' ' ' GLY . 5.7 tt -66.27 -30.83 51.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 48.7 mttp -69.61 -45.99 67.3 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -54.16 -45.55 72.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 32' ' ' MET . 62.2 mt -65.39 -48.97 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.737 0.304 . . . . 0.0 110.921 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.498 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 46.1 mt-30 -59.77 -33.69 72.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.55 -42.96 23.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.251 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.18 -37.1 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.46 -14.91 19.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.532 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.32 47.16 53.49 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.499 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 37' ' ' GLN . 31.5 m -124.77 176.23 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.283 -174.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 19.0 tpt180 -116.57 128.91 55.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.247 168.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -113.28 108.79 26.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -122.78 129.87 52.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 26' ' ' ILE . 38.0 m-85 -85.11 123.7 30.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 111.456 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 15.1 mttp . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.592 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 13.9 mp0 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 23.6 mtpp -83.49 178.66 7.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.09 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 50.2 mm -117.45 114.04 44.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.342 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.835 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -82.45 130.37 35.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -104.42 101.46 11.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 13' ' ' ILE . 48.9 mt -88.71 132.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.9 mtm -143.21 160.07 41.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.297 0.57 . . . . 0.0 111.754 -170.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.23 -119.48 2.65 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -175.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -82.04 131.0 6.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.675 2.25 . . . . 0.0 110.499 172.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 40.8 Cg_exo -57.23 -28.93 81.8 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.254 2.636 . . . . 0.0 112.863 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.04 -40.05 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 110.075 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.4 tpp180 -60.59 -35.49 76.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.82 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' HG12 ' A' ' 13' ' ' ILE . 85.7 m -56.6 -33.91 66.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.8 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.69 -43.48 72.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -69.19 -39.83 78.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.0 0.429 . . . . 0.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.7 -30.94 70.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.424 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.432 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.95 -41.3 87.09 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.337 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -65.47 -42.47 92.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.916 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.89 -50.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.395 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.0 mt -69.73 -51.01 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.148 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -62.54 -41.48 98.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.866 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.44 -35.79 82.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.423 . . . . 0.0 110.22 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 25' ' ' VAL . 59.0 tp -63.84 -47.61 80.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 79.3 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.646 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 60' ' ' ILE . 41.6 pt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.055 0.455 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.57 124.71 43.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.457 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 t -123.15 121.76 27.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.61 0.243 . . . . 0.0 111.336 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.1 Cg_exo -70.74 104.37 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.906 2.404 . . . . 0.0 111.928 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 p -118.09 105.88 46.25 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.644 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 85.3 Cg_exo -46.82 133.53 17.49 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.447 2.765 . . . . 0.0 112.604 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.677 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 38.4 mtt180 -60.4 -29.48 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -83.18 -13.13 56.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.9 m -99.61 -14.52 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.785 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 HG21 ' HD3' ' A' ' 56' ' ' LYS . 28.0 t -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.133 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.04 -24.57 60.87 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.9 -42.04 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 21' ' ' SER . 60.5 t -61.89 -37.24 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.877 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 46' ' ' PHE . 47.0 mm -79.66 -51.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.616 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.4 44.24 11.44 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.876 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 65.6 -73.14 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.457 0.703 . . . . 0.0 111.828 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 m -75.98 -16.55 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.701 0.286 . . . . 0.0 111.73 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 97.15 2.02 59.34 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -173.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.53 -32.88 69.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.094 -0.553 . . . . 0.0 111.751 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.1 tpt -74.48 -43.0 58.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.949 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.552 HD11 ' HB ' ' A' ' 44' ' ' ILE . 13.0 tt -69.32 -31.34 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 7.2 mmpt? -65.26 -36.11 83.11 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.69 174.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 32' ' ' MET . 28.1 tptp -62.59 -51.02 68.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.259 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 73' ' ' ILE . 73.4 mt -60.69 -50.26 81.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.5 -33.08 74.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.064 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -75.41 -32.24 60.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.989 0.423 . . . . 0.0 110.456 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.28 -46.84 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.053 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.12 -28.44 20.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.844 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.58 40.17 7.9 Favored Glycine 0 CA--C 1.517 0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.773 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 28.8 m -121.93 176.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 0.0 111.194 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -118.58 131.98 56.2 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 33' ' ' ILE . 85.0 mt -111.92 109.01 26.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.463 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.564 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 15.7 tm0? -121.71 120.85 35.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 26' ' ' ILE . 80.4 m-85 -74.02 116.4 14.6 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.509 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.145 0.498 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.677 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 26.9 mtpp -88.18 177.34 6.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 50.1 mm -120.91 107.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.618 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -79.55 140.08 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 45' ' ' GLN . 3.2 p-80 -118.91 112.46 19.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.121 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 13' ' ' ILE . 22.2 mt -92.17 148.77 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.623 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 mtm -142.92 175.23 9.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 111.86 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.66 -137.37 14.19 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.032 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 11.2 Cg_exo -67.13 148.31 80.79 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.72 2.28 . . . . 0.0 111.472 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 37.0 Cg_exo -60.11 -48.3 12.52 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.502 2.135 . . . . 0.0 112.484 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.75 -32.69 74.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.462 0.649 . . . . 0.0 109.739 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 5.7 tpp85 -64.96 -37.21 86.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.715 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.87 -48.53 81.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.11 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.67 -33.43 68.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 0.0 111.27 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' HG13 ' A' ' 73' ' ' ILE . 3.5 t-160 -61.1 -49.75 76.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -68.6 -31.92 71.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.43 92.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.633 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -64.85 -34.78 79.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 36' ' ' ILE . 69.6 mt -62.76 -51.27 74.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.024 0.44 . . . . 0.0 110.698 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 60' ' ' ILE . 53.7 mt -66.06 -43.88 92.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.641 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.92 -36.42 83.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.615 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.45 -38.21 80.15 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.5 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.231 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.725 -173.765 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.785 HD11 HD12 ' A' ' 60' ' ' ILE . 32.7 pt . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.813 0.339 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -121.6 105.92 10.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.526 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -104.25 131.76 21.62 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.9 Cg_exo -70.2 108.28 2.13 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.546 2.831 . . . . 0.0 111.968 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.561 HG11 ' HE1' ' A' ' 46' ' ' PHE . 7.8 p -113.97 113.38 46.91 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.984 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.67 128.34 25.89 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.417 2.078 . . . . 0.0 111.253 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -62.5 -22.55 66.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.834 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.18 -27.76 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.5 m -83.33 -23.41 32.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.471 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.51 -35.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.36 -29.98 64.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.469 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -88.93 -35.25 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 110.442 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 21' ' ' SER . 47.8 t -66.84 -39.13 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.317 0.58 . . . . 0.0 109.923 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.584 HD11 ' CE2' ' A' ' 46' ' ' PHE . 37.2 mm -79.52 -45.18 23.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.965 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.08 -86.02 1.29 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.138 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -133.94 -72.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.304 0.242 . . . . 0.0 110.368 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -109.38 44.52 1.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.012 0.434 . . . . 0.0 110.262 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 64.11 23.69 68.11 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -60.65 -43.85 97.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.389 -0.906 . . . . 0.0 111.364 -168.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.3 tpt -77.42 -34.14 54.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 44' ' ' ILE . 9.0 tt -78.1 -23.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.843 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 73.3 mmtt -63.25 -36.52 83.94 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 32' ' ' MET . 17.8 tppt? -63.24 -44.29 95.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.486 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.97 -52.14 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.466 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.571 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 44.6 mt-30 -61.86 -27.6 68.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.352 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -75.34 -49.37 19.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.921 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -68.96 -43.45 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 111.35 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.72 34.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.555 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.95 32.75 66.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.763 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 m -113.75 -179.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.443 0.639 . . . . 0.0 111.533 -173.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.571 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 31.4 tpt180 -123.05 135.25 54.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.951 169.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.6 HG21 HD11 ' A' ' 33' ' ' ILE . 89.7 mt -116.54 109.09 26.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.016 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.813 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 12.8 mm100 -97.05 107.74 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.752 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CE2' HD11 ' A' ' 26' ' ' ILE . 27.2 m-85 -73.43 111.28 8.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.103 0.478 . . . . 0.0 109.765 174.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt . . . . . 0 N--CA 1.44 -0.953 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.326 -176.636 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.489 0.661 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 17' ' ' VAL . 47.5 tttp -100.07 170.65 8.34 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.312 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.98 117.97 57.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.307 0.575 . . . . 0.0 111.218 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -87.53 133.53 33.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 27.6 t60 -111.69 101.98 10.31 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.332 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 13' ' ' ILE . 31.6 mt -89.23 139.97 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.049 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.8 mtm -139.82 156.42 46.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 111.796 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.61 -126.05 4.57 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.255 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.0 Cg_exo -78.57 137.59 14.69 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.245 2.63 . . . . 0.0 111.604 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 77.4 Cg_exo -51.84 -49.28 17.78 Favored 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 122.717 2.278 . . . . 0.0 113.083 -177.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.52 -38.79 84.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.175 0.512 . . . . 0.0 110.533 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.612 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 23.9 tpp180 -63.95 -29.22 70.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.733 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.0 m -62.57 -46.47 88.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.69 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.0 110.274 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.49 -43.68 96.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.251 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.85 -32.68 65.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.583 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -59.32 -42.48 91.53 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.58 0.705 . . . . 0.0 109.361 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -62.83 -42.28 99.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.73 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -57.69 -52.11 61.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 110.529 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.641 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.7 mt -64.73 -50.64 74.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.093 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -67.1 -32.42 73.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.458 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.23 -31.67 72.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.261 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.85 -42.22 61.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.563 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 83.8 mt . . . . . 0 C--O 1.224 -0.265 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.241 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.901 HD11 HD12 ' A' ' 60' ' ' ILE . 39.6 pt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -111.54 123.44 50.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -122.52 123.86 26.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.33 -173.516 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 13.8 Cg_exo -68.47 105.37 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.734 2.289 . . . . 0.0 111.801 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.512 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -117.17 110.02 41.83 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.363 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.0 Cg_exo -47.46 129.99 17.21 Favored 'Trans proline' 0 CA--C 1.522 -0.11 0 C-N-CA 123.232 2.621 . . . . 0.0 112.129 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -62.96 -28.17 69.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.845 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -75.92 -24.8 55.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.467 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -92.16 -14.78 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.996 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -33.86 46.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.41 68.23 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.618 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -83.82 -43.8 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 109.977 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.78 -41.35 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.633 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.7 mm -79.96 -67.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.708 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 26' ' ' ILE . . . 75.76 -169.9 54.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.077 -175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.84 117.34 7.4 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.711 -0.288 . . . . 0.0 110.557 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m 62.53 16.36 8.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 71.84 26.5 72.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.166 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.26 -39.48 75.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 111.654 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.2 tpt -70.76 -39.3 73.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.981 0.419 . . . . 0.0 110.555 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 44' ' ' ILE . 7.3 tt -76.3 -26.54 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.081 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 45.1 mmtm -61.72 -43.1 99.51 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -58.87 -41.71 87.74 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.708 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 73' ' ' ILE . 70.2 mt -66.81 -49.96 69.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 110.852 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.89 -28.16 69.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.559 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -80.91 -51.26 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.54 -53.16 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.088 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.614 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -79.3 -18.51 52.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.403 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.43 40.44 60.06 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.5 m -126.81 165.66 24.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.975 0.417 . . . . 0.0 111.159 -174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 13.7 ttm180 -104.87 135.27 46.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.512 167.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.558 HG21 HD11 ' A' ' 33' ' ' ILE . 88.9 mt -116.06 108.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.53 106.67 12.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.016 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 26' ' ' ILE . 87.1 m-85 -65.15 136.4 56.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 mttt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.931 177.325 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 42.2 mt-10 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.387 0.613 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -92.17 172.61 8.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.76 114.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.434 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -85.9 140.48 30.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 24.2 t60 -116.24 108.88 16.67 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.48 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 13' ' ' ILE . 55.0 mt -88.3 148.8 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.886 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.1 mmt -122.27 147.38 46.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.61 -137.88 11.17 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.515 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 56.6 Cg_endo -91.09 147.59 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.436 2.757 . . . . 0.0 112.56 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.11 -48.88 19.41 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 113.318 -172.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.91 -43.3 96.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.683 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 2.8 tpp180 -68.37 -37.23 80.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.149 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 96.4 m -59.06 -42.42 90.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.165 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.54 -31.7 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.294 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.433 0.635 . . . . 0.0 109.304 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.84 -34.78 67.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.603 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.04 90.44 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.677 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -60.57 -47.6 85.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.434 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 40' ' ' ALA . 70.4 mt -56.7 -49.01 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.156 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 60' ' ' ILE . 78.8 mt -67.81 -46.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.987 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.68 -44.18 96.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.094 -177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.84 -40.89 94.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.818 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.96 -46.48 90.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.945 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 58.1 mt . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.054 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.08 0.467 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -110.22 114.8 28.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -118.42 126.15 27.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.4 Cg_exo -69.45 113.69 3.41 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 123.15 2.567 . . . . 0.0 112.237 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.1 p -119.14 114.41 35.03 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.25 133.42 58.01 Favored 'Trans proline' 0 N--CA 1.469 0.044 0 C-N-CA 122.773 2.315 . . . . 0.0 112.236 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -62.71 -13.3 30.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -85.59 -45.04 12.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.101 0.477 . . . . 0.0 109.877 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -79.1 -22.43 45.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.671 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.71 -24.49 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.648 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.07 -35.27 88.78 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.688 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -75.96 -31.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 110.127 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.38 -38.02 81.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.938 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.08 -51.24 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.348 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.05 -133.57 14.43 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.651 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -108.17 127.14 53.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 65.3 m 62.37 6.45 1.92 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.882 0.473 . . . . 0.0 111.781 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.658 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 80.93 8.04 87.91 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.231 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' A' ' 29' ' ' SER . 60.4 mm-40 -54.03 -32.54 54.72 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.477 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.5 tpt -70.13 -46.39 64.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 36' ' ' ILE . 6.3 tt -73.76 -23.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.139 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 96.1 mttt -65.11 -38.24 90.03 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -64.17 -44.22 92.72 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 33' ' ' ILE . 12.5 mt -58.09 -56.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.484 0.659 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.43 -23.65 66.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.703 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -85.39 -45.41 11.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.14 -32.69 69.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.36 -10.92 23.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.65 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.54 34.06 88.91 Favored Glycine 0 C--N 1.328 0.112 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.982 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.53 178.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.352 0.596 . . . . 0.0 111.248 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.5 tpp180 -119.06 131.49 55.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.077 170.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 33' ' ' ILE . 89.7 mt -119.46 108.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 123.682 0.614 . . . . 0.0 109.761 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -124.11 118.38 26.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.802 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 22.1 m-85 -76.99 109.67 11.0 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.64 -178.746 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 53.8 mtpt -83.96 163.95 19.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.97 112.25 39.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.617 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.39 135.6 37.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -107.47 101.48 10.82 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.832 HD12 HD11 ' A' ' 13' ' ' ILE . 34.9 mt -89.76 135.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.8 mtm -141.6 169.69 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.816 -171.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 120.08 -124.34 5.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -174.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.3 Cg_exo -80.9 133.07 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.066 2.511 . . . . 0.0 110.74 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 76.2 Cg_exo -51.64 -40.92 63.63 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.889 3.059 . . . . 0.0 114.077 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.28 -38.18 43.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.37 0.605 . . . . 0.0 109.946 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 12.2 tpp85 -62.57 -32.85 73.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.797 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.0 m -58.83 -44.24 90.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.491 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.27 -25.75 51.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.221 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -73.07 -40.2 65.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.02 68.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.858 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.25 -36.31 77.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.494 174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -68.64 -40.28 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.331 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.473 HG21 HG23 ' A' ' 36' ' ' ILE . 65.3 mt -56.73 -46.26 83.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.418 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.595 HD12 HD11 ' A' ' 60' ' ' ILE . 73.6 mt -72.03 -45.06 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -59.83 -44.82 93.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' HB2' ' HE ' ' A' ' 72' ' ' ARG . 15.5 t70 -58.75 -40.76 84.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.462 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.98 -48.85 77.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.756 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 75.8 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 110.536 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 60' ' ' ILE . 37.6 pt . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.924 0.392 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -110.19 105.48 14.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -103.41 120.27 52.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 112.163 -176.5 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 16.3 Cg_exo -67.6 103.66 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.221 2.614 . . . . 0.0 111.497 175.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.29 110.03 53.69 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 86.2 Cg_exo -47.39 129.0 15.64 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.316 2.677 . . . . 0.0 112.103 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.51 -25.56 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.483 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.48 -33.43 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 110.288 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.442 ' O ' HG23 ' A' ' 25' ' ' VAL . 39.9 m -79.23 -22.08 45.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.386 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.531 HG21 ' HD3' ' A' ' 56' ' ' LYS . 37.8 t -54.95 -34.83 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -31.38 68.83 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.724 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 t -89.38 -36.37 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.763 0.316 . . . . 0.0 110.417 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' SER . 57.8 t -64.51 -37.52 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.115 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.503 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.2 mm -79.09 -40.49 22.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.657 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.3 -115.11 4.99 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.365 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 29.0 ttp85 -133.08 121.32 22.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.2 m 67.8 22.12 8.92 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.505 0.503 . . . . 0.0 110.637 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 71.37 13.13 73.63 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.499 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -52.57 -40.99 63.17 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.768 0.427 . . . . 0.0 111.32 -175.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.76 -35.96 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.494 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 36' ' ' ILE . 8.2 tt -75.94 -28.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.34 0.59 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -66.85 -34.7 78.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.661 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -59.62 -44.37 93.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.944 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 33' ' ' ILE . 8.8 mt -62.88 -62.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.432 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -52.98 -40.12 63.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.738 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.24 -49.77 58.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.603 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -83.75 -26.58 29.56 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -84.36 -25.59 29.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.899 0.38 . . . . 0.0 110.893 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.48 26.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.774 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.8 m -126.35 173.06 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.307 0.575 . . . . 0.0 111.148 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 17.4 tpt180 -116.63 122.46 44.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.167 170.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 33' ' ' ILE . 67.6 mt -109.6 108.32 25.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.36 115.57 19.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.736 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CE1' HD11 ' A' ' 26' ' ' ILE . 90.8 m-85 -63.4 128.34 35.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.734 -177.252 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 40.0 mt-10 . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.241 0.543 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HD3' HG21 ' A' ' 22' ' ' VAL . 63.5 mtpt -84.59 166.08 17.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.0 mm -113.26 108.94 26.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.609 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.98 139.41 35.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.868 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -109.83 101.95 10.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 13' ' ' ILE . 36.0 mt -89.8 137.65 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -138.2 161.97 35.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.463 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 123.43 -127.81 6.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.082 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.0 Cg_exo -81.01 134.21 9.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.145 2.563 . . . . 0.0 110.965 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 78.5 Cg_exo -53.2 -39.6 80.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.638 2.892 . . . . 0.0 113.359 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.54 -37.1 68.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.171 0.51 . . . . 0.0 110.011 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 5.5 tpp180 -70.56 -28.86 65.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.664 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.2 m -62.17 -41.48 98.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.04 -36.86 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.957 0.408 . . . . 0.0 110.597 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.89 -38.5 88.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.591 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -72.5 -36.67 68.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.254 177.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.72 79.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.185 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -63.51 -44.08 95.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.886 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 40' ' ' ALA . 54.6 mt -61.06 -50.24 81.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 60' ' ' ILE . 83.8 mt -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -68.73 -33.91 74.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.244 0.545 . . . . 0.0 110.778 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.75 -29.22 70.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.493 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.74 -46.26 38.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 90.4 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.231 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.889 HD11 HD12 ' A' ' 60' ' ' ILE . 39.9 pt . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.986 0.422 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -119.8 112.9 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -113.72 127.15 27.14 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.714 -170.211 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.8 Cg_exo -71.0 104.91 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.994 2.462 . . . . 0.0 111.88 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.46 116.87 41.22 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.4 Cg_exo -56.16 135.09 68.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.808 2.339 . . . . 0.0 111.674 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.806 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 80.9 mtm180 -62.31 -38.38 89.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.33 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -68.25 -30.57 69.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.046 0.45 . . . . 0.0 110.172 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.1 m -80.0 -26.49 39.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG21 ' HD3' ' A' ' 56' ' ' LYS . 44.4 t -55.85 -37.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.93 -28.91 61.33 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.534 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.3 -37.09 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.728 0.299 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 21' ' ' SER . 48.3 t -63.92 -37.83 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.496 0.665 . . . . 0.0 110.233 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 ' CE2' ' A' ' 46' ' ' PHE . 41.2 mm -82.58 -41.19 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.579 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.54 -65.3 3.07 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -173.28 -68.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -72.79 -35.5 67.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.304 0.574 . . . . 0.0 110.061 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 119.49 12.21 6.87 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.057 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -59.44 -35.2 73.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.962 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -67.12 -47.63 70.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.705 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.629 HD11 ' CG2' ' A' ' 44' ' ' ILE . 18.0 tt -71.45 -30.41 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.603 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mtmt -65.97 -30.05 70.54 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -77.93 -38.83 44.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 32' ' ' MET . 80.2 mt -59.1 -47.2 90.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.44 0.638 . . . . 0.0 109.746 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -63.1 -31.92 73.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.021 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -70.97 -48.45 53.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.03 -36.33 77.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.599 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -92.53 -22.91 19.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.43 37.12 42.17 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' ALA . 27.9 m -119.25 -177.3 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 111.485 -174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.4 ttt85 -127.8 125.21 39.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.198 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' CG2' HD11 ' A' ' 33' ' ' ILE . 61.6 mt -111.14 108.99 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.603 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -102.72 163.65 12.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.919 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 26' ' ' ILE . 84.7 m-85 -105.63 113.32 26.82 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.7 tttm . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.347 -177.716 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.806 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.7 mtpp -98.95 174.46 6.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.622 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.82 110.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.49 135.55 38.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -115.99 100.95 8.33 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.889 HD12 HD11 ' A' ' 13' ' ' ILE . 37.1 mt -89.85 146.73 5.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.529 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.3 mtm -142.98 160.78 39.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -172.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.74 -125.39 5.54 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.396 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -81.13 136.22 10.12 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.161 2.574 . . . . 0.0 111.187 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.46 -49.56 17.02 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.574 2.183 . . . . 0.0 112.778 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -41.28 97.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.339 0.59 . . . . 0.0 110.424 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.46 -31.96 73.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.142 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 75.3 m -60.96 -44.31 97.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.27 -28.5 57.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.78 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.504 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.9 t-80 -59.34 -46.97 87.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.92 -34.22 73.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.696 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.71 -42.5 99.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.452 0.644 . . . . 0.0 109.663 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttm105 -67.17 -34.14 76.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.572 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' HIS . 74.8 mt -62.26 -48.6 87.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 110.261 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 78.9 mt -64.89 -45.49 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.626 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -63.16 -36.9 85.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.546 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.54 -39.7 88.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.703 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.8 tp -66.66 -30.41 70.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 110.458 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 78.5 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.778 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 60' ' ' ILE . 28.3 pt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB3' HG21 ' A' ' 57' ' ' ILE . 17.1 m-20 -122.28 108.31 13.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.908 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.52 127.11 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.478 -170.551 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.8 Cg_exo -71.07 106.47 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.908 2.406 . . . . 0.0 111.922 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.534 HG23 HD21 ' A' ' 78' ' ' LEU . 6.4 p -116.02 109.68 44.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.787 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 80.6 Cg_exo -46.09 129.14 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.5 2.8 . . . . 0.0 112.853 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.633 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 37.2 mtt180 -59.71 -27.97 66.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.936 -175.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -79.57 -27.8 41.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.928 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -88.43 -18.35 28.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.9 t -52.72 -34.72 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.77 68.25 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 t -80.96 -38.39 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.912 0.387 . . . . 0.0 110.456 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 24.7 t -64.36 -35.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.221 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 46' ' ' PHE . 30.0 mm -78.44 -65.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.24 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.16 86.58 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.421 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' GLY . 37.8 ttm180 60.1 82.99 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.864 0.465 . . . . 0.0 111.808 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m 70.59 -25.33 0.16 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.454 0.702 . . . . 0.0 111.491 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' ARG . . . 113.1 74.27 0.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.25 -25.77 11.34 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.8 tpt -77.06 -51.88 10.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.305 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 36' ' ' ILE . 11.5 tt -70.23 -27.28 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.934 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -76.14 -32.47 59.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -62.96 -41.8 99.63 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.32 170.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 33' ' ' ILE . 94.0 mt -59.78 -52.37 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.911 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.4 -40.03 73.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.562 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -81.03 -17.79 49.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.966 0.412 . . . . 0.0 111.534 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.81 -40.17 17.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -96.24 -13.18 23.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.28 46.44 49.69 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.19 177.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.705 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.7 ttt180 -126.34 135.37 51.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.357 171.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD11 ' A' ' 33' ' ' ILE . 65.4 mt -119.94 108.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.87 119.14 38.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 26' ' ' ILE . 74.0 m-85 -75.47 110.73 10.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.366 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 22.8 mtpp . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.245 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.1 mt-10 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 41.3 mttp -79.65 165.65 22.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 47' ' ' LYS . 50.4 mm -111.62 108.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.501 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.61 127.13 31.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -105.92 101.9 11.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 43' ' ' ARG . 47.8 mt -89.58 143.12 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.508 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.7 mtm -144.36 178.49 7.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.838 0.352 . . . . 0.0 110.966 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 107.96 -125.15 7.8 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.83 133.58 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.903 2.402 . . . . 0.0 111.1 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.1 Cg_exo -56.75 -35.94 98.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.463 2.775 . . . . 0.0 113.315 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.52 -36.68 28.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.637 0.732 . . . . 0.0 109.816 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 7.8 tpp85 -67.91 -39.32 83.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.66 -176.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -58.46 -38.65 77.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.88 -36.07 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -72.6 -36.46 68.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.077 0.465 . . . . 0.0 110.288 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.32 -31.55 70.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.995 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.45 -37.6 81.49 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.49 175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -72.6 -31.76 65.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.528 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG21 HG23 ' A' ' 36' ' ' ILE . 57.6 mt -57.57 -52.39 57.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 109.785 174.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 60' ' ' ILE . 64.5 mt -67.35 -46.73 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.778 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -61.72 -39.38 91.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.158 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.51 -44.46 93.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.79 -44.04 94.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.426 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 17' ' ' VAL . 80.0 mt . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.111 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.444 -0.826 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 60' ' ' ILE . 25.4 pt -128.06 142.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.151 0.501 . . . . 0.0 111.336 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 57' ' ' ILE . 5.1 m-20 -97.59 114.05 25.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -119.06 132.55 23.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -170.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.86 124.36 12.18 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.685 2.257 . . . . 0.0 112.119 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.51 HG23 HD11 ' A' ' 78' ' ' LEU . 11.3 p -131.99 111.56 14.5 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.965 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 50.7 Cg_exo -52.83 133.61 51.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.874 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 16.2 mtp180 -66.9 -15.76 63.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.326 0.584 . . . . 0.0 110.468 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -88.49 -13.29 40.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.216 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 81' ' ' LEU . 20.0 m -107.71 -20.65 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.92 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 m -58.5 -24.7 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.656 0.265 . . . . 0.0 111.535 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.88 91.27 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.98 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.19 -38.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.293 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.34 -37.91 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.81 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.586 HG23 ' HA2' ' A' ' 30' ' ' GLY . 27.0 mm -79.73 -38.14 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.12 -119.84 9.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -120.87 131.7 54.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 70.26 -5.37 1.35 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.464 0.478 . . . . 0.0 111.84 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 85.94 12.69 70.86 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -170.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.5 -39.6 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.758 0.423 . . . . 0.0 110.716 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.6 tpt -65.89 -46.17 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.0 tt -70.39 -26.41 28.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.418 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 51.7 mttp -68.61 -37.11 79.52 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.117 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 73' ' ' ILE . 85.9 mt -65.23 -53.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.53 -31.74 66.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.329 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.95 -55.33 13.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.279 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -29.52 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.413 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.758 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -83.19 -29.02 28.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.908 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.17 42.2 24.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 31.2 m -130.37 178.67 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 tpp180 -120.65 128.35 52.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.212 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 74' ' ' ILE . 59.5 mt -119.5 109.21 25.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -111.7 119.2 37.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.466 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -76.01 114.92 15.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.024 0.44 . . . . 0.0 110.127 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 54.4 mtpt -75.9 171.99 13.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.374 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -49.64 -61.49 2.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.393 0.616 . . . . 0.0 110.094 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -155.77 -75.8 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.03 144.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.013 0.82 . . . . 0.0 112.752 169.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.58 -51.33 3.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.262 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.659 HG21 ' HB2' ' A' ' 55' ' ' GLU . 6.6 t -140.72 -167.6 2.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.513 ' H ' ' HD2' ' A' ' 54' ' ' PRO . . . -108.71 -64.56 0.56 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.926 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' A' ' 53' ' ' GLY . 56.9 Cg_endo -73.07 -2.02 11.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.851 2.367 . . . . 0.0 113.054 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.659 ' HB2' HG21 ' A' ' 52' ' ' THR . 32.5 mt-10 -125.58 150.01 47.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.222 0.534 . . . . 0.0 110.662 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.0 mtpp -97.53 173.17 7.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.438 173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.571 ' HB ' ' HD3' ' A' ' 47' ' ' LYS . 46.6 mm -109.22 114.58 47.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.552 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -80.06 118.57 21.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -97.09 102.06 13.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 13' ' ' ILE . 17.5 mt -88.57 137.01 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.8 mtm -147.82 160.44 42.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 0.0 111.531 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 127.53 -122.34 4.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.43 145.63 18.85 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.917 2.411 . . . . 0.0 110.89 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 -41.92 18.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.021 2.481 . . . . 0.0 113.023 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.03 -37.37 61.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.474 0.654 . . . . 0.0 109.339 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.3 tpp180 -61.78 -32.99 73.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.053 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 99.7 m -56.51 -41.95 77.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.465 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.45 -34.39 65.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -60.7 -49.67 76.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -69.75 -30.37 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.03 -41.64 92.68 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.792 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 12.4 tpt180 -69.31 -38.25 78.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.532 HG21 HG23 ' A' ' 36' ' ' ILE . 65.1 mt -54.92 -52.1 46.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.136 0.493 . . . . 0.0 110.149 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 60' ' ' ILE . 53.2 mt -68.75 -45.94 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.949 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -60.38 -46.09 91.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.342 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.34 -39.76 84.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.74 -37.55 84.87 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.595 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HG23 ' A' ' 17' ' ' VAL . 88.2 mt -80.65 -9.91 59.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.647 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -58.17 -50.36 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.736 0.303 . . . . 0.0 110.627 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -71.03 -31.34 67.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 21' ' ' SER . 97.2 mt -76.47 -33.47 58.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 7.8 ptp180 . . . . . 0 C--N 1.33 -0.274 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.253 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 60' ' ' ILE . 41.8 pt -116.31 149.68 18.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 0.0 110.653 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.31 105.46 12.89 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.064 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -106.83 127.49 27.96 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 112.171 -173.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.3 Cg_exo -69.96 116.32 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.992 2.462 . . . . 0.0 111.981 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 111.24 32.82 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 110.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 78' ' ' LEU . 79.5 Cg_exo -49.26 128.35 19.83 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.501 2.801 . . . . 0.0 112.522 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -60.47 -31.69 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -77.81 -18.82 55.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 m -91.84 -18.3 24.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.074 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.07 -31.85 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.569 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.88 -30.84 70.49 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.84 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.26 -35.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.556 -0.379 . . . . 0.0 110.242 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 77' ' ' LEU . 48.7 t -65.85 -38.65 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.894 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.607 HD11 ' CE1' ' A' ' 46' ' ' PHE . 28.8 mm -79.77 -51.56 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.358 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 28' ' ' ARG . . . 98.83 -96.11 1.67 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.317 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 27' ' ' GLY . 23.8 mmt180 -132.81 -56.65 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -98.89 -17.06 18.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.005 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 110.34 15.34 11.56 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -173.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -73.77 -23.25 59.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.959 -175.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.9 tpt -73.6 -38.89 64.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.032 0.444 . . . . 0.0 109.972 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.5 tt -77.44 -22.57 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 29.3 mmtp -64.49 -38.45 91.08 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 32' ' ' MET . 1.2 tmtp? -57.45 -47.37 82.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.787 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 33' ' ' ILE . 38.8 mt -61.51 -48.8 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.661 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -63.35 -30.12 71.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.085 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -82.65 -46.16 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.583 0.23 . . . . 0.0 111.323 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -46.8 88.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.32 -22.98 26.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.458 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.93 33.7 45.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.655 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.9 m -113.64 -177.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 111.639 -174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 40.3 ttt180 -126.22 133.57 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.064 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.651 HD13 HD11 ' A' ' 74' ' ' ILE . 37.3 mt -132.57 109.95 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.345 0.403 . . . . 0.0 110.311 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -114.6 139.36 49.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.945 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CE1' HD11 ' A' ' 26' ' ' ILE . 82.1 m-85 -84.17 112.78 20.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.136 0.493 . . . . 0.0 110.332 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.524 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 52.6 mtpt -75.46 146.19 40.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.297 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -93.17 -15.34 26.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -76.63 159.94 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.896 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.26 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.702 0.626 . . . . 0.0 110.294 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.77 94.04 0.01 OUTLIER Glycine 0 C--N 1.33 0.232 0 O-C-N 123.305 0.378 . . . . 0.0 112.995 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 p -90.6 30.88 1.09 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.303 -0.527 . . . . 0.0 112.325 -175.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.82 -111.37 4.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.765 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.86 0.65 9.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.887 2.391 . . . . 0.0 112.344 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -122.25 135.09 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.359 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 46' ' ' PHE . 27.0 mttm -89.77 171.3 9.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.469 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.61 111.59 36.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.993 0.425 . . . . 0.0 109.944 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.54 133.58 35.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.524 ' CD2' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -105.87 101.34 10.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.29 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 13' ' ' ILE . 33.5 mt -91.0 137.03 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.983 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.8 mtm -146.11 162.11 38.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.964 0.411 . . . . 0.0 111.407 -169.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 124.98 -119.32 3.58 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 6.3 Cg_exo -83.0 129.64 5.42 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.13 2.553 . . . . 0.0 110.965 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 54.0 Cg_exo -54.41 -34.73 82.34 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.631 2.888 . . . . 0.0 113.813 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -81.24 -40.05 24.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.1 tpp180 -64.0 -26.8 68.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.951 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.84 -43.69 86.02 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.82 -37.36 84.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.751 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 43.9 t-80 -61.7 -44.81 96.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.07 -37.76 84.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.26 -38.04 85.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.89 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -68.85 -38.58 79.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.551 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 77.0 mt -62.85 -48.81 86.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.598 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 60' ' ' ILE . 91.2 mt -64.71 -39.89 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.474 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -62.3 -45.93 91.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.747 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.54 -39.62 84.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.951 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 25' ' ' VAL . 6.6 tt -63.81 -48.08 78.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.643 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt -67.13 -23.33 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.342 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -63.85 -36.91 85.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 t -69.65 -23.24 63.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.442 0.639 . . . . 0.0 109.797 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -98.1 12.21 35.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.256 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 . . . . . 0 C--O 1.233 0.225 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.493 177.67 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 26.4 pt -127.28 149.17 32.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.028 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -109.66 117.55 34.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.327 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.46 124.99 30.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.073 -173.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 57' ' ' ILE . 19.1 Cg_endo -77.01 111.5 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.106 1.87 . . . . 0.0 111.323 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG11 ' HE2' ' A' ' 46' ' ' PHE . 6.3 p -114.96 114.62 43.76 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.518 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.623 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.1 Cg_exo -48.64 126.98 15.4 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.176 2.584 . . . . 0.0 111.766 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.814 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 83.9 mtp180 -59.97 -33.6 72.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.102 -172.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -82.72 -13.83 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.575 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -94.91 -13.37 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.98 0.419 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG21 ' HD3' ' A' ' 56' ' ' LYS . 25.3 t -57.41 -33.48 44.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.773 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.9 61.07 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.002 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' HB ' HD13 ' A' ' 81' ' ' LEU . 31.1 t -88.75 -35.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 32' ' ' MET . 45.0 t -66.07 -36.28 77.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.426 0.632 . . . . 0.0 110.162 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.9 mm -81.59 -60.18 2.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.271 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.84 -116.73 4.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.656 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.56 -49.15 2.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 109.954 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -119.59 -0.64 10.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 112.0 22.04 6.09 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.567 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -51.05 -50.91 57.7 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.876 0.47 . . . . 0.0 111.68 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.507 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.1 tpt -68.3 -47.31 67.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.166 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD11 ' HB ' ' A' ' 44' ' ' ILE . 11.4 tt -69.23 -29.75 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.76 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 59.0 mttm -63.09 -42.44 99.62 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 7.2 tmtm? -65.73 -44.79 84.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.988 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 32' ' ' MET . 77.7 mt -60.29 -50.48 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.032 0.444 . . . . 0.0 110.761 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 mt-30 -62.31 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.031 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.38 -46.07 18.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.522 0.201 . . . . 0.0 110.971 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.69 -46.27 87.63 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.272 0.558 . . . . 0.0 111.146 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.53 -21.05 23.1 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.682 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.26 37.92 63.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.852 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 37' ' ' GLN . 25.7 m -113.17 -179.48 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 0.0 111.003 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -126.82 133.36 50.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 166.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 60' ' ' ILE . 72.1 mt -123.96 109.07 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.189 0.931 . . . . 0.0 109.301 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -126.89 136.89 52.94 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 75.4 m-85 -85.32 118.39 24.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.036 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -91.22 144.12 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.161 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -93.5 -2.56 54.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.804 0.812 . . . . 0.0 108.911 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.71 -76.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.597 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.692 ' HB2' HG13 ' A' ' 57' ' ' ILE . 1.9 m-20 -77.25 -16.08 59.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.944 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.5 122.89 27.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.727 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -158.89 151.39 21.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.846 0.355 . . . . 0.0 110.344 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.19 -136.12 26.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.129 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.41 6.4 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.088 2.526 . . . . 0.0 112.886 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.08 131.36 44.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.457 0.646 . . . . 0.0 111.618 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.814 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 27.9 mtpp -86.41 175.86 8.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.692 HG13 ' HB2' ' A' ' 50' ' ' ASP . 46.0 mm -119.86 108.69 24.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.643 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -73.78 130.02 39.11 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -104.47 102.85 12.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.726 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.683 HD11 HD12 ' A' ' 74' ' ' ILE . 40.6 mt -89.61 136.21 24.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.403 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 40.0 mtm -145.1 144.23 30.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.63 -169.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 139.18 -124.51 2.81 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.147 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.34 138.3 12.37 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 123.438 2.759 . . . . 0.0 112.099 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.05 -49.28 16.62 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 113.399 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.07 -41.63 70.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.219 0.533 . . . . 0.0 110.625 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.0 tpp180 -65.49 -31.22 72.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.438 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 94.0 m -58.34 -44.7 88.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -70.46 -32.9 70.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.673 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 4.3 t60 -56.71 -50.05 73.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -70.03 -34.66 73.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.861 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.28 -41.39 98.44 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.012 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -66.78 -37.56 84.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.121 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 73.4 mt -57.13 -50.62 75.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.529 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 60' ' ' ILE . 68.5 mt -68.67 -44.81 82.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.039 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -61.06 -49.95 75.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.798 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.18 -39.57 75.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.485 ' HG ' HD11 ' A' ' 81' ' ' LEU . 44.1 tp -66.97 -50.11 63.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.526 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' HD2' ' A' ' 18' ' ' PRO . 94.0 mt -64.44 -28.42 69.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.302 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -53.69 -42.66 68.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.48 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -88.45 -18.03 29.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.029 0.442 . . . . 0.0 110.76 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.485 HD11 ' HG ' ' A' ' 77' ' ' LEU . 90.3 mt -86.48 -13.65 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.056 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 82' ' ' ARG . 63.5 mtt180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 0.0 111.34 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.843 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 60' ' ' ILE . 29.3 pt -97.35 145.51 9.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.873 0.368 . . . . 0.0 110.635 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 14.7 p-10 -111.03 120.11 41.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.821 0.819 . . . . 0.0 109.544 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -116.65 133.77 22.99 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.985 -167.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HA ' HD13 ' A' ' 57' ' ' ILE . 11.1 Cg_exo -69.24 117.48 5.08 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 123.109 2.539 . . . . 0.0 112.13 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -132.25 108.63 13.67 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.368 0.604 . . . . 0.0 110.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.721 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 83.7 Cg_exo -48.81 141.44 21.19 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.543 2.828 . . . . 0.0 113.487 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -54.82 -53.7 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.725 0.298 . . . . 0.0 111.545 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.72 -26.87 67.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.113 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.9 m -79.16 -25.13 42.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.378 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.7 t -60.12 -32.69 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.01 -29.82 68.84 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.13 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.441 HG11 HD21 ' A' ' 81' ' ' LEU . 40.3 t -89.5 -35.33 7.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 21' ' ' SER . 61.1 t -68.19 -38.31 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.543 HD11 ' CE1' ' A' ' 46' ' ' PHE . 34.7 mm -79.37 -55.99 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.464 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.2 -134.3 12.07 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 2.5 mmp_? -105.39 -59.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 50.0 m -93.21 -18.19 22.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.859 174.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 123.2 13.92 4.24 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.238 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 29' ' ' SER . 18.4 mp0 -57.21 -39.05 74.65 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.19 0.596 . . . . 0.0 111.352 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.5 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -68.82 -49.32 59.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.675 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.577 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -68.7 -30.02 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 110.402 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 32.3 mmtp -72.94 -29.72 63.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.91 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.92 -42.28 77.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 32' ' ' MET . 74.8 mt -60.65 -49.38 84.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.352 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.66 -27.34 68.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.294 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.34 -50.04 15.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.79 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.68 -53.22 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 111.173 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.47 -11.34 52.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.934 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.34 37.94 95.63 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.371 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.0 m -113.34 177.11 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.322 0.582 . . . . 0.0 110.827 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -122.36 123.44 41.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.681 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HD11 ' A' ' 33' ' ' ILE . 86.6 mt -105.68 108.43 25.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -115.47 114.99 25.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.148 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CE1' HD11 ' A' ' 26' ' ' ILE . 58.6 m-85 -70.93 114.23 8.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.525 0.678 . . . . 0.0 110.804 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 49' ' ' ASP . 47.9 mtpt -68.46 -39.27 81.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.933 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? 72.06 -34.19 0.29 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.223 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 47' ' ' LYS . 6.7 t70 -68.66 -177.38 0.95 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' HG13 ' A' ' 57' ' ' ILE . 2.8 m-20 65.05 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -168.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.75 97.14 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.33 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' A' ' 55' ' ' GLU . 3.2 p -84.16 21.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.356 -0.497 . . . . 0.0 111.262 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.93 -104.77 1.7 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.857 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.66 13.0 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.966 2.444 . . . . 0.0 112.11 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.6 mt-10 -121.95 143.4 49.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.09 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -96.21 175.69 6.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.757 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 43.4 mm -122.7 114.58 42.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.699 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -81.55 140.45 34.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.611 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -114.11 103.64 11.33 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 70' ' ' ALA . 45.1 mt -88.64 137.62 20.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.4 mtm -143.48 171.51 14.05 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.599 -173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 116.02 -128.74 8.14 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_exo -75.98 141.48 23.95 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.788 2.325 . . . . 0.0 111.204 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 27.9 Cg_exo -62.7 -35.69 67.69 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.563 2.842 . . . . 0.0 113.266 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.43 -31.04 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.548 0.69 . . . . 0.0 109.717 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.5 tpp180 -66.09 -27.09 67.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.676 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.1 m -55.77 -37.77 68.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.402 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 mt-10 -79.31 -30.89 43.07 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.453 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 73' ' ' ILE . 2.3 t-160 -57.56 -50.62 72.49 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -73.11 -32.82 65.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.208 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . . . -61.74 -41.07 97.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.955 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 18.4 tpt180 -63.5 -43.91 95.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.44 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 69' ' ' HIS . 70.3 mt -54.33 -50.51 56.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.804 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 60' ' ' ILE . 70.3 mt -71.36 -42.57 73.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.148 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -61.77 -50.27 73.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.93 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.036 0.446 . . . . 0.0 110.395 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.37 -48.18 80.9 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.5 mt -66.05 -27.45 68.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.67 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -66.38 -37.81 86.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.901 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 m -72.15 -26.81 62.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.441 HD21 HG11 ' A' ' 24' ' ' VAL . 90.7 mt -78.84 -12.05 60.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.665 176.766 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 CA-C-O 120.734 0.074 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 60' ' ' ILE . 22.1 pt -107.07 165.35 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.596 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 8.3 p-10 -117.24 128.64 55.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.08 122.8 23.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.996 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 52' ' ' THR . 26.0 Cg_exo -65.42 103.53 0.55 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.082 2.522 . . . . 0.0 111.898 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.4 p -102.34 118.13 59.58 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.715 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 52.5 Cg_exo -56.01 122.41 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.59 2.194 . . . . 0.0 111.438 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.749 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 53.5 mtp180 -62.76 -28.16 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -73.53 -18.37 61.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 m -102.75 -11.37 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.94 -35.29 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.33 63.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.928 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG11 HD21 ' A' ' 81' ' ' LEU . 36.0 t -89.21 -34.17 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.138 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.88 -39.39 67.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.412 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 ' CE1' ' A' ' 46' ' ' PHE . 38.8 mm -86.42 -56.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.973 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.27 -127.45 8.66 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -113.35 -45.99 3.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.049 0.424 . . . . 0.0 110.342 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.2 m -95.6 -36.13 11.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.439 0.638 . . . . 0.0 109.843 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.632 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 128.38 12.63 2.77 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.596 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.64 -28.16 69.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 110.997 -174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 17.6 tpt -67.72 -43.82 79.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.371 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG21 ' A' ' 44' ' ' ILE . 10.9 tt -79.93 -24.73 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 74.4 mmtt -62.77 -40.43 97.27 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 32' ' ' MET . 53.2 tttm -59.85 -45.92 90.9 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.55 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -60.75 -49.24 85.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.56 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -59.69 -39.64 85.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.388 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.97 -49.35 38.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.252 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.0 -46.72 86.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.437 -173.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.747 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.572 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.41 44.1 7.6 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 34.4 m -129.31 172.98 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.277 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -117.69 137.35 52.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.695 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 33' ' ' ILE . 29.2 mt -123.44 106.06 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -105.75 119.05 38.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.066 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE1' HD11 ' A' ' 26' ' ' ILE . 55.8 m-85 -73.13 126.06 29.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 21.6 mtpp -58.55 144.59 42.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.167 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -80.55 6.0 13.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.229 0.538 . . . . 0.0 110.093 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.35 140.37 49.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.497 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.97 85.51 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.67 -30.0 68.13 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.756 -170.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 55' ' ' GLU . 5.3 t -132.23 90.75 2.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.596 0.712 . . . . 0.0 110.989 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.65 -116.79 9.85 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 19' ' ' ARG . 75.5 Cg_endo -96.69 13.15 1.02 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.062 2.508 . . . . 0.0 113.249 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 52' ' ' THR . 4.0 mm-40 -108.43 153.3 23.5 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 111.217 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.749 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.6 mtpp -92.47 160.69 14.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.677 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.9 mm -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.895 174.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -75.12 140.07 43.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 35.1 t-80 -118.06 108.43 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.592 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -88.68 131.49 35.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.7 mtp -131.03 128.24 39.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.88 0.371 . . . . 0.0 111.691 -162.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.05 -135.35 6.64 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.851 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 11.3 Cg_exo -69.17 150.08 71.39 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.403 2.735 . . . . 0.0 112.227 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 32.3 Cg_exo -60.04 -50.0 8.44 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -71.87 -30.51 65.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 109.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.747 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.35 -42.79 87.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.595 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.7 -40.35 87.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.824 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -74.19 -35.24 63.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 73' ' ' ILE . 17.9 t-160 -68.69 -41.5 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.93 -34.41 76.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.332 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -37.77 84.27 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.734 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -74.59 -31.88 62.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.487 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.515 HD12 ' HB2' ' A' ' 40' ' ' ALA . 74.6 mt -60.37 -50.48 80.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 109.933 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 76.7 mt -67.29 -39.5 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.714 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -64.55 -45.96 84.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.165 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -57.85 -40.1 79.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.819 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.8 tp -59.29 -41.89 90.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.59 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 67.4 mt -69.94 -33.28 71.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.696 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.75 -32.59 74.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -76.61 -21.99 54.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 24' ' ' VAL . 90.6 mt -79.57 -29.94 41.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.535 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.511 0.672 . . . . 0.0 111.819 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 67' ' ' CYS . 16.7 pt -96.43 145.8 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.147 0.498 . . . . 0.0 111.786 -174.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 5.2 p-10 -97.71 122.04 40.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.951 175.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -119.31 125.67 27.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.044 -175.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 12.1 Cg_exo -69.29 104.58 1.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.187 2.592 . . . . 0.0 111.999 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 22' ' ' VAL . 11.2 p -106.75 113.65 62.6 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.282 0.563 . . . . 0.0 109.686 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.0 Cg_exo -60.4 129.76 31.06 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.098 2.532 . . . . 0.0 112.978 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.731 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 98.6 mtt180 -55.67 -29.94 60.2 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.996 0.81 . . . . 0.0 112.587 -172.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -71.96 -34.48 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.478 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -90.32 -19.72 23.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.447 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 17' ' ' VAL . 6.0 t -60.35 -33.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.56 87.71 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.125 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.694 HG21 HD11 ' A' ' 81' ' ' LEU . 42.9 t -75.31 -36.1 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.391 . . . . 0.0 110.391 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.0 -36.7 78.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.253 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 46' ' ' PHE . 36.8 mm -81.41 -58.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.59 -113.01 4.12 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -118.44 -61.02 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -93.51 -28.96 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.739 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 133.75 19.98 0.89 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.104 -175.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.22 -37.78 81.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.5 -40.82 69.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.562 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -75.02 -27.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 49.4 mtpt -63.72 -36.82 85.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.26 -43.92 96.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.15 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 73' ' ' ILE . 60.5 mt -63.47 -46.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.171 0.51 . . . . 0.0 110.468 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.73 -30.83 71.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.317 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -74.97 -48.07 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.56 -42.94 86.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -90.78 -16.41 28.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.851 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 31.96 65.64 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.983 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.4 m -113.58 176.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.413 0.625 . . . . 0.0 111.205 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -117.87 131.19 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.891 167.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.562 ' CG2' HD11 ' A' ' 33' ' ' ILE . 81.7 mt -115.34 108.54 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 45' ' ' GLN . 4.3 tp60 -123.73 131.67 53.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 26' ' ' ILE . 78.7 m-85 -84.07 131.17 34.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.447 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 50' ' ' ASP . 24.8 mtpp -70.46 109.81 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.183 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -89.63 22.45 3.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.489 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -120.55 -68.73 0.89 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.158 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 14.8 m-20 -84.88 107.4 17.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -103.52 126.4 8.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.602 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 p -92.8 52.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 111.444 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.81 -125.36 8.3 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.078 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.77 9.49 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.954 2.436 . . . . 0.0 112.49 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 1.6 mp0 -108.3 166.42 10.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.356 0.598 . . . . 0.0 110.873 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.731 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 30.3 mtpp -109.67 165.95 11.28 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.6 mm -114.78 110.12 30.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.022 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.75 140.15 38.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -114.49 108.25 16.6 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.517 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.634 HG21 ' HB3' ' A' ' 70' ' ' ALA . 38.8 mt -88.46 127.94 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.5 mtm -141.54 167.01 23.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 111.357 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.13 -118.65 3.86 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.4 135.92 10.9 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.999 2.466 . . . . 0.0 111.449 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 50.5 Cg_exo -57.23 -36.05 98.98 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.478 2.785 . . . . 0.0 112.915 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.87 -36.62 70.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.078 0.942 . . . . 0.0 109.799 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.657 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 18.7 tpp85 -71.6 -31.91 67.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.897 -171.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.522 ' HB2' HG12 ' A' ' 13' ' ' ILE . 21.2 p -58.85 -41.85 87.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.46 -37.03 79.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.059 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -61.56 -46.12 91.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.103 0.477 . . . . 0.0 109.901 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.634 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.54 -28.13 62.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.879 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.25 -42.11 85.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.0 tmm_? -65.62 -45.41 83.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.976 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 36' ' ' ILE . 66.6 mt -55.06 -52.43 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 65.0 mt -67.88 -43.33 86.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -61.28 -48.84 79.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.1 -32.43 74.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.96 -49.78 68.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 17' ' ' VAL . 88.7 mt -61.26 -35.07 76.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 62.9 tp60 -63.15 -23.02 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.328 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.4 t -67.72 -28.6 67.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.041 0.448 . . . . 0.0 110.078 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.694 HD11 HG21 ' A' ' 24' ' ' VAL . 85.8 mt -103.09 -5.7 23.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.306 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.639 ' HB3' ' HA ' ' A' ' 79' ' ' GLN . 41.5 ttm180 . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.783 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.794 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.907 HD11 HD12 ' A' ' 60' ' ' ILE . 30.9 pt -128.31 160.38 38.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.813 0.34 . . . . 0.0 111.109 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 36.6 m-20 -116.86 110.17 18.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.128 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -110.82 128.81 24.72 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.004 -171.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.6 Cg_exo -71.44 99.06 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.419 2.746 . . . . 0.0 111.933 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 17' ' ' VAL . 14.3 p -110.15 109.82 58.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.451 0.643 . . . . 0.0 110.677 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 50.0 Cg_exo -55.91 149.64 50.55 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.217 2.611 . . . . 0.0 113.425 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -68.18 -26.14 65.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.759 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -79.34 -22.88 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.328 0.585 . . . . 0.0 109.526 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.8 m -86.44 -37.69 18.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.534 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 16.4 m -57.69 -27.17 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.22 92.27 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HB ' HD21 ' A' ' 77' ' ' LEU . 40.6 t -89.6 -31.61 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.812 0.339 . . . . 0.0 110.365 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 21' ' ' SER . 93.7 t -61.79 -38.63 80.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.168 0.509 . . . . 0.0 109.851 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.08 -58.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.115 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.6 -138.1 13.65 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.686 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -69.24 -77.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.379 . . . . 0.0 110.586 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.459 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 66.1 m -93.79 -53.5 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.642 0.734 . . . . 0.0 109.567 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -174.29 20.54 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.362 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 1.6 mm-40 -47.05 -53.03 13.53 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.398 0.679 . . . . 0.0 111.827 -169.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.548 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.9 tpt -68.45 -45.16 73.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.116 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 HG22 ' A' ' 44' ' ' ILE . 8.3 tt -72.47 -29.77 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.812 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 28.2 mmmt -69.47 -40.67 76.95 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.58 -46.15 91.1 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.678 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 32' ' ' MET . 84.0 mt -60.71 -49.37 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.659 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.02 -29.9 67.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.814 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -87.43 -35.69 18.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.653 0.264 . . . . 0.0 111.671 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.04 -40.98 78.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 0.0 110.018 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -93.03 -23.91 18.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.226 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.94 47.55 9.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.227 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.5 m -127.4 177.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.5 tpt180 -120.04 128.35 53.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.842 168.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.633 HD13 HD11 ' A' ' 74' ' ' ILE . 72.3 mt -125.92 112.59 30.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.964 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.92 138.78 39.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.125 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' ALA . 12.5 m-85 -85.5 121.0 27.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.574 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HB3' ' HZ3' ' A' ' 47' ' ' LYS . 8.0 mtpm? -66.71 108.16 2.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.183 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -71.81 -12.53 61.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.677 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -96.33 -6.04 38.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.622 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.65 81.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.58 117.04 3.56 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -84.73 -11.52 55.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.511 . . . . 0.0 110.989 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.11 -100.79 0.29 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.42 -5.12 15.84 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.477 2.118 . . . . 0.0 111.352 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.9 mt-10 -128.75 145.81 51.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.631 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 56.0 mtpt -107.41 155.63 19.81 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.836 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 38.1 mm -98.51 104.69 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.682 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.54 140.38 41.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.979 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -115.58 109.95 18.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 13' ' ' ILE . 40.0 mt -93.49 146.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.713 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -145.33 166.87 24.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.945 0.402 . . . . 0.0 111.989 -172.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 122.91 -124.92 5.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -81.03 134.89 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.994 2.463 . . . . 0.0 110.75 174.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 74.6 Cg_exo -51.82 -42.92 54.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.617 2.878 . . . . 0.0 113.293 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.26 -39.94 65.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.7 tpp180 -61.7 -34.64 76.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.979 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 85.2 m -57.94 -42.9 85.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.458 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.84 -41.58 91.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 73' ' ' ILE . 24.1 t60 -66.65 -38.75 87.53 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -66.95 -35.51 80.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.27 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.5 -36.86 83.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.441 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -67.79 -39.28 84.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.472 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.6 mt -59.93 -49.56 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.438 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.633 HD11 HD13 ' A' ' 44' ' ' ILE . 84.5 mt -65.28 -45.27 94.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.781 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.73 -37.08 86.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.88 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.75 -43.42 80.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.404 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD21 ' HB ' ' A' ' 24' ' ' VAL . 9.8 tt -63.54 -43.2 97.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.932 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 21.2 mt -61.09 -44.13 97.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.113 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.605 ' OE1' ' HD2' ' A' ' 82' ' ' ARG . 7.1 tp60 -59.83 -40.96 90.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.569 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.5 m -64.3 -39.15 93.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 21' ' ' SER . 74.0 mt -68.55 -48.6 63.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.626 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.605 ' HD2' ' OE1' ' A' ' 79' ' ' GLN . 6.4 ptp180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 60' ' ' ILE . 38.6 pt -138.65 163.45 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.062 0.458 . . . . 0.0 111.613 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -114.34 126.88 55.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.308 173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -131.04 117.05 16.97 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.43 . . . . 0.0 111.603 -176.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 17.2 Cg_exo -66.52 102.24 0.59 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.219 2.612 . . . . 0.0 112.298 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.65 117.91 58.75 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.3 Cg_exo -57.17 131.15 43.42 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.241 2.628 . . . . 0.0 112.371 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.8 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 76.6 mtt180 -66.29 -26.44 67.33 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.815 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -80.51 -15.15 57.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.0 110.242 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 81' ' ' LEU . 30.1 m -101.41 -14.82 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.435 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 18' ' ' PRO . 24.1 t -56.49 -38.57 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.451 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.93 -35.47 53.63 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.751 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' HD11 ' A' ' 81' ' ' LEU . 44.6 t -86.34 -36.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.662 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 21' ' ' SER . 60.0 t -62.32 -36.97 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.417 0.627 . . . . 0.0 109.904 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.476 HD11 ' CE1' ' A' ' 46' ' ' PHE . 35.9 mm -78.46 -58.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.614 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.87 63.5 1.67 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.889 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 63.97 -87.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.492 0.717 . . . . 0.0 112.162 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.55 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 75.4 m -84.03 -20.37 32.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.128 0.49 . . . . 0.0 110.339 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 119.9 4.59 11.4 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 29' ' ' SER . 0.8 OUTLIER -63.03 -15.07 55.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.385 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 tpt -80.08 -45.36 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.595 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.717 HG13 HD12 ' A' ' 36' ' ' ILE . 8.0 tt -74.78 -21.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 31.7 mmtp -57.4 -49.65 75.53 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.153 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 33' ' ' ILE . 35.6 mt -61.36 -58.29 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 0.0 110.148 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -65.3 -23.78 67.12 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.133 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.55 -45.11 19.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.072 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.18 -53.46 24.8 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 110.441 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -77.41 -14.43 59.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.565 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.78 34.33 88.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.254 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.11 171.22 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.22 0.533 . . . . 0.0 110.725 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.4 tpp180 -116.75 125.56 51.82 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.333 170.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 33' ' ' ILE . 84.7 mt -110.83 114.0 45.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.34 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -113.26 155.76 24.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.647 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 82.0 m-85 -111.21 112.65 24.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.932 0.396 . . . . 0.0 110.97 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 9.1 mtpm? -77.7 87.01 3.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.366 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -74.68 -13.47 60.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.677 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 15.8 p-10 -71.16 -34.81 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.359 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.46 98.25 4.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.299 0.571 . . . . 0.0 110.73 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.36 130.06 9.96 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.503 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 55' ' ' GLU . 20.3 p -83.74 63.0 7.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.291 0.567 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.9 -115.63 4.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.668 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -85.79 14.78 2.37 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.088 2.526 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 45.4 mt-10 -119.68 163.4 17.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.074 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.8 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 57.3 mtpt -123.26 146.19 48.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.64 107.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.33 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -77.38 140.62 39.96 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 65.4 t-80 -118.16 109.68 16.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.971 HD12 HD11 ' A' ' 13' ' ' ILE . 46.8 mt -89.23 147.64 5.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 49.5 mtt -130.62 137.22 49.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.492 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 135.85 -134.95 7.51 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.264 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -81.29 139.92 11.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.554 2.836 . . . . 0.0 112.382 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 76.7 Cg_exo -50.43 -50.09 14.59 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.242 1.961 . . . . 0.0 112.931 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.67 -40.1 80.3 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 0.0 110.725 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.601 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 12.8 tpp180 -64.82 -40.36 95.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.329 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 84.2 m -59.58 -45.33 92.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.364 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 45.0 mt-10 -63.0 -36.65 84.26 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 111.204 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.94 -46.87 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.041 0.448 . . . . 0.0 109.812 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.71 70.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.284 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.81 98.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.674 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' A' ' 75' ' ' ASN . 58.9 ttt180 -76.53 -24.57 53.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.721 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 36' ' ' ILE . 58.0 mt -57.47 -50.54 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.663 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 56.8 mt -68.93 -45.9 79.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.761 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 72' ' ' ARG . 62.0 t30 -60.73 -48.32 82.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.743 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 7.6 t70 -63.29 -35.31 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.53 -44.43 94.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt -63.71 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.732 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 18.8 pt20 -71.56 -25.21 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.542 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -68.26 -29.92 68.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 110.088 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' A' ' 24' ' ' VAL . 66.9 mt -87.48 -27.52 22.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.521 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.415 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.443 -0.854 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.823 HD11 HD12 ' A' ' 60' ' ' ILE . 38.4 pt -115.96 165.64 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.126 0.488 . . . . 0.0 111.065 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 6.3 p-10 -117.65 129.42 55.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.827 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.04 127.79 24.28 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.085 0.469 . . . . 0.0 111.973 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.621 ' HB3' HG21 ' A' ' 52' ' ' THR . 7.1 Cg_exo -70.72 112.78 3.33 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.226 2.617 . . . . 0.0 111.897 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.1 113.53 26.37 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.559 0.695 . . . . 0.0 110.47 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 22' ' ' VAL . 46.9 Cg_exo -57.95 138.78 87.74 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.126 2.551 . . . . 0.0 112.013 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 71.3 mtp180 -62.9 -34.52 77.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.722 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -69.08 -26.28 64.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB3' HD22 ' A' ' 78' ' ' LEU . 18.9 m -86.86 -28.83 22.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.267 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 18' ' ' PRO . 45.7 t -55.28 -35.41 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.882 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.7 61.82 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.799 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG11 HD21 ' A' ' 81' ' ' LEU . 33.7 t -82.53 -38.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 21' ' ' SER . 33.5 t -62.49 -37.8 79.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.398 0.618 . . . . 0.0 109.938 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE2' ' A' ' 46' ' ' PHE . 34.9 mm -79.49 -51.84 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.599 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.06 30.9 49.77 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.365 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 72.04 -56.43 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.612 0.765 . . . . 0.0 112.393 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 m -78.03 -25.26 47.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 111.002 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 100.13 -0.2 56.06 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -169.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -47.81 -49.59 28.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.691 0.796 . . . . 0.0 111.947 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.57 -41.45 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.73 0.3 . . . . 0.0 111.594 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.4 tt -73.03 -27.43 24.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.487 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 30.0 mmmt -68.96 -35.31 76.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -60.93 -43.51 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.496 HG23 HG21 ' A' ' 73' ' ' ILE . 70.6 mt -62.34 -50.54 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.544 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -58.27 -34.49 70.57 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.593 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -78.21 -40.17 38.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.8 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.56 -47.25 64.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.069 0.461 . . . . 0.0 110.786 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.72 -16.11 40.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 44.67 54.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.519 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.4 m -125.14 176.96 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.402 0.62 . . . . 0.0 111.178 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -120.78 129.99 53.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.46 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -123.79 107.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.8 139.45 53.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.61 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 62.4 m-85 -84.1 133.2 34.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.416 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -71.96 142.06 49.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.66 -16.63 41.22 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -106.99 89.3 2.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.865 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 21.2 m-20 -79.04 143.64 35.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.735 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.587 ' H ' ' CG1' ' A' ' 57' ' ' ILE . . . -84.85 -19.77 59.02 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.222 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -97.78 -25.46 15.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 108.13 -105.31 2.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.903 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 24.0 Cg_exo -64.45 -43.12 14.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.72 2.28 . . . . 0.0 111.171 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -69.84 143.75 52.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' PHE . 16.5 mtpp -90.09 161.96 15.55 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 110.646 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' CG1' ' H ' ' A' ' 51' ' ' GLY . 34.8 mm -107.92 105.61 19.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.103 0.478 . . . . 0.0 110.133 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -73.23 127.75 33.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -103.79 101.92 11.74 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.394 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 13' ' ' ILE . 41.2 mt -91.83 131.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.053 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.8 mtm -143.12 166.66 24.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.16 -122.09 4.95 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.6 Cg_exo -78.89 131.18 9.94 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.039 2.492 . . . . 0.0 110.896 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.4 Cg_exo -57.07 -36.97 99.43 Favored 'Trans proline' 0 N--CA 1.475 0.384 0 C-N-CA 123.344 2.696 . . . . 0.0 113.122 -176.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.39 -32.59 60.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 11.4 tpp180 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.391 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 13' ' ' ILE . 84.4 m -54.14 -40.1 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.276 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -66.11 -40.33 90.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.903 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 73' ' ' ILE . 11.9 t-80 -66.73 -43.1 85.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.189 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.68 -34.34 78.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -43.79 98.31 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.535 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -64.78 -35.26 80.52 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.244 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.496 HG21 HG23 ' A' ' 36' ' ' ILE . 64.6 mt -62.25 -50.24 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.0 110.208 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 44' ' ' ILE . 68.6 mt -66.49 -46.62 86.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.962 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -70.19 -32.42 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -33.83 76.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 8.4 tt -63.9 -44.62 92.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 21' ' ' SER . 65.8 mt -61.8 -40.88 96.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.515 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -61.14 -38.57 86.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.675 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 m -65.03 -29.78 70.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.694 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.699 HD21 HG11 ' A' ' 24' ' ' VAL . 85.8 mt -76.93 -54.01 7.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.415 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.215 -172.702 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.002 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.753 HD11 HD12 ' A' ' 60' ' ' ILE . 39.8 pt -109.46 150.16 12.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.111 0.481 . . . . 0.0 111.265 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -106.29 105.28 15.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.233 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -105.45 132.04 21.23 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.2 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 5.5 Cg_exo -72.78 112.92 3.61 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.289 2.659 . . . . 0.0 112.191 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 HD21 ' A' ' 78' ' ' LEU . 7.4 p -121.02 107.3 37.87 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 72.4 Cg_exo -48.53 133.45 26.06 Favored 'Trans proline' 0 N--CA 1.47 0.118 0 C-N-CA 123.505 2.803 . . . . 0.0 112.39 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 22.8 mtm180 -62.84 -28.32 69.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.693 -176.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.7 -32.14 63.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.249 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.6 m -79.99 -24.22 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' PRO . 62.3 t -54.97 -35.06 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.173 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.07 65.49 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.418 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.61 -36.89 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 0.0 110.556 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 21' ' ' SER . 38.3 t -67.91 -40.39 83.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.596 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -82.32 -46.65 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.38 -118.74 4.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.041 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -97.96 -77.74 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.484 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 21.0 m -82.56 -55.63 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.74 0.781 . . . . 0.0 109.443 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 175.18 32.21 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 4.2 mm-40 -57.49 -47.49 81.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.261 -0.47 . . . . 0.0 111.724 -167.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.6 tpt -66.55 -45.88 77.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 44' ' ' ILE . 6.1 tt -69.0 -31.15 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.912 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 92.9 mttt -62.97 -42.35 99.8 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -66.6 -37.95 85.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 32' ' ' MET . 75.6 mt -63.16 -51.13 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.0 -35.71 73.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.581 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -77.98 -32.98 51.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.94 -46.52 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -81.69 -28.43 33.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.465 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.31 39.03 8.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.4 m -122.47 175.72 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.381 0.61 . . . . 0.0 111.517 -174.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -116.43 127.0 54.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.863 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -125.54 108.61 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.43 154.18 27.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.482 ' HE2' HG22 ' A' ' 22' ' ' VAL . 4.4 m-85 -100.78 120.68 40.46 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.213 0.53 . . . . 0.0 112.055 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -87.46 130.12 34.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.831 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.37 -21.28 66.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.59 109.93 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 4.3 p30 -81.69 140.81 34.12 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.93 -3.44 54.84 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.618 -170.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -160.64 12.67 0.11 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.913 0.356 . . . . 0.0 111.387 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -93.36 0.68 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.768 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.68 -11.03 14.24 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.576 2.184 . . . . 0.0 112.753 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.9 mt-10 -107.27 124.71 50.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.71 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 44.8 mtpt -78.24 177.78 8.14 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.665 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.1 mm -115.24 113.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.426 0.631 . . . . 0.0 111.174 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.745 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -84.79 140.6 31.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -110.83 101.51 10.11 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.753 HD12 HD11 ' A' ' 13' ' ' ILE . 21.5 mt -91.24 137.37 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.1 mtm -142.82 163.33 33.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 111.823 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.04 -135.53 9.75 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.61 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 7.7 Cg_exo -69.27 150.86 71.67 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.675 2.25 . . . . 0.0 111.692 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.08 -48.85 5.69 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.538 2.159 . . . . 0.0 112.742 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.57 -34.79 77.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.429 0.633 . . . . 0.0 109.431 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.635 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.8 tpp180 -61.82 -38.95 90.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.587 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 76.9 m -58.95 -47.99 83.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.228 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -69.53 -34.99 75.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.678 0.275 . . . . 0.0 110.823 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -62.68 -46.35 88.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.469 . . . . 0.0 110.169 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -71.06 -35.72 72.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.42 -36.9 79.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.824 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 72' ' ' ARG . 11.5 ttm180 -66.08 -43.04 88.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.187 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.68 -49.49 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.613 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 44' ' ' ILE . 77.0 mt -68.93 -46.24 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.28 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.01 -43.67 98.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.25 -34.0 77.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.275 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.88 -45.64 85.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.032 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.4 mt -61.02 -34.72 75.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.25 -35.2 79.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 m -71.8 -14.96 62.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.039 0.447 . . . . 0.0 110.798 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.4 mt -96.59 -34.96 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.329 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 27.5 ptt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.005 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 60' ' ' ILE . 38.1 pt -124.35 160.23 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.905 0.383 . . . . 0.0 111.293 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.51 105.34 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.128 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.81 130.29 23.0 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.8 Cg_exo -75.06 104.15 1.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.372 2.715 . . . . 0.0 112.259 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -112.83 113.02 50.21 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.367 0.603 . . . . 0.0 110.214 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.36 134.57 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 123.096 2.531 . . . . 0.0 112.042 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -61.04 -33.14 72.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.035 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.35 -22.87 60.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 109.798 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 25' ' ' VAL . 17.9 m -87.03 -25.74 24.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.037 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.3 -32.28 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.616 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.44 -33.73 62.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.213 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.71 -34.36 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.644 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 21' ' ' SER . 95.6 t -64.52 -38.55 82.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 46' ' ' PHE . 42.8 mm -79.83 -54.76 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.205 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.579 ' O ' ' HD2' ' A' ' 28' ' ' ARG . . . 105.04 -128.52 9.47 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 15.0 mmm180 -125.76 -29.7 3.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.064 0.459 . . . . 0.0 110.186 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -114.32 3.72 15.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.853 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 10.44 84.04 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -63.89 -32.53 74.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.841 0.456 . . . . 0.0 111.4 -172.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -70.81 -45.35 64.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 44' ' ' ILE . 7.9 tt -72.2 -28.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.188 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -67.22 -36.53 81.87 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.01 -44.21 89.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.239 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 HG21 ' A' ' 73' ' ' ILE . 78.9 mt -58.11 -52.09 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.231 0.539 . . . . 0.0 110.523 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.84 -33.68 75.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.411 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.29 -44.1 65.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.32 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.85 -53.15 29.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.364 . . . . 0.0 111.409 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -77.53 -27.08 51.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.89 42.22 9.91 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 70' ' ' ALA . 20.4 m -125.79 174.34 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.074 -174.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.6 tpp180 -116.91 131.86 56.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.169 167.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 33' ' ' ILE . 80.4 mt -111.35 108.64 26.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -118.23 117.1 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.694 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 26' ' ' ILE . 96.9 m-85 -72.66 126.04 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -75.94 -175.27 2.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -81.06 166.27 20.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 -176.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.7 38.39 1.97 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.233 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 17.8 m-20 69.69 -70.32 0.15 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.805 ' HA3' HG12 ' A' ' 57' ' ' ILE . . . 152.49 -65.29 0.35 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.046 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.812 HG23 ' HB2' ' A' ' 55' ' ' GLU . 3.0 t -150.78 72.19 1.07 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.85 . . . . 0.0 111.097 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 -116.77 4.77 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.354 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.86 -4.11 12.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.894 2.396 . . . . 0.0 111.879 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.812 ' HB2' HG23 ' A' ' 52' ' ' THR . 44.2 mt-10 -108.48 129.37 55.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 46.3 mttp -86.87 149.37 24.87 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.805 HG12 ' HA3' ' A' ' 51' ' ' GLY . 40.9 mm -95.96 108.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.418 0.627 . . . . 0.0 110.115 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.767 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.58 123.61 26.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.597 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.52 101.29 12.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 13' ' ' ILE . 47.0 mt -89.07 136.09 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -143.52 164.37 30.55 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.058 -168.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.11 -115.81 2.98 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.7 Cg_endo -85.53 126.69 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.263 2.642 . . . . 0.0 110.212 172.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 52.8 Cg_exo -56.02 -35.44 94.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.474 2.783 . . . . 0.0 113.408 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.38 -33.06 32.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.001 0.429 . . . . 0.0 110.175 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.4 tpp180 -65.78 -28.73 69.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.381 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 13' ' ' ILE . 82.9 m -59.63 -30.09 68.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.48 -32.21 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.019 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.486 ' O ' HG13 ' A' ' 73' ' ' ILE . 27.3 t-80 -64.27 -42.8 96.29 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.21 -33.77 73.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.215 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.22 98.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.5 -46.25 90.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 36' ' ' ILE . 67.1 mt -55.0 -51.42 53.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.732 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.648 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 75.6 mt -66.76 -48.21 80.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.791 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -59.84 -46.57 88.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.192 0.52 . . . . 0.0 111.611 -176.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.72 -36.1 79.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.544 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.76 -40.73 79.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 77.3 mt -64.05 -32.54 74.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.338 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -58.17 -38.92 77.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.365 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 -30.09 70.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.184 0.516 . . . . 0.0 110.758 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.01 -29.45 17.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.02 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.917 -178.268 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 60' ' ' ILE . 45.8 pt -119.43 155.39 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.69 0.757 . . . . 0.0 112.419 -174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 7.1 m-20 -123.44 112.46 17.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.334 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.03 129.0 24.98 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.383 -171.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 18.4 Cg_endo -79.52 106.89 2.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.42 2.08 . . . . 0.0 111.52 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 56' ' ' LYS . 7.6 p -113.81 113.23 47.42 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.419 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.2 Cg_exo -52.14 134.11 49.08 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.335 2.69 . . . . 0.0 112.522 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 97.7 mtt180 -58.73 -35.09 72.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.447 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -80.71 -6.08 57.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.698 0.285 . . . . 0.0 111.207 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -107.11 -16.9 14.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.4 t -57.0 -38.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.194 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.25 57.0 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.006 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.6 t -85.08 -39.15 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.368 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 77' ' ' LEU . 42.5 t -63.68 -37.19 79.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.35 0.595 . . . . 0.0 110.108 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 46' ' ' PHE . 40.4 mm -79.61 -50.95 17.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.853 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.79 -147.87 19.18 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -83.09 -70.77 0.53 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.418 0.609 . . . . 0.0 110.471 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -96.76 26.22 4.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.53 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 78.81 7.81 88.09 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.476 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 18.4 mt-10 -54.54 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.603 0.761 . . . . 0.0 112.538 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.2 tpt -74.47 -50.63 17.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.72 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 tt -69.09 -27.41 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.412 . . . . 0.0 110.363 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -68.25 -40.14 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.045 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -59.6 -42.51 92.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG23 HG21 ' A' ' 73' ' ' ILE . 67.6 mt -63.87 -54.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.819 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.26 -39.02 81.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.036 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -81.87 -26.21 34.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.439 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.5 -49.77 24.93 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.345 0.593 . . . . 0.0 109.78 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . -84.16 -9.86 58.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.748 -175.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.66 31.98 80.08 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.255 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 172.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.719 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.9 ttm180 -117.75 129.18 55.54 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 60' ' ' ILE . 68.7 mt -119.53 108.93 24.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.875 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -119.16 131.85 55.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 110.552 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.599 ' CE1' HD11 ' A' ' 26' ' ' ILE . 85.8 m-85 -81.17 115.06 20.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.948 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 8.6 mtpm? -62.98 131.21 47.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.212 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 46.58 0.45 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.638 0.733 . . . . 0.0 109.176 173.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -171.98 97.3 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.316 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 17.4 m-20 -77.68 128.15 33.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.297 -176.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 57' ' ' ILE . . . -83.99 -13.64 74.18 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.3 m -107.89 -52.81 2.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.429 . . . . 0.0 110.633 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.24 -82.63 0.29 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 15.0 Cg_exo -69.95 -26.92 26.18 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.873 2.382 . . . . 0.0 110.731 171.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.02 132.82 45.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.091 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 22.3 mtpp -81.99 174.75 10.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.562 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG12 ' H ' ' A' ' 51' ' ' GLY . 48.4 mm -120.96 111.11 30.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.117 0.485 . . . . 0.0 110.227 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -82.2 125.18 30.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 171.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -102.56 102.96 13.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.375 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 44' ' ' ILE . 47.0 mt -92.86 144.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.603 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 50.2 mtm -145.16 174.93 10.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.888 0.375 . . . . 0.0 111.935 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 112.7 -125.54 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.097 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.493 ' CG ' ' HB3' ' A' ' 66' ' ' ARG . 5.8 Cg_exo -82.89 134.12 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.232 2.621 . . . . 0.0 111.689 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 56.4 Cg_exo -53.56 -34.61 73.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.818 3.012 . . . . 0.0 113.586 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.59 -42.58 24.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.659 0.743 . . . . 0.0 109.759 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.547 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 18.5 tpp85 -67.57 -34.29 76.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.814 -176.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.5 p -61.86 -40.48 95.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.026 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -68.26 -34.25 75.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.375 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 51.9 t-80 -63.7 -44.78 92.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.01 -36.3 83.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.444 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.03 87.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -69.69 -35.82 75.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.524 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.2 mt -60.52 -49.01 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.79 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 44' ' ' ILE . 87.4 mt -64.28 -40.94 90.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.793 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.65 -37.77 82.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.944 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 15.7 t70 -60.87 -36.27 78.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.428 0.633 . . . . 0.0 110.012 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 25' ' ' VAL . 9.7 tt -66.83 -44.15 81.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.685 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 81.0 mt -67.57 -39.72 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.669 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.5 pt20 -65.78 -20.13 66.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.734 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.5 m -80.06 -23.95 41.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.143 0.496 . . . . 0.0 110.394 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.4 mt -93.25 -49.74 5.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.193 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 11.4 ptm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.266 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 61' ' ' MET . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 113.517 0.167 . . . . 0.0 113.517 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 60' ' ' ILE . 42.0 pt -118.81 166.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 22.2 m-20 -122.57 114.18 20.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.099 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -113.04 126.23 28.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.177 -175.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 15.0 Cg_exo -67.15 116.45 4.18 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.908 2.405 . . . . 0.0 111.965 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.627 HG23 HD21 ' A' ' 78' ' ' LEU . 7.6 p -123.64 108.98 30.73 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 121.506 0.669 . . . . 0.0 110.807 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 75.9 Cg_exo -50.96 131.86 35.97 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.192 2.595 . . . . 0.0 112.054 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 48.2 mtp85 -58.22 -32.5 68.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.716 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.43 . . . . 0.0 110.535 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB3' HD12 ' A' ' 81' ' ' LEU . 17.9 m -88.42 -23.28 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.9 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.51 -32.7 65.04 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.604 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.39 -36.93 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.69 0.281 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 77' ' ' LEU . 48.2 t -65.34 -37.02 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 110.444 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.8 mm -81.51 -61.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.174 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.12 -152.1 18.46 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.641 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -37.49 9.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.246 0.546 . . . . 0.0 109.957 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 m -106.23 3.06 27.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.024 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 74.59 24.59 72.24 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -168.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.16 90.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.488 -0.856 . . . . 0.0 111.909 -174.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -72.77 -42.25 64.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.03 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 30' ' ' GLY . 5.7 tt -66.27 -30.83 51.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 48.7 mttp -69.61 -45.99 67.3 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -54.16 -45.55 72.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 32' ' ' MET . 62.2 mt -65.39 -48.97 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.737 0.304 . . . . 0.0 110.921 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.498 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 46.1 mt-30 -59.77 -33.69 72.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.55 -42.96 23.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.251 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.18 -37.1 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.46 -14.91 19.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.532 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.32 47.16 53.49 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.499 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 37' ' ' GLN . 31.5 m -124.77 176.23 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.283 -174.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 19.0 tpt180 -116.57 128.91 55.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.247 168.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -113.28 108.79 26.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -122.78 129.87 52.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 26' ' ' ILE . 38.0 m-85 -85.11 123.7 30.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 111.456 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 15.1 mttp -66.99 144.87 55.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.592 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -95.99 5.42 51.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -107.58 75.04 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.985 175.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 59.6 m-20 -68.07 121.41 16.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 0.0 110.415 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -31.43 80.23 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.028 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -119.21 -42.39 2.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.913 0.357 . . . . 0.0 111.434 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.25 -78.81 0.38 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.312 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 11.3 Cg_endo -58.84 -27.77 85.14 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.747 2.298 . . . . 0.0 111.211 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 52' ' ' THR . 13.9 mp0 -106.38 130.04 54.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.483 171.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 23.6 mtpp -83.49 178.66 7.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.09 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 50.2 mm -117.45 114.04 44.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.342 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.835 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -82.45 130.37 35.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -104.42 101.46 11.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 13' ' ' ILE . 48.9 mt -88.71 132.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.427 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 70.9 mtm -143.21 160.07 41.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.297 0.57 . . . . 0.0 111.754 -170.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.23 -119.48 2.65 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -175.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -82.04 131.0 6.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.675 2.25 . . . . 0.0 110.499 172.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 40.8 Cg_exo -57.23 -28.93 81.8 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.254 2.636 . . . . 0.0 112.863 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.04 -40.05 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 110.075 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.4 tpp180 -60.59 -35.49 76.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.82 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' HG12 ' A' ' 13' ' ' ILE . 85.7 m -56.6 -33.91 66.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.8 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.69 -43.48 72.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -69.19 -39.83 78.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.0 0.429 . . . . 0.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.7 -30.94 70.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.424 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.432 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.95 -41.3 87.09 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.337 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -65.47 -42.47 92.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.916 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.89 -50.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.395 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.0 mt -69.73 -51.01 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.148 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -62.54 -41.48 98.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.866 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.44 -35.79 82.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.423 . . . . 0.0 110.22 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 59.0 tp -63.84 -47.61 80.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 79.3 mt -57.82 -46.84 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.646 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -27.7 69.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.795 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 t -80.25 -15.63 56.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.466 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 67.2 mt -95.27 -21.11 18.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.489 . . . . 0.0 110.42 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.525 179.504 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 60' ' ' ILE . 41.6 pt -124.99 155.98 33.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.055 0.455 . . . . 0.0 111.409 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.57 124.71 43.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.457 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 t -123.15 121.76 27.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.61 0.243 . . . . 0.0 111.336 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.1 Cg_exo -70.74 104.37 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.906 2.404 . . . . 0.0 111.928 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 p -118.09 105.88 46.25 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.644 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 85.3 Cg_exo -46.82 133.53 17.49 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.447 2.765 . . . . 0.0 112.604 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.677 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 38.4 mtt180 -60.4 -29.48 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -83.18 -13.13 56.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.9 m -99.61 -14.52 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.785 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.579 HG21 ' HD3' ' A' ' 56' ' ' LYS . 28.0 t -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.133 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.04 -24.57 60.87 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.9 -42.04 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 21' ' ' SER . 60.5 t -61.89 -37.24 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.877 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 46' ' ' PHE . 47.0 mm -79.66 -51.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.616 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.4 44.24 11.44 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.876 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 65.6 -73.14 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.457 0.703 . . . . 0.0 111.828 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 m -75.98 -16.55 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.701 0.286 . . . . 0.0 111.73 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 97.15 2.02 59.34 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -173.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.53 -32.88 69.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.094 -0.553 . . . . 0.0 111.751 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.1 tpt -74.48 -43.0 58.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.949 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.552 HD11 ' HB ' ' A' ' 44' ' ' ILE . 13.0 tt -69.32 -31.34 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 7.2 mmpt? -65.26 -36.11 83.11 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.69 174.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 32' ' ' MET . 28.1 tptp -62.59 -51.02 68.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.259 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 73' ' ' ILE . 73.4 mt -60.69 -50.26 81.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.5 -33.08 74.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.064 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -75.41 -32.24 60.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.989 0.423 . . . . 0.0 110.456 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.28 -46.84 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.053 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.12 -28.44 20.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.844 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.58 40.17 7.9 Favored Glycine 0 CA--C 1.517 0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.773 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 28.8 m -121.93 176.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 0.0 111.194 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -118.58 131.98 56.2 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 33' ' ' ILE . 85.0 mt -111.92 109.01 26.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.463 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.564 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 15.7 tm0? -121.71 120.85 35.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 26' ' ' ILE . 80.4 m-85 -74.02 116.4 14.6 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -60.32 127.56 32.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -70.67 -13.82 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.041 0.448 . . . . 0.0 110.788 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -117.55 -158.12 0.69 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 57' ' ' ILE . 1.4 m-20 59.43 47.82 10.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.251 0.548 . . . . 0.0 111.309 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.08 84.75 1.59 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.456 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.5 p -74.33 91.74 2.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 111.522 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.6 -132.34 47.2 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.266 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.63 8.11 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.628 2.218 . . . . 0.0 112.284 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -121.27 138.98 53.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.145 0.498 . . . . 0.0 111.035 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.677 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 26.9 mtpp -88.18 177.34 6.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 50.1 mm -120.91 107.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.618 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -79.55 140.08 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 45' ' ' GLN . 3.2 p-80 -118.91 112.46 19.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.121 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 13' ' ' ILE . 22.2 mt -92.17 148.77 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.623 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 mtm -142.92 175.23 9.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 111.86 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.66 -137.37 14.19 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.032 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 11.2 Cg_exo -67.13 148.31 80.79 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.72 2.28 . . . . 0.0 111.472 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 37.0 Cg_exo -60.11 -48.3 12.52 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.502 2.135 . . . . 0.0 112.484 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.75 -32.69 74.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.462 0.649 . . . . 0.0 109.739 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 5.7 tpp85 -64.96 -37.21 86.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.715 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.87 -48.53 81.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.11 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.67 -33.43 68.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 0.0 111.27 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' HG13 ' A' ' 73' ' ' ILE . 3.5 t-160 -61.1 -49.75 76.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -68.6 -31.92 71.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.43 92.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.633 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -64.85 -34.78 79.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 36' ' ' ILE . 69.6 mt -62.76 -51.27 74.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.024 0.44 . . . . 0.0 110.698 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 60' ' ' ILE . 53.7 mt -66.06 -43.88 92.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.641 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.92 -36.42 83.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.615 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 16.5 t70 -59.45 -38.21 80.15 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.5 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.231 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 81' ' ' LEU . 82.9 mt -70.13 -26.14 63.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.725 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.0 pt20 -64.04 -25.86 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.858 0.361 . . . . 0.0 111.089 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.2 t -87.56 -35.66 18.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.039 0.447 . . . . 0.0 110.171 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 78' ' ' LEU . 79.4 mt -73.23 -6.57 46.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.81 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 82' ' ' ARG . 10.6 ptp180 . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.256 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.785 HD11 HD12 ' A' ' 60' ' ' ILE . 32.7 pt -129.22 166.55 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.813 0.339 . . . . 0.0 111.261 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -121.6 105.92 10.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.526 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -104.25 131.76 21.62 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.9 Cg_exo -70.2 108.28 2.13 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.546 2.831 . . . . 0.0 111.968 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.561 HG11 ' HE1' ' A' ' 46' ' ' PHE . 7.8 p -113.97 113.38 46.91 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.984 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.67 128.34 25.89 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.417 2.078 . . . . 0.0 111.253 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -62.5 -22.55 66.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.834 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.18 -27.76 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.5 m -83.33 -23.41 32.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.471 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.51 -35.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.36 -29.98 64.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.469 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -88.93 -35.25 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 110.442 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 21' ' ' SER . 47.8 t -66.84 -39.13 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.317 0.58 . . . . 0.0 109.923 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.584 HD11 ' CE2' ' A' ' 46' ' ' PHE . 37.2 mm -79.52 -45.18 23.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.965 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.08 -86.02 1.29 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.138 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -133.94 -72.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.304 0.242 . . . . 0.0 110.368 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -109.38 44.52 1.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.012 0.434 . . . . 0.0 110.262 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 64.11 23.69 68.11 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -60.65 -43.85 97.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.389 -0.906 . . . . 0.0 111.364 -168.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.3 tpt -77.42 -34.14 54.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 44' ' ' ILE . 9.0 tt -78.1 -23.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.843 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 73.3 mmtt -63.25 -36.52 83.94 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 32' ' ' MET . 17.8 tppt? -63.24 -44.29 95.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.486 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.97 -52.14 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.466 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.571 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 44.6 mt-30 -61.86 -27.6 68.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.352 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -75.34 -49.37 19.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.921 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -68.96 -43.45 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 111.35 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.72 34.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.555 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.95 32.75 66.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.763 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 m -113.75 -179.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.443 0.639 . . . . 0.0 111.533 -173.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.571 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 31.4 tpt180 -123.05 135.25 54.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.951 169.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.6 HG21 HD11 ' A' ' 33' ' ' ILE . 89.7 mt -116.54 109.09 26.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.016 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.813 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 12.8 mm100 -97.05 107.74 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.752 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CE2' HD11 ' A' ' 26' ' ' ILE . 27.2 m-85 -73.43 111.28 8.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.103 0.478 . . . . 0.0 109.765 174.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 29.2 mtmt -96.03 138.61 33.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.326 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -98.38 -7.11 29.37 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 161.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 33.4 t70 -51.63 -45.44 63.28 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.526 174.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.37 127.27 48.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.819 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.27 115.54 0.71 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 p -85.91 3.2 42.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.532 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 117.73 -88.61 0.46 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.825 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 6.7 Cg_exo -75.35 -20.91 15.74 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.006 2.471 . . . . 0.0 112.027 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.91 139.27 50.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.489 0.661 . . . . 0.0 111.288 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 17' ' ' VAL . 47.5 tttp -100.07 170.65 8.34 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.312 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.98 117.97 57.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.307 0.575 . . . . 0.0 111.218 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -87.53 133.53 33.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 27.6 t60 -111.69 101.98 10.31 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.332 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 13' ' ' ILE . 31.6 mt -89.23 139.97 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.049 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.8 mtm -139.82 156.42 46.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 111.796 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.61 -126.05 4.57 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.255 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.0 Cg_exo -78.57 137.59 14.69 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.245 2.63 . . . . 0.0 111.604 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 77.4 Cg_exo -51.84 -49.28 17.78 Favored 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 122.717 2.278 . . . . 0.0 113.083 -177.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.52 -38.79 84.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.175 0.512 . . . . 0.0 110.533 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 23.9 tpp180 -63.95 -29.22 70.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.733 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.0 m -62.57 -46.47 88.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.69 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.0 110.274 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.49 -43.68 96.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.251 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.85 -32.68 65.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.583 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -59.32 -42.48 91.53 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.58 0.705 . . . . 0.0 109.361 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -62.83 -42.28 99.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.73 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -57.69 -52.11 61.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 110.529 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.641 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.7 mt -64.73 -50.64 74.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.093 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -67.1 -32.42 73.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.458 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 t70 -65.23 -31.67 72.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.261 176.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.85 -42.22 61.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.563 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 83.8 mt -62.6 -34.59 77.33 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.241 -175.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 29.7 pt20 -61.38 -19.92 62.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 t -87.24 -19.86 27.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.571 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.6 mt -104.41 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -177.569 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.901 HD11 HD12 ' A' ' 60' ' ' ILE . 39.6 pt -120.75 162.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.761 0.315 . . . . 0.0 111.134 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -111.54 123.44 50.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -122.52 123.86 26.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.33 -173.516 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 13.8 Cg_exo -68.47 105.37 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.734 2.289 . . . . 0.0 111.801 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.512 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -117.17 110.02 41.83 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.363 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.0 Cg_exo -47.46 129.99 17.21 Favored 'Trans proline' 0 CA--C 1.522 -0.11 0 C-N-CA 123.232 2.621 . . . . 0.0 112.129 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -62.96 -28.17 69.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.845 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -75.92 -24.8 55.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.467 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -92.16 -14.78 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.996 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -33.86 46.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.41 68.23 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.618 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG21 HD11 ' A' ' 81' ' ' LEU . 38.4 t -83.82 -43.8 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 109.977 177.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.78 -41.35 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.633 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.7 mm -79.96 -67.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.708 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 26' ' ' ILE . . . 75.76 -169.9 54.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.077 -175.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.84 117.34 7.4 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.711 -0.288 . . . . 0.0 110.557 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m 62.53 16.36 8.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 71.84 26.5 72.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.166 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.26 -39.48 75.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 111.654 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.2 tpt -70.76 -39.3 73.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.981 0.419 . . . . 0.0 110.555 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 44' ' ' ILE . 7.3 tt -76.3 -26.54 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.081 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 45.1 mmtm -61.72 -43.1 99.51 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -58.87 -41.71 87.74 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.708 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 73' ' ' ILE . 70.2 mt -66.81 -49.96 69.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 110.852 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -61.89 -28.16 69.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.559 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -80.91 -51.26 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.54 -53.16 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.088 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.614 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -79.3 -18.51 52.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.403 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.43 40.44 60.06 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.5 m -126.81 165.66 24.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.975 0.417 . . . . 0.0 111.159 -174.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 13.7 ttm180 -104.87 135.27 46.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.512 167.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.558 HG21 HD11 ' A' ' 33' ' ' ILE . 88.9 mt -116.06 108.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.53 106.67 12.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.016 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 26' ' ' ILE . 87.1 m-85 -65.15 136.4 56.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -82.51 150.97 26.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.931 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 13.1 mm100 -107.59 168.19 9.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER 71.55 -72.72 0.11 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.858 0.724 . . . . 0.0 111.681 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.11 119.54 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.904 0.859 . . . . 0.0 111.577 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.1 113.58 0.59 Allowed Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -67.3 95.37 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -170.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 66.67 -132.05 31.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 1.7 Cg_endo -80.2 3.18 7.87 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.955 2.437 . . . . 0.0 111.928 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 42.2 mt-10 -115.73 139.06 50.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.471 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -92.17 172.61 8.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.76 114.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.434 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -85.9 140.48 30.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 24.2 t60 -116.24 108.88 16.67 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.48 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 13' ' ' ILE . 55.0 mt -88.3 148.8 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.886 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.1 mmt -122.27 147.38 46.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.61 -137.88 11.17 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.515 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 56.6 Cg_endo -91.09 147.59 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.436 2.757 . . . . 0.0 112.56 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.11 -48.88 19.41 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 113.318 -172.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.91 -43.3 96.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.683 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 2.8 tpp180 -68.37 -37.23 80.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.149 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 96.4 m -59.06 -42.42 90.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.165 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.54 -31.7 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.294 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.433 0.635 . . . . 0.0 109.304 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.84 -34.78 67.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.603 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.04 90.44 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.677 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -60.57 -47.6 85.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.434 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 40' ' ' ALA . 70.4 mt -56.7 -49.01 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.156 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 60' ' ' ILE . 78.8 mt -67.81 -46.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.987 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.68 -44.18 96.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.094 -177.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.84 -40.89 94.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.818 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.96 -46.48 90.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.945 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 58.1 mt -68.17 -27.74 66.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.054 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -58.19 -39.51 79.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.638 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 t -72.09 -19.76 61.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD11 HG21 ' A' ' 24' ' ' VAL . 70.2 mt -97.47 19.08 13.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.371 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 1.2 ptp180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.507 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 60' ' ' ILE . 39.1 pt -120.69 157.02 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.08 0.467 . . . . 0.0 111.088 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -110.22 114.8 28.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -118.42 126.15 27.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.4 Cg_exo -69.45 113.69 3.41 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 123.15 2.567 . . . . 0.0 112.237 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.1 p -119.14 114.41 35.03 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.25 133.42 58.01 Favored 'Trans proline' 0 N--CA 1.469 0.044 0 C-N-CA 122.773 2.315 . . . . 0.0 112.236 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -62.71 -13.3 30.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -85.59 -45.04 12.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.101 0.477 . . . . 0.0 109.877 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.48 ' HB3' HD12 ' A' ' 81' ' ' LEU . 14.4 m -79.1 -22.43 45.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.671 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.71 -24.49 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.648 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.07 -35.27 88.78 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.688 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -75.96 -31.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 110.127 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.38 -38.02 81.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.938 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.08 -51.24 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.348 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.05 -133.57 14.43 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.651 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -108.17 127.14 53.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 65.3 m 62.37 6.45 1.92 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.882 0.473 . . . . 0.0 111.781 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.658 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 80.93 8.04 87.91 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.231 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' A' ' 29' ' ' SER . 60.4 mm-40 -54.03 -32.54 54.72 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.477 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.5 tpt -70.13 -46.39 64.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 36' ' ' ILE . 6.3 tt -73.76 -23.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.139 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 96.1 mttt -65.11 -38.24 90.03 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -64.17 -44.22 92.72 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 33' ' ' ILE . 12.5 mt -58.09 -56.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.484 0.659 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.43 -23.65 66.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.703 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -85.39 -45.41 11.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.14 -32.69 69.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.36 -10.92 23.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.65 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.54 34.06 88.91 Favored Glycine 0 C--N 1.328 0.112 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.982 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.53 178.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.352 0.596 . . . . 0.0 111.248 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.5 tpp180 -119.06 131.49 55.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.077 170.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 33' ' ' ILE . 89.7 mt -119.46 108.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 123.682 0.614 . . . . 0.0 109.761 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -124.11 118.38 26.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.802 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 22.1 m-85 -76.99 109.67 11.0 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 41.6 mtpt -61.43 112.72 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.64 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -76.34 -6.93 53.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.659 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.59 -42.43 6.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.881 0.372 . . . . 0.0 110.062 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 1.4 m-20 -72.26 86.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.86 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.68 87.74 0.42 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.977 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 p -75.93 85.62 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 110.798 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.26 -126.28 35.7 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.873 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -84.42 8.91 4.36 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.777 2.318 . . . . 0.0 112.419 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -117.15 123.11 45.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 0.0 110.896 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 53.8 mtpt -83.96 163.95 19.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.97 112.25 39.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.617 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.39 135.6 37.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -107.47 101.48 10.82 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.832 HD12 HD11 ' A' ' 13' ' ' ILE . 34.9 mt -89.76 135.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.8 mtm -141.6 169.69 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.816 -171.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 120.08 -124.34 5.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -174.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.3 Cg_exo -80.9 133.07 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.066 2.511 . . . . 0.0 110.74 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 76.2 Cg_exo -51.64 -40.92 63.63 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.889 3.059 . . . . 0.0 114.077 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.28 -38.18 43.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.37 0.605 . . . . 0.0 109.946 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 12.2 tpp85 -62.57 -32.85 73.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.797 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.0 m -58.83 -44.24 90.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.491 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.27 -25.75 51.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.221 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -73.07 -40.2 65.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.02 68.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.858 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.25 -36.31 77.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.494 174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -68.64 -40.28 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.331 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.473 HG21 HG23 ' A' ' 36' ' ' ILE . 65.3 mt -56.73 -46.26 83.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.418 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.595 HD12 HD11 ' A' ' 60' ' ' ILE . 73.6 mt -72.03 -45.06 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -59.83 -44.82 93.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' HB2' ' HE ' ' A' ' 72' ' ' ARG . 15.5 t70 -58.75 -40.76 84.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.462 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.98 -48.85 77.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.756 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 75.8 mt -60.88 -38.58 86.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 82' ' ' ARG . 30.7 tt0 -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -69.62 -14.87 63.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.727 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 21' ' ' SER . 70.9 mt -101.39 4.41 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.511 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 15.4 ptp180 . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.162 0.506 . . . . 0.0 110.986 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 60' ' ' ILE . 37.6 pt -106.97 160.43 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.924 0.392 . . . . 0.0 111.447 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -110.19 105.48 14.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -103.41 120.27 52.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 112.163 -176.5 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 16.3 Cg_exo -67.6 103.66 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.221 2.614 . . . . 0.0 111.497 175.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.29 110.03 53.69 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 86.2 Cg_exo -47.39 129.0 15.64 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.316 2.677 . . . . 0.0 112.103 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.51 -25.56 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.483 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.48 -33.43 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 110.288 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.442 ' O ' HG23 ' A' ' 25' ' ' VAL . 39.9 m -79.23 -22.08 45.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.386 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.531 HG21 ' HD3' ' A' ' 56' ' ' LYS . 37.8 t -54.95 -34.83 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -31.38 68.83 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.724 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 t -89.38 -36.37 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.763 0.316 . . . . 0.0 110.417 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' SER . 57.8 t -64.51 -37.52 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.115 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.503 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.2 mm -79.09 -40.49 22.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.657 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.3 -115.11 4.99 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.365 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 29.0 ttp85 -133.08 121.32 22.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.2 m 67.8 22.12 8.92 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.505 0.503 . . . . 0.0 110.637 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 71.37 13.13 73.63 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.499 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -52.57 -40.99 63.17 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.768 0.427 . . . . 0.0 111.32 -175.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.76 -35.96 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.494 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 36' ' ' ILE . 8.2 tt -75.94 -28.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.34 0.59 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -66.85 -34.7 78.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.661 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -59.62 -44.37 93.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.944 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 33' ' ' ILE . 8.8 mt -62.88 -62.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.432 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -52.98 -40.12 63.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.738 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.24 -49.77 58.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.603 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -83.75 -26.58 29.56 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -84.36 -25.59 29.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.899 0.38 . . . . 0.0 110.893 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.48 26.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.774 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.8 m -126.35 173.06 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.307 0.575 . . . . 0.0 111.148 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 17.4 tpt180 -116.63 122.46 44.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.167 170.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 33' ' ' ILE . 67.6 mt -109.6 108.32 25.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.36 115.57 19.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.736 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CE1' HD11 ' A' ' 26' ' ' ILE . 90.8 m-85 -63.4 128.34 35.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.61 98.55 0.18 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.734 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 62.85 13.05 6.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.435 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' PHE . 31.9 t70 54.76 31.75 16.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.739 0.78 . . . . 0.0 110.428 -171.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -110.16 -179.09 3.69 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.048 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.755 ' HA3' ' HA ' ' A' ' 56' ' ' LYS . . . -157.86 158.69 29.31 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.82 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -86.68 52.01 2.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.52 0.676 . . . . 0.0 111.051 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 116.47 -119.41 4.5 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.961 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 2.8 Cg_exo -76.19 -25.04 10.46 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.125 2.55 . . . . 0.0 112.289 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 40.0 mt-10 -114.56 128.8 56.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.241 0.543 . . . . 0.0 110.925 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.755 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 63.5 mtpt -84.59 166.08 17.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.0 mm -113.26 108.94 26.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.609 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.98 139.41 35.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.868 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -109.83 101.95 10.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 13' ' ' ILE . 36.0 mt -89.8 137.65 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -138.2 161.97 35.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.463 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 123.43 -127.81 6.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.082 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.0 Cg_exo -81.01 134.21 9.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.145 2.563 . . . . 0.0 110.965 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 78.5 Cg_exo -53.2 -39.6 80.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.638 2.892 . . . . 0.0 113.359 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.54 -37.1 68.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.171 0.51 . . . . 0.0 110.011 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 5.5 tpp180 -70.56 -28.86 65.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.664 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.2 m -62.17 -41.48 98.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.04 -36.86 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.957 0.408 . . . . 0.0 110.597 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.89 -38.5 88.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.591 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -72.5 -36.67 68.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.254 177.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.72 79.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.185 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -63.51 -44.08 95.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.886 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 40' ' ' ALA . 54.6 mt -61.06 -50.24 81.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 60' ' ' ILE . 83.8 mt -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -68.73 -33.91 74.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.244 0.545 . . . . 0.0 110.778 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 36.1 t70 -64.75 -29.22 70.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.493 177.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.74 -46.26 38.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 90.4 mt -62.98 -37.7 88.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.231 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.5 pt20 -61.65 -27.97 69.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.8 m -75.57 -30.72 59.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -87.04 -25.92 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.211 0.529 . . . . 0.0 110.378 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.146 -175.426 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.889 HD11 HD12 ' A' ' 60' ' ' ILE . 39.9 pt -134.81 164.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -119.8 112.9 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -113.72 127.15 27.14 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.714 -170.211 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.8 Cg_exo -71.0 104.91 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.994 2.462 . . . . 0.0 111.88 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.46 116.87 41.22 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.4 Cg_exo -56.16 135.09 68.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.808 2.339 . . . . 0.0 111.674 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.806 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 80.9 mtm180 -62.31 -38.38 89.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.33 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -68.25 -30.57 69.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.046 0.45 . . . . 0.0 110.172 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.1 m -80.0 -26.49 39.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG21 ' HD3' ' A' ' 56' ' ' LYS . 44.4 t -55.85 -37.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 176.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.93 -28.91 61.33 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.534 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.3 -37.09 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.728 0.299 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 21' ' ' SER . 48.3 t -63.92 -37.83 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.496 0.665 . . . . 0.0 110.233 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 ' CE2' ' A' ' 46' ' ' PHE . 41.2 mm -82.58 -41.19 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.579 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.54 -65.3 3.07 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -173.28 -68.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -72.79 -35.5 67.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.304 0.574 . . . . 0.0 110.061 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 119.49 12.21 6.87 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.057 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -59.44 -35.2 73.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.962 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -67.12 -47.63 70.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.705 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.629 HD11 ' CG2' ' A' ' 44' ' ' ILE . 18.0 tt -71.45 -30.41 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.603 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mtmt -65.97 -30.05 70.54 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -77.93 -38.83 44.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 32' ' ' MET . 80.2 mt -59.1 -47.2 90.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.44 0.638 . . . . 0.0 109.746 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -63.1 -31.92 73.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.021 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -70.97 -48.45 53.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.03 -36.33 77.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.599 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -92.53 -22.91 19.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.43 37.12 42.17 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' ALA . 27.9 m -119.25 -177.3 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 111.485 -174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.4 ttt85 -127.8 125.21 39.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.198 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.629 ' CG2' HD11 ' A' ' 33' ' ' ILE . 61.6 mt -111.14 108.99 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.603 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -102.72 163.65 12.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.919 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 26' ' ' ILE . 84.7 m-85 -105.63 113.32 26.82 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 49' ' ' ASP . 31.7 tttm -61.43 121.03 11.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.347 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -80.03 31.6 0.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.198 0.523 . . . . 0.0 111.614 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 5.5 m-20 -110.34 32.07 5.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 69.45 -56.91 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.94 0.896 . . . . 0.0 110.484 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.752 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 129.46 -86.95 0.31 Allowed Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 55' ' ' GLU . 13.1 t -145.88 3.27 0.94 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.455 0.645 . . . . 0.0 109.436 172.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.29 -94.3 0.64 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.92 -16.74 41.38 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.637 2.225 . . . . 0.0 112.033 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 52' ' ' THR . 56.5 mt-10 -125.42 151.74 45.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.169 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.806 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.7 mtpp -98.95 174.46 6.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.622 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.752 HG12 ' HA2' ' A' ' 51' ' ' GLY . 48.6 mm -120.82 110.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.49 135.55 38.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -115.99 100.95 8.33 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.889 HD12 HD11 ' A' ' 13' ' ' ILE . 37.1 mt -89.85 146.73 5.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.529 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.3 mtm -142.98 160.78 39.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -172.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.74 -125.39 5.54 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.396 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -81.13 136.22 10.12 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.161 2.574 . . . . 0.0 111.187 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.46 -49.56 17.02 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.574 2.183 . . . . 0.0 112.778 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -41.28 97.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.339 0.59 . . . . 0.0 110.424 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.46 -31.96 73.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.142 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.458 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 75.3 m -60.96 -44.31 97.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.27 -28.5 57.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.78 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.504 ' O ' HG13 ' A' ' 73' ' ' ILE . 20.9 t-80 -59.34 -46.97 87.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.92 -34.22 73.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.696 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.71 -42.5 99.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.452 0.644 . . . . 0.0 109.663 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttm105 -67.17 -34.14 76.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.572 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' HIS . 74.8 mt -62.26 -48.6 87.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 110.261 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 78.9 mt -64.89 -45.49 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.626 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -63.16 -36.9 85.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.546 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.54 -39.7 88.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.703 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.8 tp -66.66 -30.41 70.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 110.458 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.621 HD23 HD12 ' A' ' 81' ' ' LEU . 78.5 mt -75.54 -7.17 53.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.778 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -63.48 -34.14 77.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.9 t -86.7 -14.65 41.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.034 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD12 HD23 ' A' ' 78' ' ' LEU . 76.3 mt -96.84 -4.05 41.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.141 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.384 176.813 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 60' ' ' ILE . 28.3 pt -110.89 161.51 9.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.17 0.51 . . . . 0.0 111.603 -177.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB3' HG21 ' A' ' 57' ' ' ILE . 17.1 m-20 -122.28 108.31 13.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.908 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.52 127.11 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.478 -170.551 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.8 Cg_exo -71.07 106.47 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.908 2.406 . . . . 0.0 111.922 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.534 HG23 HD21 ' A' ' 78' ' ' LEU . 6.4 p -116.02 109.68 44.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.787 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 80.6 Cg_exo -46.09 129.14 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.5 2.8 . . . . 0.0 112.853 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.633 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 37.2 mtt180 -59.71 -27.97 66.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.936 -175.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -79.57 -27.8 41.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.928 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -88.43 -18.35 28.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.9 t -52.72 -34.72 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.77 68.25 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 t -80.96 -38.39 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.912 0.387 . . . . 0.0 110.456 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 24.7 t -64.36 -35.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.221 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 46' ' ' PHE . 30.0 mm -78.44 -65.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.24 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.16 86.58 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.421 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' GLY . 37.8 ttm180 60.1 82.99 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.864 0.465 . . . . 0.0 111.808 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m 70.59 -25.33 0.16 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.454 0.702 . . . . 0.0 111.491 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' ARG . . . 113.1 74.27 0.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.25 -25.77 11.34 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.8 tpt -77.06 -51.88 10.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.305 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 36' ' ' ILE . 11.5 tt -70.23 -27.28 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.934 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -76.14 -32.47 59.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -62.96 -41.8 99.63 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.32 170.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 33' ' ' ILE . 94.0 mt -59.78 -52.37 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.911 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -56.4 -40.03 73.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.562 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -81.03 -17.79 49.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.966 0.412 . . . . 0.0 111.534 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.81 -40.17 17.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -96.24 -13.18 23.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.28 46.44 49.69 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.19 177.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.705 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.7 ttt180 -126.34 135.37 51.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.357 171.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD11 ' A' ' 33' ' ' ILE . 65.4 mt -119.94 108.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.87 119.14 38.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 26' ' ' ILE . 74.0 m-85 -75.47 110.73 10.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.366 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 22.8 mtpp -76.14 105.0 6.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.245 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -80.61 -18.02 49.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.859 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -78.24 137.53 38.16 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.734 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.92 -75.56 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.425 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.47 103.17 0.03 OUTLIER Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.634 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.3 p -69.74 85.96 0.48 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.046 0.45 . . . . 0.0 112.022 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.76 -132.33 40.62 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.817 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.56 10.99 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.113 2.542 . . . . 0.0 112.529 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.1 mt-10 -124.6 132.45 53.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.973 0.416 . . . . 0.0 110.777 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 41.3 mttp -79.65 165.65 22.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 47' ' ' LYS . 50.4 mm -111.62 108.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.501 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.61 127.13 31.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -105.92 101.9 11.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 43' ' ' ARG . 47.8 mt -89.58 143.12 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.508 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.7 mtm -144.36 178.49 7.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.838 0.352 . . . . 0.0 110.966 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 107.96 -125.15 7.8 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.83 133.58 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.903 2.402 . . . . 0.0 111.1 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.1 Cg_exo -56.75 -35.94 98.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.463 2.775 . . . . 0.0 113.315 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.52 -36.68 28.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.637 0.732 . . . . 0.0 109.816 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 7.8 tpp85 -67.91 -39.32 83.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.66 -176.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -58.46 -38.65 77.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.88 -36.07 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -72.6 -36.46 68.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.077 0.465 . . . . 0.0 110.288 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.32 -31.55 70.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.995 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.45 -37.6 81.49 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.49 175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -72.6 -31.76 65.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.528 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG21 HG23 ' A' ' 36' ' ' ILE . 57.6 mt -57.57 -52.39 57.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 109.785 174.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 60' ' ' ILE . 64.5 mt -67.35 -46.73 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.778 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -61.72 -39.38 91.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.158 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.51 -44.46 93.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.79 -44.04 94.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.426 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 17' ' ' VAL . 80.0 mt -62.82 -37.57 87.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.111 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.31 -42.08 81.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.342 . . . . 0.0 111.006 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.4 t -63.48 -34.81 78.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.469 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.9 mt -88.75 -19.89 25.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.435 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 -174.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 60' ' ' ILE . 25.4 pt . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.151 0.501 . . . . 0.0 111.336 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 57' ' ' ILE . 5.1 m-20 -97.59 114.05 25.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -119.06 132.55 23.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -170.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.86 124.36 12.18 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.685 2.257 . . . . 0.0 112.119 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.51 HG23 HD11 ' A' ' 78' ' ' LEU . 11.3 p -131.99 111.56 14.5 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.965 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 50.7 Cg_exo -52.83 133.61 51.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.874 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 16.2 mtp180 -66.9 -15.76 63.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.326 0.584 . . . . 0.0 110.468 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -88.49 -13.29 40.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.216 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.0 m -107.71 -20.65 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.92 -175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 m -58.5 -24.7 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.656 0.265 . . . . 0.0 111.535 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.88 91.27 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.98 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.19 -38.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.293 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.34 -37.91 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.81 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.586 HG23 ' HA2' ' A' ' 30' ' ' GLY . 27.0 mm -79.73 -38.14 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.12 -119.84 9.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -120.87 131.7 54.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 70.26 -5.37 1.35 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.464 0.478 . . . . 0.0 111.84 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 85.94 12.69 70.86 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -170.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.5 -39.6 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.758 0.423 . . . . 0.0 110.716 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.6 tpt -65.89 -46.17 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.0 tt -70.39 -26.41 28.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.418 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 51.7 mttp -68.61 -37.11 79.52 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.117 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 73' ' ' ILE . 85.9 mt -65.23 -53.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -57.53 -31.74 66.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.329 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.95 -55.33 13.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.279 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -29.52 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.413 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.758 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -83.19 -29.02 28.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.908 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.17 42.2 24.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.493 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 31.2 m -130.37 178.67 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 tpp180 -120.65 128.35 52.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.212 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 74' ' ' ILE . 59.5 mt -119.5 109.21 25.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -111.7 119.2 37.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.466 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -76.01 114.92 15.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.024 0.44 . . . . 0.0 110.127 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 54.4 mtpt . . . . . 0 C--N 1.322 -0.626 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.374 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 32.5 mt-10 . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.222 0.534 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.0 mtpp -97.53 173.17 7.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.438 173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.571 ' HB ' ' HD3' ' A' ' 47' ' ' LYS . 46.6 mm -109.22 114.58 47.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.552 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -80.06 118.57 21.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -97.09 102.06 13.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 13' ' ' ILE . 17.5 mt -88.57 137.01 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.8 mtm -147.82 160.44 42.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 0.0 111.531 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 127.53 -122.34 4.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.43 145.63 18.85 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.917 2.411 . . . . 0.0 110.89 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 -41.92 18.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.021 2.481 . . . . 0.0 113.023 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.03 -37.37 61.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.474 0.654 . . . . 0.0 109.339 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.3 tpp180 -61.78 -32.99 73.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.053 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 99.7 m -56.51 -41.95 77.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.465 176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.45 -34.39 65.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -60.7 -49.67 76.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -69.75 -30.37 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.03 -41.64 92.68 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.792 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 12.4 tpt180 -69.31 -38.25 78.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.532 HG21 HG23 ' A' ' 36' ' ' ILE . 65.1 mt -54.92 -52.1 46.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.136 0.493 . . . . 0.0 110.149 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 60' ' ' ILE . 53.2 mt -68.75 -45.94 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.949 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -60.38 -46.09 91.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.342 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.34 -39.76 84.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.74 -37.55 84.87 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.595 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HG23 ' A' ' 17' ' ' VAL . 88.2 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.647 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 60' ' ' ILE . 41.8 pt . . . . . 0 C--O 1.236 0.375 0 CA-C-O 121.064 0.459 . . . . 0.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.31 105.46 12.89 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.064 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -106.83 127.49 27.96 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 112.171 -173.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.3 Cg_exo -69.96 116.32 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.992 2.462 . . . . 0.0 111.981 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 111.24 32.82 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 110.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 78' ' ' LEU . 79.5 Cg_exo -49.26 128.35 19.83 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.501 2.801 . . . . 0.0 112.522 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -60.47 -31.69 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -77.81 -18.82 55.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 m -91.84 -18.3 24.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.074 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.07 -31.85 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.569 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.88 -30.84 70.49 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.84 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.26 -35.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.556 -0.379 . . . . 0.0 110.242 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 77' ' ' LEU . 48.7 t -65.85 -38.65 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.894 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.607 HD11 ' CE1' ' A' ' 46' ' ' PHE . 28.8 mm -79.77 -51.56 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.358 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 28' ' ' ARG . . . 98.83 -96.11 1.67 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.317 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 27' ' ' GLY . 23.8 mmt180 -132.81 -56.65 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -98.89 -17.06 18.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.005 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 110.34 15.34 11.56 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -173.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -73.77 -23.25 59.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.959 -175.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.9 tpt -73.6 -38.89 64.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.032 0.444 . . . . 0.0 109.972 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.5 tt -77.44 -22.57 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 29.3 mmtp -64.49 -38.45 91.08 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 32' ' ' MET . 1.2 tmtp? -57.45 -47.37 82.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.787 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 33' ' ' ILE . 38.8 mt -61.51 -48.8 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.661 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -63.35 -30.12 71.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.085 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -82.65 -46.16 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.583 0.23 . . . . 0.0 111.323 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -46.8 88.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.32 -22.98 26.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.458 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.93 33.7 45.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.655 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.9 m -113.64 -177.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 111.639 -174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 40.3 ttt180 -126.22 133.57 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.064 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.651 HD13 HD11 ' A' ' 74' ' ' ILE . 37.3 mt -132.57 109.95 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.345 0.403 . . . . 0.0 110.311 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -114.6 139.36 49.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.945 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CE1' HD11 ' A' ' 26' ' ' ILE . 82.1 m-85 -84.17 112.78 20.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.136 0.493 . . . . 0.0 110.332 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.297 -179.155 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.078 0.466 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 46' ' ' PHE . 27.0 mttm -89.77 171.3 9.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.469 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.61 111.59 36.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.993 0.425 . . . . 0.0 109.944 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.54 133.58 35.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.485 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -105.87 101.34 10.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.29 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 13' ' ' ILE . 33.5 mt -91.0 137.03 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.983 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.8 mtm -146.11 162.11 38.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.964 0.411 . . . . 0.0 111.407 -169.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 124.98 -119.32 3.58 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 6.3 Cg_exo -83.0 129.64 5.42 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.13 2.553 . . . . 0.0 110.965 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 54.0 Cg_exo -54.41 -34.73 82.34 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.631 2.888 . . . . 0.0 113.813 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -81.24 -40.05 24.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.1 tpp180 -64.0 -26.8 68.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.951 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.84 -43.69 86.02 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.82 -37.36 84.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.751 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -61.7 -44.81 96.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.07 -37.76 84.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.26 -38.04 85.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.89 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -68.85 -38.58 79.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.551 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 77.0 mt -62.85 -48.81 86.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.598 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 60' ' ' ILE . 91.2 mt -64.71 -39.89 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.474 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -62.3 -45.93 91.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.747 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.54 -39.62 84.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.951 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 25' ' ' VAL . 6.6 tt -63.81 -48.08 78.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.643 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.342 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 26.4 pt . . . . . 0 C--O 1.237 0.418 0 CA-C-O 121.121 0.486 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -109.66 117.55 34.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.327 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.46 124.99 30.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.073 -173.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 57' ' ' ILE . 19.1 Cg_endo -77.01 111.5 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.106 1.87 . . . . 0.0 111.323 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG11 ' HE2' ' A' ' 46' ' ' PHE . 6.3 p -114.96 114.62 43.76 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.518 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.623 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.1 Cg_exo -48.64 126.98 15.4 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.176 2.584 . . . . 0.0 111.766 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.814 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 83.9 mtp180 -59.97 -33.6 72.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.102 -172.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -82.72 -13.83 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.575 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -94.91 -13.37 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.98 0.419 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.611 HG21 ' HD3' ' A' ' 56' ' ' LYS . 25.3 t -57.41 -33.48 44.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.773 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.9 61.07 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.002 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.1 t -88.75 -35.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 32' ' ' MET . 45.0 t -66.07 -36.28 77.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.426 0.632 . . . . 0.0 110.162 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.9 mm -81.59 -60.18 2.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.271 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.84 -116.73 4.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.656 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.56 -49.15 2.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 109.954 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -119.59 -0.64 10.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 112.0 22.04 6.09 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.567 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -51.05 -50.91 57.7 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.876 0.47 . . . . 0.0 111.68 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.507 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.1 tpt -68.3 -47.31 67.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.166 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.41 HD11 ' HB ' ' A' ' 44' ' ' ILE . 11.4 tt -69.23 -29.75 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.76 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 59.0 mttm -63.09 -42.44 99.62 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 7.2 tmtm? -65.73 -44.79 84.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.988 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 32' ' ' MET . 77.7 mt -60.29 -50.48 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.032 0.444 . . . . 0.0 110.761 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 mt-30 -62.31 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.031 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.38 -46.07 18.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.522 0.201 . . . . 0.0 110.971 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.69 -46.27 87.63 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.272 0.558 . . . . 0.0 111.146 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.53 -21.05 23.1 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.682 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.26 37.92 63.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.852 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 37' ' ' GLN . 25.7 m -113.17 -179.48 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 0.0 111.003 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -126.82 133.36 50.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 166.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 60' ' ' ILE . 72.1 mt -123.96 109.07 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.189 0.931 . . . . 0.0 109.301 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -126.89 136.89 52.94 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 75.4 m-85 -85.32 118.39 24.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.036 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.161 -175.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 121.457 0.646 . . . . 0.0 111.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.814 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 27.9 mtpp -86.41 175.86 8.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.47 HD13 ' HA ' ' A' ' 16' ' ' PRO . 46.0 mm -119.86 108.69 24.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.643 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -73.78 130.02 39.11 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -104.47 102.85 12.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.726 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.683 HD11 HD12 ' A' ' 74' ' ' ILE . 40.6 mt -89.61 136.21 24.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 40.0 mtm -145.1 144.23 30.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.63 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 139.18 -124.51 2.81 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.147 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.34 138.3 12.37 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 123.438 2.759 . . . . 0.0 112.099 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.05 -49.28 16.62 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 113.399 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.07 -41.63 70.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.219 0.533 . . . . 0.0 110.625 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.0 tpp180 -65.49 -31.22 72.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.438 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 94.0 m -58.34 -44.7 88.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -70.46 -32.9 70.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.673 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 4.3 t60 -56.71 -50.05 73.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -70.03 -34.66 73.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.861 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.28 -41.39 98.44 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.012 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -66.78 -37.56 84.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.121 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 73.4 mt -57.13 -50.62 75.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.529 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 60' ' ' ILE . 68.5 mt -68.67 -44.81 82.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.039 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -61.06 -49.95 75.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.798 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.18 -39.57 75.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.97 -50.11 63.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.526 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' HD2' ' A' ' 18' ' ' PRO . 94.0 mt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.302 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 60' ' ' ILE . 29.3 pt . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 14.7 p-10 -111.03 120.11 41.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.821 0.819 . . . . 0.0 109.544 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -116.65 133.77 22.99 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.985 -167.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HA ' HD13 ' A' ' 57' ' ' ILE . 11.1 Cg_exo -69.24 117.48 5.08 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 123.109 2.539 . . . . 0.0 112.13 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -132.25 108.63 13.67 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.368 0.604 . . . . 0.0 110.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.721 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 83.7 Cg_exo -48.81 141.44 21.19 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.543 2.828 . . . . 0.0 113.487 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -54.82 -53.7 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.725 0.298 . . . . 0.0 111.545 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.72 -26.87 67.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.113 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.9 m -79.16 -25.13 42.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.378 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.7 t -60.12 -32.69 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.01 -29.82 68.84 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.13 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -89.5 -35.33 7.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 21' ' ' SER . 61.1 t -68.19 -38.31 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.543 HD11 ' CE1' ' A' ' 46' ' ' PHE . 34.7 mm -79.37 -55.99 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.464 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.2 -134.3 12.07 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 2.5 mmp_? -105.39 -59.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 50.0 m -93.21 -18.19 22.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.859 174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 123.2 13.92 4.24 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.238 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 29' ' ' SER . 18.4 mp0 -57.21 -39.05 74.65 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.19 0.596 . . . . 0.0 111.352 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.5 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -68.82 -49.32 59.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.675 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.577 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -68.7 -30.02 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 110.402 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 32.3 mmtp -72.94 -29.72 63.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.91 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.92 -42.28 77.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 32' ' ' MET . 74.8 mt -60.65 -49.38 84.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.352 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.66 -27.34 68.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.294 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.34 -50.04 15.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.79 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.68 -53.22 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 111.173 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.47 -11.34 52.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.934 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.34 37.94 95.63 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.371 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.0 m -113.34 177.11 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.322 0.582 . . . . 0.0 110.827 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -122.36 123.44 41.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.681 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HD11 ' A' ' 33' ' ' ILE . 86.6 mt -105.68 108.43 25.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -115.47 114.99 25.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.148 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CE1' HD11 ' A' ' 26' ' ' ILE . 58.6 m-85 -70.93 114.23 8.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.525 0.678 . . . . 0.0 110.804 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.933 -179.042 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.6 mt-10 . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -96.21 175.69 6.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.757 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 43.4 mm -122.7 114.58 42.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.699 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -81.55 140.45 34.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.611 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -114.11 103.64 11.33 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 70' ' ' ALA . 45.1 mt -88.64 137.62 20.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.4 mtm -143.48 171.51 14.05 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.599 -173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 116.02 -128.74 8.14 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_exo -75.98 141.48 23.95 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.788 2.325 . . . . 0.0 111.204 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 27.9 Cg_exo -62.7 -35.69 67.69 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.563 2.842 . . . . 0.0 113.266 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.43 -31.04 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.548 0.69 . . . . 0.0 109.717 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.5 tpp180 -66.09 -27.09 67.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.676 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.1 m -55.77 -37.77 68.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.402 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 mt-10 -79.31 -30.89 43.07 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.453 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 73' ' ' ILE . 2.3 t-160 -57.56 -50.62 72.49 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -73.11 -32.82 65.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.208 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . . . -61.74 -41.07 97.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.955 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 18.4 tpt180 -63.5 -43.91 95.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.44 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 69' ' ' HIS . 70.3 mt -54.33 -50.51 56.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.804 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 60' ' ' ILE . 70.3 mt -71.36 -42.57 73.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.148 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -61.77 -50.27 73.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.93 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.036 0.446 . . . . 0.0 110.395 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.37 -48.18 80.9 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.5 mt . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.67 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 60' ' ' ILE . 22.1 pt . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.935 0.398 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 8.3 p-10 -117.24 128.64 55.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.08 122.8 23.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.996 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -65.42 103.53 0.55 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.082 2.522 . . . . 0.0 111.898 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.4 p -102.34 118.13 59.58 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.715 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 52.5 Cg_exo -56.01 122.41 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.59 2.194 . . . . 0.0 111.438 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.749 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 53.5 mtp180 -62.76 -28.16 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -73.53 -18.37 61.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 m -102.75 -11.37 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.94 -35.29 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.33 63.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.928 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.0 t -89.21 -34.17 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.138 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.88 -39.39 67.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.412 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 ' CE1' ' A' ' 46' ' ' PHE . 38.8 mm -86.42 -56.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.973 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.27 -127.45 8.66 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -113.35 -45.99 3.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.049 0.424 . . . . 0.0 110.342 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.2 m -95.6 -36.13 11.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.439 0.638 . . . . 0.0 109.843 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.632 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 128.38 12.63 2.77 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.596 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.64 -28.16 69.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 110.997 -174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 17.6 tpt -67.72 -43.82 79.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.371 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG21 ' A' ' 44' ' ' ILE . 10.9 tt -79.93 -24.73 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 74.4 mmtt -62.77 -40.43 97.27 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 32' ' ' MET . 53.2 tttm -59.85 -45.92 90.9 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.55 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -60.75 -49.24 85.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.56 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -59.69 -39.64 85.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.388 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.97 -49.35 38.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.252 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.0 -46.72 86.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.437 -173.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.747 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.572 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.41 44.1 7.6 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 34.4 m -129.31 172.98 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.277 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -117.69 137.35 52.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.695 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 33' ' ' ILE . 29.2 mt -123.44 106.06 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -105.75 119.05 38.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.066 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE1' HD11 ' A' ' 26' ' ' ILE . 55.8 m-85 -73.13 126.06 29.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 21.6 mtpp . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.167 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.715 ' CD ' ' HA ' ' A' ' 18' ' ' PRO . 4.0 mm-40 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.749 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.6 mtpp -92.47 160.69 14.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.677 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.9 mm -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.895 174.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -75.12 140.07 43.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.5 t60 -118.06 108.43 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.592 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -88.68 131.49 35.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.7 mtp -131.03 128.24 39.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.88 0.371 . . . . 0.0 111.691 -162.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.05 -135.35 6.64 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.851 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 11.3 Cg_exo -69.17 150.08 71.39 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.403 2.735 . . . . 0.0 112.227 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 32.3 Cg_exo -60.04 -50.0 8.44 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -71.87 -30.51 65.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 109.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.747 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.35 -42.79 87.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.595 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.7 -40.35 87.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.824 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -74.19 -35.24 63.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 73' ' ' ILE . 17.9 t-160 -68.69 -41.5 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.93 -34.41 76.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.332 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -37.77 84.27 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.734 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -74.59 -31.88 62.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.487 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.515 HD12 ' HB2' ' A' ' 40' ' ' ALA . 74.6 mt -60.37 -50.48 80.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 109.933 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 76.7 mt -67.29 -39.5 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.714 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -64.55 -45.96 84.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.165 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -57.85 -40.1 79.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.819 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.8 tp -59.29 -41.89 90.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.59 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 67.4 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.696 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 67' ' ' CYS . 16.7 pt . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.147 0.498 . . . . 0.0 111.786 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.466 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 5.2 p-10 -97.71 122.04 40.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.951 175.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -119.31 125.67 27.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.044 -175.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 12.1 Cg_exo -69.29 104.58 1.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.187 2.592 . . . . 0.0 111.999 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 22' ' ' VAL . 11.2 p -106.75 113.65 62.6 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.282 0.563 . . . . 0.0 109.686 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.0 Cg_exo -60.4 129.76 31.06 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.098 2.532 . . . . 0.0 112.978 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.731 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 98.6 mtt180 -55.67 -29.94 60.2 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.996 0.81 . . . . 0.0 112.587 -172.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -71.96 -34.48 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.478 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -90.32 -19.72 23.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.447 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 17' ' ' VAL . 6.0 t -60.35 -33.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.56 87.71 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.125 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.9 t -75.31 -36.1 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.391 . . . . 0.0 110.391 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.0 -36.7 78.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.253 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 46' ' ' PHE . 36.8 mm -81.41 -58.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.59 -113.01 4.12 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -118.44 -61.02 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -93.51 -28.96 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.739 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 133.75 19.98 0.89 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.104 -175.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.22 -37.78 81.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.5 -40.82 69.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.562 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -75.02 -27.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 49.4 mtpt -63.72 -36.82 85.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.26 -43.92 96.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.15 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 73' ' ' ILE . 60.5 mt -63.47 -46.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.171 0.51 . . . . 0.0 110.468 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.73 -30.83 71.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.317 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -74.97 -48.07 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.56 -42.94 86.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -90.78 -16.41 28.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.851 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 31.96 65.64 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.983 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.4 m -113.58 176.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.413 0.625 . . . . 0.0 111.205 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -117.87 131.19 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.891 167.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.562 ' CG2' HD11 ' A' ' 33' ' ' ILE . 81.7 mt -115.34 108.54 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 45' ' ' GLN . 4.3 tp60 -123.73 131.67 53.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 26' ' ' ILE . 78.7 m-85 -84.07 131.17 34.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.447 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 24.8 mtpp . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.183 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 1.6 mp0 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.356 0.598 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.731 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 30.3 mtpp -109.67 165.95 11.28 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.6 mm -114.78 110.12 30.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.022 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.75 140.15 38.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -114.49 108.25 16.6 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.517 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.634 HG21 ' HB3' ' A' ' 70' ' ' ALA . 38.8 mt -88.46 127.94 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.5 mtm -141.54 167.01 23.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 111.357 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.13 -118.65 3.86 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.4 135.92 10.9 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.999 2.466 . . . . 0.0 111.449 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 50.5 Cg_exo -57.23 -36.05 98.98 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.478 2.785 . . . . 0.0 112.915 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.87 -36.62 70.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.078 0.942 . . . . 0.0 109.799 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.657 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 18.7 tpp85 -71.6 -31.91 67.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.897 -171.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.522 ' HB2' HG12 ' A' ' 13' ' ' ILE . 21.2 p -58.85 -41.85 87.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.46 -37.03 79.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.059 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -61.56 -46.12 91.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.103 0.477 . . . . 0.0 109.901 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.634 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.54 -28.13 62.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.879 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.25 -42.11 85.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.0 tmm_? -65.62 -45.41 83.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.976 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 36' ' ' ILE . 66.6 mt -55.06 -52.43 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 65.0 mt -67.88 -43.33 86.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -61.28 -48.84 79.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.1 -32.43 74.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.96 -49.78 68.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 17' ' ' VAL . 88.7 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.907 HD11 HD12 ' A' ' 60' ' ' ILE . 30.9 pt . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 36.6 m-20 -116.86 110.17 18.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.128 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -110.82 128.81 24.72 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.004 -171.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.6 Cg_exo -71.44 99.06 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.419 2.746 . . . . 0.0 111.933 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 17' ' ' VAL . 14.3 p -110.15 109.82 58.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.451 0.643 . . . . 0.0 110.677 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 50.0 Cg_exo -55.91 149.64 50.55 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.217 2.611 . . . . 0.0 113.425 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -68.18 -26.14 65.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.759 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -79.34 -22.88 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.328 0.585 . . . . 0.0 109.526 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.8 m -86.44 -37.69 18.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.534 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 16.4 m -57.69 -27.17 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.22 92.27 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HB ' HD21 ' A' ' 77' ' ' LEU . 40.6 t -89.6 -31.61 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.812 0.339 . . . . 0.0 110.365 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 21' ' ' SER . 93.7 t -61.79 -38.63 80.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.168 0.509 . . . . 0.0 109.851 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.08 -58.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.115 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.6 -138.1 13.65 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.686 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -69.24 -77.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.379 . . . . 0.0 110.586 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.459 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 66.1 m -93.79 -53.5 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.642 0.734 . . . . 0.0 109.567 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -174.29 20.54 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.362 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 1.6 mm-40 -47.05 -53.03 13.53 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.398 0.679 . . . . 0.0 111.827 -169.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.548 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.9 tpt -68.45 -45.16 73.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.116 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 HG22 ' A' ' 44' ' ' ILE . 8.3 tt -72.47 -29.77 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.812 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 28.2 mmmt -69.47 -40.67 76.95 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.58 -46.15 91.1 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.678 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 32' ' ' MET . 84.0 mt -60.71 -49.37 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.659 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.02 -29.9 67.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.814 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -87.43 -35.69 18.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.653 0.264 . . . . 0.0 111.671 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.04 -40.98 78.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 0.0 110.018 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -93.03 -23.91 18.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.226 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.94 47.55 9.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.227 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.5 m -127.4 177.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.5 tpt180 -120.04 128.35 53.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.842 168.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.633 HD13 HD11 ' A' ' 74' ' ' ILE . 72.3 mt -125.92 112.59 30.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.964 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.92 138.78 39.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.125 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' ALA . 12.5 m-85 -85.5 121.0 27.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.574 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.183 178.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.9 mt-10 . . . . . 0 N--CA 1.449 -0.496 0 CA-C-O 121.335 0.588 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 56.0 mtpt -107.41 155.63 19.81 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.836 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 38.1 mm -98.51 104.69 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.682 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.54 140.38 41.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.979 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -115.58 109.95 18.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 13' ' ' ILE . 40.0 mt -93.49 146.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.713 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -145.33 166.87 24.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.945 0.402 . . . . 0.0 111.989 -172.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 122.91 -124.92 5.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -81.03 134.89 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.994 2.463 . . . . 0.0 110.75 174.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 74.6 Cg_exo -51.82 -42.92 54.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.617 2.878 . . . . 0.0 113.293 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.26 -39.94 65.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.7 tpp180 -61.7 -34.64 76.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.979 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 85.2 m -57.94 -42.9 85.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.458 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.84 -41.58 91.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 73' ' ' ILE . 24.1 t60 -66.65 -38.75 87.53 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -66.95 -35.51 80.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.27 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.5 -36.86 83.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.441 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -67.79 -39.28 84.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.472 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.6 mt -59.93 -49.56 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.438 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.633 HD11 HD13 ' A' ' 44' ' ' ILE . 84.5 mt -65.28 -45.27 94.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.781 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.73 -37.08 86.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.88 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.75 -43.42 80.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.404 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD21 ' HB ' ' A' ' 24' ' ' VAL . 9.8 tt -63.54 -43.2 97.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.932 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 21.2 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.113 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 60' ' ' ILE . 38.6 pt . . . . . 0 C--O 1.235 0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -114.34 126.88 55.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.308 173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -131.04 117.05 16.97 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.43 . . . . 0.0 111.603 -176.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 17.2 Cg_exo -66.52 102.24 0.59 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.219 2.612 . . . . 0.0 112.298 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.65 117.91 58.75 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.3 Cg_exo -57.17 131.15 43.42 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.241 2.628 . . . . 0.0 112.371 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.8 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 76.6 mtt180 -66.29 -26.44 67.33 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.815 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -80.51 -15.15 57.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.0 110.242 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.1 m -101.41 -14.82 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.435 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 18' ' ' PRO . 24.1 t -56.49 -38.57 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.451 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.93 -35.47 53.63 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.751 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -86.34 -36.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.662 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 21' ' ' SER . 60.0 t -62.32 -36.97 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.417 0.627 . . . . 0.0 109.904 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.476 HD11 ' CE1' ' A' ' 46' ' ' PHE . 35.9 mm -78.46 -58.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.614 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.87 63.5 1.67 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.889 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 63.97 -87.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.492 0.717 . . . . 0.0 112.162 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.55 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 75.4 m -84.03 -20.37 32.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.128 0.49 . . . . 0.0 110.339 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 119.9 4.59 11.4 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 29' ' ' SER . 0.8 OUTLIER -63.03 -15.07 55.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 tpt -80.08 -45.36 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.595 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.717 HG13 HD12 ' A' ' 36' ' ' ILE . 8.0 tt -74.78 -21.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 31.7 mmtp -57.4 -49.65 75.53 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.153 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 33' ' ' ILE . 35.6 mt -61.36 -58.29 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 0.0 110.148 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -65.3 -23.78 67.12 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.133 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.55 -45.11 19.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.072 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.18 -53.46 24.8 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 110.441 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -77.41 -14.43 59.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.565 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.78 34.33 88.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.254 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.11 171.22 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.22 0.533 . . . . 0.0 110.725 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.4 tpp180 -116.75 125.56 51.82 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.333 170.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 33' ' ' ILE . 84.7 mt -110.83 114.0 45.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.34 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -113.26 155.76 24.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.647 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 82.0 m-85 -111.21 112.65 24.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.932 0.396 . . . . 0.0 110.97 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 9.1 mtpm? . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.366 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.184 0.516 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.8 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 57.3 mtpt -123.26 146.19 48.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.64 107.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.33 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -77.38 140.62 39.96 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 22.2 t60 -118.16 109.68 16.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.971 HD12 HD11 ' A' ' 13' ' ' ILE . 46.8 mt -89.23 147.64 5.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 49.5 mtt -130.62 137.22 49.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.492 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 135.85 -134.95 7.51 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.264 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -81.29 139.92 11.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.554 2.836 . . . . 0.0 112.382 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 76.7 Cg_exo -50.43 -50.09 14.59 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.242 1.961 . . . . 0.0 112.931 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.67 -40.1 80.3 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 0.0 110.725 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.601 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 12.8 tpp180 -64.82 -40.36 95.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.329 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 84.2 m -59.58 -45.33 92.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.364 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 45.0 mt-10 -63.0 -36.65 84.26 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 111.204 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.94 -46.87 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.041 0.448 . . . . 0.0 109.812 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.71 70.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.284 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.81 98.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.674 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' A' ' 75' ' ' ASN . 58.9 ttt180 -76.53 -24.57 53.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.721 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 36' ' ' ILE . 58.0 mt -57.47 -50.54 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.663 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 56.8 mt -68.93 -45.9 79.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.761 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 72' ' ' ARG . 62.0 t30 -60.73 -48.32 82.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.743 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -63.29 -35.31 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.745 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.53 -44.43 94.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.732 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.823 HD11 HD12 ' A' ' 60' ' ' ILE . 38.4 pt . . . . . 0 C--O 1.238 0.453 0 CA-C-O 121.126 0.488 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.584 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 6.3 p-10 -117.65 129.42 55.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.827 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.04 127.79 24.28 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.085 0.469 . . . . 0.0 111.973 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.1 Cg_exo -70.72 112.78 3.33 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.226 2.617 . . . . 0.0 111.897 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.1 113.53 26.37 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.559 0.695 . . . . 0.0 110.47 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 22' ' ' VAL . 46.9 Cg_exo -57.95 138.78 87.74 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.126 2.551 . . . . 0.0 112.013 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 71.3 mtp180 -62.9 -34.52 77.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.722 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -69.08 -26.28 64.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB3' HD22 ' A' ' 78' ' ' LEU . 18.9 m -86.86 -28.83 22.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.267 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 18' ' ' PRO . 45.7 t -55.28 -35.41 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.882 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.7 61.82 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.799 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.7 t -82.53 -38.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 21' ' ' SER . 33.5 t -62.49 -37.8 79.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.398 0.618 . . . . 0.0 109.938 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE2' ' A' ' 46' ' ' PHE . 34.9 mm -79.49 -51.84 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.599 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.06 30.9 49.77 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.365 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 72.04 -56.43 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.612 0.765 . . . . 0.0 112.393 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 m -78.03 -25.26 47.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 111.002 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 100.13 -0.2 56.06 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -169.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -47.81 -49.59 28.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.691 0.796 . . . . 0.0 111.947 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.57 -41.45 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.73 0.3 . . . . 0.0 111.594 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.4 tt -73.03 -27.43 24.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.487 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 30.0 mmmt -68.96 -35.31 76.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -60.93 -43.51 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.496 HG23 HG21 ' A' ' 73' ' ' ILE . 70.6 mt -62.34 -50.54 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.544 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -58.27 -34.49 70.57 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.593 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -78.21 -40.17 38.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.8 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.56 -47.25 64.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.069 0.461 . . . . 0.0 110.786 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.72 -16.11 40.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 44.67 54.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.519 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.4 m -125.14 176.96 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.402 0.62 . . . . 0.0 111.178 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -120.78 129.99 53.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.46 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -123.79 107.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.8 139.45 53.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.61 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 62.4 m-85 -84.1 133.2 34.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.416 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.061 176.368 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' PHE . 16.5 mtpp -90.09 161.96 15.55 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 110.646 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.584 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 34.8 mm -107.92 105.61 19.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.103 0.478 . . . . 0.0 110.133 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -73.23 127.75 33.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -103.79 101.92 11.74 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.394 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 13' ' ' ILE . 41.2 mt -91.83 131.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.053 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.8 mtm -143.12 166.66 24.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.16 -122.09 4.95 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.6 Cg_exo -78.89 131.18 9.94 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.039 2.492 . . . . 0.0 110.896 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.4 Cg_exo -57.07 -36.97 99.43 Favored 'Trans proline' 0 N--CA 1.475 0.384 0 C-N-CA 123.344 2.696 . . . . 0.0 113.122 -176.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.39 -32.59 60.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 11.4 tpp180 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.391 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 13' ' ' ILE . 84.4 m -54.14 -40.1 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.276 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -66.11 -40.33 90.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.903 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 73' ' ' ILE . 11.9 t-80 -66.73 -43.1 85.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.189 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.68 -34.34 78.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -43.79 98.31 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.535 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -64.78 -35.26 80.52 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.244 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.496 HG21 HG23 ' A' ' 36' ' ' ILE . 64.6 mt -62.25 -50.24 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.0 110.208 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 44' ' ' ILE . 68.6 mt -66.49 -46.62 86.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.962 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -70.19 -32.42 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -33.83 76.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD22 HG22 ' A' ' 25' ' ' VAL . 8.4 tt -63.9 -44.62 92.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 21' ' ' SER . 65.8 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.515 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.753 HD11 HD12 ' A' ' 60' ' ' ILE . 39.8 pt . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -106.29 105.28 15.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.233 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -105.45 132.04 21.23 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 5.5 Cg_exo -72.78 112.92 3.61 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.289 2.659 . . . . 0.0 112.191 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 HD21 ' A' ' 78' ' ' LEU . 7.4 p -121.02 107.3 37.87 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 72.4 Cg_exo -48.53 133.45 26.06 Favored 'Trans proline' 0 N--CA 1.47 0.118 0 C-N-CA 123.505 2.803 . . . . 0.0 112.39 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 22.8 mtm180 -62.84 -28.32 69.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.693 -176.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.7 -32.14 63.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.249 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.6 m -79.99 -24.22 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' PRO . 62.3 t -54.97 -35.06 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.173 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.07 65.49 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.418 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.61 -36.89 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 0.0 110.556 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 21' ' ' SER . 38.3 t -67.91 -40.39 83.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.596 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -82.32 -46.65 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.38 -118.74 4.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.041 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -97.96 -77.74 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.484 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 21.0 m -82.56 -55.63 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.74 0.781 . . . . 0.0 109.443 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 175.18 32.21 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 4.2 mm-40 -57.49 -47.49 81.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.261 -0.47 . . . . 0.0 111.724 -167.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.6 tpt -66.55 -45.88 77.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 44' ' ' ILE . 6.1 tt -69.0 -31.15 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.912 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 92.9 mttt -62.97 -42.35 99.8 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -66.6 -37.95 85.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 32' ' ' MET . 75.6 mt -63.16 -51.13 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.0 -35.71 73.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.581 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -77.98 -32.98 51.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.94 -46.52 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -81.69 -28.43 33.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.465 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.31 39.03 8.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.4 m -122.47 175.72 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.381 0.61 . . . . 0.0 111.517 -174.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -116.43 127.0 54.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.863 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -125.54 108.61 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.43 154.18 27.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.482 ' HE2' HG22 ' A' ' 22' ' ' VAL . 4.4 m-85 -100.78 120.68 40.46 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.213 0.53 . . . . 0.0 112.055 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.831 172.159 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.9 mt-10 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.778 0.323 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 44.8 mtpt -78.24 177.78 8.14 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.665 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.1 mm -115.24 113.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.426 0.631 . . . . 0.0 111.174 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.745 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -84.79 140.6 31.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -110.83 101.51 10.11 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.753 HD12 HD11 ' A' ' 13' ' ' ILE . 21.5 mt -91.24 137.37 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.1 mtm -142.82 163.33 33.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 111.823 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.04 -135.53 9.75 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.61 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 7.7 Cg_exo -69.27 150.86 71.67 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.675 2.25 . . . . 0.0 111.692 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.08 -48.85 5.69 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.538 2.159 . . . . 0.0 112.742 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.57 -34.79 77.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.429 0.633 . . . . 0.0 109.431 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.635 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.8 tpp180 -61.82 -38.95 90.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.587 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 76.9 m -58.95 -47.99 83.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.228 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -69.53 -34.99 75.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.678 0.275 . . . . 0.0 110.823 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -62.68 -46.35 88.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.469 . . . . 0.0 110.169 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -71.06 -35.72 72.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.534 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.42 -36.9 79.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.824 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 72' ' ' ARG . 11.5 ttm180 -66.08 -43.04 88.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.187 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.68 -49.49 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.613 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 44' ' ' ILE . 77.0 mt -68.93 -46.24 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.28 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.01 -43.67 98.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.25 -34.0 77.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.275 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.88 -45.64 85.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.032 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.4 mt . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.769 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 60' ' ' ILE . 38.1 pt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.905 0.383 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.51 105.34 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.128 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.81 130.29 23.0 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.8 Cg_exo -75.06 104.15 1.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.372 2.715 . . . . 0.0 112.259 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.523 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -112.83 113.02 50.21 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.367 0.603 . . . . 0.0 110.214 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.36 134.57 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 123.096 2.531 . . . . 0.0 112.042 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -61.04 -33.14 72.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.035 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.35 -22.87 60.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 109.798 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 25' ' ' VAL . 17.9 m -87.03 -25.74 24.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.037 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.3 -32.28 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.616 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.44 -33.73 62.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.213 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.71 -34.36 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.644 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 21' ' ' SER . 95.6 t -64.52 -38.55 82.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 46' ' ' PHE . 42.8 mm -79.83 -54.76 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.205 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.579 ' O ' ' HD2' ' A' ' 28' ' ' ARG . . . 105.04 -128.52 9.47 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 15.0 mmm180 -125.76 -29.7 3.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.064 0.459 . . . . 0.0 110.186 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -114.32 3.72 15.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.853 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 10.44 84.04 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -63.89 -32.53 74.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.841 0.456 . . . . 0.0 111.4 -172.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -70.81 -45.35 64.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 44' ' ' ILE . 7.9 tt -72.2 -28.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.188 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -67.22 -36.53 81.87 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.01 -44.21 89.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.239 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 HG21 ' A' ' 73' ' ' ILE . 78.9 mt -58.11 -52.09 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.231 0.539 . . . . 0.0 110.523 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.84 -33.68 75.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.411 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.29 -44.1 65.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.32 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.85 -53.15 29.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.364 . . . . 0.0 111.409 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -77.53 -27.08 51.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.89 42.22 9.91 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 70' ' ' ALA . 20.4 m -125.79 174.34 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.074 -174.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.6 tpp180 -116.91 131.86 56.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.169 167.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 33' ' ' ILE . 80.4 mt -111.35 108.64 26.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -118.23 117.1 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.694 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 26' ' ' ILE . 96.9 m-85 -72.66 126.04 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -175.429 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 N--CA 1.448 -0.535 0 CA-C-O 121.115 0.483 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -86.87 149.37 24.87 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mm -95.96 108.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.418 0.627 . . . . 0.0 110.115 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.767 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.58 123.61 26.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.597 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 7.7 t-160 -98.52 101.29 12.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 13' ' ' ILE . 47.0 mt -89.07 136.09 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -143.52 164.37 30.55 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.058 -168.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.11 -115.81 2.98 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.7 Cg_endo -85.53 126.69 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.263 2.642 . . . . 0.0 110.212 172.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 52.8 Cg_exo -56.02 -35.44 94.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.474 2.783 . . . . 0.0 113.408 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.38 -33.06 32.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.001 0.429 . . . . 0.0 110.175 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.4 tpp180 -65.78 -28.73 69.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.381 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 13' ' ' ILE . 82.9 m -59.63 -30.09 68.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.48 -32.21 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.019 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.486 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -64.27 -42.8 96.29 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.21 -33.77 73.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.215 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.22 98.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.5 -46.25 90.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 36' ' ' ILE . 67.1 mt -55.0 -51.42 53.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.732 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.648 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 75.6 mt -66.76 -48.21 80.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.791 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -59.84 -46.57 88.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.192 0.52 . . . . 0.0 111.611 -176.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.72 -36.1 79.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.544 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.76 -40.73 79.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 77.3 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 60' ' ' ILE . 45.8 pt . . . . . 0 C--O 1.236 0.35 0 CA-C-O 121.69 0.757 . . . . 0.0 112.419 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 7.1 m-20 -123.44 112.46 17.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.334 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.03 129.0 24.98 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.383 -171.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 18.4 Cg_endo -79.52 106.89 2.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.42 2.08 . . . . 0.0 111.52 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 56' ' ' LYS . 7.6 p -113.81 113.23 47.42 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.419 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.2 Cg_exo -52.14 134.11 49.08 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.335 2.69 . . . . 0.0 112.522 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -58.73 -35.09 72.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.447 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -80.71 -6.08 57.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.698 0.285 . . . . 0.0 111.207 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -107.11 -16.9 14.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.4 t -57.0 -38.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.194 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.25 57.0 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.006 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.6 t -85.08 -39.15 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.368 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 77' ' ' LEU . 42.5 t -63.68 -37.19 79.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.35 0.595 . . . . 0.0 110.108 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 46' ' ' PHE . 40.4 mm -79.61 -50.95 17.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.853 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.79 -147.87 19.18 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -83.09 -70.77 0.53 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.418 0.609 . . . . 0.0 110.471 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -96.76 26.22 4.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.53 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 78.81 7.81 88.09 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.476 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 18.4 mt-10 -54.54 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.603 0.761 . . . . 0.0 112.538 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.2 tpt -74.47 -50.63 17.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.72 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 tt -69.09 -27.41 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.412 . . . . 0.0 110.363 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -68.25 -40.14 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.045 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -59.6 -42.51 92.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.45 HG23 HG21 ' A' ' 73' ' ' ILE . 67.6 mt -63.87 -54.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.819 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.26 -39.02 81.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.036 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -81.87 -26.21 34.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.439 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.5 -49.77 24.93 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.345 0.593 . . . . 0.0 109.78 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . -84.16 -9.86 58.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.748 -175.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.66 31.98 80.08 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.255 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 172.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.719 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.9 ttm180 -117.75 129.18 55.54 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 60' ' ' ILE . 68.7 mt -119.53 108.93 24.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.875 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -119.16 131.85 55.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 110.552 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.599 ' CE1' HD11 ' A' ' 26' ' ' ILE . 85.8 m-85 -81.17 115.06 20.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.948 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 8.6 mtpm? . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.212 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.964 0.412 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 22.3 mtpp -81.99 174.75 10.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.562 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 48.4 mm -120.96 111.11 30.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.117 0.485 . . . . 0.0 110.227 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -82.2 125.18 30.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 171.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -102.56 102.96 13.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.375 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 44' ' ' ILE . 47.0 mt -92.86 144.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.603 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 50.2 mtm -145.16 174.93 10.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.888 0.375 . . . . 0.0 111.935 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 112.7 -125.54 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.097 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.493 ' CG ' ' HB3' ' A' ' 66' ' ' ARG . 5.8 Cg_exo -82.89 134.12 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.232 2.621 . . . . 0.0 111.689 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 56.4 Cg_exo -53.56 -34.61 73.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.818 3.012 . . . . 0.0 113.586 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.59 -42.58 24.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.659 0.743 . . . . 0.0 109.759 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.547 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 18.5 tpp85 -67.57 -34.29 76.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.814 -176.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.5 p -61.86 -40.48 95.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.026 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -68.26 -34.25 75.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.375 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.3 t60 -63.7 -44.78 92.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.01 -36.3 83.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.444 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.03 87.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -69.69 -35.82 75.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.524 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.2 mt -60.52 -49.01 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.79 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 44' ' ' ILE . 87.4 mt -64.28 -40.94 90.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.793 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.65 -37.77 82.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.944 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -60.87 -36.27 78.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.428 0.633 . . . . 0.0 110.012 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 25' ' ' VAL . 9.7 tt -66.83 -44.15 81.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.685 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 81.0 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.669 -177.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 60' ' ' ILE . 42.0 pt . . . . . 0 C--O 1.233 0.196 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 22.2 m-20 -122.57 114.18 20.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.099 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -113.04 126.23 28.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.177 -175.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 15.0 Cg_exo -67.15 116.45 4.18 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.908 2.405 . . . . 0.0 111.965 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.627 HG23 HD21 ' A' ' 78' ' ' LEU . 7.6 p -123.64 108.98 30.73 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 121.506 0.669 . . . . 0.0 110.807 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 75.9 Cg_exo -50.96 131.86 35.97 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.192 2.595 . . . . 0.0 112.054 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 48.2 mtp85 -58.22 -32.5 68.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.716 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.43 . . . . 0.0 110.535 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 25' ' ' VAL . 17.9 m -88.42 -23.28 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.9 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.51 -32.7 65.04 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.604 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.39 -36.93 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.69 0.281 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 77' ' ' LEU . 48.2 t -65.34 -37.02 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 110.444 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.8 mm -81.51 -61.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.174 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.12 -152.1 18.46 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.641 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -37.49 9.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.246 0.546 . . . . 0.0 109.957 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 m -106.23 3.06 27.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.024 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 74.59 24.59 72.24 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -168.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.16 90.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.488 -0.856 . . . . 0.0 111.909 -174.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -72.77 -42.25 64.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.03 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 30' ' ' GLY . 5.7 tt -66.27 -30.83 51.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 48.7 mttp -69.61 -45.99 67.3 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -54.16 -45.55 72.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 32' ' ' MET . 62.2 mt -65.39 -48.97 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.737 0.304 . . . . 0.0 110.921 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.498 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 46.1 mt-30 -59.77 -33.69 72.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.55 -42.96 23.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.251 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.18 -37.1 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.46 -14.91 19.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.532 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.32 47.16 53.49 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.499 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 37' ' ' GLN . 31.5 m -124.77 176.23 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.283 -174.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 19.0 tpt180 -116.57 128.91 55.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.247 168.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -113.28 108.79 26.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -122.78 129.87 52.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 26' ' ' ILE . 38.0 m-85 -85.11 123.7 30.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 111.456 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 15.1 mttp . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.592 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 13.9 mp0 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 23.6 mtpp -83.49 178.66 7.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.09 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 50.2 mm -117.45 114.04 44.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.342 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.835 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -82.45 130.37 35.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 13.2 t-160 -104.42 101.46 11.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 13' ' ' ILE . 48.9 mt -88.71 132.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 70.9 mtm -143.21 160.07 41.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.297 0.57 . . . . 0.0 111.754 -170.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.23 -119.48 2.65 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -175.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -82.04 131.0 6.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.675 2.25 . . . . 0.0 110.499 172.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 40.8 Cg_exo -57.23 -28.93 81.8 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.254 2.636 . . . . 0.0 112.863 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.04 -40.05 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 110.075 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.4 tpp180 -60.59 -35.49 76.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.82 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' HG12 ' A' ' 13' ' ' ILE . 85.7 m -56.6 -33.91 66.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.8 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.69 -43.48 72.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -69.19 -39.83 78.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.0 0.429 . . . . 0.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.7 -30.94 70.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.424 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.432 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.95 -41.3 87.09 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.337 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -65.47 -42.47 92.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.916 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.89 -50.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.395 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.0 mt -69.73 -51.01 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.148 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -62.54 -41.48 98.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.866 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.44 -35.79 82.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.423 . . . . 0.0 110.22 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 25' ' ' VAL . 59.0 tp -63.84 -47.61 80.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 79.3 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.646 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 60' ' ' ILE . 41.6 pt . . . . . 0 C--O 1.235 0.32 0 CA-C-O 121.055 0.455 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.57 124.71 43.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.457 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 t -123.15 121.76 27.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.61 0.243 . . . . 0.0 111.336 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.1 Cg_exo -70.74 104.37 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.906 2.404 . . . . 0.0 111.928 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 p -118.09 105.88 46.25 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.644 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 85.3 Cg_exo -46.82 133.53 17.49 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.447 2.765 . . . . 0.0 112.604 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.677 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 38.4 mtt180 -60.4 -29.48 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -83.18 -13.13 56.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.9 m -99.61 -14.52 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.785 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 HG21 ' HD3' ' A' ' 56' ' ' LYS . 28.0 t -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.133 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.04 -24.57 60.87 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.9 -42.04 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 21' ' ' SER . 60.5 t -61.89 -37.24 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.877 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 46' ' ' PHE . 47.0 mm -79.66 -51.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.616 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.4 44.24 11.44 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.876 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 65.6 -73.14 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.457 0.703 . . . . 0.0 111.828 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 m -75.98 -16.55 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.701 0.286 . . . . 0.0 111.73 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 97.15 2.02 59.34 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -173.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.53 -32.88 69.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.094 -0.553 . . . . 0.0 111.751 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.1 tpt -74.48 -43.0 58.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.949 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.552 HD11 ' HB ' ' A' ' 44' ' ' ILE . 13.0 tt -69.32 -31.34 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 7.2 mmpt? -65.26 -36.11 83.11 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.69 174.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 32' ' ' MET . 28.1 tptp -62.59 -51.02 68.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.259 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 73' ' ' ILE . 73.4 mt -60.69 -50.26 81.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.5 -33.08 74.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.064 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.41 -32.24 60.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.989 0.423 . . . . 0.0 110.456 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.28 -46.84 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.053 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.12 -28.44 20.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.844 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.58 40.17 7.9 Favored Glycine 0 CA--C 1.517 0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.773 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 28.8 m -121.93 176.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 0.0 111.194 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -118.58 131.98 56.2 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 33' ' ' ILE . 85.0 mt -111.92 109.01 26.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.463 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.564 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 15.7 tm0? -121.71 120.85 35.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 26' ' ' ILE . 80.4 m-85 -74.02 116.4 14.6 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.145 0.498 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.677 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 26.9 mtpp -88.18 177.34 6.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 50.1 mm -120.91 107.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.618 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -79.55 140.08 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 45' ' ' GLN . 3.2 p-80 -118.91 112.46 19.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.121 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 13' ' ' ILE . 22.2 mt -92.17 148.77 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.623 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 mtm -142.92 175.23 9.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 111.86 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.66 -137.37 14.19 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.032 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 11.2 Cg_exo -67.13 148.31 80.79 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.72 2.28 . . . . 0.0 111.472 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 37.0 Cg_exo -60.11 -48.3 12.52 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.502 2.135 . . . . 0.0 112.484 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.75 -32.69 74.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.462 0.649 . . . . 0.0 109.739 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 5.7 tpp85 -64.96 -37.21 86.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.715 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.87 -48.53 81.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.11 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.67 -33.43 68.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 0.0 111.27 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' HG13 ' A' ' 73' ' ' ILE . 3.5 t-160 -61.1 -49.75 76.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -68.6 -31.92 71.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.43 92.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.633 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -64.85 -34.78 79.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 36' ' ' ILE . 69.6 mt -62.76 -51.27 74.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.024 0.44 . . . . 0.0 110.698 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 60' ' ' ILE . 53.7 mt -66.06 -43.88 92.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.641 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.92 -36.42 83.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.615 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -59.45 -38.21 80.15 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.5 176.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.231 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.725 -173.765 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.785 HD11 HD12 ' A' ' 60' ' ' ILE . 32.7 pt . . . . . 0 C--O 1.235 0.33 0 CA-C-O 120.813 0.339 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -121.6 105.92 10.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.526 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -104.25 131.76 21.62 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.9 Cg_exo -70.2 108.28 2.13 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.546 2.831 . . . . 0.0 111.968 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.561 HG11 ' HE1' ' A' ' 46' ' ' PHE . 7.8 p -113.97 113.38 46.91 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.984 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.67 128.34 25.89 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.417 2.078 . . . . 0.0 111.253 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -62.5 -22.55 66.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.834 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.18 -27.76 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.5 m -83.33 -23.41 32.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.471 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.51 -35.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.36 -29.98 64.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.469 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -88.93 -35.25 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 110.442 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 21' ' ' SER . 47.8 t -66.84 -39.13 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.317 0.58 . . . . 0.0 109.923 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.584 HD11 ' CE2' ' A' ' 46' ' ' PHE . 37.2 mm -79.52 -45.18 23.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.965 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.08 -86.02 1.29 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.138 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -133.94 -72.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.304 0.242 . . . . 0.0 110.368 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -109.38 44.52 1.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.012 0.434 . . . . 0.0 110.262 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 64.11 23.69 68.11 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -60.65 -43.85 97.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.389 -0.906 . . . . 0.0 111.364 -168.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.3 tpt -77.42 -34.14 54.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 44' ' ' ILE . 9.0 tt -78.1 -23.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.843 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 73.3 mmtt -63.25 -36.52 83.94 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 32' ' ' MET . 17.8 tppt? -63.24 -44.29 95.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.486 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.97 -52.14 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.466 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.571 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 44.6 mt-30 -61.86 -27.6 68.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.352 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -75.34 -49.37 19.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.921 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -68.96 -43.45 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 111.35 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.72 34.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.555 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.95 32.75 66.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.763 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 m -113.75 -179.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.443 0.639 . . . . 0.0 111.533 -173.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.571 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 31.4 tpt180 -123.05 135.25 54.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.951 169.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.6 HG21 HD11 ' A' ' 33' ' ' ILE . 89.7 mt -116.54 109.09 26.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.016 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.813 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 12.8 mm100 -97.05 107.74 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.752 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CE2' HD11 ' A' ' 26' ' ' ILE . 27.2 m-85 -73.43 111.28 8.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.103 0.478 . . . . 0.0 109.765 174.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt . . . . . 0 N--CA 1.44 -0.953 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.326 -176.636 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.489 0.661 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 17' ' ' VAL . 47.5 tttp -100.07 170.65 8.34 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.312 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.98 117.97 57.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.307 0.575 . . . . 0.0 111.218 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -87.53 133.53 33.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 27.6 t60 -111.69 101.98 10.31 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.332 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 13' ' ' ILE . 31.6 mt -89.23 139.97 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.049 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.8 mtm -139.82 156.42 46.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 111.796 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.61 -126.05 4.57 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.255 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.0 Cg_exo -78.57 137.59 14.69 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.245 2.63 . . . . 0.0 111.604 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 77.4 Cg_exo -51.84 -49.28 17.78 Favored 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 122.717 2.278 . . . . 0.0 113.083 -177.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.52 -38.79 84.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.175 0.512 . . . . 0.0 110.533 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.612 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 23.9 tpp180 -63.95 -29.22 70.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.733 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.0 m -62.57 -46.47 88.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.69 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.0 110.274 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.49 -43.68 96.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.251 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.85 -32.68 65.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.583 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -59.32 -42.48 91.53 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.58 0.705 . . . . 0.0 109.361 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -62.83 -42.28 99.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.73 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -57.69 -52.11 61.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 110.529 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.641 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.7 mt -64.73 -50.64 74.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.093 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -67.1 -32.42 73.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.458 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -65.23 -31.67 72.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.261 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.85 -42.22 61.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.563 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 83.8 mt . . . . . 0 C--O 1.224 -0.265 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.241 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.901 HD11 HD12 ' A' ' 60' ' ' ILE . 39.6 pt . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.761 0.315 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -111.54 123.44 50.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -122.52 123.86 26.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.33 -173.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 13.8 Cg_exo -68.47 105.37 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.734 2.289 . . . . 0.0 111.801 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.512 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -117.17 110.02 41.83 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.363 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.0 Cg_exo -47.46 129.99 17.21 Favored 'Trans proline' 0 CA--C 1.522 -0.11 0 C-N-CA 123.232 2.621 . . . . 0.0 112.129 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -62.96 -28.17 69.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.845 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -75.92 -24.8 55.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.467 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -92.16 -14.78 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.996 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -33.86 46.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.41 68.23 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.618 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -83.82 -43.8 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 109.977 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.78 -41.35 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.633 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.7 mm -79.96 -67.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.708 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 26' ' ' ILE . . . 75.76 -169.9 54.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.077 -175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.84 117.34 7.4 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.711 -0.288 . . . . 0.0 110.557 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m 62.53 16.36 8.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 71.84 26.5 72.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.166 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.26 -39.48 75.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 111.654 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.2 tpt -70.76 -39.3 73.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.981 0.419 . . . . 0.0 110.555 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 44' ' ' ILE . 7.3 tt -76.3 -26.54 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.081 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 45.1 mmtm -61.72 -43.1 99.51 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -58.87 -41.71 87.74 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.708 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 73' ' ' ILE . 70.2 mt -66.81 -49.96 69.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 110.852 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -61.89 -28.16 69.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.559 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -80.91 -51.26 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.54 -53.16 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.088 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.614 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -79.3 -18.51 52.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.403 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.43 40.44 60.06 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.5 m -126.81 165.66 24.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.975 0.417 . . . . 0.0 111.159 -174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 13.7 ttm180 -104.87 135.27 46.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.512 167.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.558 HG21 HD11 ' A' ' 33' ' ' ILE . 88.9 mt -116.06 108.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.53 106.67 12.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.016 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 26' ' ' ILE . 87.1 m-85 -65.15 136.4 56.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 mttt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.931 177.325 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 42.2 mt-10 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.387 0.613 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -92.17 172.61 8.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.76 114.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.434 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -85.9 140.48 30.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 24.2 t60 -116.24 108.88 16.67 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.48 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 13' ' ' ILE . 55.0 mt -88.3 148.8 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.886 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.1 mmt -122.27 147.38 46.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.61 -137.88 11.17 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.515 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 56.6 Cg_endo -91.09 147.59 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.436 2.757 . . . . 0.0 112.56 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.11 -48.88 19.41 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 113.318 -172.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.91 -43.3 96.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.683 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 2.8 tpp180 -68.37 -37.23 80.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.149 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 96.4 m -59.06 -42.42 90.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.165 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.54 -31.7 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.294 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.433 0.635 . . . . 0.0 109.304 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.84 -34.78 67.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.603 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.04 90.44 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.677 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -60.57 -47.6 85.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.434 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 40' ' ' ALA . 70.4 mt -56.7 -49.01 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.156 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 60' ' ' ILE . 78.8 mt -67.81 -46.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.987 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.68 -44.18 96.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.094 -177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.84 -40.89 94.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.818 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.96 -46.48 90.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.945 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 58.1 mt . . . . . 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.054 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 60' ' ' ILE . 39.1 pt . . . . . 0 C--O 1.233 0.227 0 CA-C-O 121.08 0.467 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -110.22 114.8 28.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -118.42 126.15 27.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.4 Cg_exo -69.45 113.69 3.41 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 123.15 2.567 . . . . 0.0 112.237 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.1 p -119.14 114.41 35.03 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.25 133.42 58.01 Favored 'Trans proline' 0 N--CA 1.469 0.044 0 C-N-CA 122.773 2.315 . . . . 0.0 112.236 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -62.71 -13.3 30.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -85.59 -45.04 12.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.101 0.477 . . . . 0.0 109.877 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -79.1 -22.43 45.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.671 -177.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.71 -24.49 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.648 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.07 -35.27 88.78 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.688 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -75.96 -31.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 110.127 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.38 -38.02 81.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.938 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.08 -51.24 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.348 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.05 -133.57 14.43 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.651 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -108.17 127.14 53.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 65.3 m 62.37 6.45 1.92 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.882 0.473 . . . . 0.0 111.781 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.658 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 80.93 8.04 87.91 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.231 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' A' ' 29' ' ' SER . 60.4 mm-40 -54.03 -32.54 54.72 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.477 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.5 tpt -70.13 -46.39 64.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 36' ' ' ILE . 6.3 tt -73.76 -23.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.139 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 96.1 mttt -65.11 -38.24 90.03 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -64.17 -44.22 92.72 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 33' ' ' ILE . 12.5 mt -58.09 -56.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.484 0.659 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.43 -23.65 66.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.703 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.39 -45.41 11.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.14 -32.69 69.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.36 -10.92 23.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.65 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.54 34.06 88.91 Favored Glycine 0 C--N 1.328 0.112 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.982 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.53 178.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.352 0.596 . . . . 0.0 111.248 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.5 tpp180 -119.06 131.49 55.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.077 170.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 33' ' ' ILE . 89.7 mt -119.46 108.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 123.682 0.614 . . . . 0.0 109.761 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -124.11 118.38 26.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.802 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 22.1 m-85 -76.99 109.67 11.0 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.64 -178.746 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 53.8 mtpt -83.96 163.95 19.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.97 112.25 39.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.617 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.39 135.6 37.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 11.7 t-160 -107.47 101.48 10.82 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.832 HD12 HD11 ' A' ' 13' ' ' ILE . 34.9 mt -89.76 135.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.8 mtm -141.6 169.69 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.816 -171.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 120.08 -124.34 5.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -174.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.3 Cg_exo -80.9 133.07 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.066 2.511 . . . . 0.0 110.74 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 76.2 Cg_exo -51.64 -40.92 63.63 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.889 3.059 . . . . 0.0 114.077 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.28 -38.18 43.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.37 0.605 . . . . 0.0 109.946 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 12.2 tpp85 -62.57 -32.85 73.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.797 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.0 m -58.83 -44.24 90.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.491 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.27 -25.75 51.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.221 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -73.07 -40.2 65.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.02 68.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.858 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.25 -36.31 77.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.494 174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -68.64 -40.28 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.331 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.473 HG21 HG23 ' A' ' 36' ' ' ILE . 65.3 mt -56.73 -46.26 83.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.418 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.595 HD12 HD11 ' A' ' 60' ' ' ILE . 73.6 mt -72.03 -45.06 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -59.83 -44.82 93.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.424 ' HB2' ' HE ' ' A' ' 72' ' ' ARG . 15.5 t70 -58.75 -40.76 84.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.462 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.98 -48.85 77.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.756 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 75.8 mt . . . . . 0 C--O 1.232 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 110.536 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 60' ' ' ILE . 37.6 pt . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.924 0.392 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -110.19 105.48 14.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -103.41 120.27 52.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 112.163 -176.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 16.3 Cg_exo -67.6 103.66 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.221 2.614 . . . . 0.0 111.497 175.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.29 110.03 53.69 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 86.2 Cg_exo -47.39 129.0 15.64 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.316 2.677 . . . . 0.0 112.103 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.51 -25.56 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.483 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.48 -33.43 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 110.288 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.442 ' O ' HG23 ' A' ' 25' ' ' VAL . 39.9 m -79.23 -22.08 45.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.386 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.531 HG21 ' HD3' ' A' ' 56' ' ' LYS . 37.8 t -54.95 -34.83 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -31.38 68.83 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.724 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 t -89.38 -36.37 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.763 0.316 . . . . 0.0 110.417 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' SER . 57.8 t -64.51 -37.52 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.115 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.503 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.2 mm -79.09 -40.49 22.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.657 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.3 -115.11 4.99 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.365 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 29.0 ttp85 -133.08 121.32 22.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.2 m 67.8 22.12 8.92 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.505 0.503 . . . . 0.0 110.637 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 71.37 13.13 73.63 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.499 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -52.57 -40.99 63.17 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.768 0.427 . . . . 0.0 111.32 -175.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.76 -35.96 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.494 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 36' ' ' ILE . 8.2 tt -75.94 -28.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.34 0.59 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -66.85 -34.7 78.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.661 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -59.62 -44.37 93.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.944 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 33' ' ' ILE . 8.8 mt -62.88 -62.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.432 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -52.98 -40.12 63.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.738 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.24 -49.77 58.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.603 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -83.75 -26.58 29.56 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -84.36 -25.59 29.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.899 0.38 . . . . 0.0 110.893 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.48 26.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.774 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.8 m -126.35 173.06 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.307 0.575 . . . . 0.0 111.148 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 17.4 tpt180 -116.63 122.46 44.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.167 170.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 33' ' ' ILE . 67.6 mt -109.6 108.32 25.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.36 115.57 19.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.736 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CE1' HD11 ' A' ' 26' ' ' ILE . 90.8 m-85 -63.4 128.34 35.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.734 -177.252 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 40.0 mt-10 . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 121.241 0.543 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' HD3' HG21 ' A' ' 22' ' ' VAL . 63.5 mtpt -84.59 166.08 17.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.0 mm -113.26 108.94 26.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.609 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.98 139.41 35.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.868 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -109.83 101.95 10.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 13' ' ' ILE . 36.0 mt -89.8 137.65 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -138.2 161.97 35.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.463 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 123.43 -127.81 6.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.082 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.0 Cg_exo -81.01 134.21 9.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.145 2.563 . . . . 0.0 110.965 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 78.5 Cg_exo -53.2 -39.6 80.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.638 2.892 . . . . 0.0 113.359 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.54 -37.1 68.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.171 0.51 . . . . 0.0 110.011 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 5.5 tpp180 -70.56 -28.86 65.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.664 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.2 m -62.17 -41.48 98.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.04 -36.86 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.957 0.408 . . . . 0.0 110.597 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.89 -38.5 88.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.591 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -72.5 -36.67 68.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.254 177.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.72 79.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.185 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -63.51 -44.08 95.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.886 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 40' ' ' ALA . 54.6 mt -61.06 -50.24 81.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 60' ' ' ILE . 83.8 mt -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -68.73 -33.91 74.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.244 0.545 . . . . 0.0 110.778 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -64.75 -29.22 70.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.493 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.74 -46.26 38.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 90.4 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.231 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.889 HD11 HD12 ' A' ' 60' ' ' ILE . 39.9 pt . . . . . 0 C--O 1.236 0.355 0 CA-C-O 120.986 0.422 . . . . 0.0 111.224 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -119.8 112.9 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -113.72 127.15 27.14 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.714 -170.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.8 Cg_exo -71.0 104.91 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.994 2.462 . . . . 0.0 111.88 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.46 116.87 41.22 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.4 Cg_exo -56.16 135.09 68.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.808 2.339 . . . . 0.0 111.674 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.806 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 80.9 mtm180 -62.31 -38.38 89.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.33 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -68.25 -30.57 69.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.046 0.45 . . . . 0.0 110.172 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.1 m -80.0 -26.49 39.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.41 HG21 ' HD3' ' A' ' 56' ' ' LYS . 44.4 t -55.85 -37.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.93 -28.91 61.33 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.534 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.3 -37.09 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.728 0.299 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 21' ' ' SER . 48.3 t -63.92 -37.83 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.496 0.665 . . . . 0.0 110.233 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 ' CE2' ' A' ' 46' ' ' PHE . 41.2 mm -82.58 -41.19 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.579 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.54 -65.3 3.07 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -173.28 -68.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -72.79 -35.5 67.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.304 0.574 . . . . 0.0 110.061 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 119.49 12.21 6.87 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.057 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -59.44 -35.2 73.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.962 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -67.12 -47.63 70.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.705 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.629 HD11 ' CG2' ' A' ' 44' ' ' ILE . 18.0 tt -71.45 -30.41 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.603 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mtmt -65.97 -30.05 70.54 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -77.93 -38.83 44.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 32' ' ' MET . 80.2 mt -59.1 -47.2 90.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.44 0.638 . . . . 0.0 109.746 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -63.1 -31.92 73.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.021 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -70.97 -48.45 53.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.03 -36.33 77.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.599 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -92.53 -22.91 19.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.43 37.12 42.17 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' ALA . 27.9 m -119.25 -177.3 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 111.485 -174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.4 ttt85 -127.8 125.21 39.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.198 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.629 ' CG2' HD11 ' A' ' 33' ' ' ILE . 61.6 mt -111.14 108.99 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.603 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -102.72 163.65 12.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.919 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 26' ' ' ILE . 84.7 m-85 -105.63 113.32 26.82 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.7 tttm . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.347 -177.716 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.806 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.7 mtpp -98.95 174.46 6.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.622 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.82 110.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.49 135.55 38.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -115.99 100.95 8.33 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.889 HD12 HD11 ' A' ' 13' ' ' ILE . 37.1 mt -89.85 146.73 5.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.529 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.3 mtm -142.98 160.78 39.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -172.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.74 -125.39 5.54 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.396 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -81.13 136.22 10.12 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.161 2.574 . . . . 0.0 111.187 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.46 -49.56 17.02 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.574 2.183 . . . . 0.0 112.778 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -41.28 97.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.339 0.59 . . . . 0.0 110.424 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.46 -31.96 73.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.142 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 75.3 m -60.96 -44.31 97.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.27 -28.5 57.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.78 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.504 ' O ' HG13 ' A' ' 73' ' ' ILE . 5.6 t60 -59.34 -46.97 87.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.92 -34.22 73.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.696 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.71 -42.5 99.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.452 0.644 . . . . 0.0 109.663 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttm105 -67.17 -34.14 76.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.572 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' HIS . 74.8 mt -62.26 -48.6 87.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 110.261 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 78.9 mt -64.89 -45.49 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.626 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -63.16 -36.9 85.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.546 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.54 -39.7 88.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.703 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.8 tp -66.66 -30.41 70.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 110.458 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 78.5 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.778 -177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 60' ' ' ILE . 28.3 pt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB3' HG21 ' A' ' 57' ' ' ILE . 17.1 m-20 -122.28 108.31 13.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.908 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.52 127.11 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.478 -170.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.8 Cg_exo -71.07 106.47 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.908 2.406 . . . . 0.0 111.922 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.534 HG23 HD21 ' A' ' 78' ' ' LEU . 6.4 p -116.02 109.68 44.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.787 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 80.6 Cg_exo -46.09 129.14 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.5 2.8 . . . . 0.0 112.853 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.633 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 37.2 mtt180 -59.71 -27.97 66.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.936 -175.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -79.57 -27.8 41.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.928 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -88.43 -18.35 28.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.9 t -52.72 -34.72 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.77 68.25 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 t -80.96 -38.39 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.912 0.387 . . . . 0.0 110.456 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 24.7 t -64.36 -35.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.221 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 46' ' ' PHE . 30.0 mm -78.44 -65.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.24 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.16 86.58 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.421 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' GLY . 37.8 ttm180 60.1 82.99 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.864 0.465 . . . . 0.0 111.808 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m 70.59 -25.33 0.16 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.454 0.702 . . . . 0.0 111.491 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' ARG . . . 113.1 74.27 0.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.25 -25.77 11.34 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.8 tpt -77.06 -51.88 10.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.305 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 36' ' ' ILE . 11.5 tt -70.23 -27.28 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.934 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -76.14 -32.47 59.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -62.96 -41.8 99.63 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.32 170.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 33' ' ' ILE . 94.0 mt -59.78 -52.37 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.911 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.4 -40.03 73.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.562 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -81.03 -17.79 49.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.966 0.412 . . . . 0.0 111.534 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.81 -40.17 17.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -96.24 -13.18 23.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.28 46.44 49.69 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.19 177.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.705 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.7 ttt180 -126.34 135.37 51.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.357 171.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD11 ' A' ' 33' ' ' ILE . 65.4 mt -119.94 108.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.87 119.14 38.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 26' ' ' ILE . 74.0 m-85 -75.47 110.73 10.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.366 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 22.8 mtpp . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.245 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.1 mt-10 . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.973 0.416 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 41.3 mttp -79.65 165.65 22.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 47' ' ' LYS . 50.4 mm -111.62 108.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.501 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.61 127.13 31.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -105.92 101.9 11.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 43' ' ' ARG . 47.8 mt -89.58 143.12 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.508 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.7 mtm -144.36 178.49 7.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.838 0.352 . . . . 0.0 110.966 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 107.96 -125.15 7.8 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.83 133.58 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.903 2.402 . . . . 0.0 111.1 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.1 Cg_exo -56.75 -35.94 98.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.463 2.775 . . . . 0.0 113.315 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.52 -36.68 28.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.637 0.732 . . . . 0.0 109.816 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 7.8 tpp85 -67.91 -39.32 83.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.66 -176.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -58.46 -38.65 77.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.88 -36.07 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -72.6 -36.46 68.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.077 0.465 . . . . 0.0 110.288 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.32 -31.55 70.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.995 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.45 -37.6 81.49 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.49 175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -72.6 -31.76 65.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.528 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG21 HG23 ' A' ' 36' ' ' ILE . 57.6 mt -57.57 -52.39 57.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 109.785 174.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 60' ' ' ILE . 64.5 mt -67.35 -46.73 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.778 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -61.72 -39.38 91.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.158 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.51 -44.46 93.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.79 -44.04 94.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.426 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 17' ' ' VAL . 80.0 mt . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.111 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.444 -0.826 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 HD12 ' A' ' 60' ' ' ILE . 25.4 pt -128.06 142.96 42.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.151 0.501 . . . . 0.0 111.336 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 57' ' ' ILE . 5.1 m-20 -97.59 114.05 25.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -119.06 132.55 23.91 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -170.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.86 124.36 12.18 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.685 2.257 . . . . 0.0 112.119 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.51 HG23 HD11 ' A' ' 78' ' ' LEU . 11.3 p -131.99 111.56 14.5 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.965 175.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HA ' ' HG2' ' A' ' 55' ' ' GLU . 50.7 Cg_exo -52.83 133.61 51.58 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.874 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 16.2 mtp180 -66.9 -15.76 63.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.326 0.584 . . . . 0.0 110.468 -178.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -88.49 -13.29 40.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.216 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.568 ' HB3' HD13 ' A' ' 81' ' ' LEU . 20.0 m -107.71 -20.65 13.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.92 -175.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 m -58.5 -24.7 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 120.656 0.265 . . . . 0.0 111.535 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.17 -38.88 91.27 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.98 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.19 -38.5 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.293 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.5 t -67.34 -37.91 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.81 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.586 HG23 ' HA2' ' A' ' 30' ' ' GLY . 27.0 mm -79.73 -38.14 18.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.191 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.12 -119.84 9.06 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mtm180 -120.87 131.7 54.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 70.26 -5.37 1.35 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.464 0.478 . . . . 0.0 111.84 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 85.94 12.69 70.86 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -170.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -59.5 -39.6 84.31 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.758 0.423 . . . . 0.0 110.716 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.6 tpt -65.89 -46.17 79.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.905 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.0 tt -70.39 -26.41 28.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.418 -178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 51.7 mttp -68.61 -37.11 79.52 Favored 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -66.2 -34.43 78.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.117 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 73' ' ' ILE . 85.9 mt -65.23 -53.96 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.942 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -57.53 -31.74 66.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.329 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -67.95 -55.33 13.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.279 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -29.52 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.413 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.758 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -83.19 -29.02 28.89 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.908 178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.17 42.2 24.58 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 31.2 m -130.37 178.67 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 5.9 tpp180 -120.65 128.35 52.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.212 169.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 74' ' ' ILE . 59.5 mt -119.5 109.21 25.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -111.7 119.2 37.84 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.466 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -76.01 114.92 15.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.024 0.44 . . . . 0.0 110.127 175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 54.4 mtpt -75.9 171.99 13.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.374 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -49.64 -61.49 2.09 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.393 0.616 . . . . 0.0 110.094 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -155.77 -75.8 0.1 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 171.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 67.03 144.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.013 0.82 . . . . 0.0 112.752 169.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.58 -51.33 3.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.262 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.659 HG21 ' HB2' ' A' ' 55' ' ' GLU . 6.6 t -140.72 -167.6 2.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.513 ' H ' ' HD2' ' A' ' 54' ' ' PRO . . . -108.71 -64.56 0.56 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.926 -177.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' A' ' 53' ' ' GLY . 56.9 Cg_endo -73.07 -2.02 11.41 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.851 2.367 . . . . 0.0 113.054 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.659 ' HB2' HG21 ' A' ' 52' ' ' THR . 32.5 mt-10 -125.58 150.01 47.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.222 0.534 . . . . 0.0 110.662 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.874 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.0 mtpp -97.53 173.17 7.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.438 173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.571 ' HB ' ' HD3' ' A' ' 47' ' ' LYS . 46.6 mm -109.22 114.58 47.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.552 173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.539 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -80.06 118.57 21.9 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 170.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -97.09 102.06 13.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 13' ' ' ILE . 17.5 mt -88.57 137.01 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 62.8 mtm -147.82 160.44 42.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.004 0.43 . . . . 0.0 111.531 -169.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 127.53 -122.34 4.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.43 145.63 18.85 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.917 2.411 . . . . 0.0 110.89 174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -64.42 -41.92 18.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.021 2.481 . . . . 0.0 113.023 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -75.03 -37.37 61.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.474 0.654 . . . . 0.0 109.339 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.3 tpp180 -61.78 -32.99 73.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.053 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 99.7 m -56.51 -41.95 77.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.465 176.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -73.45 -34.39 65.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.883 0.373 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -60.7 -49.67 76.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -69.75 -30.37 67.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.428 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.03 -41.64 92.68 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.792 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 12.4 tpt180 -69.31 -38.25 78.17 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.532 HG21 HG23 ' A' ' 36' ' ' ILE . 65.1 mt -54.92 -52.1 46.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-O 121.136 0.493 . . . . 0.0 110.149 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 60' ' ' ILE . 53.2 mt -68.75 -45.94 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.949 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -60.38 -46.09 91.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.342 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.34 -39.76 84.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.948 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.74 -37.55 84.87 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.595 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD11 HG23 ' A' ' 17' ' ' VAL . 88.2 mt -80.65 -9.91 59.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.647 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -58.17 -50.36 73.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.736 0.303 . . . . 0.0 110.627 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.3 m -71.03 -31.34 67.78 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.625 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 21' ' ' SER . 97.2 mt -76.47 -33.47 58.71 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.967 0.728 . . . . 0.0 112.967 -173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 7.8 ptp180 . . . . . 0 C--N 1.33 -0.274 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.253 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.807 HD11 HD12 ' A' ' 60' ' ' ILE . 41.8 pt -116.31 149.68 18.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.064 0.459 . . . . 0.0 110.653 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -115.31 105.46 12.89 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.064 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.771 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -106.83 127.49 27.96 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.044 0.449 . . . . 0.0 112.171 -173.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.3 Cg_exo -69.96 116.32 4.53 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.992 2.462 . . . . 0.0 111.981 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -121.82 111.24 32.82 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 121.311 0.576 . . . . 0.0 110.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 78' ' ' LEU . 79.5 Cg_exo -49.26 128.35 19.83 Favored 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 123.501 2.801 . . . . 0.0 112.522 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -60.47 -31.69 70.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.672 -173.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -77.81 -18.82 55.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 m -91.84 -18.3 24.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.074 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -57.07 -31.85 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.569 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.88 -30.84 70.49 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.84 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.0 t -88.26 -35.86 8.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 O-C-N 122.556 -0.379 . . . . 0.0 110.242 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 77' ' ' LEU . 48.7 t -65.85 -38.65 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.894 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.607 HD11 ' CE1' ' A' ' 46' ' ' PHE . 28.8 mm -79.77 -51.56 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.358 177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' O ' ' HD3' ' A' ' 28' ' ' ARG . . . 98.83 -96.11 1.67 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.317 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 27' ' ' GLY . 23.8 mmt180 -132.81 -56.65 0.93 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -98.89 -17.06 18.58 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.005 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.59 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 110.34 15.34 11.56 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -173.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.557 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -73.77 -23.25 59.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.159 -0.52 . . . . 0.0 110.959 -175.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.491 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.9 tpt -73.6 -38.89 64.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.032 0.444 . . . . 0.0 109.972 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 30' ' ' GLY . 10.5 tt -77.44 -22.57 14.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 29.3 mmtp -64.49 -38.45 91.08 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 171.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 32' ' ' MET . 1.2 tmtp? -57.45 -47.37 82.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.787 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD12 HG13 ' A' ' 33' ' ' ILE . 38.8 mt -61.51 -48.8 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.661 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -63.35 -30.12 71.31 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.085 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -82.65 -46.16 13.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.583 0.23 . . . . 0.0 111.323 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.51 -46.8 88.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.567 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.32 -22.98 26.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.458 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.93 33.7 45.03 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.655 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.9 m -113.64 -177.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.46 0.648 . . . . 0.0 111.639 -174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 40.3 ttt180 -126.22 133.57 51.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.064 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.651 HD13 HD11 ' A' ' 74' ' ' ILE . 37.3 mt -132.57 109.95 15.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 123.345 0.403 . . . . 0.0 110.311 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -114.6 139.36 49.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.945 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CE1' HD11 ' A' ' 26' ' ' ILE . 82.1 m-85 -84.17 112.78 20.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.136 0.493 . . . . 0.0 110.332 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -75.46 146.19 40.86 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.297 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -93.17 -15.34 26.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 169.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -76.63 159.94 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.896 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 67.26 -84.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.702 0.626 . . . . 0.0 110.294 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.77 94.04 0.01 OUTLIER Glycine 0 C--N 1.33 0.232 0 O-C-N 123.305 0.378 . . . . 0.0 112.995 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.7 p -90.6 30.88 1.09 Allowed 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.303 -0.527 . . . . 0.0 112.325 -175.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.82 -111.37 4.23 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.765 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.86 0.65 9.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.887 2.391 . . . . 0.0 112.344 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -122.25 135.09 54.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.359 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.427 ' HD3' ' HD2' ' A' ' 46' ' ' PHE . 27.0 mttm -89.77 171.3 9.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.469 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.9 mm -115.61 111.59 36.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 120.993 0.425 . . . . 0.0 109.944 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.771 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.54 133.58 35.82 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.485 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -105.87 101.34 10.85 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.29 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 13' ' ' ILE . 33.5 mt -91.0 137.03 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.507 -0.77 . . . . 0.0 108.983 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 54.8 mtm -146.11 162.11 38.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.964 0.411 . . . . 0.0 111.407 -169.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 124.98 -119.32 3.58 Favored Glycine 0 N--CA 1.443 -0.89 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.492 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 6.3 Cg_exo -83.0 129.64 5.42 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.13 2.553 . . . . 0.0 110.965 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 54.0 Cg_exo -54.41 -34.73 82.34 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.631 2.888 . . . . 0.0 113.813 -175.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -81.24 -40.05 24.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.119 0.485 . . . . 0.0 110.238 177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.1 tpp180 -64.0 -26.8 68.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.951 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 73.7 m -57.84 -43.69 86.02 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -66.82 -37.36 84.36 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.751 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -61.7 -44.81 96.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.07 -37.76 84.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.26 -38.04 85.31 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.89 176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.8 ttt85 -68.85 -38.58 79.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.551 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 77.0 mt -62.85 -48.81 86.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.598 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.661 HD12 HD11 ' A' ' 60' ' ' ILE . 91.2 mt -64.71 -39.89 87.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.474 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -62.3 -45.93 91.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.747 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.54 -39.62 84.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.951 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 25' ' ' VAL . 6.6 tt -63.81 -48.08 78.25 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.643 177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt -67.13 -23.33 65.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.342 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -63.85 -36.91 85.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.0 t -69.65 -23.24 63.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.442 0.639 . . . . 0.0 109.797 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -98.1 12.21 35.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.256 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 . . . . . 0 C--O 1.233 0.225 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.493 177.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 71' ' ' ALA . 26.4 pt -127.28 149.17 32.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.121 0.486 . . . . 0.0 111.028 177.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -109.66 117.55 34.21 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.327 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.46 124.99 30.78 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.073 -173.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' A' ' 57' ' ' ILE . 19.1 Cg_endo -77.01 111.5 3.24 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.106 1.87 . . . . 0.0 111.323 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG11 ' HE2' ' A' ' 46' ' ' PHE . 6.3 p -114.96 114.62 43.76 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.518 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.623 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.1 Cg_exo -48.64 126.98 15.4 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.176 2.584 . . . . 0.0 111.766 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.814 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 83.9 mtp180 -59.97 -33.6 72.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.102 -172.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -82.72 -13.83 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.575 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.8 m -94.91 -13.37 25.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.98 0.419 . . . . 0.0 110.556 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG21 ' HD3' ' A' ' 56' ' ' LYS . 25.3 t -57.41 -33.48 44.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.773 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.42 -29.9 61.07 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 121.212 -0.518 . . . . 0.0 113.002 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.471 ' HB ' HD13 ' A' ' 81' ' ' LEU . 31.1 t -88.75 -35.16 7.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.847 0.356 . . . . 0.0 110.497 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 32' ' ' MET . 45.0 t -66.07 -36.28 77.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.426 0.632 . . . . 0.0 110.162 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.533 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.9 mm -81.59 -60.18 2.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.271 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.84 -116.73 4.75 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.656 -178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -114.56 -49.15 2.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.152 0.501 . . . . 0.0 109.954 178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -119.59 -0.64 10.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.556 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 112.0 22.04 6.09 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.567 -176.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -51.05 -50.91 57.7 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.876 0.47 . . . . 0.0 111.68 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.507 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.1 tpt -68.3 -47.31 67.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.166 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.41 HD11 ' HB ' ' A' ' 44' ' ' ILE . 11.4 tt -69.23 -29.75 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.76 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 59.0 mttm -63.09 -42.44 99.62 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 7.2 tmtm? -65.73 -44.79 84.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.988 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 32' ' ' MET . 77.7 mt -60.29 -50.48 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.032 0.444 . . . . 0.0 110.761 178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 mt-30 -62.31 -30.03 70.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.031 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.38 -46.07 18.3 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.522 0.201 . . . . 0.0 110.971 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -58.69 -46.27 87.63 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.272 0.558 . . . . 0.0 111.146 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.53 -21.05 23.1 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.682 -176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.26 37.92 63.11 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.852 -174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 37' ' ' GLN . 25.7 m -113.17 -179.48 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.196 0.522 . . . . 0.0 111.003 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -126.82 133.36 50.79 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 166.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 60' ' ' ILE . 72.1 mt -123.96 109.07 22.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 O-C-N 124.189 0.931 . . . . 0.0 109.301 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -126.89 136.89 52.94 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.325 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 75.4 m-85 -85.32 118.39 24.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.036 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -91.22 144.12 25.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.161 -175.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -93.5 -2.56 54.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.804 0.812 . . . . 0.0 108.911 173.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.71 -76.48 0.1 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.597 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.692 ' HB2' HG13 ' A' ' 57' ' ' ILE . 1.9 m-20 -77.25 -16.08 59.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.944 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.5 122.89 27.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.727 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 t -158.89 151.39 21.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.846 0.355 . . . . 0.0 110.344 -176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 70.19 -136.12 26.52 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.129 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -91.41 6.4 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.088 2.526 . . . . 0.0 112.886 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.08 131.36 44.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.457 0.646 . . . . 0.0 111.618 -177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.814 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 27.9 mtpp -86.41 175.86 8.18 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.692 HG13 ' HB2' ' A' ' 50' ' ' ASP . 46.0 mm -119.86 108.69 24.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.643 175.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -73.78 130.02 39.11 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 171.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -104.47 102.85 12.48 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 120.263 -0.575 . . . . 0.0 109.726 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.683 HD11 HD12 ' A' ' 74' ' ' ILE . 40.6 mt -89.61 136.21 24.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 40.0 mtm -145.1 144.23 30.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.63 -169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 139.18 -124.51 2.81 Favored Glycine 0 N--CA 1.44 -1.052 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.147 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.34 138.3 12.37 Favored 'Trans proline' 0 CA--C 1.53 0.275 0 C-N-CA 123.438 2.759 . . . . 0.0 112.099 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -50.05 -49.28 16.62 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 113.399 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.07 -41.63 70.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.219 0.533 . . . . 0.0 110.625 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.56 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 2.0 tpp180 -65.49 -31.22 72.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.438 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 94.0 m -58.34 -44.7 88.85 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -70.46 -32.9 70.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.673 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.472 ' O ' HG13 ' A' ' 73' ' ' ILE . 4.3 t60 -56.71 -50.05 73.34 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 172.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -70.03 -34.66 73.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.861 -178.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.506 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.28 -41.39 98.44 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.012 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -66.78 -37.56 84.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.121 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 69' ' ' HIS . 73.4 mt -57.13 -50.62 75.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.529 176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 60' ' ' ILE . 68.5 mt -68.67 -44.81 82.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.039 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -61.06 -49.95 75.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.798 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -57.18 -39.57 75.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.863 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.485 ' HG ' HD11 ' A' ' 81' ' ' LEU . 44.1 tp -66.97 -50.11 63.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.526 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.623 HD13 ' HD2' ' A' ' 18' ' ' PRO . 94.0 mt -64.44 -28.42 69.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.302 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -53.69 -42.66 68.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.794 0.33 . . . . 0.0 111.48 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -88.45 -18.03 29.14 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.029 0.442 . . . . 0.0 110.76 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.485 HD11 ' HG ' ' A' ' 77' ' ' LEU . 90.3 mt -86.48 -13.65 45.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.289 -0.414 . . . . 0.0 112.056 -174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 82' ' ' ARG . 63.5 mtt180 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.6 0.238 . . . . 0.0 111.34 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.843 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 60' ' ' ILE . 29.3 pt -97.35 145.51 9.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.873 0.368 . . . . 0.0 110.635 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.588 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 14.7 p-10 -111.03 120.11 41.28 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.821 0.819 . . . . 0.0 109.544 173.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -116.65 133.77 22.99 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.616 -1.175 . . . . 0.0 111.985 -167.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HA ' HD13 ' A' ' 57' ' ' ILE . 11.1 Cg_exo -69.24 117.48 5.08 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 123.109 2.539 . . . . 0.0 112.13 177.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 17' ' ' VAL . 6.7 p -132.25 108.63 13.67 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 121.368 0.604 . . . . 0.0 110.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.721 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 83.7 Cg_exo -48.81 141.44 21.19 Favored 'Trans proline' 0 CA--C 1.528 0.213 0 C-N-CA 123.543 2.828 . . . . 0.0 113.487 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -54.82 -53.7 51.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.725 0.298 . . . . 0.0 111.545 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -60.72 -26.87 67.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.113 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.9 m -79.16 -25.13 42.86 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.378 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.7 t -60.12 -32.69 51.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.632 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.01 -29.82 68.84 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.13 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.441 HG11 HD21 ' A' ' 81' ' ' LEU . 40.3 t -89.5 -35.33 7.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 21' ' ' SER . 61.1 t -68.19 -38.31 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.596 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.543 HD11 ' CE1' ' A' ' 46' ' ' PHE . 34.7 mm -79.37 -55.99 8.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.464 178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.2 -134.3 12.07 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -174.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 2.5 mmp_? -105.39 -59.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 50.0 m -93.21 -18.19 22.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.859 174.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 123.2 13.92 4.24 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.238 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 29' ' ' SER . 18.4 mp0 -57.21 -39.05 74.65 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.19 0.596 . . . . 0.0 111.352 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.5 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -68.82 -49.32 59.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.675 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.577 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -68.7 -30.02 45.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 110.402 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 32.3 mmtp -72.94 -29.72 63.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.418 . . . . 0.0 109.91 176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.92 -42.28 77.0 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 173.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 32' ' ' MET . 74.8 mt -60.65 -49.38 84.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.352 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.66 -27.34 68.86 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.294 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -76.34 -50.04 15.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.79 176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -59.68 -53.22 60.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 111.173 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -86.47 -11.34 52.05 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.934 -174.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.34 37.94 95.63 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.371 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.5 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.0 m -113.34 177.11 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.322 0.582 . . . . 0.0 110.827 -174.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -122.36 123.44 41.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.681 168.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.577 ' CG2' HD11 ' A' ' 33' ' ' ILE . 86.6 mt -105.68 108.43 25.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -115.47 114.99 25.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.148 -177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CE1' HD11 ' A' ' 26' ' ' ILE . 58.6 m-85 -70.93 114.23 8.78 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.525 0.678 . . . . 0.0 110.804 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 49' ' ' ASP . 47.9 mtpt -68.46 -39.27 81.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.933 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? 72.06 -34.19 0.29 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.223 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 47' ' ' LYS . 6.7 t70 -68.66 -177.38 0.95 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.417 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' HG13 ' A' ' 57' ' ' ILE . 2.8 m-20 65.05 -80.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -168.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.75 97.14 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 116.082 -0.508 . . . . 0.0 113.33 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.455 ' OG1' ' HB2' ' A' ' 55' ' ' GLU . 3.2 p -84.16 21.88 1.3 Allowed 'General case' 0 C--N 1.32 -0.717 0 O-C-N 122.356 -0.497 . . . . 0.0 111.262 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.93 -104.77 1.7 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.857 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -83.66 13.0 2.81 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.966 2.444 . . . . 0.0 112.11 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.721 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.6 mt-10 -121.95 143.4 49.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.09 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.9 mttp -96.21 175.69 6.36 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.757 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 43.4 mm -122.7 114.58 42.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.007 0.432 . . . . 0.0 110.504 176.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.699 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -81.55 140.45 34.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.611 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -114.11 103.64 11.33 Favored 'General case' 0 C--N 1.319 -0.753 0 O-C-N 121.691 -0.631 . . . . 0.0 109.462 177.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB3' ' A' ' 70' ' ' ALA . 45.1 mt -88.64 137.62 20.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 72.4 mtm -143.48 171.51 14.05 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.599 -173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 116.02 -128.74 8.14 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 -174.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_exo -75.98 141.48 23.95 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.788 2.325 . . . . 0.0 111.204 176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 27.9 Cg_exo -62.7 -35.69 67.69 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.563 2.842 . . . . 0.0 113.266 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -80.43 -31.04 37.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.548 0.69 . . . . 0.0 109.717 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.5 tpp180 -66.09 -27.09 67.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.676 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 79.1 m -55.77 -37.77 68.98 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.402 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.481 ' HA ' ' HB3' ' A' ' 71' ' ' ALA . 29.6 mt-10 -79.31 -30.89 43.07 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 121.269 -0.172 . . . . 0.0 111.453 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.528 ' O ' HG13 ' A' ' 73' ' ' ILE . 2.3 t-160 -57.56 -50.62 72.49 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 172.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -73.11 -32.82 65.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.208 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 68' ' ' GLU . . . -61.74 -41.07 97.17 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.955 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' ' 72' ' ' ARG . 18.4 tpt180 -63.5 -43.91 95.88 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.44 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 69' ' ' HIS . 70.3 mt -54.33 -50.51 56.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.804 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.553 HD12 HD11 ' A' ' 60' ' ' ILE . 70.3 mt -71.36 -42.57 73.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.148 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -61.77 -50.27 73.02 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.93 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.036 0.446 . . . . 0.0 110.395 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.37 -48.18 80.9 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.5 mt -66.05 -27.45 68.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.67 177.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -66.38 -37.81 86.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.901 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.3 m -72.15 -26.81 62.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.984 0.421 . . . . 0.0 110.618 177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.441 HD21 HG11 ' A' ' 24' ' ' VAL . 90.7 mt -78.84 -12.05 60.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.181 0.515 . . . . 0.0 110.569 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.665 176.766 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 CA-C-O 120.734 0.074 . . . . 0.0 112.919 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.684 HD11 HD12 ' A' ' 60' ' ' ILE . 22.1 pt -107.07 165.35 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.398 . . . . 0.0 110.596 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.552 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 8.3 p-10 -117.24 128.64 55.28 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.366 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.602 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.08 122.8 23.27 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.996 -174.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.562 ' HB3' HG21 ' A' ' 52' ' ' THR . 26.0 Cg_exo -65.42 103.53 0.55 Allowed 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 123.082 2.522 . . . . 0.0 111.898 175.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.437 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.4 p -102.34 118.13 59.58 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.918 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.715 ' HA ' ' CD ' ' A' ' 55' ' ' GLU . 52.5 Cg_exo -56.01 122.41 11.71 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.59 2.194 . . . . 0.0 111.438 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.749 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 53.5 mtp180 -62.76 -28.16 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -73.53 -18.37 61.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.6 m -102.75 -11.37 18.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.06 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -55.94 -35.29 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.87 -23.33 63.33 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.148 -0.548 . . . . 0.0 112.928 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG11 HD21 ' A' ' 81' ' ' LEU . 36.0 t -89.21 -34.17 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.097 0.475 . . . . 0.0 110.138 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.88 -39.39 67.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.412 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.495 HD11 ' CE1' ' A' ' 46' ' ' PHE . 38.8 mm -86.42 -56.66 5.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.973 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 108.27 -127.45 8.66 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -113.35 -45.99 3.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.049 0.424 . . . . 0.0 110.342 173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.2 m -95.6 -36.13 11.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.439 0.638 . . . . 0.0 109.843 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.632 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 128.38 12.63 2.77 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.596 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.64 -28.16 69.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.749 0.309 . . . . 0.0 110.997 -174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 17.6 tpt -67.72 -43.82 79.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.371 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 HG21 ' A' ' 44' ' ' ILE . 10.9 tt -79.93 -24.73 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.412 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 74.4 mmtt -62.77 -40.43 97.27 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 32' ' ' MET . 53.2 tttm -59.85 -45.92 90.9 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.55 174.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.6 mt -60.75 -49.24 85.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.56 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -59.69 -39.64 85.22 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.388 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -71.97 -49.35 38.07 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.252 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -63.0 -46.72 86.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.437 -173.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.747 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -80.97 -28.32 35.66 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.572 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.41 44.1 7.6 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 34.4 m -129.31 172.98 14.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.277 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -117.69 137.35 52.73 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.695 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 33' ' ' ILE . 29.2 mt -123.44 106.06 16.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -105.75 119.05 38.15 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.066 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE1' HD11 ' A' ' 26' ' ' ILE . 55.8 m-85 -73.13 126.06 29.15 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD3' ' HB ' ' A' ' 57' ' ' ILE . 21.6 mtpp -58.55 144.59 42.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.167 174.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -80.55 6.0 13.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.229 0.538 . . . . 0.0 110.093 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -118.35 140.37 49.95 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.497 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -76.97 85.51 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 170.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.67 -30.0 68.13 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.756 -170.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.775 HG23 ' HB2' ' A' ' 55' ' ' GLU . 5.3 t -132.23 90.75 2.85 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.596 0.712 . . . . 0.0 110.989 -177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.65 -116.79 9.85 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.406 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.421 ' O ' ' HD3' ' A' ' 19' ' ' ARG . 75.5 Cg_endo -96.69 13.15 1.02 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.062 2.508 . . . . 0.0 113.249 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.775 ' HB2' HG23 ' A' ' 52' ' ' THR . 4.0 mm-40 -108.43 153.3 23.5 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 111.217 -178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.749 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.6 mtpp -92.47 160.69 14.95 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.677 177.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.9 mm -108.28 107.92 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 120.522 -0.471 . . . . 0.0 109.895 174.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.602 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -75.12 140.07 43.16 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 4.5 t60 -118.06 108.43 15.22 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.592 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -88.68 131.49 35.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 51.7 mtp -131.03 128.24 39.9 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.88 0.371 . . . . 0.0 111.691 -162.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 142.05 -135.35 6.64 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.851 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 11.3 Cg_exo -69.17 150.08 71.39 Favored 'Trans proline' 0 CA--C 1.529 0.225 0 C-N-CA 123.403 2.735 . . . . 0.0 112.227 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 32.3 Cg_exo -60.04 -50.0 8.44 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.615 2.21 . . . . 0.0 112.864 -176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -71.87 -30.51 65.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.211 0.529 . . . . 0.0 109.908 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.747 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.35 -42.79 87.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.595 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.0 m -59.7 -40.35 87.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.824 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -74.19 -35.24 63.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.409 ' O ' HG13 ' A' ' 73' ' ' ILE . 17.9 t-160 -68.69 -41.5 79.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.539 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.93 -34.41 76.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.332 176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -37.77 84.27 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.734 175.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -74.59 -31.88 62.18 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.487 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.515 HD12 ' HB2' ' A' ' 40' ' ' ALA . 74.6 mt -60.37 -50.48 80.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 109.933 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 76.7 mt -67.29 -39.5 82.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.714 178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -64.55 -45.96 84.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.165 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -57.85 -40.1 79.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.819 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.8 tp -59.29 -41.89 90.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.59 177.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 67.4 mt -69.94 -33.28 71.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.696 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -65.75 -32.59 74.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.411 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -76.61 -21.99 54.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.023 0.439 . . . . 0.0 110.687 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.65 HD21 HG11 ' A' ' 24' ' ' VAL . 90.6 mt -79.57 -29.94 41.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.535 -176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 82' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 121.511 0.672 . . . . 0.0 111.819 -175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 67' ' ' CYS . 16.7 pt -96.43 145.8 8.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.147 0.498 . . . . 0.0 111.786 -174.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 5.2 p-10 -97.71 122.04 40.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.951 175.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -119.31 125.67 27.44 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.044 -175.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 12.1 Cg_exo -69.29 104.58 1.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.187 2.592 . . . . 0.0 111.999 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 22' ' ' VAL . 11.2 p -106.75 113.65 62.6 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.282 0.563 . . . . 0.0 109.686 178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.0 Cg_exo -60.4 129.76 31.06 Favored 'Trans proline' 0 CA--C 1.515 -0.428 0 C-N-CA 123.098 2.532 . . . . 0.0 112.978 -176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.731 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 98.6 mtt180 -55.67 -29.94 60.2 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.996 0.81 . . . . 0.0 112.587 -172.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -71.96 -34.48 69.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.152 0.501 . . . . 0.0 110.478 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -90.32 -19.72 23.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.447 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.673 HG22 HG22 ' A' ' 17' ' ' VAL . 6.0 t -60.35 -33.11 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.56 87.71 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.125 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.694 HG21 HD11 ' A' ' 81' ' ' LEU . 42.9 t -75.31 -36.1 35.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.391 . . . . 0.0 110.391 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.1 t -66.0 -36.7 78.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.253 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.571 HD11 ' CE2' ' A' ' 46' ' ' PHE . 36.8 mm -81.41 -58.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.008 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.59 -113.01 4.12 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -118.44 -61.02 1.72 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.9 m -93.51 -28.96 15.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.739 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 133.75 19.98 0.89 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.104 -175.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -60.22 -37.78 81.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 111.021 -175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.5 -40.82 69.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.523 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.562 HD11 ' CG2' ' A' ' 44' ' ' ILE . 8.6 tt -75.02 -27.91 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 49.4 mtpt -63.72 -36.82 85.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -63.26 -43.92 96.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.15 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.439 HG23 HG21 ' A' ' 73' ' ' ILE . 60.5 mt -63.47 -46.84 94.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.171 0.51 . . . . 0.0 110.468 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -64.73 -30.83 71.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.317 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -74.97 -48.07 26.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.014 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -66.56 -42.94 86.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 -176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -90.78 -16.41 28.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.851 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.3 31.96 65.64 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.983 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.4 m -113.58 176.85 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.413 0.625 . . . . 0.0 111.205 -174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -117.87 131.19 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.891 167.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.562 ' CG2' HD11 ' A' ' 33' ' ' ILE . 81.7 mt -115.34 108.54 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.507 ' HA ' ' OE1' ' A' ' 45' ' ' GLN . 4.3 tp60 -123.73 131.67 53.65 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.571 ' CE2' HD11 ' A' ' 26' ' ' ILE . 78.7 m-85 -84.07 131.17 34.82 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.447 -174.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 50' ' ' ASP . 24.8 mtpp -70.46 109.81 5.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.183 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -89.63 22.45 3.03 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.489 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -120.55 -68.73 0.89 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.158 -177.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HB2' ' HE3' ' A' ' 47' ' ' LYS . 14.8 m-20 -84.88 107.4 17.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -103.52 126.4 8.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.602 175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.7 p -92.8 52.34 1.84 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.022 0.439 . . . . 0.0 111.444 -177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.81 -125.36 8.3 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.078 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.77 9.49 3.8 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.954 2.436 . . . . 0.0 112.49 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.575 ' HG3' ' HA ' ' A' ' 18' ' ' PRO . 1.6 mp0 -108.3 166.42 10.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.356 0.598 . . . . 0.0 110.873 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.731 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 30.3 mtpp -109.67 165.95 11.28 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 169.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 14' ' ' ASP . 47.6 mm -114.78 110.12 30.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.022 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.75 140.15 38.32 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -114.49 108.25 16.6 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.814 -0.755 . . . . 0.0 109.517 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.634 HG21 ' HB3' ' A' ' 70' ' ' ALA . 38.8 mt -88.46 127.94 41.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.5 mtm -141.54 167.01 23.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 111.357 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.13 -118.65 3.86 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.657 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 5.1 Cg_exo -80.4 135.92 10.9 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.999 2.466 . . . . 0.0 111.449 175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 50.5 Cg_exo -57.23 -36.05 98.98 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.478 2.785 . . . . 0.0 112.915 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.87 -36.62 70.16 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.078 0.942 . . . . 0.0 109.799 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.657 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 18.7 tpp85 -71.6 -31.91 67.45 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.897 -171.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.522 ' HB2' HG12 ' A' ' 13' ' ' ILE . 21.2 p -58.85 -41.85 87.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -68.46 -37.03 79.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.748 0.309 . . . . 0.0 111.059 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -61.56 -46.12 91.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.103 0.477 . . . . 0.0 109.901 176.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.634 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.54 -28.13 62.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.879 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.25 -42.11 85.67 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 72' ' ' ARG . 4.0 tmm_? -65.62 -45.41 83.22 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.976 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 36' ' ' ILE . 66.6 mt -55.06 -52.43 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.584 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 65.0 mt -67.88 -43.33 86.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.097 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -61.28 -48.84 79.57 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.972 0.415 . . . . 0.0 111.284 -178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -64.1 -32.43 74.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.765 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.7 tt -64.96 -49.78 68.97 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD21 HG23 ' A' ' 17' ' ' VAL . 88.7 mt -61.26 -35.07 76.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.055 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.639 ' HA ' ' HB3' ' A' ' 82' ' ' ARG . 62.9 tp60 -63.15 -23.02 67.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.328 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.4 t -67.72 -28.6 67.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.041 0.448 . . . . 0.0 110.078 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.694 HD11 HG21 ' A' ' 24' ' ' VAL . 85.8 mt -103.09 -5.7 23.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.306 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.639 ' HB3' ' HA ' ' A' ' 79' ' ' GLN . 41.5 ttm180 . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.783 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.444 -0.794 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.907 HD11 HD12 ' A' ' 60' ' ' ILE . 30.9 pt -128.31 160.38 38.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 120.813 0.34 . . . . 0.0 111.109 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 36.6 m-20 -116.86 110.17 18.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.128 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -110.82 128.81 24.72 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.004 -171.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.6 Cg_exo -71.44 99.06 0.89 Allowed 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.419 2.746 . . . . 0.0 111.933 176.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 17' ' ' VAL . 14.3 p -110.15 109.82 58.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 121.451 0.643 . . . . 0.0 110.677 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 50.0 Cg_exo -55.91 149.64 50.55 Favored 'Trans proline' 0 N--CA 1.474 0.379 0 C-N-CA 123.217 2.611 . . . . 0.0 113.425 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -68.18 -26.14 65.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.759 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -79.34 -22.88 43.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.328 0.585 . . . . 0.0 109.526 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 25' ' ' VAL . 14.8 m -86.44 -37.69 18.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.534 -176.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 25' ' ' VAL . 16.4 m -57.69 -27.17 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.9 -37.22 92.27 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 176.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.442 ' HB ' HD21 ' A' ' 77' ' ' LEU . 40.6 t -89.6 -31.61 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.812 0.339 . . . . 0.0 110.365 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 21' ' ' SER . 93.7 t -61.79 -38.63 80.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.168 0.509 . . . . 0.0 109.851 175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -82.08 -58.68 3.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.115 175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.6 -138.1 13.65 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.686 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.1 mtm180 -69.24 -77.94 0.07 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.379 . . . . 0.0 110.586 176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.459 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 66.1 m -93.79 -53.5 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.642 0.734 . . . . 0.0 109.567 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.654 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -174.29 20.54 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.362 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 1.6 mm-40 -47.05 -53.03 13.53 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.398 0.679 . . . . 0.0 111.827 -169.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.548 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.9 tpt -68.45 -45.16 73.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.116 -174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 HD11 HG22 ' A' ' 44' ' ' ILE . 8.3 tt -72.47 -29.77 32.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.812 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 28.2 mmmt -69.47 -40.67 76.95 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -61.58 -46.15 91.1 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.678 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 32' ' ' MET . 84.0 mt -60.71 -49.37 84.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.79 0.329 . . . . 0.0 110.659 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.02 -29.9 67.61 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.814 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -87.43 -35.69 18.14 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.653 0.264 . . . . 0.0 111.671 178.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -69.04 -40.98 78.24 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.242 0.544 . . . . 0.0 110.018 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -93.03 -23.91 18.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.226 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.94 47.55 9.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.227 -175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.5 m -127.4 177.55 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.097 0.475 . . . . 0.0 110.98 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 12.5 tpt180 -120.04 128.35 53.43 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.842 168.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.633 HD13 HD11 ' A' ' 74' ' ' ILE . 72.3 mt -125.92 112.59 30.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.964 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -137.92 138.78 39.34 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.125 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' ALA . 12.5 m-85 -85.5 121.0 27.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.574 -174.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.5 ' HB3' ' HZ3' ' A' ' 47' ' ' LYS . 8.0 mtpm? -66.71 108.16 2.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.012 0.434 . . . . 0.0 110.183 178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -71.81 -12.53 61.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.677 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -96.33 -6.04 38.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.622 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.65 81.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 178.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -118.58 117.04 3.56 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -84.73 -11.52 55.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.174 0.511 . . . . 0.0 110.989 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.11 -100.79 0.29 Allowed Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.42 -5.12 15.84 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.477 2.118 . . . . 0.0 111.352 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.9 mt-10 -128.75 145.81 51.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.631 -178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 56.0 mtpt -107.41 155.63 19.81 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.836 176.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 38.1 mm -98.51 104.69 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.682 176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.54 140.38 41.1 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.208 -0.905 . . . . 0.0 108.979 174.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -115.58 109.95 18.51 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.907 HD12 HD11 ' A' ' 13' ' ' ILE . 40.0 mt -93.49 146.66 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.713 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -145.33 166.87 24.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.945 0.402 . . . . 0.0 111.989 -172.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 122.91 -124.92 5.81 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -81.03 134.89 9.57 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.994 2.463 . . . . 0.0 110.75 174.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 74.6 Cg_exo -51.82 -42.92 54.93 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.617 2.878 . . . . 0.0 113.293 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -73.26 -39.94 65.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.7 tpp180 -61.7 -34.64 76.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.979 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 85.2 m -57.94 -42.9 85.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.458 177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -65.84 -41.58 91.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.048 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.407 ' O ' HG13 ' A' ' 73' ' ' ILE . 24.1 t60 -66.65 -38.75 87.53 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.558 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -66.95 -35.51 80.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.27 177.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -62.5 -36.86 83.85 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.441 174.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -67.79 -39.28 84.07 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.472 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.6 mt -59.93 -49.56 83.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.232 0.539 . . . . 0.0 110.438 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.633 HD11 HD13 ' A' ' 44' ' ' ILE . 84.5 mt -65.28 -45.27 94.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.781 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -63.73 -37.08 86.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.88 -178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -56.75 -43.42 80.73 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.404 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD21 ' HB ' ' A' ' 24' ' ' VAL . 9.8 tt -63.54 -43.2 97.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.932 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 21.2 mt -61.09 -44.13 97.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 110.113 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.605 ' OE1' ' HD2' ' A' ' 82' ' ' ARG . 7.1 tp60 -59.83 -40.96 90.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.569 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.5 m -64.3 -39.15 93.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.042 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 21' ' ' SER . 74.0 mt -68.55 -48.6 63.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.626 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.605 ' HD2' ' OE1' ' A' ' 79' ' ' GLN . 6.4 ptp180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.68 0.276 . . . . 0.0 111.287 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 111.344 -0.702 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.971 HD11 HD12 ' A' ' 60' ' ' ILE . 38.6 pt -138.65 163.45 27.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.062 0.458 . . . . 0.0 111.613 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -114.34 126.88 55.51 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.308 173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.691 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -131.04 117.05 16.97 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-O 121.004 0.43 . . . . 0.0 111.603 -176.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 17.2 Cg_exo -66.52 102.24 0.59 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 123.219 2.612 . . . . 0.0 112.298 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.6 p -103.65 117.91 58.75 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 52.3 Cg_exo -57.17 131.15 43.42 Favored 'Trans proline' 0 CA--C 1.528 0.192 0 C-N-CA 123.241 2.628 . . . . 0.0 112.371 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.8 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 76.6 mtt180 -66.29 -26.44 67.33 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.815 -174.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -80.51 -15.15 57.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.0 110.242 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.425 ' HB3' HD12 ' A' ' 81' ' ' LEU . 30.1 m -101.41 -14.82 17.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.435 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 18' ' ' PRO . 24.1 t -56.49 -38.57 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.451 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.93 -35.47 53.63 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.751 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 ' HB ' HD11 ' A' ' 81' ' ' LEU . 44.6 t -86.34 -36.18 10.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.662 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 21' ' ' SER . 60.0 t -62.32 -36.97 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 121.417 0.627 . . . . 0.0 109.904 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.476 HD11 ' CE1' ' A' ' 46' ' ' PHE . 35.9 mm -78.46 -58.45 4.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.614 176.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.87 63.5 1.67 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.291 -0.956 . . . . 0.0 111.889 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.2 mtt180 63.97 -87.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.492 0.717 . . . . 0.0 112.162 176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.55 ' HB2' ' OE1' ' A' ' 31' ' ' GLU . 75.4 m -84.03 -20.37 32.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.128 0.49 . . . . 0.0 110.339 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 119.9 4.59 11.4 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.615 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.55 ' OE1' ' HB2' ' A' ' 29' ' ' SER . 0.8 OUTLIER -63.03 -15.07 55.25 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.385 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 16.2 tpt -80.08 -45.36 18.42 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.595 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.717 HG13 HD12 ' A' ' 36' ' ' ILE . 8.0 tt -74.78 -21.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.192 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 31.7 mmtp -57.4 -49.65 75.53 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.153 -177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.717 HD12 HG13 ' A' ' 33' ' ' ILE . 35.6 mt -61.36 -58.29 8.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.625 0.726 . . . . 0.0 110.148 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -65.3 -23.78 67.12 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.133 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -79.55 -45.11 19.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.072 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.18 -53.46 24.8 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.238 0.542 . . . . 0.0 110.441 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HA ' HH11 ' A' ' 66' ' ' ARG . . . -77.41 -14.43 59.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.565 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.78 34.33 88.45 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.7 -0.762 . . . . 0.0 111.254 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -113.11 171.22 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.22 0.533 . . . . 0.0 110.725 -173.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.4 tpp180 -116.75 125.56 51.82 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.333 170.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.52 HG21 HD11 ' A' ' 33' ' ' ILE . 84.7 mt -110.83 114.0 45.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.34 176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -113.26 155.76 24.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.647 175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 82.0 m-85 -111.21 112.65 24.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.932 0.396 . . . . 0.0 110.97 -178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.474 ' HB3' ' OD1' ' A' ' 49' ' ' ASP . 9.1 mtpm? -77.7 87.01 3.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.366 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -74.68 -13.47 60.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.677 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.474 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 15.8 p-10 -71.16 -34.81 71.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.359 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -128.46 98.25 4.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.299 0.571 . . . . 0.0 110.73 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.36 130.06 9.96 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.503 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 55' ' ' GLU . 20.3 p -83.74 63.0 7.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.291 0.567 . . . . 0.0 110.829 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.9 -115.63 4.1 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.668 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -85.79 14.78 2.37 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.088 2.526 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.463 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 45.4 mt-10 -119.68 163.4 17.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.074 -178.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.8 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 57.3 mtpt -123.26 146.19 48.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.8 mm -91.64 107.37 18.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.33 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -77.38 140.62 39.96 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 174.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 22.2 t60 -118.16 109.68 16.68 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.971 HD12 HD11 ' A' ' 13' ' ' ILE . 46.8 mt -89.23 147.64 5.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.465 ' HB2' ' HB3' ' A' ' 43' ' ' ARG . 49.5 mtt -130.62 137.22 49.52 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.492 -171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.429 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 135.85 -134.95 7.51 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.264 177.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -81.29 139.92 11.92 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 123.554 2.836 . . . . 0.0 112.382 -176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.452 ' O ' ' HG3' ' A' ' 68' ' ' GLU . 76.7 Cg_exo -50.43 -50.09 14.59 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.242 1.961 . . . . 0.0 112.931 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -68.67 -40.1 80.3 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.983 0.421 . . . . 0.0 110.725 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.601 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 12.8 tpp180 -64.82 -40.36 95.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.329 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 84.2 m -59.58 -45.33 92.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.364 173.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 64' ' ' PRO . 45.0 mt-10 -63.0 -36.65 84.26 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.926 0.393 . . . . 0.0 111.204 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -68.94 -46.87 67.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.041 0.448 . . . . 0.0 109.812 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.19 -29.71 70.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.284 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.95 -41.81 98.4 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.674 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' A' ' 75' ' ' ASN . 58.9 ttt180 -76.53 -24.57 53.66 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.721 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.663 HG21 HG23 ' A' ' 36' ' ' ILE . 58.0 mt -57.47 -50.54 76.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.663 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 56.8 mt -68.93 -45.9 79.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.761 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 72' ' ' ARG . 62.0 t30 -60.73 -48.32 82.32 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.743 -176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 7.6 t70 -63.29 -35.31 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.745 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.6 tt -63.53 -44.43 94.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 91.4 mt -63.71 -38.13 89.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.732 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 18.8 pt20 -71.56 -25.21 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.542 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.2 m -68.26 -29.92 68.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.173 0.511 . . . . 0.0 110.088 177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.46 HD11 ' HB ' ' A' ' 24' ' ' VAL . 66.9 mt -87.48 -27.52 22.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.521 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.507 179.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.415 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.443 -0.854 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.823 HD11 HD12 ' A' ' 60' ' ' ILE . 38.4 pt -115.96 165.64 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.126 0.488 . . . . 0.0 111.065 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.584 ' HB2' ' CG2' ' A' ' 57' ' ' ILE . 6.3 p-10 -117.65 129.42 55.73 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.827 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.778 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -127.04 127.79 24.28 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 121.085 0.469 . . . . 0.0 111.973 -177.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.621 ' HB3' HG21 ' A' ' 52' ' ' THR . 7.1 Cg_exo -70.72 112.78 3.33 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.226 2.617 . . . . 0.0 111.897 177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.1 113.53 26.37 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-O 121.559 0.695 . . . . 0.0 110.47 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG23 ' A' ' 22' ' ' VAL . 46.9 Cg_exo -57.95 138.78 87.74 Favored 'Trans proline' 0 N--CA 1.471 0.164 0 C-N-CA 123.126 2.551 . . . . 0.0 112.013 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.503 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 71.3 mtp180 -62.9 -34.52 77.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.722 -175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -69.08 -26.28 64.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.199 0.523 . . . . 0.0 110.456 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.517 ' HB3' HD22 ' A' ' 78' ' ' LEU . 18.9 m -86.86 -28.83 22.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.267 178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 18' ' ' PRO . 45.7 t -55.28 -35.41 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.882 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.7 61.82 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.799 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG11 HD21 ' A' ' 81' ' ' LEU . 33.7 t -82.53 -38.7 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.717 0.294 . . . . 0.0 110.838 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 21' ' ' SER . 33.5 t -62.49 -37.8 79.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 121.398 0.618 . . . . 0.0 109.938 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE2' ' A' ' 46' ' ' PHE . 34.9 mm -79.49 -51.84 15.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.599 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.06 30.9 49.77 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.365 -175.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 72.04 -56.43 0.64 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.612 0.765 . . . . 0.0 112.393 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.0 m -78.03 -25.26 47.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.078 0.466 . . . . 0.0 111.002 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.674 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 100.13 -0.2 56.06 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -169.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -47.81 -49.59 28.55 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.691 0.796 . . . . 0.0 111.947 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 14.2 tpt -69.57 -41.45 75.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.73 0.3 . . . . 0.0 111.594 -174.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.4 tt -73.03 -27.43 24.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.487 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 30.0 mmmt -68.96 -35.31 76.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -60.93 -43.51 98.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.496 HG23 HG21 ' A' ' 73' ' ' ILE . 70.6 mt -62.34 -50.54 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.544 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -58.27 -34.49 70.57 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.593 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -78.21 -40.17 38.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.8 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.56 -47.25 64.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.069 0.461 . . . . 0.0 110.786 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.72 -16.11 40.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.339 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.0 44.67 54.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.519 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.4 m -125.14 176.96 5.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.402 0.62 . . . . 0.0 111.178 -173.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -120.78 129.99 53.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.46 169.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.629 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -123.79 107.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -126.8 139.45 53.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.855 176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.61 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 62.4 m-85 -84.1 133.2 34.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.416 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -71.96 142.06 49.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.061 176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -84.66 -16.63 41.22 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -106.99 89.3 2.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.865 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 21.2 m-20 -79.04 143.64 35.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.367 0.603 . . . . 0.0 110.735 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.587 ' H ' ' CG1' ' A' ' 57' ' ' ILE . . . -84.85 -19.77 59.02 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.222 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 16' ' ' PRO . 0.8 OUTLIER -97.78 -25.46 15.05 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 108.13 -105.31 2.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.903 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 24.0 Cg_exo -64.45 -43.12 14.65 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.72 2.28 . . . . 0.0 111.171 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -69.84 143.75 52.77 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.61 ' HE3' ' HB3' ' A' ' 46' ' ' PHE . 16.5 mtpp -90.09 161.96 15.55 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.881 0.372 . . . . 0.0 110.646 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' CG1' ' H ' ' A' ' 51' ' ' GLY . 34.8 mm -107.92 105.61 19.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-O 121.103 0.478 . . . . 0.0 110.133 173.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.778 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -73.23 127.75 33.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -103.79 101.92 11.74 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.394 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.823 HD12 HD11 ' A' ' 13' ' ' ILE . 41.2 mt -91.83 131.83 37.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.053 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.8 mtm -143.12 166.66 24.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.16 -122.09 4.95 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.6 Cg_exo -78.89 131.18 9.94 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.039 2.492 . . . . 0.0 110.896 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.4 Cg_exo -57.07 -36.97 99.43 Favored 'Trans proline' 0 N--CA 1.475 0.384 0 C-N-CA 123.344 2.696 . . . . 0.0 113.122 -176.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -75.39 -32.59 60.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.273 0.558 . . . . 0.0 110.134 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.423 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 11.4 tpp180 -66.23 -38.15 87.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.391 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.486 ' HB3' HG12 ' A' ' 13' ' ' ILE . 84.4 m -54.14 -40.1 67.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.276 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -66.11 -40.33 90.65 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.903 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' O ' HG13 ' A' ' 73' ' ' ILE . 11.9 t-80 -66.73 -43.1 85.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.189 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.68 -34.34 78.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -61.23 -43.79 98.31 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.535 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -64.78 -35.26 80.52 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.244 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.496 HG21 HG23 ' A' ' 36' ' ' ILE . 64.6 mt -62.25 -50.24 80.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.034 0.445 . . . . 0.0 110.208 177.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.629 HD11 HD13 ' A' ' 44' ' ' ILE . 68.6 mt -66.49 -46.62 86.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.962 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -70.19 -32.42 70.33 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -33.83 76.01 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.186 0.517 . . . . 0.0 109.957 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 8.4 tt -63.9 -44.62 92.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.517 HD22 ' HB3' ' A' ' 21' ' ' SER . 65.8 mt -61.8 -40.88 96.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.515 178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -61.14 -38.57 86.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.675 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.5 m -65.03 -29.78 70.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.694 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.699 HD21 HG11 ' A' ' 24' ' ' VAL . 85.8 mt -76.93 -54.01 7.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.415 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.215 -172.702 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.002 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.753 HD11 HD12 ' A' ' 60' ' ' ILE . 39.8 pt -109.46 150.16 12.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.111 0.481 . . . . 0.0 111.265 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -106.29 105.28 15.24 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.233 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.745 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -105.45 132.04 21.23 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -173.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 5.5 Cg_exo -72.78 112.92 3.61 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 123.289 2.659 . . . . 0.0 112.191 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG23 HD21 ' A' ' 78' ' ' LEU . 7.4 p -121.02 107.3 37.87 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.311 0.577 . . . . 0.0 110.428 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 22' ' ' VAL . 72.4 Cg_exo -48.53 133.45 26.06 Favored 'Trans proline' 0 N--CA 1.47 0.118 0 C-N-CA 123.505 2.803 . . . . 0.0 112.39 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.672 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 22.8 mtm180 -62.84 -28.32 69.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.693 -176.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -73.7 -32.14 63.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.156 0.503 . . . . 0.0 110.249 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 25' ' ' VAL . 30.6 m -79.99 -24.22 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.505 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 18' ' ' PRO . 62.3 t -54.97 -35.06 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.173 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.93 -28.07 65.49 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.418 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.61 -36.89 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.877 0.37 . . . . 0.0 110.556 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 21' ' ' SER . 38.3 t -67.91 -40.39 83.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.088 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.596 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.5 mm -82.32 -46.65 19.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.841 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.38 -118.74 4.87 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.041 -175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -97.96 -77.74 0.5 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.484 ' HB2' ' OE2' ' A' ' 31' ' ' GLU . 21.0 m -82.56 -55.63 4.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.74 0.781 . . . . 0.0 109.443 176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 175.18 32.21 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' OE2' ' HB2' ' A' ' 29' ' ' SER . 4.2 mm-40 -57.49 -47.49 81.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.261 -0.47 . . . . 0.0 111.724 -167.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.449 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.6 tpt -66.55 -45.88 77.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 44' ' ' ILE . 6.1 tt -69.0 -31.15 49.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.912 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 92.9 mttt -62.97 -42.35 99.8 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 173.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -66.6 -37.95 85.97 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.782 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 32' ' ' MET . 75.6 mt -63.16 -51.13 75.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.208 0.528 . . . . 0.0 110.233 176.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -59.0 -35.71 73.69 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.581 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -77.98 -32.98 51.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.187 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.94 -46.52 18.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.41 . . . . 0.0 110.837 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -81.69 -28.43 33.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.465 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.31 39.03 8.61 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 HG11 ' HB2' ' A' ' 70' ' ' ALA . 33.4 m -122.47 175.72 5.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.381 0.61 . . . . 0.0 111.517 -174.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -116.43 127.0 54.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.863 169.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.706 HD13 HD11 ' A' ' 74' ' ' ILE . 45.7 mt -125.54 108.61 20.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.43 154.18 27.41 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.482 ' HE2' HG22 ' A' ' 22' ' ' VAL . 4.4 m-85 -100.78 120.68 40.46 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.213 0.53 . . . . 0.0 112.055 -174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -87.46 130.12 34.8 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.831 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -65.37 -21.28 66.66 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -59.59 109.93 1.01 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.37 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 4.3 p30 -81.69 140.81 34.12 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.93 -3.44 54.84 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.618 -170.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 t -160.64 12.67 0.11 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.913 0.356 . . . . 0.0 111.387 -177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -93.36 0.68 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.768 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.68 -11.03 14.24 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.576 2.184 . . . . 0.0 112.753 -175.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.9 mt-10 -107.27 124.71 50.16 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.71 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.672 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 44.8 mtpt -78.24 177.78 8.14 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.665 177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.1 mm -115.24 113.77 44.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.426 0.631 . . . . 0.0 111.174 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.745 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -84.79 140.6 31.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 171.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -110.83 101.51 10.11 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.863 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.753 HD12 HD11 ' A' ' 13' ' ' ILE . 21.5 mt -91.24 137.37 21.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.1 mtm -142.82 163.33 33.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 111.823 -172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 124.04 -135.53 9.75 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.61 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 7.7 Cg_exo -69.27 150.86 71.67 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.675 2.25 . . . . 0.0 111.692 177.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -63.08 -48.85 5.69 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.538 2.159 . . . . 0.0 112.742 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.57 -34.79 77.76 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.429 0.633 . . . . 0.0 109.431 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.635 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.8 tpp180 -61.82 -38.95 90.05 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.587 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 76.9 m -58.95 -47.99 83.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.228 177.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -69.53 -34.99 75.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.678 0.275 . . . . 0.0 110.823 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -62.68 -46.35 88.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.086 0.469 . . . . 0.0 110.169 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -71.06 -35.72 72.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.891 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.534 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.42 -36.9 79.26 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.824 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 72' ' ' ARG . 11.5 ttm180 -66.08 -43.04 88.52 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.187 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.3 mt -56.68 -49.49 77.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.613 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 44' ' ' ILE . 77.0 mt -68.93 -46.24 79.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.28 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -63.01 -43.67 98.1 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.16 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.25 -34.0 77.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.275 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.9 tp -64.88 -45.64 85.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.032 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 80.4 mt -61.02 -34.72 75.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.769 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -63.25 -35.2 79.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.9 m -71.8 -14.96 62.13 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.039 0.447 . . . . 0.0 110.798 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.4 mt -96.59 -34.96 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.329 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 27.5 ptt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.019 0.437 . . . . 0.0 111.005 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.85 HD11 HD12 ' A' ' 60' ' ' ILE . 38.1 pt -124.35 160.23 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.905 0.383 . . . . 0.0 111.293 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.51 105.34 12.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.128 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.767 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.81 130.29 23.0 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -174.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 2.8 Cg_exo -75.06 104.15 1.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.372 2.715 . . . . 0.0 112.259 177.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.523 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -112.83 113.02 50.21 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 121.367 0.603 . . . . 0.0 110.214 177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -52.36 134.57 51.94 Favored 'Trans proline' 0 CA--C 1.528 0.195 0 C-N-CA 123.096 2.531 . . . . 0.0 112.042 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -61.04 -33.14 72.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.035 -174.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -73.35 -22.87 60.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 109.798 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' HG23 ' A' ' 25' ' ' VAL . 17.9 m -87.03 -25.74 24.08 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.037 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.3 -32.28 40.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.616 176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.44 -33.73 62.52 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.213 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.6 t -89.71 -34.36 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.62 0.248 . . . . 0.0 110.644 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 21' ' ' SER . 95.6 t -64.52 -38.55 82.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.217 0.532 . . . . 0.0 110.214 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 46' ' ' PHE . 42.8 mm -79.83 -54.76 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.205 176.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.579 ' O ' ' HD2' ' A' ' 28' ' ' ARG . . . 105.04 -128.52 9.47 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 15.0 mmm180 -125.76 -29.7 3.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.064 0.459 . . . . 0.0 110.186 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.5 m -114.32 3.72 15.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.853 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 10.44 84.04 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -174.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -63.89 -32.53 74.09 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 122.841 0.456 . . . . 0.0 111.4 -172.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -70.81 -45.35 64.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.547 HD11 ' CG2' ' A' ' 44' ' ' ILE . 7.9 tt -72.2 -28.72 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.188 -178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -67.22 -36.53 81.87 Favored 'General case' 0 C--O 1.224 -0.25 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 174.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -65.01 -44.21 89.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.239 176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.526 HG23 HG21 ' A' ' 73' ' ' ILE . 78.9 mt -58.11 -52.09 62.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.231 0.539 . . . . 0.0 110.523 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -62.84 -33.68 75.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.411 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -71.29 -44.1 65.85 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.32 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.85 -53.15 29.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.863 0.364 . . . . 0.0 111.409 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.592 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -77.53 -27.08 51.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.804 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.89 42.22 9.91 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 70' ' ' ALA . 20.4 m -125.79 174.34 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.074 -174.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 6.6 tpp180 -116.91 131.86 56.85 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.169 167.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 33' ' ' ILE . 80.4 mt -111.35 108.64 26.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -118.23 117.1 28.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.694 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' CE1' HD11 ' A' ' 26' ' ' ILE . 96.9 m-85 -72.66 126.04 28.94 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -75.94 -175.27 2.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.895 -175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -81.06 166.27 20.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.76 -176.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.7 38.39 1.97 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.33 1.019 . . . . 0.0 112.233 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 17.8 m-20 69.69 -70.32 0.15 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.88 -178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.805 ' HA3' HG12 ' A' ' 57' ' ' ILE . . . 152.49 -65.29 0.35 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.046 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.812 HG23 ' HB2' ' A' ' 55' ' ' GLU . 3.0 t -150.78 72.19 1.07 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.886 0.85 . . . . 0.0 111.097 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.56 -116.77 4.77 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.354 176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.86 -4.11 12.61 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.894 2.396 . . . . 0.0 111.879 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.812 ' HB2' HG23 ' A' ' 52' ' ' THR . 44.2 mt-10 -108.48 129.37 55.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 46.3 mttp -86.87 149.37 24.87 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.805 HG12 ' HA3' ' A' ' 51' ' ' GLY . 40.9 mm -95.96 108.37 21.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.418 0.627 . . . . 0.0 110.115 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.767 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -76.58 123.61 26.34 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.597 174.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 7.7 t-160 -98.52 101.29 12.68 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.85 HD12 HD11 ' A' ' 13' ' ' ILE . 47.0 mt -89.07 136.09 24.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -143.52 164.37 30.55 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.356 -0.538 . . . . 0.0 112.058 -168.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 121.11 -115.81 2.98 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 2.7 Cg_endo -85.53 126.69 3.11 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.263 2.642 . . . . 0.0 110.212 172.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 52.8 Cg_exo -56.02 -35.44 94.63 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.474 2.783 . . . . 0.0 113.408 -174.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.38 -33.06 32.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.001 0.429 . . . . 0.0 110.175 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 1.4 tpp180 -65.78 -28.73 69.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.381 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.469 ' HB3' HG12 ' A' ' 13' ' ' ILE . 82.9 m -59.63 -30.09 68.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -76.48 -32.21 58.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.019 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.486 ' O ' HG13 ' A' ' 73' ' ' ILE . 7.3 t60 -64.27 -42.8 96.29 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.21 -33.77 73.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.215 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.22 98.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.545 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -61.5 -46.25 90.81 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.575 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.526 HG21 HG23 ' A' ' 36' ' ' ILE . 67.1 mt -55.0 -51.42 53.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.732 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.648 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 75.6 mt -66.76 -48.21 80.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.791 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -59.84 -46.57 88.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.192 0.52 . . . . 0.0 111.611 -176.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -61.72 -36.1 79.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.544 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.0 tp -68.76 -40.73 79.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 77.3 mt -64.05 -32.54 74.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.338 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -58.17 -38.92 77.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.365 -177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 -30.09 70.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.184 0.516 . . . . 0.0 110.758 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.01 -29.45 17.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.02 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.917 -178.268 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.617 HD11 HD12 ' A' ' 60' ' ' ILE . 45.8 pt -119.43 155.39 21.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.69 0.757 . . . . 0.0 112.419 -174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 7.1 m-20 -123.44 112.46 17.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.0 108.334 174.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -107.03 129.0 24.98 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.383 -171.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' LYS . 18.4 Cg_endo -79.52 106.89 2.07 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.42 2.08 . . . . 0.0 111.52 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 56' ' ' LYS . 7.6 p -113.81 113.23 47.42 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.419 -176.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.4 ' O ' HG23 ' A' ' 22' ' ' VAL . 76.2 Cg_exo -52.14 134.11 49.08 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.335 2.69 . . . . 0.0 112.522 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 97.7 mtt180 -58.73 -35.09 72.14 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.447 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -80.71 -6.08 57.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.698 0.285 . . . . 0.0 111.207 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -107.11 -16.9 14.31 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.494 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.4 t -57.0 -38.28 59.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.194 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.47 -31.25 57.0 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.006 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.6 t -85.08 -39.15 13.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.368 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 77' ' ' LEU . 42.5 t -63.68 -37.19 79.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-O 121.35 0.595 . . . . 0.0 110.108 178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.599 HD11 ' CE1' ' A' ' 46' ' ' PHE . 40.4 mm -79.61 -50.95 17.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.853 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.79 -147.87 19.18 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -83.09 -70.77 0.53 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.418 0.609 . . . . 0.0 110.471 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.9 m -96.76 26.22 4.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.53 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 26' ' ' ILE . . . 78.81 7.81 88.09 Favored Glycine 0 C--O 1.227 -0.311 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.476 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 31' ' ' GLU . 18.4 mt-10 -54.54 -34.6 62.09 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.603 0.761 . . . . 0.0 112.538 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 36' ' ' ILE . 15.2 tpt -74.47 -50.63 17.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.72 -175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' CG2' ' A' ' 44' ' ' ILE . 9.9 tt -69.09 -27.41 35.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.964 0.412 . . . . 0.0 110.363 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -68.25 -40.14 82.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.045 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -59.6 -42.51 92.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.239 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.45 HG23 HG21 ' A' ' 73' ' ' ILE . 67.6 mt -63.87 -54.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.819 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.26 -39.02 81.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.036 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -81.87 -26.21 34.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.439 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -73.5 -49.77 24.93 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.345 0.593 . . . . 0.0 109.78 176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB1' ' HD2' ' A' ' 66' ' ' ARG . . . -84.16 -9.86 58.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.748 -175.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.66 31.98 80.08 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.255 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.77 172.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.103 0.478 . . . . 0.0 110.719 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.9 ttm180 -117.75 129.18 55.54 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 169.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 60' ' ' ILE . 68.7 mt -119.53 108.93 24.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.875 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -119.16 131.85 55.91 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.94 0.4 . . . . 0.0 110.552 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.599 ' CE1' HD11 ' A' ' 26' ' ' ILE . 85.8 m-85 -81.17 115.06 20.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.948 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HB3' ' NZ ' ' A' ' 47' ' ' LYS . 8.6 mtpm? -62.98 131.21 47.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.212 177.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -76.57 46.58 0.45 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.638 0.733 . . . . 0.0 109.176 173.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -171.98 97.3 0.17 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.699 -1.137 . . . . 0.0 108.316 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 17.4 m-20 -77.68 128.15 33.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.297 -176.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 57' ' ' ILE . . . -83.99 -13.64 74.18 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.908 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.3 m -107.89 -52.81 2.71 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.002 0.429 . . . . 0.0 110.633 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.24 -82.63 0.29 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 15.0 Cg_exo -69.95 -26.92 26.18 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.873 2.382 . . . . 0.0 110.731 171.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -100.02 132.82 45.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.091 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 22.3 mtpp -81.99 174.75 10.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.562 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.543 HG12 ' H ' ' A' ' 51' ' ' GLY . 48.4 mm -120.96 111.11 30.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.117 0.485 . . . . 0.0 110.227 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -82.2 125.18 30.62 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 171.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -102.56 102.96 13.26 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.375 -177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.647 HG12 HG12 ' A' ' 44' ' ' ILE . 47.0 mt -92.86 144.91 8.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.603 -177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 50.2 mtm -145.16 174.93 10.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.888 0.375 . . . . 0.0 111.935 -172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 112.7 -125.54 7.12 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.097 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.493 ' CG ' ' HB3' ' A' ' 66' ' ' ARG . 5.8 Cg_exo -82.89 134.12 7.06 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.232 2.621 . . . . 0.0 111.689 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 56.4 Cg_exo -53.56 -34.61 73.61 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.818 3.012 . . . . 0.0 113.586 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.59 -42.58 24.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.659 0.743 . . . . 0.0 109.759 177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.547 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 18.5 tpp85 -67.57 -34.29 76.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.814 -176.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.5 p -61.86 -40.48 95.5 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.026 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -68.26 -34.25 75.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.375 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.511 ' O ' HG13 ' A' ' 73' ' ' ILE . 9.3 t60 -63.7 -44.78 92.64 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -64.01 -36.3 83.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.444 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.14 -38.03 87.46 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.787 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -69.69 -35.82 75.43 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.524 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 69' ' ' HIS . 66.2 mt -60.52 -49.01 86.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 121.23 0.538 . . . . 0.0 109.79 176.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 HD13 ' A' ' 44' ' ' ILE . 87.4 mt -64.28 -40.94 90.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.793 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -67.65 -37.77 82.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.944 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 15.7 t70 -60.87 -36.27 78.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.428 0.633 . . . . 0.0 110.012 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 25' ' ' VAL . 9.7 tt -66.83 -44.15 81.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.685 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 81.0 mt -67.57 -39.72 84.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.669 -177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.5 pt20 -65.78 -20.13 66.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.937 0.398 . . . . 0.0 110.734 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.5 m -80.06 -23.95 41.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.143 0.496 . . . . 0.0 110.394 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.4 mt -93.25 -49.74 5.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.193 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 11.4 ptm180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.266 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 61' ' ' MET . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 113.517 0.167 . . . . 0.0 113.517 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.682 HD11 HD12 ' A' ' 60' ' ' ILE . 42.0 pt -118.81 166.8 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 176.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' CG2' ' A' ' 57' ' ' ILE . 22.2 m-20 -122.57 114.18 20.29 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.099 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.835 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -113.04 126.23 28.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.177 -175.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 15.0 Cg_exo -67.15 116.45 4.18 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.908 2.405 . . . . 0.0 111.965 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.627 HG23 HD21 ' A' ' 78' ' ' LEU . 7.6 p -123.64 108.98 30.73 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 121.506 0.669 . . . . 0.0 110.807 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 75.9 Cg_exo -50.96 131.86 35.97 Favored 'Trans proline' 0 CA--C 1.527 0.148 0 C-N-CA 123.192 2.595 . . . . 0.0 112.054 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 48.2 mtp85 -58.22 -32.5 68.36 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.716 -177.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.004 0.43 . . . . 0.0 110.535 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB3' HD12 ' A' ' 81' ' ' LEU . 17.9 m -88.42 -23.28 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.9 -35.09 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.934 177.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.51 -32.7 65.04 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.604 177.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 32.2 t -87.39 -36.93 10.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.69 0.281 . . . . 0.0 110.447 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 77' ' ' LEU . 48.2 t -65.34 -37.02 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 121.289 0.566 . . . . 0.0 110.444 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.508 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.8 mm -81.51 -61.24 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.174 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.12 -152.1 18.46 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.641 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.03 -37.49 9.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.246 0.546 . . . . 0.0 109.957 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 m -106.23 3.06 27.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.024 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.545 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 74.59 24.59 72.24 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -168.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -39.16 90.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.488 -0.856 . . . . 0.0 111.909 -174.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.6 tpt -72.77 -42.25 64.17 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.03 -174.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG22 ' O ' ' A' ' 30' ' ' GLY . 5.7 tt -66.27 -30.83 51.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.177 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 48.7 mttp -69.61 -45.99 67.3 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 174.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -54.16 -45.55 72.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 32' ' ' MET . 62.2 mt -65.39 -48.97 81.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.737 0.304 . . . . 0.0 110.921 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.498 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 46.1 mt-30 -59.77 -33.69 72.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.444 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -79.55 -42.96 23.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.251 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -67.18 -37.1 83.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.942 0.401 . . . . 0.0 110.897 -174.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.46 -14.91 19.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.532 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.32 47.16 53.49 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.499 -175.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 37' ' ' GLN . 31.5 m -124.77 176.23 6.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.163 0.506 . . . . 0.0 111.283 -174.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.498 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 19.0 tpt180 -116.57 128.91 55.85 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.247 168.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -113.28 108.79 26.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -122.78 129.87 52.24 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE1' HD11 ' A' ' 26' ' ' ILE . 38.0 m-85 -85.11 123.7 30.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.085 0.469 . . . . 0.0 111.456 -174.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 15.1 mttp -66.99 144.87 55.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.592 177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -95.99 5.42 51.22 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -107.58 75.04 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.985 175.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 56' ' ' LYS . 59.6 m-20 -68.07 121.41 16.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.076 0.465 . . . . 0.0 110.415 -175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -65.46 -31.43 80.23 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.028 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -119.21 -42.39 2.68 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.913 0.357 . . . . 0.0 111.434 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.25 -78.81 0.38 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.312 178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.423 ' HG2' ' OE1' ' A' ' 55' ' ' GLU . 11.3 Cg_endo -58.84 -27.77 85.14 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.747 2.298 . . . . 0.0 111.211 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 52' ' ' THR . 13.9 mp0 -106.38 130.04 54.27 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.483 171.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.458 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 23.6 mtpp -83.49 178.66 7.91 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.09 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 14' ' ' ASP . 50.2 mm -117.45 114.04 44.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.342 173.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.835 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -82.45 130.37 35.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 13.2 t-160 -104.42 101.46 11.15 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.682 HD12 HD11 ' A' ' 13' ' ' ILE . 48.9 mt -88.71 132.41 33.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.427 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 70.9 mtm -143.21 160.07 41.15 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.297 0.57 . . . . 0.0 111.754 -170.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.23 -119.48 2.65 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -175.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.6 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -82.04 131.0 6.72 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.675 2.25 . . . . 0.0 110.499 172.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 40.8 Cg_exo -57.23 -28.93 81.8 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.254 2.636 . . . . 0.0 112.863 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.04 -40.05 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 110.075 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 7.4 tpp180 -60.59 -35.49 76.22 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.82 179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.478 ' HB3' HG12 ' A' ' 13' ' ' ILE . 85.7 m -56.6 -33.91 66.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.8 178.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.69 -43.48 72.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.935 0.398 . . . . 0.0 111.097 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -69.19 -39.83 78.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.0 0.429 . . . . 0.0 109.944 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -67.7 -30.94 70.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.424 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.432 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -58.95 -41.3 87.09 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.337 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -65.47 -42.47 92.23 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.916 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.3 mt -54.89 -50.64 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.292 0.568 . . . . 0.0 110.395 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.669 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.0 mt -69.73 -51.01 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.148 -178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -62.54 -41.48 98.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.866 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.44 -35.79 82.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.987 0.423 . . . . 0.0 110.22 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 59.0 tp -63.84 -47.61 80.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 173.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 79.3 mt -57.82 -46.84 84.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.646 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -64.31 -27.7 69.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.795 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.1 t -80.25 -15.63 56.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.026 0.441 . . . . 0.0 110.466 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 77' ' ' LEU . 67.2 mt -95.27 -21.11 18.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.126 0.489 . . . . 0.0 110.42 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.525 179.504 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.448 -0.503 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.792 HD11 HD12 ' A' ' 60' ' ' ILE . 41.6 pt -124.99 155.98 33.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.055 0.455 . . . . 0.0 111.409 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -98.57 124.71 43.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.457 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 t -123.15 121.76 27.03 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 120.61 0.243 . . . . 0.0 111.336 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.1 Cg_exo -70.74 104.37 1.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.906 2.404 . . . . 0.0 111.928 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG11 ' CE2' ' A' ' 46' ' ' PHE . 7.7 p -118.09 105.88 46.25 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.385 0.612 . . . . 0.0 110.644 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 85.3 Cg_exo -46.82 133.53 17.49 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.447 2.765 . . . . 0.0 112.604 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.677 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 38.4 mtt180 -60.4 -29.48 69.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.283 -175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -83.18 -13.13 56.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.975 0.417 . . . . 0.0 110.852 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' HG23 ' A' ' 25' ' ' VAL . 18.9 m -99.61 -14.52 18.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.785 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.579 HG21 ' HD3' ' A' ' 56' ' ' LYS . 28.0 t -57.78 -38.55 66.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.133 178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.04 -24.57 60.87 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.451 178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.9 -42.04 14.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 110.226 -0.286 . . . . 0.0 110.226 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 21' ' ' SER . 60.5 t -61.89 -37.24 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.394 0.616 . . . . 0.0 109.877 178.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 46' ' ' PHE . 47.0 mm -79.66 -51.7 16.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.616 175.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.4 44.24 11.44 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.876 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 65.6 -73.14 0.07 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.457 0.703 . . . . 0.0 111.828 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.5 m -75.98 -16.55 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.701 0.286 . . . . 0.0 111.73 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 97.15 2.02 59.34 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 -173.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.53 -32.88 69.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.094 -0.553 . . . . 0.0 111.751 -174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.432 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.1 tpt -74.48 -43.0 58.05 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.949 -177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.552 HD11 ' HB ' ' A' ' 44' ' ' ILE . 13.0 tt -69.32 -31.34 49.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 7.2 mmpt? -65.26 -36.11 83.11 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.69 174.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 32' ' ' MET . 28.1 tptp -62.59 -51.02 68.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.259 177.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.451 HG23 HG21 ' A' ' 73' ' ' ILE . 73.4 mt -60.69 -50.26 81.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.83 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -62.5 -33.08 74.16 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.064 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.41 -32.24 60.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.989 0.423 . . . . 0.0 110.456 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.28 -46.84 38.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.053 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -89.12 -28.44 20.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.844 -178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.58 40.17 7.9 Favored Glycine 0 CA--C 1.517 0.167 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.773 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 28.8 m -121.93 176.81 4.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.881 0.372 . . . . 0.0 111.194 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -118.58 131.98 56.2 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 164.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 33' ' ' ILE . 85.0 mt -111.92 109.01 26.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.463 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.564 ' HB3' ' CE1' ' A' ' 59' ' ' HIS . 15.7 tm0? -121.71 120.85 35.89 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 26' ' ' ILE . 80.4 m-85 -74.02 116.4 14.6 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -60.32 127.56 32.37 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -70.67 -13.82 62.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.041 0.448 . . . . 0.0 110.788 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -117.55 -158.12 0.69 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 173.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' HG12 ' A' ' 57' ' ' ILE . 1.4 m-20 59.43 47.82 10.64 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.251 0.548 . . . . 0.0 111.309 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.08 84.75 1.59 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.178 -1.011 . . . . 0.0 111.456 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.5 p -74.33 91.74 2.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.114 0.483 . . . . 0.0 111.522 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.6 -132.34 47.2 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.266 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.63 8.11 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.628 2.218 . . . . 0.0 112.284 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -121.27 138.98 53.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.145 0.498 . . . . 0.0 111.035 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.677 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 26.9 mtpp -88.18 177.34 6.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 172.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 50.1 mm -120.91 107.69 21.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.618 173.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -79.55 140.08 37.32 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 170.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 45' ' ' GLN . 3.2 p-80 -118.91 112.46 19.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.121 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.792 HD12 HD11 ' A' ' 13' ' ' ILE . 22.2 mt -92.17 148.77 4.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.623 -173.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 mtm -142.92 175.23 9.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 111.86 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.66 -137.37 14.19 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.032 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.625 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 11.2 Cg_exo -67.13 148.31 80.79 Favored 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 122.72 2.28 . . . . 0.0 111.472 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 37.0 Cg_exo -60.11 -48.3 12.52 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.502 2.135 . . . . 0.0 112.484 -178.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.75 -32.69 74.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.462 0.649 . . . . 0.0 109.739 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' HB2' ' HB2' ' A' ' 63' ' ' PRO . 5.7 tpp85 -64.96 -37.21 86.91 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.715 -178.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.2 m -59.87 -48.53 81.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.11 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -71.67 -33.43 68.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.855 0.359 . . . . 0.0 111.27 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.45 ' O ' HG13 ' A' ' 73' ' ' ILE . 3.5 t-160 -61.1 -49.75 76.04 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -68.6 -31.92 71.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.045 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.71 -45.43 92.19 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.633 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -64.85 -34.78 79.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 HG21 HG23 ' A' ' 36' ' ' ILE . 69.6 mt -62.76 -51.27 74.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.024 0.44 . . . . 0.0 110.698 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.653 HD12 HD11 ' A' ' 60' ' ' ILE . 53.7 mt -66.06 -43.88 92.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.641 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.92 -36.42 83.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.615 -178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.56 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 16.5 t70 -59.45 -38.21 80.15 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.5 176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.6 tp -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.276 0.56 . . . . 0.0 110.231 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.61 HD23 HD12 ' A' ' 81' ' ' LEU . 82.9 mt -70.13 -26.14 63.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.725 -173.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.0 pt20 -64.04 -25.86 68.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.858 0.361 . . . . 0.0 111.089 -177.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.2 t -87.56 -35.66 18.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.039 0.447 . . . . 0.0 110.171 175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.61 HD12 HD23 ' A' ' 78' ' ' LEU . 79.4 mt -73.23 -6.57 46.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.81 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 82' ' ' ARG . 10.6 ptp180 . . . . . 0 C--N 1.326 -0.44 0 CA-C-O 121.125 0.488 . . . . 0.0 110.256 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 60' ' ' ILE . . . . . . . . 0 N--CA 1.442 -0.93 0 N-CA-C 112.073 -0.411 . . . . 0.0 112.073 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.785 HD11 HD12 ' A' ' 60' ' ' ILE . 32.7 pt -129.22 166.55 26.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.813 0.339 . . . . 0.0 111.261 -176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -121.6 105.92 10.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.526 175.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.762 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -104.25 131.76 21.62 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 9.9 Cg_exo -70.2 108.28 2.13 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 123.546 2.831 . . . . 0.0 111.968 176.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.561 HG11 ' HE1' ' A' ' 46' ' ' PHE . 7.8 p -113.97 113.38 46.91 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.984 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.67 128.34 25.89 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.417 2.078 . . . . 0.0 111.253 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -62.5 -22.55 66.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.834 -173.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.18 -27.76 42.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 175.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' HG23 ' A' ' 25' ' ' VAL . 16.5 m -83.33 -23.41 32.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.471 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.51 -35.49 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.608 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.36 -29.98 64.05 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.469 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.2 t -88.93 -35.25 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.748 0.309 . . . . 0.0 110.442 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 21' ' ' SER . 47.8 t -66.84 -39.13 82.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 121.317 0.58 . . . . 0.0 109.923 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.584 HD11 ' CE2' ' A' ' 46' ' ' PHE . 37.2 mm -79.52 -45.18 23.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.965 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.08 -86.02 1.29 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.138 177.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -133.94 -72.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.304 0.242 . . . . 0.0 110.368 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -109.38 44.52 1.16 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.012 0.434 . . . . 0.0 110.262 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.633 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 64.11 23.69 68.11 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -60.65 -43.85 97.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.389 -0.906 . . . . 0.0 111.364 -168.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 16.3 tpt -77.42 -34.14 54.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.021 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 44' ' ' ILE . 9.0 tt -78.1 -23.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.843 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 73.3 mmtt -63.25 -36.52 83.94 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 32' ' ' MET . 17.8 tppt? -63.24 -44.29 95.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.486 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.97 -52.14 60.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.466 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.571 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 44.6 mt-30 -61.86 -27.6 68.9 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.352 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.8 t30 -75.34 -49.37 19.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.921 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -68.96 -43.45 74.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.966 0.412 . . . . 0.0 111.35 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.83 -17.72 34.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.555 -177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.95 32.75 66.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.763 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.4 ' CG1' ' HG3' ' A' ' 66' ' ' ARG . 32.8 m -113.75 -179.52 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.443 0.639 . . . . 0.0 111.533 -173.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.571 ' HD2' ' OE1' ' A' ' 37' ' ' GLN . 31.4 tpt180 -123.05 135.25 54.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.951 169.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.6 HG21 HD11 ' A' ' 33' ' ' ILE . 89.7 mt -116.54 109.09 26.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.016 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.813 ' HB2' ' HB3' ' A' ' 59' ' ' HIS . 12.8 mm100 -97.05 107.74 20.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.752 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CE2' HD11 ' A' ' 26' ' ' ILE . 27.2 m-85 -73.43 111.28 8.41 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.103 0.478 . . . . 0.0 109.765 174.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 49' ' ' ASP . 29.2 mtmt -96.03 138.61 33.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.326 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -98.38 -7.11 29.37 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 161.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.614 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 33.4 t70 -51.63 -45.44 63.28 Favored 'General case' 0 C--O 1.228 -0.071 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.526 174.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -123.37 127.27 48.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.819 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.27 115.54 0.71 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 p -85.91 3.2 42.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.929 0.395 . . . . 0.0 111.532 -175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 117.73 -88.61 0.46 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.825 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.418 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 6.7 Cg_exo -75.35 -20.91 15.74 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 123.006 2.471 . . . . 0.0 112.027 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -115.91 139.27 50.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.489 0.661 . . . . 0.0 111.288 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HB3' HG13 ' A' ' 17' ' ' VAL . 47.5 tttp -100.07 170.65 8.34 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.312 178.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.6 mm -113.98 117.97 57.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.307 0.575 . . . . 0.0 111.218 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -87.53 133.53 33.76 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 172.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.813 ' HB3' ' HB2' ' A' ' 45' ' ' GLN . 27.6 t60 -111.69 101.98 10.31 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.332 -177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.785 HD12 HD11 ' A' ' 13' ' ' ILE . 31.6 mt -89.23 139.97 16.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.049 -177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.8 mtm -139.82 156.42 46.74 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.072 0.463 . . . . 0.0 111.796 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 131.61 -126.05 4.57 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.255 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.612 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 3.0 Cg_exo -78.57 137.59 14.69 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.245 2.63 . . . . 0.0 111.604 174.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 77.4 Cg_exo -51.84 -49.28 17.78 Favored 'Trans proline' 0 N--CA 1.474 0.329 0 C-N-CA 122.717 2.278 . . . . 0.0 113.083 -177.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.52 -38.79 84.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.175 0.512 . . . . 0.0 110.533 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.612 ' HB3' ' HD2' ' A' ' 63' ' ' PRO . 23.9 tpp180 -63.95 -29.22 70.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.733 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 81.0 m -62.57 -46.47 88.18 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.69 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.0 110.274 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.49 -43.68 96.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.251 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.85 -32.68 65.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.583 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -59.32 -42.48 91.53 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.58 0.705 . . . . 0.0 109.361 176.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -62.83 -42.28 99.67 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.48 -1.237 . . . . 0.0 110.73 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.5 mt -57.69 -52.11 61.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.152 0.501 . . . . 0.0 110.529 178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.641 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 62.7 mt -64.73 -50.64 74.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.093 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -67.1 -32.42 73.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.458 -175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.524 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 21.8 t70 -65.23 -31.67 72.95 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.042 0.449 . . . . 0.0 110.261 176.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tt -73.85 -42.22 61.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.563 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 83.8 mt -62.6 -34.59 77.33 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.241 -175.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 29.7 pt20 -61.38 -19.92 62.44 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.1 t -87.24 -19.86 27.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.571 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.6 mt -104.41 -25.56 12.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.858 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -177.569 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.692 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.901 HD11 HD12 ' A' ' 60' ' ' ILE . 39.6 pt -120.75 162.2 19.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.761 0.315 . . . . 0.0 111.134 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -111.54 123.44 50.23 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -122.52 123.86 26.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.33 -173.516 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 13.8 Cg_exo -68.47 105.37 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.734 2.289 . . . . 0.0 111.801 175.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.512 HG23 HD21 ' A' ' 78' ' ' LEU . 7.7 p -117.17 110.02 41.83 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.363 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 78' ' ' LEU . 77.0 Cg_exo -47.46 129.99 17.21 Favored 'Trans proline' 0 CA--C 1.522 -0.11 0 C-N-CA 123.232 2.621 . . . . 0.0 112.129 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -62.96 -28.17 69.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.845 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -75.92 -24.8 55.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.035 0.445 . . . . 0.0 110.467 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -92.16 -14.78 28.57 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.996 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 44.7 t -57.87 -33.86 46.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.697 177.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.53 -26.41 68.23 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.618 177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG21 HD11 ' A' ' 81' ' ' LEU . 38.4 t -83.82 -43.8 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 109.977 177.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.7 t -62.78 -41.35 92.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.633 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.523 HD11 ' CE1' ' A' ' 46' ' ' PHE . 46.7 mm -79.96 -67.1 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.708 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' O ' HG22 ' A' ' 26' ' ' ILE . . . 75.76 -169.9 54.7 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.077 -175.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -64.84 117.34 7.4 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 122.711 -0.288 . . . . 0.0 110.557 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m 62.53 16.36 8.68 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.677 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . 71.84 26.5 72.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.166 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -57.26 -39.48 75.73 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.709 0.29 . . . . 0.0 111.654 -177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.2 tpt -70.76 -39.3 73.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.981 0.419 . . . . 0.0 110.555 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.558 HD11 HG21 ' A' ' 44' ' ' ILE . 7.3 tt -76.3 -26.54 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.081 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 30' ' ' GLY . 45.1 mmtm -61.72 -43.1 99.51 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 171.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -58.87 -41.71 87.74 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.708 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 HG23 HG21 ' A' ' 73' ' ' ILE . 70.2 mt -66.81 -49.96 69.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.009 0.433 . . . . 0.0 110.852 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -61.89 -28.16 69.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.559 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -80.91 -51.26 8.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 175.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -59.54 -53.16 61.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.088 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.614 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -79.3 -18.51 52.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.403 -179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.43 40.44 60.06 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' A' ' 70' ' ' ALA . 35.5 m -126.81 165.66 24.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.975 0.417 . . . . 0.0 111.159 -174.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 43' ' ' ARG . 13.7 ttm180 -104.87 135.27 46.54 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.512 167.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.558 HG21 HD11 ' A' ' 33' ' ' ILE . 88.9 mt -116.06 108.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -118.53 106.67 12.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.016 -176.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE1' HD11 ' A' ' 26' ' ' ILE . 87.1 m-85 -65.15 136.4 56.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.78 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -82.51 150.97 26.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.931 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 13.1 mm100 -107.59 168.19 9.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.019 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER 71.55 -72.72 0.11 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.858 0.724 . . . . 0.0 111.681 -179.072 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -87.11 119.54 27.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.904 0.859 . . . . 0.0 111.577 -176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -151.1 113.58 0.59 Allowed Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -67.3 95.37 0.43 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -170.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 66.67 -132.05 31.87 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 1.7 Cg_endo -80.2 3.18 7.87 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.955 2.437 . . . . 0.0 111.928 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 18' ' ' PRO . 42.2 mt-10 -115.73 139.06 50.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.471 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttm -92.17 172.61 8.31 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.76 114.65 47.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.434 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -85.9 140.48 30.34 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 171.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.498 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 24.2 t60 -116.24 108.88 16.67 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.48 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.901 HD12 HD11 ' A' ' 13' ' ' ILE . 55.0 mt -88.3 148.8 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.468 -0.787 . . . . 0.0 108.886 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.1 mmt -122.27 147.38 46.3 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -169.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.61 -137.88 11.17 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.515 174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.683 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 56.6 Cg_endo -91.09 147.59 3.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.436 2.757 . . . . 0.0 112.56 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -52.11 -48.88 19.41 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.784 2.323 . . . . 0.0 113.318 -172.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -63.91 -43.3 96.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.683 ' HB3' ' HG2' ' A' ' 63' ' ' PRO . 2.8 tpp180 -68.37 -37.23 80.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.149 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 96.4 m -59.06 -42.42 90.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.165 174.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.54 -31.7 67.31 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.246 -0.182 . . . . 0.0 111.294 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -62.73 -42.44 99.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.433 0.635 . . . . 0.0 109.304 174.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.496 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -72.84 -34.78 67.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.603 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.04 90.44 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.677 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -60.57 -47.6 85.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.434 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 40' ' ' ALA . 70.4 mt -56.7 -49.01 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.156 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.684 HD12 HD11 ' A' ' 60' ' ' ILE . 78.8 mt -67.81 -46.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.987 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -60.68 -44.18 96.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.094 -177.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -60.84 -40.89 94.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.818 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.96 -46.48 90.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.945 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 58.1 mt -68.17 -27.74 66.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.054 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -58.19 -39.51 79.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.638 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.4 t -72.09 -19.76 61.75 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.06 0.457 . . . . 0.0 110.652 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.449 HD11 HG21 ' A' ' 24' ' ' VAL . 70.2 mt -97.47 19.08 13.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.984 0.421 . . . . 0.0 111.371 -177.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 78' ' ' LEU . 1.2 ptp180 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.507 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.804 -0.518 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.832 HD11 HD12 ' A' ' 60' ' ' ILE . 39.1 pt -120.69 157.02 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.08 0.467 . . . . 0.0 111.088 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -110.22 114.8 28.56 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.74 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -118.42 126.15 27.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 11.4 Cg_exo -69.45 113.69 3.41 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 123.15 2.567 . . . . 0.0 112.237 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 17' ' ' VAL . 9.1 p -119.14 114.41 35.03 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.208 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.25 133.42 58.01 Favored 'Trans proline' 0 N--CA 1.469 0.044 0 C-N-CA 122.773 2.315 . . . . 0.0 112.236 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -62.71 -13.3 30.85 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -85.59 -45.04 12.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.101 0.477 . . . . 0.0 109.877 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.48 ' HB3' HD12 ' A' ' 81' ' ' LEU . 14.4 m -79.1 -22.43 45.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.671 -177.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.1 p -62.71 -24.49 35.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.648 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.07 -35.27 88.78 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.688 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -75.96 -31.33 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 110.127 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.2 t -63.38 -38.02 81.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.938 177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.08 -51.24 17.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.348 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.05 -133.57 14.43 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.651 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -108.17 127.14 53.56 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.401 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 65.3 m 62.37 6.45 1.92 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.882 0.473 . . . . 0.0 111.781 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.658 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 80.93 8.04 87.91 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.231 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' HG2' ' HB2' ' A' ' 29' ' ' SER . 60.4 mm-40 -54.03 -32.54 54.72 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.724 0.297 . . . . 0.0 111.477 -176.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 17.5 tpt -70.13 -46.39 64.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.404 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 36' ' ' ILE . 6.3 tt -73.76 -23.95 19.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.139 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.658 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 96.1 mttt -65.11 -38.24 90.03 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -64.17 -44.22 92.72 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.905 177.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.642 HD12 ' HA ' ' A' ' 33' ' ' ILE . 12.5 mt -58.09 -56.48 15.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.484 0.659 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.43 -23.65 66.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.703 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.39 -45.41 11.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.844 0.354 . . . . 0.0 110.804 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.14 -32.69 69.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -98.36 -10.92 23.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.65 179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.54 34.06 88.91 Favored Glycine 0 C--N 1.328 0.112 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.982 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -113.53 178.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.352 0.596 . . . . 0.0 111.248 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 19.5 tpp180 -119.06 131.49 55.96 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.077 170.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.533 ' CG2' HD11 ' A' ' 33' ' ' ILE . 89.7 mt -119.46 108.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 123.682 0.614 . . . . 0.0 109.761 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -124.11 118.38 26.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.802 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.522 ' HB3' ' HE2' ' A' ' 56' ' ' LYS . 22.1 m-85 -76.99 109.67 11.0 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 41.6 mtpt -61.43 112.72 2.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.64 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -76.34 -6.93 53.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.659 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.59 -42.43 6.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.881 0.372 . . . . 0.0 110.062 177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 1.4 m-20 -72.26 86.7 1.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.86 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.68 87.74 0.42 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.977 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.6 p -75.93 85.62 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.0 110.798 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.26 -126.28 35.7 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.873 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -84.42 8.91 4.36 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.777 2.318 . . . . 0.0 112.419 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -117.15 123.11 45.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.107 0.479 . . . . 0.0 110.896 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.522 ' HE2' ' HB3' ' A' ' 46' ' ' PHE . 53.8 mtpt -83.96 163.95 19.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.97 112.25 39.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.617 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.74 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -78.39 135.6 37.48 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.411 ' HD2' ' O ' ' A' ' 13' ' ' ILE . 11.7 t-160 -107.47 101.48 10.82 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.832 HD12 HD11 ' A' ' 13' ' ' ILE . 34.9 mt -89.76 135.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.8 mtm -141.6 169.69 17.13 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.374 -0.53 . . . . 0.0 111.816 -171.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 120.08 -124.34 5.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -174.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 3.3 Cg_exo -80.9 133.07 8.91 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.066 2.511 . . . . 0.0 110.74 173.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 76.2 Cg_exo -51.64 -40.92 63.63 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.889 3.059 . . . . 0.0 114.077 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -78.28 -38.18 43.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.37 0.605 . . . . 0.0 109.946 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 12.2 tpp85 -62.57 -32.85 73.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.797 178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 72.0 m -58.83 -44.24 90.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.491 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.27 -25.75 51.75 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.559 0.219 . . . . 0.0 111.221 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -73.07 -40.2 65.25 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.05 -30.02 68.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.858 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.436 ' HB2' HD11 ' A' ' 13' ' ' ILE . . . -60.25 -36.31 77.47 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.494 174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -68.64 -40.28 80.36 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.331 178.448 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.473 HG21 HG23 ' A' ' 36' ' ' ILE . 65.3 mt -56.73 -46.26 83.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.418 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.595 HD12 HD11 ' A' ' 60' ' ' ILE . 73.6 mt -72.03 -45.06 64.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.351 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -59.83 -44.82 93.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.084 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.424 ' HB2' ' HE ' ' A' ' 72' ' ' ARG . 15.5 t70 -58.75 -40.76 84.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.462 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.4 tt -62.98 -48.85 77.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.756 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 75.8 mt -60.88 -38.58 86.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.043 0.449 . . . . 0.0 110.536 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 82' ' ' ARG . 30.7 tt0 -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -69.62 -14.87 63.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.727 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 21' ' ' SER . 70.9 mt -101.39 4.41 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.511 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 79' ' ' GLN . 15.4 ptp180 . . . . . 0 C--N 1.327 -0.391 0 CA-C-O 121.162 0.506 . . . . 0.0 110.986 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 N-CA-C 112.192 -0.363 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 60' ' ' ILE . 37.6 pt -106.97 160.43 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.924 0.392 . . . . 0.0 111.447 -176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -110.19 105.48 14.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.828 HG23 ' HB3' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -103.41 120.27 52.38 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.092 0.472 . . . . 0.0 112.163 -176.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 16.3 Cg_exo -67.6 103.66 0.85 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.221 2.614 . . . . 0.0 111.497 175.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.29 110.03 53.69 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.103 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 86.2 Cg_exo -47.39 129.0 15.64 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.316 2.677 . . . . 0.0 112.103 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -62.51 -25.56 68.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.483 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.48 -33.43 48.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.939 0.4 . . . . 0.0 110.288 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.442 ' O ' HG23 ' A' ' 25' ' ' VAL . 39.9 m -79.23 -22.08 45.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.386 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.531 HG21 ' HD3' ' A' ' 56' ' ' LYS . 37.8 t -54.95 -34.83 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.855 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -31.38 68.83 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.724 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 t -89.38 -36.37 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.763 0.316 . . . . 0.0 110.417 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' SER . 57.8 t -64.51 -37.52 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.115 178.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.503 HD11 ' CE1' ' A' ' 46' ' ' PHE . 44.2 mm -79.09 -40.49 22.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.657 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.3 -115.11 4.99 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.365 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 31' ' ' GLU . 29.0 ttp85 -133.08 121.32 22.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.2 m 67.8 22.12 8.92 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.505 0.503 . . . . 0.0 110.637 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' ILE . . . 71.37 13.13 73.63 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.499 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 28' ' ' ARG . 0.6 OUTLIER -52.57 -40.99 63.17 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 122.768 0.427 . . . . 0.0 111.32 -175.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 15.2 tpt -77.76 -35.96 51.11 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.494 -175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.592 ' HA ' HD12 ' A' ' 36' ' ' ILE . 8.2 tt -75.94 -28.23 18.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.34 0.59 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mmtt -66.85 -34.7 78.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.661 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 tppt? -59.62 -44.37 93.46 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.944 176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 33' ' ' ILE . 8.8 mt -62.88 -62.82 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.432 178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -52.98 -40.12 63.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.738 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.24 -49.77 58.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.603 -177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -83.75 -26.58 29.56 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.646 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -84.36 -25.59 29.03 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.899 0.38 . . . . 0.0 110.893 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.93 38.48 26.75 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.774 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 70' ' ' ALA . 32.8 m -126.35 173.06 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.307 0.575 . . . . 0.0 111.148 -176.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 17.4 tpt180 -116.63 122.46 44.66 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.167 170.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.514 ' CG2' HD11 ' A' ' 33' ' ' ILE . 67.6 mt -109.6 108.32 25.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -127.36 115.57 19.17 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.736 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CE1' HD11 ' A' ' 26' ' ' ILE . 90.8 m-85 -63.4 128.34 35.41 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.61 98.55 0.18 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.734 -177.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 62.85 13.05 6.22 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.435 -174.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' HA ' ' CB ' ' A' ' 46' ' ' PHE . 31.9 t70 54.76 31.75 16.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.739 0.78 . . . . 0.0 110.428 -171.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -110.16 -179.09 3.69 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.048 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.755 ' HA3' ' HA ' ' A' ' 56' ' ' LYS . . . -157.86 158.69 29.31 Favored Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.82 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.2 p -86.68 52.01 2.39 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.52 0.676 . . . . 0.0 111.051 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' HA3' ' HD3' ' A' ' 54' ' ' PRO . . . 116.47 -119.41 4.5 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.961 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD3' ' HA3' ' A' ' 53' ' ' GLY . 2.8 Cg_exo -76.19 -25.04 10.46 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.125 2.55 . . . . 0.0 112.289 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 40.0 mt-10 -114.56 128.8 56.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.241 0.543 . . . . 0.0 110.925 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.755 ' HA ' ' HA3' ' A' ' 51' ' ' GLY . 63.5 mtpt -84.59 166.08 17.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 45.0 mm -113.26 108.94 26.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.609 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.828 ' HB3' HG23 ' A' ' 15' ' ' VAL . . . -80.98 139.41 35.82 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.868 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -109.83 101.95 10.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.895 HD12 HD11 ' A' ' 13' ' ' ILE . 36.0 mt -89.8 137.65 20.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.0 mtm -138.2 161.97 35.47 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.463 -172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 123.43 -127.81 6.74 Favored Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 114.704 -1.135 . . . . 0.0 111.082 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.597 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.0 Cg_exo -81.01 134.21 9.29 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.145 2.563 . . . . 0.0 110.965 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 78.5 Cg_exo -53.2 -39.6 80.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.638 2.892 . . . . 0.0 113.359 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.54 -37.1 68.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.171 0.51 . . . . 0.0 110.011 177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.646 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 5.5 tpp180 -70.56 -28.86 65.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.664 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 77.2 m -62.17 -41.48 98.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.04 -36.86 72.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.957 0.408 . . . . 0.0 110.597 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.89 -38.5 88.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.847 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.591 ' HB2' HG11 ' A' ' 42' ' ' VAL . . . -72.5 -36.67 68.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.254 177.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.72 79.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.185 175.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -63.51 -44.08 95.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.886 177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 40' ' ' ALA . 54.6 mt -61.06 -50.24 81.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.092 0.472 . . . . 0.0 110.801 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.606 HD12 HD11 ' A' ' 60' ' ' ILE . 83.8 mt -62.96 -43.49 99.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.898 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -68.73 -33.91 74.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.244 0.545 . . . . 0.0 110.778 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 36.1 t70 -64.75 -29.22 70.19 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.493 177.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.74 -46.26 38.53 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 173.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 74' ' ' ILE . 90.4 mt -62.98 -37.7 88.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.231 -176.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 13.5 pt20 -61.65 -27.97 69.05 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -175.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.8 m -75.57 -30.72 59.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.865 0.364 . . . . 0.0 110.7 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.3 mt -87.04 -25.92 23.97 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.211 0.529 . . . . 0.0 110.378 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.146 -175.426 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 67' ' ' CYS . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.889 HD11 HD12 ' A' ' 60' ' ' ILE . 39.9 pt -134.81 164.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.986 0.422 . . . . 0.0 111.224 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -119.8 112.9 19.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -113.72 127.15 27.14 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.714 -170.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 10.8 Cg_exo -71.0 104.91 1.59 Allowed 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.994 2.462 . . . . 0.0 111.88 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -115.46 116.87 41.22 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.149 0.499 . . . . 0.0 110.355 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' O ' HG23 ' A' ' 22' ' ' VAL . 50.4 Cg_exo -56.16 135.09 68.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.808 2.339 . . . . 0.0 111.674 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.806 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 80.9 mtm180 -62.31 -38.38 89.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.33 -174.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -68.25 -30.57 69.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.046 0.45 . . . . 0.0 110.172 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 25' ' ' VAL . 28.1 m -80.0 -26.49 39.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.722 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.41 HG21 ' HD3' ' A' ' 56' ' ' LYS . 44.4 t -55.85 -37.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 176.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.93 -28.91 61.33 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.534 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -89.3 -37.09 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.728 0.299 . . . . 0.0 110.477 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 21' ' ' SER . 48.3 t -63.92 -37.83 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 121.496 0.665 . . . . 0.0 110.233 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 ' CE2' ' A' ' 46' ' ' PHE . 41.2 mm -82.58 -41.19 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.579 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.54 -65.3 3.07 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -173.28 -68.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.5 m -72.79 -35.5 67.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.304 0.574 . . . . 0.0 110.061 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . 119.49 12.21 6.87 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.057 -174.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -59.44 -35.2 73.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.962 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 36' ' ' ILE . 17.1 tpt -67.12 -47.63 70.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.705 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.629 HD11 ' CG2' ' A' ' 44' ' ' ILE . 18.0 tt -71.45 -30.41 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.603 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 30' ' ' GLY . 47.4 mtmt -65.97 -30.05 70.54 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 174.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -77.93 -38.83 44.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.393 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 32' ' ' MET . 80.2 mt -59.1 -47.2 90.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.44 0.638 . . . . 0.0 109.746 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -63.1 -31.92 73.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.021 176.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -70.97 -48.45 53.27 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.34 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.03 -36.33 77.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.423 -176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.599 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -92.53 -22.91 19.28 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.019 0.378 . . . . 0.0 112.019 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.43 37.12 42.17 Favored Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -177.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 70' ' ' ALA . 27.9 m -119.25 -177.3 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.455 0.645 . . . . 0.0 111.485 -174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 38.4 ttt85 -127.8 125.21 39.4 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.198 169.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.629 ' CG2' HD11 ' A' ' 33' ' ' ILE . 61.6 mt -111.14 108.99 26.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.603 178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -102.72 163.65 12.1 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.919 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE2' HD11 ' A' ' 26' ' ' ILE . 84.7 m-85 -105.63 113.32 26.82 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 170.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 49' ' ' ASP . 31.7 tttm -61.43 121.03 11.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.347 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -80.03 31.6 0.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.198 0.523 . . . . 0.0 111.614 -170.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.487 ' OD1' ' HG2' ' A' ' 47' ' ' LYS . 5.5 m-20 -110.34 32.07 5.44 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 69.45 -56.91 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.94 0.896 . . . . 0.0 110.484 -172.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.752 ' HA2' HG12 ' A' ' 57' ' ' ILE . . . 129.46 -86.95 0.31 Allowed Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -176.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.417 ' CG2' ' HB2' ' A' ' 55' ' ' GLU . 13.1 t -145.88 3.27 0.94 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.455 0.645 . . . . 0.0 109.436 172.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.29 -94.3 0.64 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.393 -176.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.92 -16.74 41.38 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.637 2.225 . . . . 0.0 112.033 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HB2' ' CG2' ' A' ' 52' ' ' THR . 56.5 mt-10 -125.42 151.74 45.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.169 177.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.806 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 29.7 mtpp -98.95 174.46 6.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.622 177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.752 HG12 ' HA2' ' A' ' 51' ' ' GLY . 48.6 mm -120.82 110.99 29.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.49 135.55 38.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 171.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -115.99 100.95 8.33 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.889 HD12 HD11 ' A' ' 13' ' ' ILE . 37.1 mt -89.85 146.73 5.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.529 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.3 mtm -142.98 160.78 39.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.262 0.553 . . . . 0.0 112.009 -172.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.74 -125.39 5.54 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.396 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 66' ' ' ARG . 6.1 Cg_exo -81.13 136.22 10.12 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.161 2.574 . . . . 0.0 111.187 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.46 -49.56 17.02 Favored 'Trans proline' 0 CA--C 1.532 0.399 0 C-N-CA 122.574 2.183 . . . . 0.0 112.778 -177.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.86 -41.28 97.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.339 0.59 . . . . 0.0 110.424 178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 4.7 tpp180 -66.46 -31.96 73.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.142 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.458 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 75.3 m -60.96 -44.31 97.49 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.27 -28.5 57.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.572 0.225 . . . . 0.0 110.78 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.504 ' O ' HG13 ' A' ' 73' ' ' ILE . 5.6 t60 -59.34 -46.97 87.15 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 171.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' HB3' HG21 ' A' ' 60' ' ' ILE . . . -69.92 -34.22 73.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.696 178.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -61.71 -42.5 99.03 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.452 0.644 . . . . 0.0 109.663 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.6 ttm105 -67.17 -34.14 76.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.746 -1.115 . . . . 0.0 110.572 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' HIS . 74.8 mt -62.26 -48.6 87.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 110.261 176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 78.9 mt -64.89 -45.49 94.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.626 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -63.16 -36.9 85.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.546 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -60.54 -39.7 88.87 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.703 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.8 tp -66.66 -30.41 70.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.227 0.537 . . . . 0.0 110.458 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.621 HD23 HD12 ' A' ' 81' ' ' LEU . 78.5 mt -75.54 -7.17 53.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.778 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -63.48 -34.14 77.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.055 0.455 . . . . 0.0 110.457 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.9 t -86.7 -14.65 41.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.034 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.621 HD12 HD23 ' A' ' 78' ' ' LEU . 76.3 mt -96.84 -4.05 41.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.141 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.384 176.813 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.233 -0.347 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 60' ' ' ILE . 28.3 pt -110.89 161.51 9.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.17 0.51 . . . . 0.0 111.603 -177.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB3' HG21 ' A' ' 57' ' ' ILE . 17.1 m-20 -122.28 108.31 13.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.908 178.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.52 127.11 27.37 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.478 -170.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 15' ' ' VAL . 7.8 Cg_exo -71.07 106.47 1.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.908 2.406 . . . . 0.0 111.922 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.534 HG23 HD21 ' A' ' 78' ' ' LEU . 6.4 p -116.02 109.68 44.61 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.787 176.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . 80.6 Cg_exo -46.09 129.14 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.5 2.8 . . . . 0.0 112.853 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.633 ' HG2' ' HG3' ' A' ' 56' ' ' LYS . 37.2 mtt180 -59.71 -27.97 66.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.936 -175.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -79.57 -27.8 41.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.928 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.9 m -88.43 -18.35 28.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.915 -177.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 18' ' ' PRO . 37.9 t -52.72 -34.72 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.52 -37.77 68.25 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.6 t -80.96 -38.39 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.912 0.387 . . . . 0.0 110.456 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 33' ' ' ILE . 24.7 t -64.36 -35.46 74.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.221 179.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 46' ' ' PHE . 30.0 mm -78.44 -65.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.24 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.16 86.58 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.421 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' GLY . 37.8 ttm180 60.1 82.99 0.14 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 122.864 0.465 . . . . 0.0 111.808 170.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.5 m 70.59 -25.33 0.16 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.454 0.702 . . . . 0.0 111.491 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' ARG . . . 113.1 74.27 0.66 Allowed Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 -174.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.25 -25.77 11.34 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 36' ' ' ILE . 16.8 tpt -77.06 -51.88 10.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.305 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.635 ' HA ' HD12 ' A' ' 36' ' ' ILE . 11.5 tt -70.23 -27.28 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.004 0.43 . . . . 0.0 110.934 -177.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -76.14 -32.47 59.12 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -62.96 -41.8 99.63 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.32 170.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HA ' ' A' ' 33' ' ' ILE . 94.0 mt -59.78 -52.37 61.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.911 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -56.4 -40.03 73.97 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.562 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -81.03 -17.79 49.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.966 0.412 . . . . 0.0 111.534 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.81 -40.17 17.49 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.328 0.585 . . . . 0.0 110.138 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.488 ' O ' ' HD2' ' A' ' 66' ' ' ARG . . . -96.24 -13.18 23.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.463 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.28 46.44 49.69 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.19 177.35 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.99 0.424 . . . . 0.0 110.705 -174.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.627 ' O ' ' HA ' ' A' ' 60' ' ' ILE . 10.7 ttt180 -126.34 135.37 51.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.357 171.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.625 HG21 HD11 ' A' ' 33' ' ' ILE . 65.4 mt -119.94 108.19 22.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -108.87 119.14 38.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 26' ' ' ILE . 74.0 m-85 -75.47 110.73 10.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 111.366 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 57' ' ' ILE . 22.8 mtpp -76.14 105.0 6.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.245 175.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -80.61 -18.02 49.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.859 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -78.24 137.53 38.16 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.734 -177.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.8 t70 69.92 -75.56 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.425 -176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.47 103.17 0.03 OUTLIER Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.345 -0.389 . . . . 0.0 112.634 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.3 p -69.74 85.96 0.48 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.046 0.45 . . . . 0.0 112.022 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.76 -132.33 40.62 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.817 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.56 10.99 3.06 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.113 2.542 . . . . 0.0 112.529 -176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 43.1 mt-10 -124.6 132.45 53.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.973 0.416 . . . . 0.0 110.777 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.633 ' HG3' ' HG2' ' A' ' 19' ' ' ARG . 41.3 mttp -79.65 165.65 22.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 172.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 47' ' ' LYS . 50.4 mm -111.62 108.34 25.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.501 176.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.632 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -77.61 127.13 31.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -105.92 101.9 11.37 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.627 ' HA ' ' O ' ' A' ' 43' ' ' ARG . 47.8 mt -89.58 143.12 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.508 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 55.7 mtm -144.36 178.49 7.89 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.838 0.352 . . . . 0.0 110.966 -169.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . 107.96 -125.15 7.8 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -173.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.506 ' HB2' ' HB3' ' A' ' 66' ' ' ARG . 2.8 Cg_exo -79.83 133.58 10.31 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.903 2.402 . . . . 0.0 111.1 177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 63' ' ' PRO . 46.1 Cg_exo -56.75 -35.94 98.15 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.463 2.775 . . . . 0.0 113.315 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -81.52 -36.68 28.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.637 0.732 . . . . 0.0 109.816 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.506 ' HB3' ' HB2' ' A' ' 63' ' ' PRO . 7.8 tpp85 -67.91 -39.32 83.58 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.66 -176.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.1 p -58.46 -38.65 77.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -65.88 -36.07 82.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -72.6 -36.46 68.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.077 0.465 . . . . 0.0 110.288 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.32 -31.55 70.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.995 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 13' ' ' ILE . . . -60.45 -37.6 81.49 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.49 175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -72.6 -31.76 65.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.528 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG21 HG23 ' A' ' 36' ' ' ILE . 57.6 mt -57.57 -52.39 57.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-O 121.289 0.566 . . . . 0.0 109.785 174.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.626 HD12 HD11 ' A' ' 60' ' ' ILE . 64.5 mt -67.35 -46.73 83.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.778 -179.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -61.72 -39.38 91.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.158 -176.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -59.51 -44.46 93.14 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.559 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.8 tt -63.79 -44.04 94.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.426 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.534 HD21 HG23 ' A' ' 17' ' ' VAL . 80.0 mt -62.82 -37.57 87.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.111 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.31 -42.08 81.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.817 0.342 . . . . 0.0 111.006 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.4 t -63.48 -34.81 78.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.469 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 75.9 mt -88.75 -19.89 25.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.435 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.722 -174.857 . . . . . . . . 0 0 . 1 stop_ save_